DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2018-01-30	29212900	Li C	2017-12-06	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/29212900	Genome-Wide Gene-Potassium Interaction Analyses on Blood Pressure: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity).	Systolic blood pressure (dietary potassium intake interaction)	1,876 Han Chinese ancestry individuals	775 Chinese ancestry individuals	5q11.2	5	54207072.0	ARL15, HSPB3	ARL15			ENSG00000185305			rs16882447-A	rs16882447	0.0	16882447	intron_variant	0	0.010	1e-09	9.0		0.83	[0.54-1.12] unit decrease	Affymetrix [2216774] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Interleukin-6 (red blood cell fatty acid level interaction)	2,703 individuals		2q24.3	2	163162632.0	RPL7P61	RPL7P61 - NA	ENSG00000230282			9325.0		rs12623456-?	rs12623456	0.0	12623456	intergenic_variant	1	0.016121001	3e-09	8.522878745280337	(DHA)	3.0244586	[2.03-4.02] unit increase	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Interleukin-6 (red blood cell fatty acid level interaction)	2,703 individuals		1q43	1	239648090.0	LOC105373225, CHRM3	CHRM3			ENSG00000133019			rs16838623-?	rs16838623	0.0	16838623	intron_variant	0	0.022262677	5e-08	7.301029995663981	(ALA)	0.8960381	[0.58-1.22] unit increase	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	2,703 individuals		7q33	7	133111563.0	CHCHD3, LOC105375512	RNU6-92P - ST13P7	ENSG00000272393	ENSG00000237821		28631.0	57853.0	rs17424324-?	rs17424324	0.0	17424324	intergenic_variant	1	0.115717954	1e-08	8.0	(DPA_N6)	0.29533502	[0.19-0.4] unit decrease	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Cellular adhesion molecule (red blood cell fatty acid level interaction)	2,703 individuals		14q12	14	27352193.0	CTD-3006G17.2, LOC728755							rs17112580-?	rs17112580	0.0	17112580	intron_variant	1	0.24883988	4e-08	7.397940008672037	(OA)	0.5738272	[0.37-0.78] unit decrease	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	2,703 individuals		3q26.2	3	170654068.0	RP11-373E16.1, CLDN11	SLC7A14-AS1			ENSG00000285051			rs7611820-?	rs7611820	0.0	7611820	non_coding_transcript_exon_variant	0	0.072408487	5e-10	9.30102999566398	(OA)	1.3171505	[0.9-1.73] unit decrease	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	2,703 individuals		13q12.12	13	23959467.0	LOC105370115, ANKRD20A19P, SPATA13	ANKRD20A19P - SPATA13	ENSG00000196593	ENSG00000182957		12685.0	20338.0	rs17079653-?	rs17079653	0.0	17079653	intron_variant	1	0.023286181	3e-08	7.522878745280337	(OA)	15.490697	[10.03-20.95] unit decrease	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	C-reactive protein (red blood cell fatty acid level interaction)	2,703 individuals		20p11.23	20	18797336.0	LINC00652, LOC107985399, LOC100270804, EEF1A1P34, DTD1, C20orf78	LINC00653 - SCP2D1-AS1	ENSG00000273148	ENSG00000149443		1269.0	12392.0	rs3762220-?	rs3762220	0.0	3762220	intergenic_variant	1	0.048384603	3e-08	7.522878745280337	(OA)	5.2152896	[3.37-7.06] unit increase	Affymetrix [2500000] (imputed)	N
2017-09-29	28820441	Veenstra J	2017-08-19	Nutrients	www.ncbi.nlm.nih.gov/pubmed/28820441	Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study.	C-reactive protein (red blood cell fatty acid level interaction)	2,703 individuals		14q21.3	14	49336446.0	LOC105378178	NA - ATP5MC2P2		ENSG00000258401			37520.0	rs7160151-?	rs7160151	0.0	7160151	intergenic_variant	1	0.290015234	3e-08	7.522878745280337	(EDA)	1.189542	[0.77-1.61] unit increase	Affymetrix [2500000] (imputed)	N
2009-12-29	20031564	Ridker PM	2009-02-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031564	Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.	HDL cholesterol	18,245 European ancestry females		16q13	16	56961324.0	SLC12A3, HERPUD1, CETP, NUP93	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		16460.0	599.0	rs1800775-A	rs1800775	0.0	1800775	upstream_gene_variant	1	0.49	4e-93	92.39794000867204		3.09	mg/dL increase	Illumina [~ 318237]	N
2018-01-26	29212897	Salminen A	2017-12-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/29212897	Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis.	Matrix metalloproteinase-8 levels	6,049 Finnish ancestry individuals		1q21.3	1	153362049.0	S100A9, S100A12, S100A8	S100A9 - S100A12	ENSG00000163220	ENSG00000163221		1026.0	11662.0	rs1560833-A	rs1560833	0.0	1560833	intergenic_variant	1	0.28	5e-13	12.30102999566398		0.16	[0.12-0.2] unit decrease	Illumina [at least 2300000] (imputed)	N
2018-01-26	29212897	Salminen A	2017-12-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/29212897	Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis.	Matrix metalloproteinase-8 levels	6,049 Finnish ancestry individuals		1q31.3	1	196673103.0	CFH, CFHR1, LOC100996886, CFHR4, CFHR5, ASPM	CFH			ENSG00000000971			rs800292-A	rs800292	0.0	800292	missense_variant	0	0.3	2e-35	34.69897000433602		0.24	[0.2-0.28] unit decrease	Illumina [at least 2300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	Low density lipoprotein cholesterol levels	2,045 European ancestry individuals		19q13.32	19	44908822.0	NR	APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	NR	1e-17	17.0		0.5648	[0.44-0.69] unit decrease	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	High density lipoprotein cholesterol levels	2,045 European ancestry individuals		16q13	16	56960616.0	NR	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0.0	17231506	upstream_gene_variant	1	NR	1e-12	12.0		0.238	[0.17-0.3] unit increase	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	High density lipoprotein cholesterol levels	2,045 European ancestry individuals		8p21.3	8	20054859.0	NR	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0.0	115849089	intergenic_variant	1	NR	7e-06	5.154901959985743		0.2317	[0.13-0.33] unit increase	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	High density lipoprotein cholesterol levels	2,045 European ancestry individuals		15q21.3	15	58431227.0	NR	ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs1077835-G	rs1077835	0.0	1077835	intron_variant	0	NR	8e-06	5.096910013008056		0.156	[0.088-0.224] unit increase	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	Triglyceride levels	2,045 European ancestry individuals		11q23.3	11	116778201.0	NR	ZPR1			ENSG00000109917			rs964184-C	rs964184	0.0	964184	3_prime_UTR_variant	0	NR	2e-10	9.69897000433602		0.2758	[0.19-0.36] unit decrease	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	Triglyceride levels	2,045 European ancestry individuals		8p21.3	8	19962213.0	NR	LPL			ENSG00000175445			rs328-G	rs328	0.0	328	stop_gained	0	NR	2e-06	5.698970004336019		0.2792	[0.16-0.39] unit decrease	Illumina [~ 9300000] (imputed)	N
2019-10-25	31551469	Tabassum R	2019-09-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31551469	Genetic architecture of human plasma lipidome and its link to cardiovascular disease.	Total cholesterol levels	2,045 European ancestry individuals		19q13.32	19	44908822.0	NR	APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	NR	6e-06	5.221848749616356		0.3107	[0.18-0.44] unit decrease	Illumina [~ 9300000] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		6q25.3	6	159774018.0	ACAT2	ACAT2			ENSG00000120437			rs754054303-G	rs754054303	0.0	754054303	intron_variant	0	NR	1e-06	6.0		0.76	[0.45-1.07] unit decrease	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		6q25.3	6	160590288.0	LPA	LPA			ENSG00000198670			rs185882981-A	rs185882981	0.0	185882981	intron_variant	0	NR	1e-06	6.0		0.779	[0.46-1.09] unit decrease	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.2	13	49500017.0	PHF11, SETDB2-PHF11	PHF11			ENSG00000136147			rs756877701-T	rs756877701	0.0	756877701	intron_variant	0	NR	2e-06	5.698970004336019		1.223	[0.73-1.72] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.2	13	49688450.0	EBPL	EBPL			ENSG00000123179			rs535598832-A	rs535598832	0.0	535598832	intron_variant	0	NR	1e-06	6.0		1.224	[0.73-1.72] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.2	13	50055529.0	DLEU2	DLEU2			ENSG00000231607			rs749307626-C	rs749307626	0.0	749307626	intron_variant	0	NR	1e-06	6.0		1.225	[0.73-1.72] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.3	13	50339520.0	DLEU1	DLEU1			ENSG00000176124			rs767873499-C	rs767873499	0.0	767873499	intron_variant	0	NR	1e-06	6.0		1.235	[0.74-1.73] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals					DLEU1							chr13:51065795-C	chr13:51065795	0.0			1	NR	1e-06	6.0		1.23	[0.73-1.73] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.3	13	50642135.0	BCMS	DLEU7, DLEU1			ENSG00000186047, ENSG00000176124			rs751733865-A	rs751733865	0.0	751733865	intron_variant	0	NR	1e-06	6.0		1.242	[0.74-1.74] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.3	13	50810602.0	DLEU7, DLEU7-AS1	DLEU1, DLEU7			ENSG00000176124, ENSG00000186047			rs780360029-T	rs780360029	0.0	780360029	intron_variant	0	NR	4e-07	6.3979400086720375		1.253	[0.77-1.74] unit increase	Illumina [212505] (imputed)	N
2019-02-07	30108283	Granot-Hershkovitz E	2018-08-14	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30108283	A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure.	Lipoprotein (a) levels	733 Ashkenazi Jewish ancestry individuals (founder/population isolate), 168 Sephardi Jewish, North African Jewish, Middle Eastern, Caucasian and Yemenite Jewish individuals		13q14.3	13	51297734.0	FAM124A	FAM124A - SERPINE3	ENSG00000150510	ENSG00000253309		13495.0	38039.0	rs766345636-C	rs766345636	0.0	766345636	TF_binding_site_variant	1	NR	5e-07	6.301029995663981		1.275	[0.78-1.77] unit increase	Illumina [212505] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	14q31.1	14	79427703.0	NRXN3	NRXN3			ENSG00000021645			rs10136360-G	rs10136360	0.0	10136360	intron_variant	0	0.779217	2e-10	9.69897000433602	(EA)	0.00957388	[0.0066-0.0125] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	20q13.2	20	52644875.0	LINC01524	LINC01524			ENSG00000234948			rs1996928-G	rs1996928	0.0	1996928	intron_variant	0	0.744975	2e-10	9.69897000433602	(EA)	0.00904149	[0.0063-0.0118] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2p15	2	61541286.0	XPO1	XPO1 - RPS29P10	ENSG00000082898	ENSG00000226884		2545.0	48212.0	rs1562308-A	rs1562308	0.0	1562308	intergenic_variant	1	0.395945	2e-10	9.69897000433602	(EA)	0.00801334	[0.0055-0.0105] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	13q21.1	13	55535703.0	MIR2113	MIR5007 - HNF4GP1	ENSG00000264387	ENSG00000228611		361155.0	463497.0	rs9537160-C	rs9537160	0.0	9537160	non_coding_transcript_exon_variant	1	0.721695	2e-10	9.69897000433602	(EA)	0.00877585	[0.0061-0.0115] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	5q21.2	5	104646025.0	RAB9BP1	LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		239904.0	134263.0	rs40465-T	rs40465	0.0	40465	intron_variant	1	0.668425	3e-10	9.522878745280336	(EA)	0.00832914	[0.0057-0.0109] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2p16.3	2	51703026.0	LOC730100	NA - CRYGGP		ENSG00000223710			72232.0	rs1516187-T	rs1516187	0.0	1516187	intron_variant	1	0.131756	3e-10	9.522878745280336	(EA)	0.0115549	[0.008-0.0151] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	11p14.1	11	27771923.0	BDNF	BDNF - CBX3P1	ENSG00000176697	ENSG00000177447		49865.0	34520.0	rs34452566-G	rs34452566	0.0	34452566	intron_variant	1	0.801102	3e-10	9.522878745280336	(EA)	0.00972968	[0.0067-0.0128] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	16p11.2	16	29915150.0	KCTD13	ASPHD1, KCTD13			ENSG00000174939, ENSG00000174943			rs11646118-T	rs11646118	0.0	11646118	non_coding_transcript_exon_variant	0	0.912927	4e-10	9.397940008672036	(EA)	0.013771	[0.0095-0.0181] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2p23.2	2	28198606.0	LOC100505736	BABAM2			ENSG00000158019			rs55807911-T	rs55807911	0.0	55807911	intron_variant	0	0.801572	5e-10	9.30102999566398	(EA)	0.0101316	[0.0069-0.0133] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	6q22.32	6	126491463.0	MIR588	MIR588 - RNU6-200P	ENSG00000207632	ENSG00000201613		6750.0	98824.0	rs10457480-C	rs10457480	0.0	10457480	intron_variant	1	0.697788	7e-10	9.154901959985745	(EA)	0.0083187	[0.0057-0.011] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	8q24.3	8	142280097.0	intergenic	TSNARE1			ENSG00000171045			rs141086701-G	rs141086701	0.0	141086701	stop_gained	0	0.991838	9e-10	9.045757490560677	(EA)	0.0449508	[0.031-0.059] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	14q23.1	14	60558899.0	SIX6	C14orf39 - SALRNA1	ENSG00000179008	ENSG00000258952		43356.0	80317.0	rs4442732-A	rs4442732	0.0	4442732	downstream_gene_variant	1	0.377013	1e-09	9.0	(EA)	0.00779507	[0.0053-0.0103] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	1p32.3	1	54263185.0	SSBP3-AS1	SSBP3			ENSG00000157216			rs643428-C	rs643428	0.0	643428	intron_variant	0	0.393146	2e-09	8.698970004336019	(EA)	0.00768192	[0.0052-0.0102] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	1p31.1	1	72154278.0	NEGR1	NEGR1			ENSG00000172260			rs2422137-C	rs2422137	0.0	2422137	intron_variant	0	0.545986	2e-09	8.698970004336019	(EA)	0.00750123	[0.0051-0.0099] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	5q14.3	5	88387060.0	STK24	TMEM161B-DT			ENSG00000247828			rs7442885-C	rs7442885	0.0	7442885	intron_variant	0	0.786513	2e-09	8.698970004336019	(EA)	0.00905755	[0.0061-0.012] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	9q33.1	9	119402824.0	BRINP1	BRINP1 - NA	ENSG00000078725			33389.0		rs17635778-C	rs17635778	0.0	17635778	intergenic_variant	1	0.82607	3e-09	8.522878745280337	(EA)	0.00974302	[0.0065-0.013] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	11p14.1	11	28824022.0	intergenic	LINC02742			ENSG00000249867			rs2945091-G	rs2945091	0.0	2945091	intron_variant	0	0.440867	9e-09	8.045757490560675	(EA)	0.00716434	[0.0047-0.0096] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	4q23	4	99318162.0	ADH1B	ADH1B			ENSG00000196616			rs1229984-T	rs1229984	0.0	1229984	missense_variant	0	0.0265565	2e-10	9.69897000433602	(EA)	0.0241902	[0.017-0.032] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	10q21.2	10	61706996.0	CABCOCO1	CABCOCO1			ENSG00000183346			rs2393831-A	rs2393831	0.0	2393831	intron_variant	0	0.777106	4e-10	9.397940008672036	(EA)	0.00928993	[0.0064-0.0122] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	1q32.1	1	204607855.0	LRRN2	RNA5SP74 - LRRN2	ENSG00000200408	ENSG00000170382		45334.0	9315.0	rs11584700-A	rs11584700	0.0	11584700	intron_variant	1	0.790836	3e-09	8.522878745280337	(EA)	0.00898544	[0.006-0.012] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2q33.1	2	198099396.0	PLCL1	PLCL1			ENSG00000115896			rs1036336-T	rs1036336	0.0	1036336	intron_variant	0	0.488795	4e-09	8.397940008672037	(EA)	0.00729244	[0.0049-0.0097] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	22q11.23	22	24446484.0	SPECC1L-ADORA2A	ADORA2A-AS1			ENSG00000178803			rs5760425-T	rs5760425	0.0	5760425	intron_variant	0	0.391409	4e-09	8.397940008672037	(EA)	0.00745825	[0.005-0.0099] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	14q22.1	14	50865617.0	ABHD12B	PYGL			ENSG00000100504			rs17123039-T	rs17123039	0.0	17123039	non_coding_transcript_exon_variant	0	0.581866	8e-09	8.096910013008056	(EA)	0.00725318	[0.0048-0.0097] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	16q24.1	16	85302129.0	MIR5093	GSE1			ENSG00000131149			rs2968426-G	rs2968426	0.0	2968426	intron_variant	0	0.255075	8e-09	8.096910013008056	(EA)	0.00822175	[0.0054-0.011] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	8p12	8	34467799.0	NOVA1-AS1							rs72634682-G	rs72634682	0.0	72634682	intergenic_variant	1	0.861156	1e-08	8.0	(EA)	0.0102914	[0.0068-0.0138] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	19q13.33	19	48756272.0	MLIP	FGF21			ENSG00000105550			rs838133-A	rs838133	0.0	838133	synonymous_variant	0	0.450813	1.9999999999999998e-25	24.69897000433602	(EA)	0.0133353	[0.011-0.016] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	16q12.2	16	53768582.0	FTO	FTO			ENSG00000140718			rs11642015-C	rs11642015	0.0	11642015	intron_variant	0	0.596261	7.000000000000001e-23	22.154901959985743	(EA)	0.0124196	[0.0099-0.0149] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	15q24.1	15	74735539.0	CYP1A1	CYP1A1 - CYP1A2	ENSG00000140465	ENSG00000140505		10003.0	13306.0	rs2472297-C	rs2472297	0.0	2472297	intergenic_variant	1	0.737388	7.000000000000001e-23	22.154901959985743	(EA)	0.0138093	[0.011-0.017] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-T	rs1260326	0.0	1260326	missense_variant	0	0.395664	1e-20	20.0	(EA)	0.0117743	[0.0093-0.0142] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	19q13.32	19	45677156.0	MIR642A	GIPR			ENSG00000010310			rs34783010-G	rs34783010	0.0	34783010	intron_variant	0	0.805604	8e-18	17.096910013008056	(EA)	0.0134311	[0.01-0.016] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	6p12.3	6	51340779.0	PKHD1	FTH1P5 - PKHD1	ENSG00000230204	ENSG00000170927		427523.0	274520.0	rs2504671-C	rs2504671	0.0	2504671	intergenic_variant	1	0.765267	1e-17	17.0	(EA)	0.0125233	[0.0097-0.0154] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	7p21.1	7	17244953.0	AHR	AHR			ENSG00000106546			rs4410790-T	rs4410790	0.0	4410790	intron_variant	0	0.368736	2e-17	16.69897000433602	(EA)	0.0108651	[0.0084-0.0134] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	12q21.2	12	78379471.0	LINC02424	LINC02424 - SYT1	ENSG00000258220	ENSG00000067715		19725.0	484522.0	rs12581220-C	rs12581220	0.0	12581220	intron_variant	1	0.685554	1e-14	14.0	(EA)	0.01034	[0.0077-0.013] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	10p12.31	10	21744013.0	LINC01114	MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383.0	12535.0	rs7072776-A	rs7072776	0.0	7072776	downstream_gene_variant	1	0.278052	7e-14	13.154901959985745	(EA)	0.0103876	[0.0077-0.0131] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	6p12.1	6	54130706.0	LOC105378330	MLIP			ENSG00000146147			rs816366-C	rs816366	0.0	816366	intron_variant	0	0.311488	1e-13	13.0	(EA)	0.00987744	[0.0073-0.0125] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	7q11.23	7	73615107.0	MLXIPL	MLXIPL			ENSG00000009950			rs33951980-C	rs33951980	0.0	33951980	intron_variant	0	0.870155	9e-13	12.045757490560677	(EA)	0.0131522	[0.0095-0.0168] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	11p13	11	31289882.0	DCDC1	DCDC1			ENSG00000170959			rs2761589-C	rs2761589	0.0	2761589	intron_variant	0	0.370028	3e-12	11.522878745280336	(EA)	0.00897032	[0.0065-0.0115] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	3p22.3	3	35742043.0	MIR128-2	ARPP21			ENSG00000172995			rs1513481-C	rs1513481	0.0	1513481	intron_variant	0	0.689494	3e-12	11.522878745280336	(EA)	0.00933683	[0.0067-0.012] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	16p11.2	16	30427988.0	DCTPP1	DCTPP1, ZNF771			ENSG00000179958, ENSG00000179965			rs4788415-T	rs4788415	0.0	4788415	intron_variant	0	0.0966553	5e-12	11.30102999566398	(EA)	0.0148019	[0.011-0.019] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	5q32	5	148710024.0	HTR4	HTR4 - NA	ENSG00000164270			32789.0		rs13163314-C	rs13163314	0.0	13163314	intergenic_variant	1	0.768009	9e-12	11.045757490560677	(EA)	0.0100176	[0.0071-0.0129] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	14q12	14	29311972.0	PRKD1							rs1957111-C	rs1957111	0.0	1957111	intron_variant	1	0.947639	1e-11	11.0	(EA)	0.018951	[0.013-0.024] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	19q13.2	19	40835508.0	CYP2A6	CYP2F2P - CYP2A6	ENSG00000237118	ENSG00000255974		8736.0	8033.0	rs117287096-G	rs117287096	0.0	117287096	intron_variant	1	0.977611	2e-11	10.69897000433602	(EA)	0.0281939	[0.02-0.036] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	10q21.3	10	63431885.0	LINC01415	JMJD1C			ENSG00000171988			rs7924036-G	rs7924036	0.0	7924036	intron_variant	0	0.49654	2e-11	10.69897000433602	(EA)	0.00833585	[0.0059-0.0108] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	18q21.2	18	55729968.0	RARB	TCF4 - LINC01415	ENSG00000196628	ENSG00000267325		65181.0	46759.0	rs784257-T	rs784257	0.0	784257	intron_variant	1	0.187588	3e-11	10.522878745280336	(EA)	0.0105962	[0.0075-0.0137] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	14q12	14	26637960.0	MLLT10	LINC02588						rs7140993-G	rs7140993	0.0	7140993	non_coding_transcript_exon_variant	0	0.738394	4e-11	10.397940008672036	(EA)	0.00933716	[0.0066-0.0121] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	13q32.2	13	98468230.0	LINC01288	STK24			ENSG00000102572			rs7334078-T	rs7334078	0.0	7334078	intron_variant	0	0.717026	4e-11	10.397940008672036	(EA)	0.0090649	[0.0064-0.0118] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	6q16.1	6	97975332.0	FGF21	NA - MIR2113		ENSG00000238367			49199.0	rs9387963-G	rs9387963	0.0	9387963	intron_variant	1	0.442994	5e-11	10.30102999566398	(EA)	0.00819859	[0.0058-0.0106] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	3p24.2	3	25068924.0	TMEM161B-AS1	RARB			ENSG00000077092			rs7619139-T	rs7619139	0.0	7619139	intron_variant	0	0.41119	1e-10	10.0	(EA)	0.00815329	[0.0057-0.0106] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2q11.2	2	100370502.0	CHST10	CYCSP7			ENSG00000269383			rs1437971-A	rs1437971	0.0	1437971	non_coding_transcript_exon_variant	0	0.349361	1e-10	10.0	(EA)	0.00847493	[0.0059-0.011] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary sodium excretion	446,237 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2q24.3	2	165408506.0	SCN2A	SCN2A - CSRNP3	ENSG00000136531	ENSG00000178662		16196.0	61141.0	rs16850592-T	rs16850592	0.0	16850592	regulatory_region_variant	1	0.758963	1e-10	10.0	(EA)	0.00931811	[0.0065-0.0122] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	4p16.3	4	3755653.0	ADRA2C	LINC02171 - LINC02600	ENSG00000250632	ENSG00000250986		77798.0	3095.0	rs13143189-G	rs13143189	0.0	13143189	intergenic_variant	1	0.563914	2e-19	18.69897000433602	(EA)	0.0109685	[0.0086-0.0134] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	15q24.1	15	74735539.0	CYP1A1	CYP1A1 - CYP1A2	ENSG00000140465	ENSG00000140505		10003.0	13306.0	rs2472297-C	rs2472297	0.0	2472297	intergenic_variant	1	0.737346	4e-15	14.397940008672036	(EA)	0.0106514	[0.008-0.0133] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	7p21.1	7	17244953.0	AHR	AHR			ENSG00000106546			rs4410790-T	rs4410790	0.0	4410790	intron_variant	0	0.368691	2e-12	11.69897000433602	(EA)	0.00874545	[0.0063-0.0112] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	5p15.33	5	547781.0	MIR4456	MIR4456 - CEP72	ENSG00000264233	ENSG00000280688		11899.0	64559.0	rs72704791-A	rs72704791	0.0	72704791	intergenic_variant	1	0.808299	3e-12	11.522878745280336	(EA)	0.0106017	[0.0076-0.0136] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	3p24.1	3	27372075.0	SLC4A7	NEK10 - SLC4A7	ENSG00000163491	ENSG00000033867		2615.0	646.0	rs4973766-C	rs4973766	0.0	4973766	intron_variant	1	0.542639	4e-12	11.397940008672036	(EA)	0.00836621	[0.006-0.0107] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	5q21.2	5	104619660.0	RAB9BP1	LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		213539.0	160628.0	rs254023-T	rs254023	0.0	254023	intron_variant	1	0.560891	7e-11	10.154901959985745	(EA)	0.007873	[0.0055-0.0102] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	19p13.11	19	18542034.0	FKBP8	FKBP8			ENSG00000105701			rs10854166-A	rs10854166	0.0	10854166	5_prime_UTR_variant	0	0.518645	6e-10	9.221848749616356	(EA)	0.00752479	[0.0051-0.0099] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	6p12.1	6	54681503.0	FAM83B	RPSAP44 - KRASP1	ENSG00000220773	ENSG00000220635		56015.0	89080.0	rs61375854-T	rs61375854	0.0	61375854	intergenic_variant	1	0.666305	3e-09	8.522878745280337	(EA)	0.00752992	[0.005-0.01] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	2p14	2	68218222.0	PPP3R1	PPP3R1			ENSG00000221823			rs2122127-A	rs2122127	0.0	2122127	intron_variant	0	0.607895	6e-09	8.221848749616356	(EA)	0.00716293	[0.0048-0.0096] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	17p13.1	17	8169779.0	TMEM107	VAMP2 - TMEM107	ENSG00000220205	ENSG00000179029		6233.0	2678.0	rs12944041-G	rs12944041	0.0	12944041	intergenic_variant	1	0.449877	7e-09	8.154901959985743	(EA)	0.00700048	[0.0046-0.0094] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	7q32.3	7	132840387.0	CHCHD3	CHCHD3			ENSG00000106554			rs6467447-C	rs6467447	0.0	6467447	intron_variant	0	0.37173	7e-09	8.154901959985743	(EA)	0.00720042	[0.0048-0.0096] unit increase	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	13q21.32	13	66806036.0	intergenic	PCDH9			ENSG00000184226			rs7319172-G	rs7319172	0.0	7319172	intron_variant	0	0.432439	7e-09	8.154901959985743	(EA)	0.00699888	[0.0046-0.0094] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-09-12	31409800	Pazoki R	2019-08-13	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31409800	GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits.	Urinary potassium excretion	446,230 European ancestry individuals	7,612 African ancestry individuals, 10,095 South Asian ancestry individuals	18q21.2	18	55729968.0	LINC01415	TCF4 - LINC01415	ENSG00000196628	ENSG00000267325		65181.0	46759.0	rs784257-T	rs784257	0.0	784257	intron_variant	1	0.187607	8e-09	8.096910013008056	(EA)	0.00890228	[0.0059-0.0119] unit decrease	Affymetrix [~ 8800000] (imputed)	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	LDL cholesterol	3,681 individuals					PCSK9							exm62588-A	exm62588	0.0			1	0.0177	1e-08	8.0		0.121	[0.08-0.162] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	LDL cholesterol	3,681 individuals					COL6A3							exm279108-A	exm279108	0.0			1	0.0698	1e-06	6.0		0.051	[0.03-0.072] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	LDL cholesterol	3,681 individuals					intergenic							exm2271608-C	exm2271608	0.0			1	0.478	9e-06	5.045757490560675		0.024	[0.013-0.035] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	LDL cholesterol	3,681 individuals					SNAPC2							exm1417699-A	exm1417699	0.0			1	0.0622	5e-07	6.301029995663981		0.06	[0.037-0.083] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	LDL cholesterol	3,681 individuals					TOMM40, APOC1, APOE							exm1479366-A	exm1479366	0.0			1	0.0762	2.9999999999999998e-40	39.52287874528034		0.139	[0.12-0.16] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals		2p24.1	2	21014672.0	APOB	APOB			ENSG00000084674			rs673548-A	rs673548	0.0	673548	intron_variant	0	0.221	2e-06	5.698970004336019		0.053	[0.031-0.075] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals		2p23.3	2	27519736.0	C2orf16, ZNF512, GCKR	GCKR			ENSG00000084734			rs780093-A	rs780093	0.0	780093	intron_variant	0	0.449	7e-12	11.154901959985745		0.064	[0.046-0.082] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals					ZNF512, CCDC121							exm182139-A	exm182139	0.0			1	0.296	7e-07	6.154901959985743		0.05	[0.03-0.07] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals					NEK10							exm296112-G	exm296112	0.0			1	0.0151	9e-06	5.045757490560675		0.17	[0.095-0.245] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals					MLXIPL							exm625685-C	exm625685	0.0			1	0.105	6e-06	5.221848749616356		0.068	[0.039-0.097] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals		8p21.3	8	19986711.0	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		19452.0	126632.0	rs12678919-G	rs12678919	0.0	12678919	intergenic_variant	1	0.11	3e-11	10.522878745280336		0.0992	[0.070-0.128] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals		8q24.13	8	125478730.0	BUD13, ZNF259, RP11-136012.2	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		40327.0	380991.0	rs2954029-T	rs2954029	0.0	2954029	intron_variant	1	0.456	5e-08	7.301029995663981		0.05	[0.032-0.068] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	Triglycerides	3,681 individuals		11q23.3	11	116778201.0	ZNF259, APOA5	ZPR1			ENSG00000109917			rs964184-C	rs964184	0.0	964184	3_prime_UTR_variant	0	0.137	2e-11	10.69897000433602		0.091	[0.064-0.118] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals					COL6A3							exm279108-A	exm279108	0.0			1	0.0698	1e-06	6.0		0.049	[0.029-0.069] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals		8p21.3	8	19986711.0	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		19452.0	126632.0	rs12678919-G	rs12678919	0.0	12678919	intergenic_variant	1	0.11	3e-10	9.522878745280336		0.053	[0.037-0.069] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals		9q31.1	9	104902020.0	ABCA1	ABCA1			ENSG00000165029			rs1883025-A	rs1883025	0.0	1883025	intron_variant	0	0.271	3e-07	6.522878745280337		0.03	[0.018-0.042] unit decrease	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals		15q21.3	15	58434545.0	LIPC	ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-G	rs261334	0.0	261334	intron_variant	0	0.213	6e-07	6.221848749616356		0.031	[0.019-0.043] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals		16q13	16	56955678.0	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		10814.0	6245.0	rs247616-A	rs247616	0.0	247616	intergenic_variant	1	0.31	2.0000000000000002e-23	22.69897000433602		0.057	[0.046-0.068] unit increase	Illumina [101597]	N
2019-10-30	26160806	Proust C	2015-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26160806	Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.	HDL cholesterol	3,681 individuals					SNAPC2							exm1417699-A	exm1417699	0.0			1	0.0622	3e-07	6.522878745280337		0.057	[0.035-0.079] unit decrease	Illumina [101597]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and C-reactive protein levels (pleiotropy)	93,333 individuals		1p22.1	1	92362948.0	RPAP2	RPAP2			ENSG00000122484			rs17519972-?	rs17519972	0.0	17519972	intron_variant	0	NR	9e-08	7.045757490560675			[1.0719-1.1489]	NR [2418544]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and C-reactive protein levels (pleiotropy)	93,333 individuals		1p21.2	1	101157404.0	S1PR1	NA - S1PR1		ENSG00000170989			79461.0	rs17123757-?	rs17123757	0.0	17123757	intergenic_variant	1	NR	3e-06	5.522878745280337			[1.0664-1.1551]	NR [2418544]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and C-reactive protein levels (pleiotropy)	93,333 individuals		3q12.3	3	102029794.0	ZPLD1	LINC02085 - ZPLD1	ENSG00000214407	ENSG00000170044		31868.0	69450.0	rs771767-?	rs771767	0.0	771767	regulatory_region_variant	1	NR	1e-08	8.0			[1.0713-1.1401]	NR [2418544]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		3p14.3	3	56880037.0	ARHGEF3	ARHGEF3			ENSG00000163947			rs1500710-?	rs1500710	0.0	1500710	intron_variant	0	NR	6e-06	5.221848749616356			[0.8841-0.9526]	NR [2487152]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		3q12.3	3	102036894.0	ZPLD1	LINC02085 - ZPLD1	ENSG00000214407	ENSG00000170044		38968.0	62350.0	rs1398607-?	rs1398607	0.0	1398607	regulatory_region_variant	1	NR	1e-08	8.0			[1.0794-1.1687]	NR [2487152]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		3q13.33	3	121824730.0	IQCB1	IQCB1			ENSG00000173226			rs1920296-?	rs1920296	0.0	1920296	intron_variant	0	NR	7e-08	7.154901959985743			[0.8523-0.9336]	NR [2487152]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		13q14.2	13	50267187.0	DLEU1	DLEU1			ENSG00000176124			rs806321-?	rs806321	0.0	806321	intron_variant	0	NR	4e-06	5.3979400086720375			[1.0466-1.1118]	NR [2487152]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		19q13.32	19	47158236.0	SAE1	SAE1			ENSG00000142230			rs307896-?	rs307896	0.0	307896	intron_variant	0	NR	1e-06	6.0			[1.0574-1.1396]	NR [2487152]	N
2019-02-12	26920376	Wang Y	2016-02-26	Mult Scler	www.ncbi.nlm.nih.gov/pubmed/26920376	Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.	Multiple sclerosis and triglyceride levels (pleiotropy)	215,725 individuals		22q12.3	22	36872513.0	NCF4	NCF4			ENSG00000100365			rs2072711-?	rs2072711	0.0	2072711	intron_variant	0	NR	4e-06	5.3979400086720375			[1.0615-1.1455]	NR [2487152]	N
2015-05-29	25214527	Dube MP	2014-09-11	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/25214527	CKM and LILRB5 are associated with serum levels of creatine kinase.	Creatine kinase levels in statin users	3,412 European ancestry individuals	3,389 European ancestry individuals	19q13.32	19	45317925.0	CKM	CKM			ENSG00000104879			rs11559024-G	rs11559024	0.0	11559024	missense_variant	0	0.010	4e-16	15.397940008672036		0.501	[0.38-0.62] unit decrease	Illumina [3232779] (imputed)	N
2015-05-29	25214527	Dube MP	2014-09-11	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/25214527	CKM and LILRB5 are associated with serum levels of creatine kinase.	Creatine kinase levels in statin users	3,412 European ancestry individuals	3,389 European ancestry individuals	19q13.42	19	54249685.0	LILRB5	LILRB5			ENSG00000105609			rs2361797-T	rs2361797	0.0	2361797	3_prime_UTR_variant	0	0.443	2e-10	9.69897000433602		0.08	[0.055-0.105] unit increase	Illumina [3232779] (imputed)	N
2016-10-06	26516778	Bis JC	2015-10-30	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26516778	Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Up to 3,527 European ancestry individuals with cardiovascular disease, up to 11,848 European ancestry individuals without cardiovascular disease	Up to 1,751 European ancestry individuals with cardiovascular disease, up to 1,267 African American ancestry individuals with cardiovascular disease, up to 2,874 African American ancestry individuals without cardiovascular disease	2q37.2	2	236081413.0	CENTG2	AGAP1			ENSG00000157985			rs3768939-A	rs3768939	0.0	3768939	intron_variant	0	0.19	9e-07	6.045757490560675	(EA)	0.35	unit decrease	Affymetrix, Illumina [1807456] (imputed)	N
2016-10-06	26516778	Bis JC	2015-10-30	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26516778	Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Up to 3,527 European ancestry individuals with cardiovascular disease, up to 11,848 European ancestry individuals without cardiovascular disease	Up to 1,751 European ancestry individuals with cardiovascular disease, up to 1,267 African American ancestry individuals with cardiovascular disease, up to 2,874 African American ancestry individuals without cardiovascular disease	6p21.2	6	39147637.0	C6orf64	SAYSD1 - KCNK5	ENSG00000112167	ENSG00000164626		32451.0	41334.0	rs7751419-T	rs7751419	0.0	7751419	intergenic_variant	1	0.29	3e-06	5.522878745280337	(EA)	0.26	unit increase	Affymetrix, Illumina [1807456] (imputed)	N
2016-10-06	26516778	Bis JC	2015-10-30	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26516778	Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.	Myocardial infarction in hypertension (calcium channel blocker interaction)	Up to 2,114 European ancestry individuals with myocardial infarction, up to 13,261 European ancestry individuals without myocardial infarction	Up to 1,171 European ancestry individuals with myocardial infarction	19q12	19	30694303.0	ZNF536	ZNF536			ENSG00000198597			rs16964543-T	rs16964543	0.0	16964543	intron_variant	0	0.67	4e-07	6.3979400086720375		0.37	unit decrease	Affymetrix, Illumina [1194322] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	1p32.3	1	55033483.0	PCSK9	BSND - PCSK9	ENSG00000162399	ENSG00000169174		16311.0	5964.0	rs7525649-T	rs7525649	0.0	7525649	intergenic_variant	1	0.72	2e-10	9.69897000433602		2.212	[1.55-2.88] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	1p31.3	1	62584148.0	ANGPTL3	DOCK7			ENSG00000116641			rs12042319-G	rs12042319	0.0	12042319	3_prime_UTR_variant	0	0.81	5e-08	7.301029995663981		2.229	[1.44-3.02] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	2p24.1	2	21111411.0	APOB	APOB - TDRD15	ENSG00000084674	ENSG00000218819		67338.0	12557.0	rs312949-C	rs312949	0.0	312949	intergenic_variant	1	0.28	7e-06	5.154901959985743		1.594	[0.9-2.29] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	2p23.3	2	27525757.0	GCKR	GCKR - C2orf16	ENSG00000084734	ENSG00000221843		2073.0	11629.0	rs1260333-A	rs1260333	0.0	1260333	downstream_gene_variant	1	0.52	3e-08	7.522878745280337		1.773	[1.15-2.4] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	5q13.3	5	75308917.0	HMGCR	ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		72006.0	27412.0	rs6871667-A	rs6871667	0.0	6871667	intergenic_variant	1	0.55	8e-12	11.096910013008056		2.214	[1.58-2.85] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	6p21.33	6	31272702.0	HLA-C	HLA-C - USP8P1	ENSG00000228299	ENSG00000236374		572.0	2870.0	rs9357121-T	rs9357121	0.0	9357121	intron_variant	1	0.85	2e-10	9.69897000433602		2.062	[1.42-2.71] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	8q24.13	8	125478730.0	TRIB1	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		40327.0	380991.0	rs2954029-A	rs2954029	0.0	2954029	intron_variant	1	0.41	1e-11	11.0		2.218	[1.58-2.85] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	9q31.1	9	104903458.0	ABCA1	ABCA1			ENSG00000165029			rs2575876-G	rs2575876	0.0	2575876	intron_variant	0	0.79	1e-16	16.0		3.224	[2.46-3.99] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	9q34.2	9	133278724.0	ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		2700.0	59004.0	rs579459-C	rs579459	0.0	579459	upstream_gene_variant	1	0.2	3e-10	9.522878745280336		3.038	[2.1-3.98] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0.0	1800588	intron_variant	0	0.38	8e-16	15.096910013008056		2.719	[2.07-3.37] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	16q13	16	56959412.0	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		14548.0	2511.0	rs3764261-A	rs3764261	0.0	3764261	upstream_gene_variant	1	0.17	1e-22	22.0		4.439	[3.56-5.32] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	16q22.2	16	71991178.0	HPR	RPL39P31, PKD1L3			ENSG00000242176, ENSG00000277481			rs12927205-A	rs12927205	0.0	12927205	non_coding_transcript_exon_variant	0	0.74	7e-07	6.154901959985743		1.784	[1.07-2.49] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	17q24.3	17	69142737.0	ABCA8	ABCA6 - ABCA10	ENSG00000154262	ENSG00000154263		842.0	4477.0	rs12453914-A	rs12453914	0.0	12453914	intergenic_variant	1	0.42	2e-06	5.698970004336019		1.237	[0.69-1.78] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Cholesterol, total	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	19p13.2	19	11139463.0	LDLR	SPC24			ENSG00000161888			rs7258950-G	rs7258950	0.0	7258950	intron_variant	0	0.78	2e-16	15.69897000433602		3.168	[2.42-3.92] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	1p32.3	1	55033483.0	PCSK9	BSND - PCSK9	ENSG00000162399	ENSG00000169174		16311.0	5964.0	rs7525649-T	rs7525649	0.0	7525649	intergenic_variant	1	0.72	3e-11	10.522878745280336		1.954	[1.39-2.52] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	2p24.1	2	21111411.0	APOB	APOB - TDRD15	ENSG00000084674	ENSG00000218819		67338.0	12557.0	rs312949-C	rs312949	0.0	312949	intergenic_variant	1	0.28	3e-06	5.522878745280337		1.415	[0.82-2.01] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	5q13.3	5	75308917.0	HMGCR	ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		72006.0	27412.0	rs6871667-A	rs6871667	0.0	6871667	intergenic_variant	1	0.55	7e-13	12.154901959985745		2.014	[1.47-2.56] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	6p21.33	6	31272702.0	HLA-C	HLA-C - USP8P1	ENSG00000228299	ENSG00000236374		572.0	2870.0	rs9357121-T	rs9357121	0.0	9357121	intron_variant	1	0.85	3e-10	9.522878745280336		1.842	[1.25-2.43] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	9q34.2	9	133278724.0	ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		2700.0	59004.0	rs579459-C	rs579459	0.0	579459	upstream_gene_variant	1	0.2	6e-13	12.221848749616356		2.853	[2.08-3.62] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	16q22.2	16	71991178.0	HPR	RPL39P31, PKD1L3			ENSG00000242176, ENSG00000277481			rs12927205-A	rs12927205	0.0	12927205	non_coding_transcript_exon_variant	0	0.74	8e-07	6.096910013008056		1.462	[0.86-2.07] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	LDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	19p13.2	19	11139463.0	LDLR	SPC24			ENSG00000161888			rs7258950-G	rs7258950	0.0	7258950	intron_variant	0	0.78	1.0000000000000001e-24	24.0		3.387	[2.75-4.03] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	8p21.3	8	19986711.0	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		19452.0	126632.0	rs12678919-A	rs12678919	0.0	12678919	intergenic_variant	1	0.91	2e-21	20.69897000433602		1.954	[1.55-2.35] unit decrease	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	11q23.3	11	116792991.0	APOA1, APOC3, APOA4, APOA5	APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-G	rs662799	0.0	662799	upstream_gene_variant	1	0.28	2e-85	84.69897000433602		2.516	[2.27-2.76] unit decrease	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0.0	1800588	intron_variant	0	0.38	2.0000000000000003e-34	33.69897000433602		1.462	[1.23-1.69] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	16q13	16	56959412.0	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		14548.0	2511.0	rs3764261-A	rs3764261	0.0	3764261	upstream_gene_variant	1	0.17	1.9999999999999998e-97	96.69897000433602		3.353	[3.04-3.66] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	18q21.1	18	49580782.0	LIPG	LIPG			ENSG00000101670			rs12970066-G	rs12970066	0.0	12970066	intron_variant	0	0.28	2e-09	8.698970004336019		0.784	[0.53-1.03] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	HDL cholesterol	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	9q31.1	9	104903458.0	ABCA1	ABCA1			ENSG00000165029			rs2575876-G	rs2575876	0.0	2575876	intron_variant	0	0.79	4e-13	12.397940008672036		1.006	[0.73-1.28] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	2p23.3	2	27525757.0	GCKR	GCKR - C2orf16	ENSG00000084734	ENSG00000221843		2073.0	11629.0	rs1260333-A	rs1260333	0.0	1260333	downstream_gene_variant	1	0.52	2e-21	20.69897000433602		0.022	[0.018-0.026] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	1p31.3	1	62584148.0	ANGPTL3	DOCK7			ENSG00000116641			rs12042319-G	rs12042319	0.0	12042319	3_prime_UTR_variant	0	0.81	8e-12	11.096910013008056		0.02	[0.014-0.026] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	7q11.23	7	73448919.0	MLXIPL	BAZ1B			ENSG00000009954			rs13231516-T	rs13231516	0.0	13231516	intron_variant	0	0.87	1e-16	16.0		0.03	[0.022-0.038] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	8p21.3	8	19986711.0	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		19452.0	126632.0	rs12678919-A	rs12678919	0.0	12678919	intergenic_variant	1	0.91	3.9999999999999997e-25	24.39794000867204		0.044	[0.036-0.052] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	8q24.13	8	125478730.0	TRIB1	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		40327.0	380991.0	rs2954029-A	rs2954029	0.0	2954029	intron_variant	1	0.41	2e-20	19.69897000433602		0.023	[0.019-0.027] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	11q23.3	11	116792991.0	APOA1, APOC3, APOA4, APOA5	APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-G	rs662799	0.0	662799	upstream_gene_variant	1	0.28	4e-213	212.39794000867204		0.081	[0.075-0.087] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	12q24.13	12	112379979.0	ALDH2	HECTD4			ENSG00000173064			rs11066280-T	rs11066280	0.0	11066280	intron_variant	0	0.83	1e-08	8.0		0.017	[0.011-0.023] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0.0	1800588	intron_variant	0	0.38	3e-14	13.522878745280336		0.018	[0.014-0.022] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2016-10-07	26582766	Lu X	2015-11-18	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/26582766	Genetic Susceptibility to Lipid Levels and Lipid Change Over Time and Risk of Incident Hyperlipidemia in Chinese Populations.	Triglycerides	8,344 Han Chinese ancestry individuals	14,739 Han Chinese ancestry individuals	19q13.32	19	44892962.0	APOE	TOMM40			ENSG00000130204			rs157582-T	rs157582	0.0	157582	intron_variant	0	0.18	4e-22	21.39794000867204		0.078	[0.062-0.094] unit increase	Affymetrix, Illumina [2573667] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	10,874 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		1p13.3	1	109274570.0	CELSR2	CELSR2			ENSG00000143126			rs7528419-G	rs7528419	0.0	7528419	3_prime_UTR_variant	0	0.17701	8e-09	8.096910013008056		0.4227	[-0.5965-1.4419] unit decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	10,874 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		6p12.3	6	46709361.0	PLA2G7	PLA2G7			ENSG00000146070			rs76863441-A	rs76863441	0.0	76863441	missense_variant	0	0.01019	8e-47	46.096910013008056		0.2355	[-4.3313-4.8023] unit decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	10,874 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	0.06071	2e-27	26.69897000433602		0.04	[-1.5672-1.6472] unit decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		12q24.31	12	124822507.0	SCARB1	SCARB1			ENSG00000073060			rs11057830-A	rs11057830	0.0	11057830	intron_variant	0	0.14991	7e-09	8.154901959985743		3.67	[2.44-4.9] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		1p13.3	1	109274968.0	CELSR2	CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	0.17646	4.0000000000000004e-39	38.39794000867204		7.44	[6.32-8.56] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		15q15.3	15	43464986.0	TP53BP1	TP53BP1			ENSG00000067369			rs190543502-C	rs190543502	0.0	190543502	intron_variant	0	0.02721	3e-08	7.522878745280337		7.61	[4.92-10.3] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		15q15.3	15	43735849.0	intergenic	CATSPER2P1			ENSG00000205771			rs147233090-T	rs147233090	0.0	147233090	intron_variant	0	0.0299	4e-08	7.397940008672037		7.2	[4.61-9.79] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		15q15.3	15	44000939.0	FRMD5, MFAP1	FRMD5			ENSG00000171877			rs11638352-C	rs11638352	0.0	11638352	intron_variant	0	0.04988	7e-13	12.154901959985745		7.25	[5.27-9.23] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		15q15.3	15	44116203.0	FRMD5	FRMD5			ENSG00000171877			rs2733201-T	rs2733201	0.0	2733201	intron_variant	0	0.07311	6e-13	12.221848749616356		7.3	[5.32-9.28] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		15q15.3	15	44272494.0	intergenic	FRMD5 - GOLM2	ENSG00000171877	ENSG00000166734		77223.0	16225.0	rs144972973-G	rs144972973	0.0	144972973	intergenic_variant	1	0.02588	1e-09	9.0		9.93	[6.74-13.12] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		6p12.3	6	46709361.0	PLA2G7	PLA2G7			ENSG00000146070			rs76863441-A	rs76863441	0.0	76863441	missense_variant	0	0.01019	1e-178	178.0		72.79	[67.79-77.79] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		6q25.3	6	160330499.0	intergenic	SLC22A2 - SLC22A3	ENSG00000112499	ENSG00000146477		52861.0	17879.0	rs9295128-T	rs9295128	0.0	9295128	intergenic_variant	1	0.01694	4e-11	10.397940008672036		11.72	[8.25-15.19] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		6q25.3	6	160589086.0	LPA	LPA			ENSG00000198670			rs10455872-G	rs10455872	0.0	10455872	intron_variant	0	0.05875	4e-13	12.397940008672036		7.22	[5.26-9.18] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		6q26	6	160690668.0	intergenic	LPA - PLG	ENSG00000198670	ENSG00000122194		26393.0	11570.0	rs186696265-T	rs186696265	0.0	186696265	intergenic_variant	1	0.01809	1e-12	12.0		12.07	[8.76-15.38] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	0.06071	8e-78	77.09691001300806		17.11	[15.31-18.91] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		9p13.2	9	37590253.0	RP11-613M10.8, TOMM5, RP11-613M10.9	TOMM5			ENSG00000175768			rs57578064-A	rs57578064	0.0	57578064	intron_variant	0	0.009	1e-08	8.0		32.49	[21.28-43.7] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		9q31.1	9	104634643.0	intergenic	OR13I1P - OR13C1P	ENSG00000273423	ENSG00000235248		3626.0	20720.0	rs189889864-A	rs189889864	0.0	189889864	intergenic_variant	1	0.0002	9e-09	8.045757490560675		91.81	[60.53-123.09] (nmol/min/ml) increase	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		8p21.3	8	19962213.0	LPL	LPL			ENSG00000175445			rs328-G	rs328	0.0	328	stop_gained	0	0.092	2e-06	5.698970004336019		3.7	[2.19-5.21] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2017-11-20	28753643	Yeo A	2017-07-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28753643	Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.	Lipoprotein phospholipase A2 activity in cardiovascular disease	22,156 European, Asian, African, Arabic, Native American, Pacific Islander and other ancestry		19p13.2	19	11091630.0	LDLR	LDLR			ENSG00000130164			rs6511720-T	rs6511720	0.0	6511720	intron_variant	0	0.083	2e-06	5.698970004336019		3.75	[2.20-5.30] (nmol/min/ml) decrease	Affymetrix, Illumina [13572687] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11p15.4	11	10349128.0	ADM	AMPD3			ENSG00000133805			rs1580006-A	rs1580006	0.0	1580006	intron_variant	0	0.54	7e-14	13.154901959985745	(pro‐adrenomedullin)	0.19	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	6p21.32	6	32405408.0	NOTCH4, AGER, ATF6B	TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, BTNL2, BTNL2, BTNL2, BTNL2, BTNL2, BTNL2, BTNL2, BTNL2			ENSG00000230602, ENSG00000228738, ENSG00000229903, ENSG00000225834, ENSG00000226228, ENSG00000224507, ENSG00000225914, ENSG00000226127, ENSG00000225412, ENSG00000204290, ENSG00000225845, ENSG00000229741, ENSG00000224770, ENSG00000229597, ENSG00000224242			rs10947260-C	rs10947260	0.0	10947260	intron_variant	0	0.1	6e-09	8.221848749616356	(interleukin 16)	0.25	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1p36.11	1	26807930.0	PIGV	PIGV - RN7SL165P	ENSG00000060642	ENSG00000241188		7271.0	6892.0	rs35538083-T	rs35538083	0.0	35538083	intergenic_variant	1	0.93	4e-08	7.397940008672037	(xaa‐pro aminopeptidase 2)	0.27	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	13q14.11	13	42019404.0	intergenic	RPS28P8 - DGKH	ENSG00000226093	ENSG00000102780		15767.0	20632.0	rs75416436-G	rs75416436	0.0	75416436	intergenic_variant	1	0.96	1e-07	7.0	(beta-nerve growth factor)	0.5	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	10q11.23	10	48722715.0	MAPK8	WDFY4			ENSG00000128815			rs76519098-C	rs76519098	0.0	76519098	intron_variant	0	0.98	3e-06	5.522878745280337	(growth differentiation factor 15)	0.83	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1p36.22	1	11856038.0	NPPB	NPPA - NPPB	ENSG00000175206	ENSG00000120937		7693.0	1426.0	rs549596-T	rs549596	0.0	549596	downstream_gene_variant	1	0.59	2e-14	13.69897000433602	(natriuretic peptides B)	0.19	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1p36.22	1	11857564.0	NPPB	NPPB			ENSG00000120937			rs352075570-T	rs35207557	0.0	35207557	3_prime_UTR_variant	0	0.6	3e-25	24.522878745280337	(natriuretic peptides B)	0.26	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	5q33.2	5	153870393.0	intergenic	GRIA1 - LINC01861	ENSG00000155511	ENSG00000251183		56524.0	17035.0	rs184243355-T	rs184243355	0.0	184243355	intergenic_variant	1	0.94	2e-08	7.698970004336019	(C-C motif chemokine 3)	0.41	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	6q21	6	108489362.0	FOXO3	AFG1L			ENSG00000135537			rs61598054-C	rs61598054	0.0	61598054	intron_variant	0	0.87	4e-08	7.397940008672037	(beta-nerve growth factor)	0.31	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8p21.3	8	23373385.0	intergenic	LOXL2			ENSG00000134013			rs6557662-A	rs6557662	0.0	6557662	intron_variant	0	0.73	1e-08	8.0	(natriuretic peptides B)	0.23	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	15q25.1	15	81304266.0	IL16	IL16			ENSG00000172349			rs139879640-TCTCA	rs139879640	0.0	139879640	intron_variant	0	0.94	2.9999999999999997e-62	61.52287874528034	(pro‐interleukin‐16)	0.86	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19q13.33	19	48710274.0	F3	FUT2 - MAMSTR	ENSG00000176920	ENSG00000176909		4323.0	2451.0	rs200433550-TA	rs200433550	0.0	200433550	downstream_gene_variant	1	0.58	6e-10	9.221848749616356	(tissue factor)	0.16	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	Xq26.1	X	129737601.0	XPNPEP2	APLN - XPNPEP2	ENSG00000171388	ENSG00000122121		82645.0	1348.0	rs2050011-T	rs2050011	0.0	2050011	upstream_gene_variant	1	0.33	2e-68	67.69897000433602	(xaa‐pro aminopeptidase 2)	0.36	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1q32.1	1	203199346.0	CHI3L1	CHI3L1 - CHIT1	ENSG00000133048	ENSG00000133063		12642.0	13481.0	rs2153101-A	rs2153101	0.0	2153101	intergenic_variant	1	0.21	2e-236	235.698970004336	(YKL40)	0.62	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9q34.2	9	133279427.0	SURF6	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3403.0	58301.0	rs635634-T	rs635634	0.0	635634	upstream_gene_variant	1	0.22	1e-256	256.0	(e-selectin)	0.86	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2q12.1	2	102341256.0	IL1RL1	IL1RL1, IL18R1			ENSG00000115602, ENSG00000115604			rs1420101-C	rs1420101	0.0	1420101	synonymous_variant	0	0.63	6e-254	253.2218487496164	(interleukin 1 receptor-like 1)	0.58	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	4q13.3	4	73807847.0	CXCL6	CXCL8 - CXCL6	ENSG00000169429	ENSG00000124875		64131.0	28793.0	rs72650832-T	rs72650832	0.0	72650832	intergenic_variant	1	0.65	3e-130	129.52287874528034	(C-X-C motif chemokine 6)	0.53	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9q34.2	9	133279427.0	intergenic	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3403.0	58301.0	rs635634-T	rs635634	0.0	635634	upstream_gene_variant	1	0.22	7.000000000000001e-125	124.15490195998576	(platelet endothelial cell adhesion molecule)	0.41	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	20q13.12	20	46113425.0	CD40	RPL13P2 - CD40	ENSG00000213820	ENSG00000101017		13249.0	4853.0	rs1569723-C	rs1569723	0.0	1569723	upstream_gene_variant	1	0.28	2e-121	120.69897000433602	(tumor necrosis factor, receptor superfamily, member 5)	0.39	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q22.2	11	102872031.0	MMP12	MMP12			ENSG00000262406			rs17368659-C	rs17368659	0.0	17368659	intron_variant	0	0.85	3e-171	170.52287874528034	(macrophage metalloelastase)	0.82	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	5q33.3	5	157045138.0	HAVCR1	HAVCR1			ENSG00000113249			rs6555820-C	rs6555820	0.0	6555820	intron_variant	0	0.52	2.0000000000000002e-145	144.69897000433602	(hepatitis A virus cellular receptor 1)	0.46	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1q21.3	1	154453788.0	IL6R	IL6R			ENSG00000160712			rs4129267-T	rs4129267	0.0	4129267	intron_variant	0	0.36	2e-297	296.69897000433605	(interleukin 6 receptor subunit alpha)	0.81	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q22.2	11	102828729.0	MMP3	WTAPP1			ENSG00000255282			rs7946057-A	rs7946057	0.0	7946057	intron_variant	0	0.53	5e-160	159.30102999566398	(stromelysin‐1)	0.53	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q22.2	11	102827000.0	MMP1	WTAPP1			ENSG00000255282			rs471994-G	rs471994	0.0	471994	intron_variant	0	0.65	2.0000000000000002e-82	81.69897000433602	(interstitial collagenase)	0.32	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	3p21.31	3	46373484.0	CCR5	CCR5, CCR5AS			ENSG00000160791, ENSG00000223552			rs62625034-G	rs62625034	0.0	62625034	missense_variant	0	0.9	8e-83	82.09691001300806	(CCL4)	0.55	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19p13.3	19	4237070.0	EBI3	EBI3			ENSG00000105246			rs4905-G	rs4905	0.0	4905	synonymous_variant	0	0.3	5e-119	118.30102999566398	(interleukin 27 receptor subunit alpha)	0.49	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	14q22.3	14	55334969.0	LGALS3	FBXO34			ENSG00000178974			rs9323280-A	rs9323280	0.0	9323280	intron_variant	0	0.87	7e-94	93.15490195998576	(galectin-3)	0.77	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2q37.3	2	241776965.0	GAL3ST2	GAL3ST2			ENSG00000154252			rs12469459-A	rs12469459	0.0	12469459	missense_variant	0	0.68	3.0000000000000004e-75	74.52287874528034	(mucin-16)	0.65	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9q34.2	9	133256074.0	RALGDS	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176741-G	rs8176741	0.0	8176741	synonymous_variant	0	0.91	2e-78	77.69897000433602	(angiopoietin-1 receptor)	0.61	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	4q13.3	4	73868964.0	CXCL1	PF4V1 - CXCL1	ENSG00000109272	ENSG00000163739		14481.0	429.0	rs74544699-A	rs74544699	0.0	74544699	upstream_gene_variant	1	0.95	9.999999999999999e-31	30.0	(growth-regulated alpha protein)	0.45	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	20p11.21	20	23046776.0	THBD	THBD			ENSG00000178726			rs3176123-T	rs3176123	0.0	3176123	3_prime_UTR_variant	0	0.81	6e-46	45.22184874961636	(thrombomodulin)	0.3	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	10q23.31	10	89010241.0	FAS	FAS			ENSG00000026103			rs982764-C	rs982764	0.0	982764	intron_variant	0	0.32	2.0000000000000002e-28	27.69897000433602	(tumor necrosis factor receptor superfamily member 6)	0.18	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9p21.2	9	27191570.0	TEK	TEK			ENSG00000120156			rs79250370-G	rs79250370	0.0	79250370	intron_variant	0	0.94	9.999999999999999e-31	30.0	(angiopoietin-1 receptor)	0.58	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	17q12	17	36087290.0	CCL3	CCL3-AS1, CCL3-AS1			ENSG00000282721, ENSG00000277089			rs2188974-A	rs2188974	0.0	2188974	intron_variant	0	0.81	8e-35	34.096910013008056	(C-C motif chemokine 3)	0.31	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	17q12	17	36463294.0	CCL4	TBC1D3JP - ZNHIT3	ENSG00000282656	ENSG00000273611		5759.0	23335.0	rs6607368-A	rs6607368	0.0	6607368	regulatory_region_variant	1	0.8	2e-47	46.69897000433602	(CCL4)	0.51	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11p15.5	11	1748994.0	CTSD	IFITM10			ENSG00000244242			rs111693235-G	rs111693235	0.0	111693235	non_coding_transcript_exon_variant	0	0.71	1e-41	41.0	(cathepsin D)	0.35	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	20q13.12	20	45916409.0	MMP9	PLTP - PCIF1	ENSG00000100979	ENSG00000100982		4254.0	18274.0	rs4810479-T	rs4810479	0.0	4810479	upstream_gene_variant	1	0.74	3e-25	24.522878745280337	(kit ligand)	0.18	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19q13.41	19	51018565.0	KLK11	KLK10			ENSG00000129451			rs62115757-T	rs62115757	0.0	62115757	5_prime_UTR_variant	0	0.79	7e-76	75.15490195998575	(kallikrein-11)	0.77	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	16q21	16	57380089.0	CX3CL1	CX3CL1			ENSG00000006210			rs670211-G	rs670211	0.0	670211	intron_variant	0	0.41	6.9999999999999995e-25	24.154901959985743	(CX3CL1)	0.18	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19p13.3	19	6665009.0	TNFSF14	TNFSF14			ENSG00000125735			rs344560-C	rs344560	0.0	344560	stop_gained	0	0.96	1e-31	31.0	(tumor necrosis factor ligand superfamily member 14)	0.75	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	21q22.3	21	43781951.0	CSTB	CSTB - TMEM97P1	ENSG00000160213	ENSG00000234030		5621.0	1172.0	rs35285321-A	rs35285321	0.0	35285321	upstream_gene_variant	1	0.38	8e-57	56.096910013008056	(cystatin c)	0.43	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q23.1	11	112181471.0	IL18	KCTD9P4, BCO2			ENSG00000214264, ENSG00000197580			rs75649625-G	rs75649625	0.0	75649625	intron_variant	0	0.76	4e-33	32.39794000867204	(interleukin 18)	0.29	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11p15.2	11	14017074.0	SPON1	SPON1			ENSG00000262655			rs1969539-G	rs1969539	0.0	1969539	intron_variant	0	0.5	8.000000000000001e-34	33.096910013008056	(spondin-1)	0.25	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2p23.1	2	31643808.0	intergenic	SRD5A2 - LINC01946	ENSG00000277893	ENSG00000223647		62870.0	150015.0	rs693918-G	rs693918	0.0	693918	intergenic_variant	1	0.55	8e-22	21.096910013008056	(interleukin 18)	0.19	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-T	rs1260326	0.0	1260326	missense_variant	0	0.44	2e-18	17.69897000433602	(follistatin)	0.14	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2p16.1	2	60266350.0	intergenic	RNA5SP94 - MIR4432HG	ENSG00000252726	ENSG00000228590		571481.0	70096.0	rs4672375-G	rs4672375	0.0	4672375	intergenic_variant	1	0.58	8e-19	18.096910013008056	(follistatin)	0.17	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1q32.1	1	204641544.0	REN	LRRN2			ENSG00000170382			rs116661163-C	rs116661163	0.0	116661163	intron_variant	0	0.98	4e-17	16.397940008672037	(renin)	0.72	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	3q26.31	3	172516227.0	intergenic	TNFSF10			ENSG00000121858			rs142552223-G	rs142552223	0.0	142552223	intron_variant	0	0.97	1.9999999999999998e-25	24.69897000433602	(tumor necrosis factor ligand superfamily member 11)	0.81	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	7q11.23	7	76284324.0	HSPB1	SRRM3			ENSG00000177679			rs13236526-A	rs13236526	0.0	13236526	intron_variant	0	0.7	1.9999999999999998e-25	24.69897000433602	(heat shock protein beta-1)	0.36	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19p13.11	19	18365901.0	GDF15	PGPEP1			ENSG00000130517			rs3195944-A	rs3195944	0.0	3195944	3_prime_UTR_variant	0	0.88	6e-15	14.221848749616356	(growth differentiation factor 15)	0.33	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19q13.33	19	48714854.0	FUT2, RASIP1	MAMSTR			ENSG00000176909			rs33988101-T	rs33988101	0.0	33988101	synonymous_variant	0	0.48	6e-10	9.221848749616356	(galectin-3)	0.14	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	14q24.3	14	74935675.0	PGF	RPS6KL1 - PGF	ENSG00000198208	ENSG00000119630		12373.0	6159.0	rs880949-G	rs880949	0.0	880949	intergenic_variant	1	0.58	3e-09	8.522878745280337	(placenta growth factor)	0.17	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	17q22	17	58279141.0	MPO	MPO			ENSG00000005381			rs56378716-G	rs56378716	0.0	56378716	missense_variant	0	0.02	5e-16	15.30102999566398	(myeloperoxidase)	0.5	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	3p21.31	3	45780518.0	intergenic	SLC6A20			ENSG00000163817			rs73062378-T	rs73062378	0.0	73062378	intron_variant	0	0.81	2e-19	18.69897000433602	(CCL4)	0.29	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q12.1	11	57403526.0	intergenic	PRG2 - SLC43A3	ENSG00000186652	ENSG00000134802		12876.0	3428.0	rs140000161-A	rs140000161	0.0	140000161	intron_variant	1	0.91	1e-16	16.0	(pappalysin‐1)	0.37	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8q24.13	8	125487789.0	intergenic	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-C	rs28601761	0.0	28601761	intron_variant	1	0.61	1e-14	14.0	(YKL40)	0.14	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9q34.2	9	133262254.0	MED22	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176693-C	rs8176693	0.0	8176693	intron_variant	0	0.91	2e-16	15.69897000433602	(thrombomodulin)	0.27	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8q24.12	8	119111583.0	TNFRSF11B	COLEC10 - MAL2	ENSG00000184374	ENSG00000147676		3128.0	53451.0	rs7813952-C	rs7813952	0.0	7813952	downstream_gene_variant	1	0.58	1e-21	21.0	(tumor necrosis factor ligand superfamily member 11)	0.22	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19p13.11	19	18175736.0	intergenic	IFI30			ENSG00000216490			rs200373-T	rs200373	0.0	200373	intron_variant	0	0.48	2e-14	13.69897000433602	(cathepsin L1)	0.14	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8q23.1	8	105569300.0	intergenic	ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs6993770-T	rs6993770	0.0	6993770	intron_variant	0	0.27	7e-14	13.154901959985745	(dickkopf‐related protein 1)	0.17	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	16q22.1	16	66917880.0	intergenic	CDH16			ENSG00000166589			rs2271025-G	rs2271025	0.0	2271025	intron_variant	0	0.92	2e-13	12.69897000433602	(Agouti-related protein)	0.36	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	17p13.2	17	4722597.0	CXCL16	ARRB2 - MED11	ENSG00000141480	ENSG00000161920		1098.0	8831.0	rs35186877-G	rs35186877	0.0	35186877	downstream_gene_variant	1	0.81	3e-13	12.522878745280336	(C-C motif chemokine 16)	0.21	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q24.2	11	126431861.0	intergenic	KIRREL3, ST3GAL4			ENSG00000149571, ENSG00000110080			rs35166255-G	rs35166255	0.0	35166255	intron_variant	0	0.96	2e-13	12.69897000433602	(interleukin 1 receptor-like 1)	0.46	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19q13.33	19	48703160.0	FUT2, RASIP1	FUT2			ENSG00000176920			rs492602-G	rs492602	0.0	492602	synonymous_variant	0	0.45	2e-12	11.69897000433602	(stromelysin‐2)	0.14	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	19q13.41	19	50970985.0	KLK6	KLK6 - KLK7	ENSG00000167755	ENSG00000169035		1312.0	5483.0	rs11667946-C	rs11667946	0.0	11667946	intron_variant	1	0.53	3e-18	17.522878745280337	(kallikrein‐6)	0.3	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	11q24.2	11	126357828.0	TIRAP	ST3GAL4			ENSG00000110080			rs7928577-T	rs7928577	0.0	7928577	intron_variant	0	0.08	2e-12	11.69897000433602	(galectin-3)	0.26	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	9q34.2	9	133279294.0	SURF6	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3270.0	58434.0	rs495828-T	rs495828	0.0	495828	upstream_gene_variant	1	0.25	6e-13	12.221848749616356	(tissue factor)	0.17	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1p13.3	1	109960674.0	CSF1	CSF1 - AHCYL1	ENSG00000184371	ENSG00000168710		29682.0	24091.0	rs17610659-T	rs17610659	0.0	17610659	TF_binding_site_variant	1	0.48	1e-12	12.0	(macrophage colony stimulating factor)	0.15	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	10q24.2	10	100045685.0	CWF19L1	CPN1			ENSG00000120054			rs11599750-C	rs11599750	0.0	11599750	intron_variant	0	0.62	3e-13	12.522878745280336	(interleukin 27 receptor subunit alpha)	0.16	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8q24.12	8	119111105.0	TNFRSF11B	COLEC10 - MAL2	ENSG00000184374	ENSG00000147676		2650.0	53929.0	rs6469811-G	rs6469811	0.0	6469811	downstream_gene_variant	1	0.55	3e-13	12.522878745280336	(osteoprotegerin)	0.18	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	1p36.22	1	12183768.0	TNFRSF1B	TNFRSF1B			ENSG00000028137			rs76769120-G	rs76769120	0.0	76769120	intron_variant	0	0.91	7e-14	13.154901959985745	(tumor necrosis factor receptor superfamily member 1B)	0.42	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	16q23.2	16	79700330.0	intergenic	LINC01229			ENSG00000260876			rs11150189-A	rs11150189	0.0	11150189	intron_variant	0	0.69	4e-16	15.397940008672036	(xaa‐pro aminopeptidase 2)	0.2	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	6p21.32	6	32183666.0	AGER	AGER, AGER, AGER, AGER, AGER, AGER, AGER			ENSG00000204305, ENSG00000234729, ENSG00000230514, ENSG00000237405, ENSG00000231268, ENSG00000206320, ENSG00000229058			rs2070600-T	rs2070600	0.0	2070600	missense_variant	0	0.04	5e-12	11.30102999566398	(advanced glycation end-product)	0.37	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	17q11.2	17	28265920.0	intergenic	PPY2P - KRT18P55	ENSG00000265060	ENSG00000265480		17631.0	10066.0	rs241771-T	rs241771	0.0	241771	non_coding_transcript_exon_variant	1	0.45	3e-11	10.522878745280336	(osteoprotegerin)	0.15	unit decrease	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	12q24.31	12	121000508.0	HNF1A, C12orf43	C12orf43, HNF1A			ENSG00000157895, ENSG00000135100			rs1169306-T	rs1169306	0.0	1169306	3_prime_UTR_variant	0	0.38	3e-10	9.522878745280336	(galectin-3)	0.14	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	8q23.1	8	105577019.0	intergenic	ZFPM2, ZFPM2-AS1			ENSG00000169946, ENSG00000251003			rs16873402-C	rs16873402	0.0	16873402	intron_variant	0	0.71	1e-09	9.0	(platelet-derived growth factor receptor beta)	0.15	unit increase	Illumina [5270624] (imputed)	N
2020-03-03	28369058	Folkersen L	2017-04-03	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/28369058	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.	Blood protein levels in cardiovascular risk	3,394 European ancestry individuals	2,639 individuals	2p22.3	2	32636488.0	NLRC4	TTC27			ENSG00000018699			rs7599125-G	rs7599125	0.0	7599125	intron_variant	0	0.44	9e-10	9.045757490560677	(interleukin 18)	0.23	unit decrease	Illumina [5270624] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		10q21.3	10	63229171.0	JMJD1C	JMJD1C			ENSG00000171988			rs7916868-A	rs7916868	0.0	7916868	intron_variant	0	0.49678999	1.9999999999999998e-30	29.69897000433602		0.0240719	[0.02-0.028] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		10q23.33	10	92608110.0	KIF11	KIF11			ENSG00000138160			rs10882087-T	rs10882087	0.0	10882087	intron_variant	0	0.42088899	9e-06	5.045757490560675		0.00947478	[0.0053-0.0136] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		11p15.3	11	13334483.0	ARNTL	ARNTL			ENSG00000133794			rs7947951-A	rs7947951	0.0	7947951	intron_variant	0	0.30858201	6e-14	13.221848749616356		0.0170178	[0.013-0.021] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		12p13.32	12	4275678.0	CCND2	CCND2, CCND2-AS1			ENSG00000118971, ENSG00000255920			rs76895963-G	rs76895963	0.0	76895963	non_coding_transcript_exon_variant	0	0.0206487	4e-13	12.397940008672036		0.0591441	[0.043-0.075] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		16p11.2	16	31103589.0	BCKDK	VKORC1 - BCKDK	ENSG00000167397	ENSG00000103507		7609.0	2518.0	rs62057090-G	rs62057090	0.0	62057090	upstream_gene_variant	1	0.36828899	4e-06	5.3979400086720375		0.0103555	[0.006-0.0147] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		16q22.1	16	69518882.0	intergenic	CYB5B - NFAT5	ENSG00000103018	ENSG00000102908		52618.0	46212.0	rs4783581-G	rs4783581	0.0	4783581	intergenic_variant	1	0.227716	2e-06	5.698970004336019		0.0119389	[0.007-0.0169] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		16q22.1	16	69801198.0	WWP2	WWP2			ENSG00000198373			rs12923438-A	rs12923438	0.0	12923438	intron_variant	0	0.49712399	7e-06	5.154901959985743		0.00947205	[0.0053-0.0136] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		2p16.1	2	59107969.0	LINC01122	LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		44203.0	109739.0	rs7575523-T	rs7575523	0.0	7575523	intron_variant	1	0.397499	1e-06	6.0		0.00447821	[0.0027-0.0063] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		2q24.3	2	164646401.0	COBLL1	GRB14 - COBLL1	ENSG00000115290	ENSG00000082438		24919.0	7223.0	rs78343493-A	rs78343493	0.0	78343493	intergenic_variant	1	0.119101	4.9999999999999996e-26	25.30102999566398		0.014803	[0.012-0.018] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		2q36.3	2	226154700.0	NEU2							rs72979712-T	rs72979712	0.0	72979712	regulatory_region_variant	1	0.0495993	3e-08	7.522878745280337		0.0117773	[0.0076-0.0159] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		3p21.1	3	53105490.0	RFT1	RFT1			ENSG00000163933			rs2564942-C	rs2564942	0.0	2564942	intron_variant	0	0.40582901	1e-08	8.0		0.00530751	[0.0035-0.0071] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		3q22.3	3	136079816.0	PPP2R3A	PPP2R3A			ENSG00000073711			rs34894639-T	rs34894639	0.0	34894639	intron_variant	0	0.230873	1e-14	14.0		0.00838567	[0.0063-0.0105] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		4p16.3	4	960523.0	DGKQ	DGKQ			ENSG00000145214			rs3733349-T	rs3733349	0.0	3733349	3_prime_UTR_variant	0	0.465298	7e-13	12.154901959985745		0.00653048	[0.0048-0.0083] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		4q12	4	54675713.0	KIT	KIT			ENSG00000157404			rs2237025-T	rs2237025	0.0	2237025	intron_variant	0	0.44301	5e-07	6.301029995663981		0.00461859	[0.0028-0.0064] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		5q11.2	5	56498805.0	AC116606.1	LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0.0	30351	regulatory_region_variant	1	0.25520399	2e-17	16.69897000433602		0.00890599	[0.0069-0.011] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		5q31.1	5	133108436.0	HSPA4	HSPA4 - FSTL4	ENSG00000170606	ENSG00000053108		1987.0	88019.0	rs72801474-A	rs72801474	0.0	72801474	downstream_gene_variant	1	0.0930294	1e-06	6.0		0.00758832	[0.0045-0.0107] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		6p24.3	6	7255417.0	RREB1	RREB1 - SSR1	ENSG00000124782	ENSG00000124783		3437.0	12889.0	rs9505097-T	rs9505097	0.0	9505097	downstream_gene_variant	1	0.200192	3e-09	8.522878745280337		0.00677458	[0.0045-0.009] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		6p21.31	6	34221115.0	intergenic	CYCSP55 - HMGA1	ENSG00000214810	ENSG00000137309		1049.0	15758.0	rs9689096-C	rs9689096	0.0	9689096	downstream_gene_variant	1	0.0636817	5e-15	14.30102999566398		0.014666	[0.011-0.018] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		6p21.1	6	43792052.0	ACTG1P9	VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		5565.0	52826.0	rs6458349-G	rs6458349	0.0	6458349	regulatory_region_variant	1	0.27692801	2e-15	14.69897000433602		0.00804642	[0.0061-0.01] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		10q21.3	10	63229171.0	JMJD1C	JMJD1C			ENSG00000171988			rs7916868-A	rs7916868	0.0	7916868	intron_variant	0	0.49678999	2e-09	8.698970004336019		0.00546177	[0.0037-0.0072] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		10q22.3	10	79195310.0	ZMIZ1	ZMIZ1			ENSG00000108175			rs703965-T	rs703965	0.0	703965	intron_variant	0	0.453038	6e-09	8.221848749616356		0.0052878	[0.0035-0.0071] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		11q13.1	11	65793149.0	OVOL1	OVOL1			ENSG00000172818			rs642803-T	rs642803	0.0	642803	intron_variant	0	0.46447399	5e-11	10.30102999566398		0.00597245	[0.0042-0.0078] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		12q13.2	12	55985276.0	RAB5B	RAB5B			ENSG00000111540			rs773114-T	rs773114	0.0	773114	intron_variant	0	0.423641	5e-07	6.301029995663981		0.00461363	[0.0028-0.0064] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		15q15.1	15	41508455.0	LTK	LTK			ENSG00000062524			rs3837681-C	rs3837681	0.0	3837681	intron_variant	0	0.43456599	4e-08	7.397940008672037		0.00505525	[0.0032-0.0069] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		16p11.2	16	29988672.0	TAOK2	TAOK2			ENSG00000149930			rs60683614-T	rs60683614	0.0	60683614	intron_variant	0	0.066665	3e-08	7.522878745280337		0.0100877	[0.0065-0.0137] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		18q11.2	18	23246187.0	CABLES1	TMEM241, CABLES1			ENSG00000134490, ENSG00000134508			rs113949240-A	rs113949240	0.0	113949240	intron_variant	0	0.27459401	1e-06	6.0		0.00502376	[0.003-0.007] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		20q13.2	20	52297692.0	LINC01524	LINC01524			ENSG00000234948			rs12481280-C	rs12481280	0.0	12481280	intron_variant	0	0.36250001	3e-06	5.522878745280337		0.00444139	[0.0026-0.0063] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		20q13.33	20	63707707.0	ZGPAT	ARFRP1, ZGPAT			ENSG00000101246, ENSG00000197114			rs6062498-C	rs6062498	0.0	6062498	intron_variant	0	0.335334	3e-06	5.522878745280337		0.00449944	[0.0026-0.0064] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	High density lipoprotein cholesterol levels	291,107 British ancestry individuals		22q12.1	22	29059700.0	C22orf31	C22orf31			ENSG00000100249			rs5844832-CCTT	rs5844832	1.0	3037524	intron_variant	0	0.43539801	7e-08	7.154901959985743		0.00519092	[0.0033-0.0071] unit increase	Affymetrix [9463307] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		10q23.33	10	94727550.0	TM9SF3, TLL2	CYP2C18			ENSG00000108242			rs35835168-C	rs35835168	0.0	35835168	intron_variant	0	0.827305	4e-35	34.39794000867204		0.453913	[0.38-0.52] unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		10q23.33	10	94842641.0	NPM1P26, TM9SF3, PIK3AP1, RNA5SP324, RPS2P36	CYP2C19			ENSG00000165841			rs28399513-T	rs28399513	0.0	28399513	intron_variant	0	0.831002	1e-33	33.0		0.447534	[0.38-0.52] unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		4q31.23	4	148405084.0	NR3C2	NR3C2			ENSG00000151623			rs35464072-?	rs35464072	0.0	35464072	intron_variant	0	0.45	3e-07	6.522878745280337	(adjusted for CYP2C19*2)	0.14	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		9p21.1	9	28118947.0	LINGO2, LOC646700	LINGO2			ENSG00000174482			rs151216272-A	rs151216272	0.0	151216272	intron_variant	0	0.988336	2e-07	6.698970004336019	(adjusted for CYP2C19*2)	0.635567	[0.4-0.87] unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		5q34	5	163280338.0	intergenic	LINC02240 - NA	ENSG00000260192			37678111.0		rs148114323-?	rs148114323	0.0	148114323	intron_variant	1	0.01	8e-06	5.096910013008056	(adjusted for CYP2C19*2)	0.78	NR unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		10q23.33	10	94234751.0	PLCE1	PLCE1			ENSG00000138193			rs76180455-?	rs76180455	0.0	76180455	intron_variant	0	0.02	7e-06	5.154901959985743	(adjusted for CYP2C19*2)	0.4	NR unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		14q32.2	14	97014377.0	intergenic	VRK1 - NA	ENSG00000100749			59531.0		rs142225302-?	rs142225302	0.0	142225302	intergenic_variant	1	0.02	8e-06	5.096910013008056	(adjusted for CYP2C19*2)	0.5	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		14q32.2	14	97016874.0	intergenic	VRK1 - NA	ENSG00000100749			62028.0		rs140497518-?	rs140497518	0.0	140497518	intergenic_variant	1	0.02	9e-06	5.045757490560675	(adjusted for CYP2C19*2)	0.49	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		6q27	6	165694839.0	GAPDHP72	PDE10A			ENSG00000112541			rs74952072-?	rs74952072	0.0	74952072	intron_variant	0	0.04	1e-06	6.0	(adjusted for CYP2C19*2)	0.32	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		18q12.3	18	43305596.0	intergenic	SYT4 - NA	ENSG00000132872			28061.0		rs61670395-?	rs61670395	0.0	61670395	intergenic_variant	1	0.06	6e-06	5.221848749616356	(adjusted for CYP2C19*2)	0.25	NR unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		6q23.2	6	134418922.0	intergenic	LINC01010			ENSG00000236700			rs9399096-?	rs9399096	0.0	9399096	intron_variant	0	0.07	4e-06	5.3979400086720375	(adjusted for CYP2C19*2)	0.25	NR unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		10p11.21	10	36254386.0	intergenic							rs1219603-?	rs1219603	0.0	1219603	regulatory_region_variant	1	0.15	6e-06	5.221848749616356	(adjusted for CYP2C19*2)	0.18	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		12p12.3	12	19135574.0	PLEKHA5, SRSF11P1	PLEKHA5			ENSG00000052126			rs10505836-?	rs10505836	0.0	10505836	intron_variant	0	0.16	7e-06	5.154901959985743	(adjusted for CYP2C19*2)	0.17	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		13q21.33	13	70175037.0	intergenic	ATXN8OS - NA	ENSG00000230223			3299.0		rs2479921-?	rs2479921	0.0	2479921	intergenic_variant	1	0.18	3e-06	5.522878745280337	(adjusted for CYP2C19*2)	0.16	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		21q22.11	21	32632890.0	SYNJ1	SYNJ1			ENSG00000159082			rs7276140-?	rs7276140	0.0	7276140	intron_variant	0	0.44	4e-06	5.3979400086720375	(adjusted for CYP2C19*2)	0.12	NR unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		13q32.1	13	97266674.0	MBNL2	MBNL2			ENSG00000139793			rs117956006-?	rs117956006	0.0	117956006	intron_variant	0	NR	6e-06	5.221848749616356	(adjusted for CYP2C19*2)	1.19	NR unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		22q12.1	22	27363217.0	MN1	LINC02554 - NA	ENSG00000226741			44716.0		rs57908830-C	rs57908830	0.0	57908830	intron_variant	1	0.973036	3e-06	5.522878745280337	(adjusted for CYP2C19*2)	0.39621	[0.23-0.56] unit increase	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		3p26.1	3	6907543.0	GRM7	GRM7			ENSG00000196277			rs1516568-G	rs1516568	0.0	1516568	intron_variant	0	0.885066	3e-06	5.522878745280337	(adjusted for CYP2C19*2)	0.199481	[0.12-0.28] unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		4q31.23	4	148424435.0	intergenic	NR3C2			ENSG00000151623			rs13118022-T	rs13118022	0.0	13118022	intron_variant	0	0.605871	1e-06	6.0	(adjusted for CYP2C19*2)	0.135527	[0.081-0.19] unit decrease	Illumina [5009928] (imputed)	N
2020-09-04	32472697	Verma SS	2020-05-30	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32472697	Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium (ICPC).	Platelet reactivity in response to clopidogrel treatment	2,592 European ancestry individuals		4q31.23	4	148411792.0	intergenic	NR3C2			ENSG00000151623			rs1546044-T	rs1546044	0.0	1546044	intron_variant	0	0.72993	1e-06	6.0	(adjusted for CYP2C19*2)	0.149735	[0.09-0.209] unit decrease	Illumina [5009928] (imputed)	N
2020-09-21	32649856	Rodriguez BAT	2020-07-04	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32649856	A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling.	Thrombin-induced platelet aggregation	1,184 European ancestry individuals		10q26.11	10	119250744.0	GRK5	GRK5			ENSG00000198873			rs10886430-G	rs10886430	0.0	10886430	intron_variant	0	0.136	2.9999999999999996e-42	41.52287874528034		0.7	[0.6-0.8] unit increase	Affymetrix [7751469] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		11p11.2	11	47255124.0	NR1H3	NR1H3			ENSG00000025434			rs11039149-G	rs11039149	0.0	11039149	intron_variant	0	0.276328	2e-09	8.698970004336019		0.00499234	[0.0034-0.0066] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		2p21	2	43599919.0	THADA	THADA - Y_RNA	ENSG00000115970	ENSG00000264495		3881.0	20959.0	rs6760391-C	rs6760391	0.0	6760391	intergenic_variant	1	0.15274	3e-07	6.522878745280337		0.00529397	[0.0033-0.0073] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		2q24.3	2	164651879.0	COBLL1	GRB14 - COBLL1	ENSG00000115290	ENSG00000082438		30397.0	1745.0	rs10184004-T	rs10184004	0.0	10184004	downstream_gene_variant	1	0.40760899	2e-07	6.698970004336019		0.00390099	[0.0024-0.0054] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		6p24.3	6	7255417.0	RREB1	RREB1 - SSR1	ENSG00000124782	ENSG00000124783		3437.0	12889.0	rs9505097-T	rs9505097	0.0	9505097	downstream_gene_variant	1	0.200192	4e-07	6.3979400086720375		0.00472044	[0.0029-0.0065] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		5q11.2	5	56478786.0	LINC01948	LINC01948			ENSG00000248727			rs61120022-G	rs61120022	0.0	61120022	intron_variant	0	0.142426	7e-06	5.154901959985743		0.00484254	[0.0027-0.0069] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		6p21.32	6	32415273.0	TBC1D22B	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		7510.0	24605.0	rs4959027-A	rs4959027	0.0	4959027	regulatory_region_variant	1	0.234405	5e-06	5.301029995663981		0.00399988	[0.0023-0.0057] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		10q23.33	10	92608110.0	KIF11	KIF11			ENSG00000138160			rs10882087-T	rs10882087	0.0	10882087	intron_variant	0	0.42088899	7e-06	5.154901959985743		0.00338989	[0.0019-0.0049] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		16q12.2	16	53763996.0	FTO	FTO			ENSG00000140718			rs7206790-G	rs7206790	0.0	7206790	intron_variant	0	0.46612301	2e-06	5.698970004336019		0.00356595	[0.0021-0.005] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		17q21.31	17	45108124.0	NMT1	NMT1			ENSG00000136448			rs1989803-G	rs1989803	0.0	1989803	3_prime_UTR_variant	0	0.35666201	3e-06	5.522878745280337		0.00367505	[0.0021-0.0052] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		17q21.32	17	48960236.0	GIP	GIP			ENSG00000159224			rs111970447-G	rs111970447	0.0	111970447	intron_variant	0	0.28115401	7e-06	5.154901959985743		0.00386984	[0.0022-0.0056] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		1q32.3	1	213974546.0	PROX1-AS1	PROX1-AS1			ENSG00000230461			rs7529073-C	rs7529073	0.0	7529073	intron_variant	0	0.45832199	1e-06	6.0		0.0102101	[0.0061-0.0143] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		2p23.3	2	27382830.0	PPM1G	PPM1G			ENSG00000115241			rs35551468-GT	rs35551468	0.0	35551468	intron_variant	0	0.39112899	9.999999999999999e-26	25.0		0.0368347	[0.033-0.041] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		2p23.3	2	27534476.0	C2orf16	GCKR - C2orf16	ENSG00000084734	ENSG00000221843		10792.0	2910.0	rs10181342-G	rs10181342	0.0	10181342	upstream_gene_variant	1	0.21105701	9.999999999999999e-26	25.0		0.038226	[0.033-0.043] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		2q22.3	2	144898465.0	TEX41	TEX41			ENSG00000226674			rs187839668-G	rs187839668	0.0	187839668	intron_variant	0	0.0723574	7e-06	5.154901959985743		0.0184779	[0.01-0.027] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		2q24.3	2	164651879.0	COBLL1	GRB14 - COBLL1	ENSG00000115290	ENSG00000082438		30397.0	1745.0	rs10184004-T	rs10184004	0.0	10184004	downstream_gene_variant	1	0.40760899	1e-33	33.0		0.0258405	[0.022-0.03] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		3q22.3	3	136079816.0	PPP2R3A	PPP2R3A			ENSG00000073711			rs34894639-T	rs34894639	0.0	34894639	intron_variant	0	0.230873	2e-15	14.69897000433602		0.019973	[0.015-0.025] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		3q22.3	3	136214904.0	KRT18P35	MSL2 - PCCB	ENSG00000174579	ENSG00000114054		17663.0	35436.0	rs73222243-C	rs73222243	0.0	73222243	intergenic_variant	1	0.277275	2e-10	9.69897000433602		0.0149498	[0.01-0.02] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		4q12	4	54675713.0	KIT	KIT			ENSG00000157404			rs2237025-T	rs2237025	0.0	2237025	intron_variant	0	0.44301	3e-06	5.522878745280337		0.00994	[0.0058-0.0141] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		4q22.1	4	87309349.0	HSD17B13	HSD17B13			ENSG00000170509			rs111297471-C	rs111297471	0.0	111297471	intron_variant	0	0.32010499	2e-13	12.69897000433602		0.016621	[0.012-0.021] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		5q11.2	5	56498805.0	AC116606.1	LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0.0	30351	regulatory_region_variant	1	0.25520399	7e-21	20.154901959985743		0.0226889	[0.018-0.027] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		5q31.1	5	133108436.0	HSPA4	HSPA4 - FSTL4	ENSG00000170606	ENSG00000053108		1987.0	88019.0	rs72801474-A	rs72801474	0.0	72801474	downstream_gene_variant	1	0.0930294	1e-06	6.0		0.0175136	[0.01-0.025] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		6p21.33	6	31604867.0	TBC1D22B	NCR3 - UQCRHP1	ENSG00000237808	ENSG00000229189		11861.0	6216.0	rs2857594-C	rs2857594	0.0	2857594	intergenic_variant	1	0.148615	4e-11	10.397940008672036		0.01965	[0.014-0.025] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		6p21.31	6	34221115.0	intergenic	CYCSP55 - HMGA1	ENSG00000214810	ENSG00000137309		1049.0	15758.0	rs9689096-C	rs9689096	0.0	9689096	downstream_gene_variant	1	0.0636817	4e-06	5.3979400086720375		0.019882	[0.011-0.028] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		6p21.1	6	43792052.0	ACTG1P9	VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		5565.0	52826.0	rs6458349-G	rs6458349	0.0	6458349	regulatory_region_variant	1	0.27692801	9e-26	25.045757490560675		0.0246054	[0.02-0.029] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Triglyceride levels	291,107 British ancestry individuals		7p13	7	44192179.0	GCK	GCK			ENSG00000106633			rs2971669-T	rs2971669	0.0	2971669	intron_variant	0	0.216938	1e-07	7.0		0.0134101	[0.0084-0.0184] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		7p13	7	44192179.0	GCK	GCK			ENSG00000106633			rs2971669-T	rs2971669	0.0	2971669	intron_variant	0	0.216938	9.999999999999999e-26	25.0		0.0144752	[0.013-0.016] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		12p13.32	12	4275678.0	CCND2	CCND2, CCND2-AS1			ENSG00000118971, ENSG00000255920			rs76895963-G	rs76895963	0.0	76895963	non_coding_transcript_exon_variant	0	0.0206487	1e-16	16.0		0.0238714	[0.018-0.03] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		6p22.3	6	20673649.0	CDKAL1	CDKAL1			ENSG00000145996			rs7451008-C	rs7451008	0.0	7451008	intron_variant	0	0.26216301	3e-14	13.522878745280336		0.00642654	[0.0048-0.0081] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		2p23.3	2	27412596.0	intergenic	PPM1G - NRBP1	ENSG00000115241	ENSG00000115216		3005.0	15194.0	rs1728918-A	rs1728918	0.0	1728918	upstream_gene_variant	1	0.27651	1e-12	12.0		0.00593061	[0.0043-0.0076] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		10q25.2	10	112973123.0	TCF7L2	TCF7L2			ENSG00000148737			rs7917983-C	rs7917983	0.0	7917983	intron_variant	0	0.46544901	4e-11	10.397940008672036		0.00492074	[0.0035-0.0064] unit increase	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		1q32.3	1	214008423.0	PROX1	PROX1			ENSG00000117707			rs60932796-A	rs60932796	0.0	60932796	intron_variant	0	0.24232	4e-10	9.397940008672036		0.00546145	[0.0037-0.0072] unit decrease	Affymetrix [9463307] (imputed)	N
2020-10-08	31928498	Lind L	2020-01-13	Metab Syndr Relat Disord	www.ncbi.nlm.nih.gov/pubmed/31928498	Genetic Determinants of Clustering of Cardiometabolic Risk Factors in U.K. Biobank.	Blood glucose levels	291,107 British ancestry individuals		3q26.2	3	170838930.0	CLDN11	SLC7A14-AS1			ENSG00000285051			rs56375629-A	rs56375629	0.0	56375629	intron_variant	0	0.0879417	2e-10	9.69897000433602		0.00836626	[0.0058-0.0109] unit decrease	Affymetrix [9463307] (imputed)	N
2019-01-16	30305239	Macias-Kauffer LR	2018-10-01	Int J Cardiol	www.ncbi.nlm.nih.gov/pubmed/30305239	Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.	Serum uric acid levels	2153 Mexican ancestry individuals		4p16.1	4	9998877.0	SLC2A9	SLC2A9			ENSG00000109667			rs7678287-A	rs7678287	0.0	7678287	intron_variant	0	NR	1.9999999999999998e-42	41.69897000433602		0.47	[NR] unit decrease	Illumina [865896] (imputed)	N
2019-01-16	30305239	Macias-Kauffer LR	2018-10-01	Int J Cardiol	www.ncbi.nlm.nih.gov/pubmed/30305239	Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.	Serum uric acid levels	2153 Mexican ancestry individuals		4q22.1	4	88131171.0	ABCG2	ABCG2			ENSG00000118777			rs2231142-T	rs2231142	0.0	2231142	missense_variant	0	NR	2e-10	9.69897000433602		0.23	[NR] unit increase	Illumina [865896] (imputed)	N
2019-01-16	30305239	Macias-Kauffer LR	2018-10-01	Int J Cardiol	www.ncbi.nlm.nih.gov/pubmed/30305239	Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.	Serum uric acid levels	2153 Mexican ancestry individuals		4p16.1	4	9939810.0	SLC2A9	SLC2A9			ENSG00000109667			rs7675964-?	rs7675964	0.0	7675964	intron_variant	0	NR	5e-17	16.30102999566398	(Conditioned on rs7678287)			Illumina [865896] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	1p13.3	1	109274968.0		CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	0.215441066	8.999999999999998e-230	229.04575749056067	(GRN)	0.727792	unit decrease	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	1q24.2	1	169594713.0		SELP			ENSG00000174175			rs6136-G	rs6136	0.0	6136	missense_variant	0	0.103419829	4e-87	86.39794000867204	(GMP140)	0.60858214	unit decrease	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	11q23.2	11	113105212.0		NCAM1			ENSG00000149294			rs11214489-C	rs11214489	0.0	11214489	intron_variant	0	0.818	2.9999999999999995e-54	53.52287874528034	(NCAM)	0.368	unit increase	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	0.076340503	1e-52	52.0	(APOB)	0.5368132	unit decrease	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	17q22	17	58270865.0		MPO			ENSG00000005381			rs35897051-G	rs35897051	0.0	35897051	splice_acceptor_variant	0	0.007855753	1.9999999999999998e-42	41.69897000433602	(MPO)	1.4751648	unit decrease	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	6p21.33	6	31518628.0		MICB - PPIAP9	ENSG00000231372	ENSG00000235596		7504.0	852.0	rs149066340-C	rs149066340	0.0	149066340	intergenic_variant	1	0.979	1e-36	36.0	(C2)	0.92	unit increase	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	6p21.33	6	30519527.0		LINC02569 - GNL1	ENSG00000235781	ENSG00000206492		310.0	21854.0	rs143654430-T	rs143654430	0.0	143654430	intergenic_variant	1	0.981	7e-18	17.154901959985743	(C2)	0.639	unit increase	Affymetrix, Illumina [8509364] (imputed)	N
2019-02-13	30111768	Yao C	2018-08-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30111768	Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.	Blood protein levels	6861 European ancestry individuals	4298 European ancestry individuals	1q42.13	1	229532924.0		ABCB10			ENSG00000135776			rs11810108-T	rs11810108	0.0	11810108	intron_variant	0	0.746	2e-12	11.69897000433602	(MPO)	0.152	unit decrease	Affymetrix, Illumina [8509364] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC00693							chr3:28645126-?	chr3:28645126	0.0			1	NR	5e-06	5.301029995663981	(African American, female)	0.61024463	[0.35-0.87] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ZNF717, ROBO2							chr3:76533109-?	chr3:76533109	0.0			1	NR	1e-05	5.0	(African American, female)	0.19939284	[0.11-0.29] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ATP8A1							chr4:42554984-?	chr4:42554984	0.0			1	NR	1e-05	5.0	(African American, female)	0.27031332	[0.15-0.39] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					EPHA5-AS1, MIR1269A							chr4:66578699-?	chr4:66578699	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.45261192	[0.26-0.65] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					NDST4, MIR1973							chr4:117035893-?	chr4:117035893	0.0			1	NR	6e-07	6.221848749616356	(African American, female)	0.45966834	[0.28-0.64] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SORBS2							chr4:186523749-?	chr4:186523749	0.0			1	NR	5e-06	5.301029995663981	(African American, female)	0.45268822	[0.26-0.65] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ADCY2							chr5:7491239-?	chr5:7491239	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.26850262	[0.16-0.38] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC01554							chr5:95194445-?	chr5:95194445	0.0			1	NR	9e-06	5.045757490560675	(African American, female)	0.41493776	[0.23-0.6] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ARHGAP26							chr5:142468009-?	chr5:142468009	0.0			1	NR	7e-06	5.154901959985743	(African American, female)	0.59713584	[0.34-0.86] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					EYS							chr6:65244865-?	chr6:65244865	0.0			1	NR	6e-06	5.221848749616356	(African American, female)	0.44232446	[0.25-0.63] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TNRC18							chr7:5356270-?	chr7:5356270	0.0			1	NR	3e-07	6.522878745280337	(African American, female)	0.9114656	[0.56-1.26] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					FABP12							chr8:82440311-?	chr8:82440311	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.4259458	[0.25-0.6] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TMEM250, LHX3							chr9:139049385-?	chr9:139049385	0.0			1	NR	2e-06	5.698970004336019	(African American, female)	0.22133984	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC100506082, OR52B4							chr11:4264563-?	chr11:4264563	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.3284507	[0.18-0.47] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CWC15							chr11:94700612-?	chr11:94700612	0.0			1	NR	1e-06	6.0	(African American, female)	0.38382387	[0.23-0.54] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC00423, KL							chr13:33559127-?	chr13:33559127	0.0			1	NR	7e-07	6.154901959985743	(African American, female)	0.46760252	[0.28-0.65] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					FARP1							chr13:98984155-?	chr13:98984155	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.4859951	[0.27-0.7] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					C15orf59-AS1, TBC1D21							chr15:74127131-?	chr15:74127131	0.0			1	NR	1e-07	7.0	(African American, female)	0.39744818	[0.25-0.54] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					NPIPB4							chr16:21845724-?	chr16:21845724	0.0			1	NR	9e-06	5.045757490560675	(African American, female)	1.6845852	[0.94-2.43] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RBFOX3							chr17:77239458-?	chr17:77239458	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.66454226	[0.38-0.94] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					KIF16B							chr20:16263600-?	chr20:16263600	0.0			1	NR	2e-06	5.698970004336019	(African American, female)	0.22633435	[0.13-0.32] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p31.3	1	68260207.0	WLS, RPE65	RPS7P4 - COX6B1P7	ENSG00000229133	ENSG00000225242		17152.0	22181.0	rs17130635-?	rs17130635	0.0	17130635	regulatory_region_variant	1	NR	6e-06	5.221848749616356	(EA)	0.18786351	[0.11-0.27] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		2q24.3	2	167779405.0	XIRP2, LOC105616981	CTAGE14P - B3GALT1-AS1	ENSG00000214211	ENSG00000235335		63340.0	35352.0	rs10497329-?	rs10497329	0.0	10497329	intergenic_variant	1	NR	3e-06	5.522878745280337	(EA)	0.2644751	[0.15-0.38] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		3p26.1	3	7122536.0	GRM7	GRM7			ENSG00000196277			rs9872427-?	rs9872427	0.0	9872427	intron_variant	0	NR	4e-06	5.3979400086720375	(EA)	0.14203545	[0.082-0.202] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		5q23.1	5	119329463.0	TNFAIP8	TNFAIP8			ENSG00000145779			rs4392658-?	rs4392658	0.0	4392658	intron_variant	0	NR	1e-05	5.0	(EA)	0.20990263	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					GREB1							chr2:11720299-?	chr2:11720299	0.0			1	NR	9e-06	5.045757490560675	(EA, female)	0.64601326	[0.37-0.93] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CTNNA2, LINC01815							chr2:80957886-?	chr2:80957886	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.36067423	[0.21-0.52] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ARGFX							chr3:121286179-?	chr3:121286179	0.0			1	NR	9e-06	5.045757490560675	(EA, female)	0.45528618	[0.26-0.65] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02267, STPG2-AS1							chr4:97820409-?	chr4:97820409	0.0			1	NR	2e-06	5.698970004336019	(EA, female)	0.93625736	[0.56-1.32] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ATG10							chr5:81415573-?	chr5:81415573	0.0			1	NR	9e-06	5.045757490560675	(EA, female)	0.42471778	[0.24-0.61] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC01845, LINC01847							chr5:159004759-?	chr5:159004759	0.0			1	NR	3e-06	5.522878745280337	(EA, female)	0.7818339	[0.46-1.11] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC00972, GRM3							chr7:85166637-?	chr7:85166637	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.6432131	[0.37-0.92] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LHFPL3							chr7:104112838-?	chr7:104112838	0.0			1	NR	7e-06	5.154901959985743	(EA, female)	0.9546817	[0.54-1.36] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					DLC1							chr8:12981008-?	chr8:12981008	0.0			1	NR	3e-06	5.522878745280337	(EA, female)	0.41167036	[0.24-0.58] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MRPL15, SOX17							chr8:55266580-?	chr8:55266580	0.0			1	NR	7e-06	5.154901959985743	(EA, female)	2.2397923	[1.28-3.2] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC105369423, RAB38							chr11:87599916-?	chr11:87599916	0.0			1	NR	4e-06	5.3979400086720375	(EA, female)	0.455416	[0.27-0.65] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PKNOX2							chr11:125101432-?	chr11:125101432	0.0			1	NR	9e-06	5.045757490560675	(EA, female)	1.1660321	[0.66-1.67] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TMEM132B, LINC00939							chr12:126203333-?	chr12:126203333	0.0			1	NR	4e-06	5.3979400086720375	(EA, female)	0.5744462	[0.34-0.81] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC283665, AQP9							chr15:58392940-?	chr15:58392940	0.0			1	NR	4e-07	6.3979400086720375	(EA, female)	0.4258377	[0.26-0.59] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ANKRD24							chr19:4225748-?	chr19:4225748	0.0			1	NR	2e-06	5.698970004336019	(EA, female)	0.4658622	[0.28-0.65] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC284379, DPRX							chr19:54117338-?	chr19:54117338	0.0			1	NR	4e-06	5.3979400086720375	(EA, female)	0.47891095	[0.28-0.68] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SYNDIG1, CST7							chr20:24898485-?	chr20:24898485	0.0			1	NR	5e-07	6.301029995663981	(EA, female)	0.41596153	[0.26-0.57] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					HUNK							chr21:33333549-?	chr21:33333549	0.0			1	NR	1e-05	5.0	(EA, female)	1.7888114	[1.01-2.57] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TIPRL, SFT2D2							chr1:168178297-?	chr1:168178297	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.2746507	[0.15-0.39] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SHCBP1L, LAMC1							chr1:182965654-?	chr1:182965654	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	1.2519463	[0.72-1.78] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ESRRG, GPATCH2							chr1:217353640-?	chr1:217353640	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.3244241	[0.19-0.46] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					NCKAP5							chr2:134093889-?	chr2:134093889	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.6381066	[0.37-0.91] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TEX41, PABPC1P2							chr2:145860335-?	chr2:145860335	0.0			1	NR	3e-07	6.522878745280337	(African American, female)	0.29129198	[0.18-0.4] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC101927960, MAP2							chr2:209878650-?	chr2:209878650	0.0			1	NR	1e-05	5.0	(African American, female)	0.1992595	[0.11-0.29] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					DOCK10, NYAP2							chr2:226003093-?	chr2:226003093	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	1.3713361	[0.8-1.95] unit decrease	Illumina [13620258] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10q21.3	10	62805174.0	ADO	ADO			ENSG00000181915			rs10995311-C	rs10995311	0.0	10995311	missense_variant	0	0.553	4e-08	7.397940008672037		0.00921	[0.0059-0.0125] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10q22.3	10	76133928.0	C10orf11	LRMDA			ENSG00000148655			rs67339103-A	rs67339103	0.0	67339103	intron_variant	0	0.212	1e-13	13.0		0.01522	[0.011-0.019] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		11p15.4	11	10275289.0	SBF2	SBF2			ENSG00000133812			rs17368443-C	rs17368443	0.0	17368443	intron_variant	0	0.061	3e-09	8.522878745280337		0.02071	[0.014-0.028] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		11p15.4	11	11077129.0	ZBED5AS1, GALNT18	LINC02752			ENSG00000254401			rs1124694-G	rs1124694	0.0	1124694	intron_variant	0	0.331	4e-08	7.397940008672037		0.00977	[0.0063-0.0133] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		12q15	12	69585737.0	CCT2	CCT2			ENSG00000166226			rs2601006-C	rs2601006	0.0	2601006	5_prime_UTR_variant	0	0.657	2e-11	10.69897000433602		0.01176	[0.0083-0.0152] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		14q24.1	14	68835682.0	ZFP36L1, ACTN1	ZFP36L1 - MAGOH3P	ENSG00000185650	ENSG00000270975		39429.0	26080.0	rs4288924-G	rs4288924	0.0	4288924	intergenic_variant	1	0.48	6e-09	8.221848749616356		0.0098	[0.0065-0.0131] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		15q15.1	15	41785763.0	MAPKBP1	MAPKBP1			ENSG00000137802			rs8035855-A	rs8035855	0.0	8035855	intron_variant	0	0.644	2e-12	11.69897000433602		0.01227	[0.0089-0.0157] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		15q21.1	15	45411626.0	SPATA5L1	SPATA5L1			ENSG00000171763			rs1145074-T	rs1145074	0.0	1145074	intron_variant	0	0.745	2e-09	8.698970004336019		0.0114	[0.0077-0.0151] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		15q22.31	15	63512308.0	USP3	USP3			ENSG00000140455			rs146311723-C	rs146311723	0.0	146311723	intron_variant	0	0.174	2e-08	7.698970004336019		0.01231	[0.008-0.0166] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		15q24.1	15	74735539.0	CYP1A2, CYP1A1	CYP1A1 - CYP1A2	ENSG00000140465	ENSG00000140505		10003.0	13306.0	rs2472297-T	rs2472297	0.0	2472297	intergenic_variant	1	0.267	5e-22	21.30102999566398		0.01812	[0.014-0.022] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		17q12	17	39399374.0	FBXL20	FBXL20			ENSG00000108306			rs2338796-A	rs2338796	0.0	2338796	intron_variant	0	0.67	3e-08	7.522878745280337		0.00989	[0.0064-0.0134] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		17q25.3	17	81451999.0	BAHCC1	BAHCC1			ENSG00000266074			rs35572189-G	rs35572189	0.0	35572189	missense_variant	0	0.638	1e-09	9.0		0.01051	[0.0071-0.0139] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		18q21.2	18	55729968.0	TCF4, LINC01415	TCF4 - LINC01415	ENSG00000196628	ENSG00000267325		65181.0	46759.0	rs784257-T	rs784257	0.0	784257	intron_variant	1	0.187	1e-08	8.0		0.01218	[0.008-0.0164] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		19q13.33	19	48748894.0	FUT1	FUT1			ENSG00000174951			rs838142-A	rs838142	0.0	838142	3_prime_UTR_variant	0	0.723	3e-10	9.522878745280336		0.01174	[0.0081-0.0154] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1p35.1	1	33454985.0	PHC2, ZSCAN20	PHC2 - TLR12P	ENSG00000134686	ENSG00000234512		23890.0	11264.0	rs12032996-G	rs12032996	0.0	12032996	intergenic_variant	1	0.838	9e-11	10.045757490560677		0.01463	[0.01-0.019] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1p33	1	47496019.0	FOXD2, TRABD2B	FOXD2 - RPL21P24	ENSG00000186564	ENSG00000229554		55328.0	1875.0	rs10157710-T	rs10157710	0.0	10157710	intergenic_variant	1	0.802	1e-19	19.0		0.019	[0.015-0.023] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1p31.1	1	77479047.0	AK5	AK5			ENSG00000154027			rs11162351-C	rs11162351	0.0	11162351	intron_variant	0	0.602	2e-08	7.698970004336019		0.00952	[0.0062-0.0129] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1q22	1	155122631.0	EFNA3, EFNA1	Y_RNA - EFNA1	ENSG00000264495	ENSG00000169242		2033.0	5245.0	rs11264327-A	rs11264327	0.0	11264327	intergenic_variant	1	0.399	7e-09	8.154901959985743		0.00987	[0.0065-0.0132] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1q24.3	1	171454028.0	FMO4, PRRC2C	CYCSP53 - PRRC2C	ENSG00000234333	ENSG00000117523		9065.0	31502.0	rs12727104-G	rs12727104	0.0	12727104	intergenic_variant	1	0.905	1e-08	8.0		0.01614	[0.011-0.022] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		1p33	1	47496019.0	FOXD2, TRABD2B	FOXD2 - RPL21P24	ENSG00000186564	ENSG00000229554		55328.0	1875.0	rs10157710-T	rs10157710	0.0	10157710	intergenic_variant	1	0.802	3e-13	12.522878745280336		0.01599	[0.012-0.02] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2p23.3	2	27375230.0	SNX17	SNX17			ENSG00000115234			rs4665972-T	rs4665972	0.0	4665972	intron_variant	0	0.392	8e-10	9.096910013008056		0.01104	[0.0075-0.0146] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2q33.3	2	207024356.0	CPO, KLF7	CPO - KLF7	ENSG00000144410	ENSG00000118263		54882.0	49781.0	rs6712846-A	rs6712846	0.0	6712846	intergenic_variant	1	0.525	5e-08	7.301029995663981		0.00954	[0.0061-0.013] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2q34	2	210675783.0	CPS1	CPS1			ENSG00000021826			rs1047891-C	rs1047891	0.0	1047891	missense_variant	0	0.683	4e-08	7.397940008672037		0.01031	[0.0066-0.014] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2q36.3	2	225820170.0	NYAP2, LOC646736							rs183131780-T	rs183131780	0.0	183131780	intergenic_variant	1	0.002	7e-11	10.154901959985745		0.13566	[0.095-0.176] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2q36.3	2	227011971.0	COL4A4	COL4A4			ENSG00000081052			rs35483183-A	rs35483183	0.0	35483183	intron_variant	0	0.123	2e-08	7.698970004336019		0.01502	[0.0098-0.0203] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		2q36.3	2	228266570.0	SPHKAP, PID1	SPHKAP - SNF8P1	ENSG00000153820	ENSG00000203387		84883.0	85550.0	rs35924503-C	rs35924503	0.0	35924503	intergenic_variant	1	0.001	1e-10	10.0		0.17391	[0.12-0.23] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		4q31.23	4	148207444.0	NR3C2	NR3C2			ENSG00000151623			rs7670121-G	rs7670121	0.0	7670121	intron_variant	0	0.24	1e-08	8.0		0.01161	[0.0076-0.0156] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		4q35.2	4	189807855.0	LINC01262, FRG1	FRG1-DT, FRG1-DT, FRG1-DT, FRG1-DT			ENSG00000280716, ENSG00000281543, ENSG00000281787, ENSG00000245685			rs189107782-T	rs189107782	0.0	189107782	intron_variant	0	0.002	3e-21	20.522878745280337		0.20163	[0.16-0.24] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		5q12.3	5	65000644.0	CWC27	CWC27			ENSG00000153015			rs7731168-C	rs7731168	0.0	7731168	intron_variant	0	0.233	1e-08	8.0		0.01183	[0.0078-0.0159] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		7p21.1	7	17244953.0	AGR3, AHR	AHR			ENSG00000106546			rs4410790-C	rs4410790	0.0	4410790	intron_variant	0	0.633	1e-18	18.0		0.01595	[0.012-0.019] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		8q12.2	8	60708054.0	CHD7	CHD7			ENSG00000171316			rs4738817-G	rs4738817	0.0	4738817	intron_variant	0	0.549	3e-08	7.522878745280337		0.00976	[0.0063-0.0132] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		8q24.13	8	125487789.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-C	rs28601761	0.0	28601761	intron_variant	1	0.579	3e-09	8.522878745280337		0.01059	[0.0071-0.0141] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		10p13	10	16890385.0	CUBN	CUBN			ENSG00000107611			rs45551835-A	rs45551835	0.0	45551835	missense_variant	0	0.014	1e-51	51.0		0.11178	[0.097-0.126] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		10p13	10	16925418.0	CUBN	CUBN			ENSG00000107611			rs144360241-C	rs144360241	0.0	144360241	missense_variant	0	0.005	4e-09	8.397940008672037		0.0769	[0.051-0.102] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		10p13	10	16950012.0	CUBN	CUBN			ENSG00000107611			rs141640975-A	rs141640975	0.0	141640975	missense_variant	0	0.003	2.9999999999999996e-84	83.52287874528034		0.33405	[0.3-0.37] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		10q21.3	10	62805132.0	ADO	ADO			ENSG00000181915			rs2236295-G	rs2236295	0.0	2236295	missense_variant	0	0.593	1e-08	8.0		0.0102	[0.0067-0.0137] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		10q22.3	10	76133928.0	LRMDA	LRMDA			ENSG00000148655			rs67339103-A	rs67339103	0.0	67339103	intron_variant	0	0.213	6e-10	9.221848749616356		0.01328	[0.0091-0.0175] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		12q15	12	69585737.0	CCT2	CCT2			ENSG00000166226			rs2601006-C	rs2601006	0.0	2601006	5_prime_UTR_variant	0	0.657	4e-09	8.397940008672037		0.01086	[0.0073-0.0145] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		15q15.1	15	41514460.0	LTK	LTK - RPAP1	ENSG00000062524	ENSG00000103932		573.0	2716.0	rs3759794-G	rs3759794	0.0	3759794	regulatory_region_variant	1	0.883	1e-08	8.0		0.01553	[0.01-0.021] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		15q21.1	15	45428399.0	C15orf48	SPATA5L1 - C15orf48	ENSG00000171763	ENSG00000166920		6984.0	2180.0	rs16943246-G	rs16943246	0.0	16943246	intergenic_variant	1	0.753	1e-08	8.0		0.01155	[0.0076-0.0155] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		15q24.1	15	74727108.0	CYP1A1	CYP1A1 - CYP1A2	ENSG00000140465	ENSG00000140505		1572.0	21737.0	rs2470893-T	rs2470893	0.0	2470893	upstream_gene_variant	1	0.335	6e-16	15.221848749616356		0.01495	[0.011-0.019] unit increase	Affymetrix [11709857] (imputed)	N
2018-10-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion (no hypertensive medication)	302,687 European ancestry individuals without hypertensive medication		19q13.33	19	48748894.0	FUT1	FUT1			ENSG00000174951			rs838142-A	rs838142	0.0	838142	3_prime_UTR_variant	0	0.723	1e-09	9.0		0.01189	[0.008-0.0157] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		1q32.1	1	200289967.0	NR5A2, LINC00862	LINC00862			ENSG00000203721			rs12727980-C	rs12727980	0.0	12727980	intron_variant	0	0.423	2e-08	7.698970004336019		0.00957	[0.0062-0.0129] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2p23.3	2	27375230.0	SNX17	SNX17			ENSG00000115234			rs4665972-T	rs4665972	0.0	4665972	intron_variant	0	0.393	7e-12	11.154901959985745		0.01176	[0.0084-0.0151] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2p16.3	2	51084986.0	LOC730100	NRXN1			ENSG00000179915			rs6750228-A	rs6750228	0.0	6750228	intron_variant	0	0.047	2e-08	7.698970004336019		0.02232	[0.015-0.03] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2p11.2	2	85527219.0	SH2D6, MAT2A, PARTICL	RPSAP22 - PARTICL	ENSG00000229648	ENSG00000286532		35439.0	10243.0	rs13394343-C	rs13394343	0.0	13394343	intergenic_variant	1	0.57	4e-10	9.397940008672036		0.01053	[0.0072-0.0138] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2q33.2	2	202850250.0	ICA1L	ICA1L			ENSG00000163596			rs10207567-C	rs10207567	0.0	10207567	intron_variant	0	0.813	1e-11	11.0		0.01455	[0.01-0.019] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2q34	2	210675783.0	CPS1	CPS1			ENSG00000021826			rs1047891-C	rs1047891	0.0	1047891	missense_variant	0	0.684	2e-11	10.69897000433602		0.01205	[0.0085-0.0156] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2q36.3	2	225820170.0	MIR548AR, LOC646736							rs183131780-T	rs183131780	0.0	183131780	intergenic_variant	1	0.002	2e-22	21.69897000433602		0.19055	[0.15-0.23] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2q36.3	2	228266570.0	SPHKAP, PID1	SPHKAP - SNF8P1	ENSG00000153820	ENSG00000203387		84883.0	85550.0	rs35924503-C	rs35924503	0.0	35924503	intergenic_variant	1	0.001	9.000000000000001e-23	22.045757490560675		0.24742	[0.2-0.3] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		3p21.31	3	46853886.0	MYL3	MYL3			ENSG00000160808			rs6768627-T	rs6768627	0.0	6768627	intron_variant	0	0.069	2e-08	7.698970004336019		0.01852	[0.012-0.025] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		3q26.2	3	170309619.0	PRKCI	PRKCI - SKIL	ENSG00000163558	ENSG00000136603		3642.0	48059.0	rs112607182-T	rs112607182	0.0	112607182	regulatory_region_variant	1	0.077	3e-12	11.522878745280336		0.02279	[0.016-0.029] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		4q12	4	55605384.0	NMU	NMU			ENSG00000109255			rs3805382-A	rs3805382	0.0	3805382	intron_variant	0	0.711	4e-08	7.397940008672037		0.01015	[0.0065-0.0138] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		4q21.1	4	76488642.0	SHROOM3	SHROOM3			ENSG00000138771			rs7654754-G	rs7654754	0.0	7654754	intron_variant	0	0.462	1e-09	9.0		0.0102	[0.0069-0.0135] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		4q31.23	4	148211605.0	NR3C2	NR3C2			ENSG00000151623			rs6535594-A	rs6535594	0.0	6535594	intron_variant	0	0.496	7e-12	11.154901959985745		0.01146	[0.0082-0.0147] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		4q35.2	4	189807855.0	LINC01262, FRG1	FRG1-DT, FRG1-DT, FRG1-DT, FRG1-DT			ENSG00000280716, ENSG00000281543, ENSG00000281787, ENSG00000245685			rs189107782-T	rs189107782	0.0	189107782	intron_variant	0	0.002	1e-33	33.0		0.24502	[0.21-0.28] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		5q11.2	5	53975590.0	ARL15	ARL15			ENSG00000185305			rs702634-A	rs702634	0.0	702634	intron_variant	0	0.692	8e-09	8.096910013008056		0.01042	[0.0069-0.014] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		5q12.3	5	65000644.0	CWC27	CWC27			ENSG00000153015			rs7731168-C	rs7731168	0.0	7731168	intron_variant	0	0.233	2e-10	9.69897000433602		0.01253	[0.0087-0.0164] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		7p21.1	7	17244953.0	AGR3, AHR	AHR			ENSG00000106546			rs4410790-C	rs4410790	0.0	4410790	intron_variant	0	0.634	3e-25	24.522878745280337		0.01798	[0.015-0.021] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		7p15.2	7	27203619.0	HOTTIP	HOTTIP			ENSG00000243766			rs2023844-A	rs2023844	0.0	2023844	intron_variant	0	0.926	1e-09	9.0		0.01934	[0.013-0.026] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		7p14.3	7	29765745.0	WIPF3, DPY19L2P3	DPY19L2P3 - WIPF3	ENSG00000227855	ENSG00000122574		23151.0	40741.0	rs17158386-A	rs17158386	0.0	17158386	regulatory_region_variant	1	0.262	4e-12	11.397940008672036		0.0133	[0.0096-0.017] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		8p23.2	8	2808621.0	LOC101927815, CSMD1							rs55798132-G	rs55798132	0.0	55798132	intron_variant	1	0.989	3e-08	7.522878745280337		0.04472	[0.029-0.06] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		8q24.13	8	125487789.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-C	rs28601761	0.0	28601761	intron_variant	1	0.579	3e-11	10.522878745280336		0.01136	[0.008-0.0147] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		2q36.3	2	227011971.0	COL4A4	COL4A4			ENSG00000081052			rs35483183-A	rs35483183	0.0	35483183	intron_variant	0	0.123	5e-09	8.301029995663981		0.0149	[0.0099-0.0199] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		9p13.3	9	33385158.0	AQP7	AQP7			ENSG00000165269			rs144994089-T	rs144994089	0.0	144994089	missense_variant	0	0.001	1e-08	8.0		0.1456	[0.095-0.196] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10p13	10	16890385.0	CUBN	CUBN			ENSG00000107611			rs45551835-A	rs45551835	0.0	45551835	missense_variant	0	0.014	2e-92	91.69897000433602		0.14237	[0.13-0.16] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10p13	10	16925418.0	CUBN	CUBN			ENSG00000107611			rs144360241-C	rs144360241	0.0	144360241	missense_variant	0	0.005	3e-11	10.522878745280336		0.08186	[0.058-0.106] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10p13	10	16929427.0	CUBN	CUBN			ENSG00000107611			rs1276720-T	rs1276720	0.0	1276720	intron_variant	0	0.745	9e-09	8.045757490560675		0.01109	[0.0073-0.0149] unit increase	Affymetrix [11709857] (imputed)	N
2018-11-19	30220432	Haas ME	2018-09-06	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/30220432	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.	Urinary albumin excretion	382,500 European ancestry individuals		10p13	10	16950012.0	CUBN	CUBN			ENSG00000107611			rs141640975-A	rs141640975	0.0	141640975	missense_variant	0	0.003	2e-107	106.69897000433602		0.35876	[0.33-0.39] unit increase	Affymetrix [11709857] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6q22.33	6	127225882.0	RSPO3, RNF146	RSPO3 - RNF146	ENSG00000146374	ENSG00000118518		26401.0	40844.0	rs7759507-?	rs7759507	0.0	7759507	intergenic_variant	1	NR	6e-06	5.221848749616356	(EA)	0.16121642	[0.091-0.231] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		9q33.1	9	118129492.0	TLR4, BRINP1	TPT1P9 - NA	ENSG00000234782			46110.0		rs1115375-?	rs1115375	0.0	1115375	intergenic_variant	1	NR	5e-06	5.301029995663981	(EA)	0.15491548	[0.088-0.222] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		10q21.1	10	52110815.0	PRKG1	PRKG1			ENSG00000185532			rs3862583-?	rs3862583	0.0	3862583	intron_variant	0	NR	6e-06	5.221848749616356	(EA)	0.22263066	[0.13-0.32] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		14q32.31	14	102694864.0	RCOR1	RCOR1			ENSG00000089902			rs8014003-?	rs8014003	0.0	8014003	intron_variant	0	NR	9e-06	5.045757490560675	(EA)	0.31549707	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16p12.2	16	22719662.0	LOC653786, HS3ST2	NA - HS3ST2		ENSG00000122254			94500.0	rs12920706-?	rs12920706	0.0	12920706	intergenic_variant	1	NR	9e-06	5.045757490560675	(EA)	0.119369194	[0.067-0.172] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19p13.2	19	10415333.0	CDC37, PDE4A	CDC37			ENSG00000105401			rs6511698-?	rs6511698	0.0	6511698	intron_variant	0	NR	9e-06	5.045757490560675	(EA)	0.114695325	[0.064-0.165] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	9e-20	19.045757490560675	(EA)	0.45077777	[0.35-0.55] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p31.1	1	79057950.0	ADGRL4, LINC01781	ADGRL4			ENSG00000162618			rs4650387-?	rs4650387	0.0	4650387	intron_variant	0	NR	4e-06	5.3979400086720375	(African American)	0.151292	[0.087-0.216] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p13.3	1	109274968.0	CELSR2	CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0.0	12740374	3_prime_UTR_variant	0	NR	1e-07	7.0	(African American)	0.15287153	[0.097-0.209] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1q42.12	1	225410973.0	LBR	LBR			ENSG00000143815			rs6660819-?	rs6660819	0.0	6660819	intron_variant	0	NR	2e-06	5.698970004336019	(African American)	0.29744157	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		2p24.1	2	21002613.0	APOB	APOB			ENSG00000084674			rs1801702-?	rs1801702	0.0	1801702	missense_variant	0	NR	5e-07	6.301029995663981	(African American)	0.20006934	[0.12-0.28] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		2p24.1	2	21158305.0	TDRD15, LINC01822	TDRD15 - NA	ENSG00000218819			13937.0		rs12997242-?	rs12997242	0.0	12997242	intergenic_variant	1	NR	3e-06	5.522878745280337	(African American)	0.14060627	[0.082-0.199] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		5q33.1	5	151068815.0	TNIP1	TNIP1			ENSG00000145901			rs1862364-?	rs1862364	0.0	1862364	intron_variant	0	NR	7e-06	5.154901959985743	(African American)	0.15747027	[0.089-0.226] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6p21.1	6	45737342.0	RUNX2, CLIC5	RUNX2 - NA	ENSG00000124813			72993.0		rs10948250-?	rs10948250	0.0	10948250	intergenic_variant	1	NR	5e-06	5.301029995663981	(African American)	0.11508503	[0.066-0.164] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6q22.33	6	127225882.0	RSPO3, RNF146	RSPO3 - RNF146	ENSG00000146374	ENSG00000118518		26401.0	40844.0	rs7759507-?	rs7759507	0.0	7759507	intergenic_variant	1	NR	6e-06	5.221848749616356	(African American)	0.16121642	[0.091-0.231] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8p23.1	8	9330085.0	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		42507.0	41005.0	rs7004769-?	rs7004769	0.0	7004769	intron_variant	1	NR	6e-06	5.221848749616356	(African American)	0.13150437	[0.075-0.188] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		9q33.1	9	118129492.0	TLR4, BRINP1	TPT1P9 - NA	ENSG00000234782			46110.0		rs1115375-?	rs1115375	0.0	1115375	intergenic_variant	1	NR	5e-06	5.301029995663981	(African American)	0.15491548	[0.088-0.222] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		10q21.1	10	52110815.0	PRKG1	PRKG1			ENSG00000185532			rs3862583-?	rs3862583	0.0	3862583	intron_variant	0	NR	6e-06	5.221848749616356	(African American)	0.22263066	[0.13-0.32] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		14q32.31	14	102694864.0	RCOR1	RCOR1			ENSG00000089902			rs8014003-?	rs8014003	0.0	8014003	intron_variant	0	NR	9e-06	5.045757490560675	(African American)	0.31549707	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16p12.2	16	22719662.0	LOC653786, HS3ST2	NA - HS3ST2		ENSG00000122254			94500.0	rs12920706-?	rs12920706	0.0	12920706	intergenic_variant	1	NR	9e-06	5.045757490560675	(African American)	0.119369194	[0.067-0.172] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16q22.2	16	72015313.0	DHODH	DHODH			ENSG00000102967			rs7184117-?	rs7184117	0.0	7184117	intron_variant	0	NR	6e-06	5.221848749616356	(African American)	0.12157466	[0.069-0.174] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19p13.2	19	10415333.0	CDC37, PDE4A	CDC37			ENSG00000105401			rs6511698-?	rs6511698	0.0	6511698	intron_variant	0	NR	9e-06	5.045757490560675	(African American)	0.114695325	[0.064-0.165] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19p13.2	19	11079088.0	SMARCA4, LDLR	SMARCA4			ENSG00000127616			rs73015011-?	rs73015011	0.0	73015011	missense_variant	0	NR	2e-07	6.698970004336019	(African American)	0.16858114	[0.11-0.23] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	3.9999999999999995e-42	41.39794000867204	(African American)	0.5423542	[0.47-0.62] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC01346, LINC01777							chr1:4408320-?	chr1:4408320	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.6388005	[0.36-0.91] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC389602, LOC285889							chr7:155945756-?	chr7:155945756	0.0			1	NR	6e-06	5.221848749616356	(African American,female)	0.4890557	[0.28-0.7] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PTPRD							chr9:8438993-?	chr9:8438993	0.0			1	NR	6e-06	5.221848749616356	(African American,female)	1.0806648	[0.62-1.55] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CCDC171, C9orf92							chr9:16105056-?	chr9:16105056	0.0			1	NR	4e-06	5.3979400086720375	(African American,female)	0.4420056	[0.26-0.63] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PLPPR1							chr9:103972264-?	chr9:103972264	0.0			1	NR	6e-06	5.221848749616356	(African American,female)	0.4377953	[0.25-0.63] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					DEC1, LOC101928775							chr9:118347899-?	chr9:118347899	0.0			1	NR	5e-07	6.301029995663981	(African American,female)	0.26438257	[0.16-0.37] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TLR4, BRINP1							chr9:120888077-?	chr9:120888077	0.0			1	NR	4e-06	5.3979400086720375	(African American,female)	0.21090114	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CFAP77							chr9:135367661-?	chr9:135367661	0.0			1	NR	2e-06	5.698970004336019	(African American,female)	0.29443336	[0.17-0.42] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CAMK1D							chr10:12577901-?	chr10:12577901	0.0			1	NR	7e-06	5.154901959985743	(African American,female)	0.21410231	[0.12-0.31] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					FAM13C							chr10:61113993-?	chr10:61113993	0.0			1	NR	5e-06	5.301029995663981	(African American,female)	0.2117634	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					NELL1							chr11:20841394-?	chr11:20841394	0.0			1	NR	9e-06	5.045757490560675	(African American,female)	0.19714083	[0.11-0.28] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02098, ETS1							chr11:128260138-?	chr11:128260138	0.0			1	NR	7e-06	5.154901959985743	(African American,female)	0.37198475	[0.21-0.53] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TSPAN11, DDX11-AS1							chr12:31157515-?	chr12:31157515	0.0			1	NR	2e-06	5.698970004336019	(African American,female)	0.33520645	[0.2-0.47] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PIWIL1							chr12:130839645-?	chr12:130839645	0.0			1	NR	7e-07	6.154901959985743	(African American,female)	0.22847618	[0.14-0.32] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SLC24A4							chr14:92934509-?	chr14:92934509	0.0			1	NR	9e-06	5.045757490560675	(African American,female)	0.22815454	[0.13-0.33] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PAPOLA							chr14:96973712-?	chr14:96973712	0.0			1	NR	6e-06	5.221848749616356	(African American,female)	0.21230687	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					C14orf177, BCL11B							chr14:99605517-?	chr14:99605517	0.0			1	NR	7e-06	5.154901959985743	(African American,female)	0.60679746	[0.34-0.87] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MIR4313, UBE2Q2							chr15:76056561-?	chr15:76056561	0.0			1	NR	1e-06	6.0	(African American,female)	0.21762848	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MTHFSD							chr16:86562874-?	chr16:86562874	0.0			1	NR	7e-06	5.154901959985743	(African American,female)	0.6753842	[0.38-0.97] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CCR7, SMARCE1							chr17:38775805-?	chr17:38775805	0.0			1	NR	4e-06	5.3979400086720375	(African American,female)	0.21101123	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					EMID1							chr22:29627944-?	chr22:29627944	0.0			1	NR	6e-06	5.221848749616356	(African American,female)	0.46523005	[0.26-0.67] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p31.1	1	79057950.0	ADGRL4, LINC01781	ADGRL4			ENSG00000162618			rs4650387-?	rs4650387	0.0	4650387	intron_variant	0	NR	4e-06	5.3979400086720375	(EA)	0.151292	[0.087-0.216] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p13.3	1	109274968.0	CELSR2	CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0.0	12740374	3_prime_UTR_variant	0	NR	1e-06	6.0	(EA)	0.14413212	[0.086-0.202] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1q42.12	1	225410973.0	LBR	LBR			ENSG00000143815			rs6660819-?	rs6660819	0.0	6660819	intron_variant	0	NR	2e-06	5.698970004336019	(EA)	0.29744157	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		5q33.1	5	151068815.0	TNIP1	TNIP1			ENSG00000145901			rs1862364-?	rs1862364	0.0	1862364	intron_variant	0	NR	7e-06	5.154901959985743	(EA)	0.15747027	[0.089-0.226] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6p21.1	6	45737342.0	RUNX2, CLIC5	RUNX2 - NA	ENSG00000124813			72993.0		rs10948250-?	rs10948250	0.0	10948250	intergenic_variant	1	NR	5e-06	5.301029995663981	(EA)	0.11508503	[0.066-0.164] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		3q13.33	3	120165816.0	GPR156	GPR156			ENSG00000175697			rs1488763-?	rs1488763	0.0	1488763	3_prime_UTR_variant	0	NR	9e-06	5.045757490560675	(EA)	0.116307475	[0.065-0.168] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		4q28.1	4	125211924.0	ANKRD50, FAT4							rs4130333-?	rs4130333	0.0	4130333	intergenic_variant	1	NR	5e-06	5.301029995663981	(EA)	0.16636615	[0.095-0.238] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6q12	6	67042277.0	SLC25A51P1, LOC102723883							rs11968427-?	rs11968427	0.0	11968427	intergenic_variant	1	NR	5e-07	6.301029995663981	(EA)	0.40592232	[0.25-0.56] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8p21.3	8	20079176.0	LPL, SLC18A1	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		111917.0	34167.0	rs28597716-?	rs28597716	0.0	28597716	non_coding_transcript_exon_variant	1	NR	2e-06	5.698970004336019	(EA)	0.14377508	[0.085-0.203] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q13.2	8	67628737.0	CPA6	CPA6			ENSG00000165078			rs10092095-?	rs10092095	0.0	10092095	intron_variant	0	NR	5e-07	6.301029995663981	(EA)	0.12409528	[0.076-0.172] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q24.13	8	125473095.0	TRIB1, LINC00861	TRIB1 - NA	ENSG00000173334			34692.0		rs2980860-?	rs2980860	0.0	2980860	intron_variant	1	NR	6e-12	11.221848749616356	(EA)	0.16575564	[0.12-0.21] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		11q23.3	11	116778201.0	ZPR1	ZPR1			ENSG00000109917			rs964184-?	rs964184	0.0	964184	3_prime_UTR_variant	0	NR	7e-15	14.154901959985745	(EA)	0.26723298	[0.2-0.33] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16p12.1	16	28290166.0	XPO6, SBK1	SBK1			ENSG00000188322			rs9939450-?	rs9939450	0.0	9939450	intron_variant	0	NR	6e-07	6.221848749616356	(EA)	0.1207661	[0.073-0.168] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		18q23	18	76499110.0	C18orf65, LINC00908	ZNF516-DT - LINC00683	ENSG00000275763	ENSG00000266256		1022.0	29542.0	rs12456640-?	rs12456640	0.0	12456640	intergenic_variant	1	NR	3e-06	5.522878745280337	(EA)	0.1329451	[0.077-0.189] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19q13.32	19	44910319.0	APOE	APOE - APOC1	ENSG00000130203	ENSG00000130208		926.0	3928.0	rs75627662-?	rs75627662	0.0	75627662	non_coding_transcript_exon_variant	1	NR	1e-06	6.0	(EA)	0.14800182	[0.088-0.208] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1p31.3	1	62583880.0	DOCK7	DOCK7			ENSG00000116641			rs11207995-?	rs11207995	0.0	11207995	intron_variant	0	NR	2e-06	5.698970004336019	(African American)	0.11571218	[0.068-0.163] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		2q37.2	2	234948470.0	LINC01173, SH3BP4	NA - SH3BP4		ENSG00000130147			3547.0	rs2042831-?	rs2042831	0.0	2042831	intergenic_variant	1	NR	2e-07	6.698970004336019	(African American)	0.24173836	[0.15-0.33] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		3q13.33	3	120165816.0	GPR156	GPR156			ENSG00000175697			rs1488763-?	rs1488763	0.0	1488763	3_prime_UTR_variant	0	NR	9e-06	5.045757490560675	(African American)	0.116307475	[0.065-0.168] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		3q25.2	3	154564071.0	GPR149, MME	NA - SYPL1P1		ENSG00000243154			87585.0	rs10513462-?	rs10513462	0.0	10513462	intergenic_variant	1	NR	7e-06	5.154901959985743	(African American)	0.1202219	[0.068-0.172] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		4q28.1	4	125211924.0	ANKRD50, FAT4							rs4130333-?	rs4130333	0.0	4130333	intergenic_variant	1	NR	5e-06	5.301029995663981	(African American)	0.16636615	[0.095-0.238] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6q12	6	67042277.0	SLC25A51P1, LOC102723883							rs11968427-?	rs11968427	0.0	11968427	intergenic_variant	1	NR	5e-07	6.301029995663981	(African American)	0.40592232	[0.25-0.56] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		7p21.1	7	17880630.0	SNX13	SNX13			ENSG00000071189			rs17138358-?	rs17138358	0.0	17138358	3_prime_UTR_variant	0	NR	3e-06	5.522878745280337	(African American)	0.11083479	[0.064-0.158] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8p21.3	8	19973410.0	LPL, SLC18A1	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		6151.0	139933.0	rs10096633-?	rs10096633	0.0	10096633	intergenic_variant	1	NR	2e-08	7.698970004336019	(African American)	0.13571067	[0.088-0.183] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q13.2	8	67628737.0	CPA6	CPA6			ENSG00000165078			rs10092095-?	rs10092095	0.0	10092095	intron_variant	0	NR	5e-07	6.301029995663981	(African American)	0.12409528	[0.076-0.172] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		11q23.3	11	116791691.0	APOA5	APOA5			ENSG00000110243			rs3135506-?	rs3135506	0.0	3135506	missense_variant	0	NR	2e-09	8.698970004336019	(African American)	0.29291716	[0.2-0.39] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-?	rs1800588	0.0	1800588	intron_variant	0	NR	3e-06	5.522878745280337	(African American)	0.11128225	[0.065-0.158] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16p12.1	16	28290166.0	XPO6, SBK1	SBK1			ENSG00000188322			rs9939450-?	rs9939450	0.0	9939450	intron_variant	0	NR	6e-07	6.221848749616356	(African American)	0.1207661	[0.073-0.168] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		18q23	18	76499110.0	C18orf65, LINC00908	ZNF516-DT - LINC00683	ENSG00000275763	ENSG00000266256		1022.0	29542.0	rs12456640-?	rs12456640	0.0	12456640	intergenic_variant	1	NR	3e-06	5.522878745280337	(African American)	0.1329451	[0.077-0.189] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RESP18, DNPEP							chr2:220233328-?	chr2:220233328	0.0			1	NR	8e-06	5.096910013008056	(EA,female)	0.34230778	[0.19-0.49] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					BPESC1, PISRT1							chr3:138894951-?	chr3:138894951	0.0			1	NR	6e-07	6.221848749616356	(EA,female)	0.39750805	[0.24-0.55] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC00887, CPN2							chr3:194033312-?	chr3:194033312	0.0			1	NR	4e-06	5.3979400086720375	(EA,female)	0.8038189	[0.47-1.14] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					KCTD8							chr4:44447144-?	chr4:44447144	0.0			1	NR	3e-06	5.522878745280337	(EA,female)	13.816662	[8.1-19.53] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					FAT1, LINC02374							chr4:187969016-?	chr4:187969016	0.0			1	NR	8e-06	5.096910013008056	(EA,female)	0.37183353	[0.21-0.53] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ARL4A, ETV1							chr7:13826915-?	chr7:13826915	0.0			1	NR	9e-06	5.045757490560675	(EA,female)	0.6648619	[0.38-0.95] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					COL13A1							chr10:71613604-?	chr10:71613604	0.0			1	NR	2e-06	5.698970004336019	(EA,female)	0.717494	[0.43-1.01] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CYP2C8, ACSM6							chr10:96896696-?	chr10:96896696	0.0			1	NR	8e-06	5.096910013008056	(EA,female)	0.69200706	[0.39-0.99] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC01163, MGMT							chr10:130225540-?	chr10:130225540	0.0			1	NR	3e-06	5.522878745280337	(EA,female)	0.35835782	[0.21-0.51] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					AGBL1, LINC00052							chr15:87704194-?	chr15:87704194	0.0			1	NR	3e-06	5.522878745280337	(EA,female)	0.9848946	[0.58-1.39] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PKD1L3							chr16:71985222-?	chr16:71985222	0.0			1	NR	9e-06	5.045757490560675	(EA,female)	0.47122017	[0.27-0.68] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PIEZO1							chr16:88832113-?	chr16:88832113	0.0			1	NR	2e-06	5.698970004336019	(EA,female)	0.37436786	[0.22-0.53] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CCL11, CCL8							chr17:32634098-?	chr17:32634098	0.0			1	NR	9e-06	5.045757490560675	(EA,female)	0.54967254	[0.31-0.79] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SLC39A11							chr17:70859391-?	chr17:70859391	0.0			1	NR	1e-05	5.0	(EA,female)	1.0491092	[0.59-1.51] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RNF24, SMOX							chr20:4087727-?	chr20:4087727	0.0			1	NR	9e-06	5.045757490560675	(EA,female)	0.35697752	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MIR646HG							chr20:58828664-?	chr20:58828664	0.0			1	NR	5e-06	5.301029995663981	(EA,female)	0.9272821	[0.54-1.32] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					BSDC1							chr1:32842319-?	chr1:32842319	0.0			1	NR	9e-06	5.045757490560675	(African American,female)	1.512662	[0.85-2.18] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					DOCK10, NYAP2							chr2:226183918-?	chr2:226183918	0.0			1	NR	7e-07	6.154901959985743	(African American,female)	0.3059475	[0.19-0.43] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TM4SF20, MIR5703							chr2:228289059-?	chr2:228289059	0.0			1	NR	5e-07	6.301029995663981	(African American,female)	0.22941005	[0.14-0.32] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ULK4							chr3:41477354-?	chr3:41477354	0.0			1	NR	2e-06	5.698970004336019	(African American,female)	0.21390031	[0.13-0.3] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02006							chr3:153438198-?	chr3:153438198	0.0			1	NR	7e-06	5.154901959985743	(African American,female)	0.32297426	[0.18-0.46] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					NLGN1, NAALADL2							chr3:174378851-?	chr3:174378851	0.0			1	NR	3e-06	5.522878745280337	(African American,female)	0.47345334	[0.28-0.67] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SORCS2, AFAP1-AS1							chr4:7745968-?	chr4:7745968	0.0			1	NR	8e-07	6.096910013008056	(African American,female)	0.30026034	[0.18-0.42] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RBM47							chr4:40435838-?	chr4:40435838	0.0			1	NR	1e-06	6.0	(African American,female)	0.31785893	[0.19-0.45] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CLGN							chr4:141314370-?	chr4:141314370	0.0			1	NR	4e-06	5.3979400086720375	(African American,female)	0.5013034	[0.29-0.71] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TMEM244, L3MBTL3							chr6:130334409-?	chr6:130334409	0.0			1	NR	2e-06	5.698970004336019	(African American,female)	0.2423917	[0.14-0.34] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PRKN							chr6:161973869-?	chr6:161973869	0.0			1	NR	5e-06	5.301029995663981	(African American,female)	0.61362064	[0.35-0.88] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ADORA2B							chr17:15870401-?	chr17:15870401	0.0			1	NR	3e-06	5.522878745280337	(EA, female)	0.35422176	[0.21-0.5] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CELF4							chr18:34858361-?	chr18:34858361	0.0			1	NR	1e-05	5.0	(EA, female)	0.44917578	[0.25-0.65] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					KLK7							chr19:51483620-?	chr19:51483620	0.0			1	NR	5e-06	5.301029995663981	(EA, female)	1.2753114	[0.74-1.81] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					KIF16B							chr20:16504137-?	chr20:16504137	0.0			1	NR	4e-06	5.3979400086720375	(EA, female)	0.34301767	[0.2-0.49] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MAB21L3, ATP1A1							chr1:116901670-?	chr1:116901670	0.0			1	NR	6e-06	5.221848749616356	(African American, female)	0.39314917	[0.22-0.56] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					QPCT, CDC42EP3							chr2:37704862-?	chr2:37704862	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.2686339	[0.16-0.38] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TNS1							chr2:218717053-?	chr2:218717053	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.20613058	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CNTN4							chr3:2613232-?	chr3:2613232	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.5668162	[0.32-0.81] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ROBO1							chr3:79055838-?	chr3:79055838	0.0			1	NR	9e-06	5.045757490560675	(African American, female)	0.45205173	[0.25-0.65] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02010, ZIC4							chr3:146713227-?	chr3:146713227	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.5181701	[0.29-0.74] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINCR-0002, FGF12							chr3:191349175-?	chr3:191349175	0.0			1	NR	6e-07	6.221848749616356	(African American, female)	1.5991595	[0.97-2.22] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LCORL, SLIT2							chr4:18526264-?	chr4:18526264	0.0			1	NR	5e-06	5.301029995663981	(African American, female)	0.2921781	[0.17-0.42] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC101929353							chr4:101118666-?	chr4:101118666	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.62955874	[0.36-0.89] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SSBP2, ATG10							chr5:81056737-?	chr5:81056737	0.0			1	NR	5e-06	5.301029995663981	(African American, female)	0.316641	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MAN2A1							chr5:109024918-?	chr5:109024918	0.0			1	NR	2e-06	5.698970004336019	(African American, female)	1.4887193	[0.88-2.09] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					GMDS							chr6:2151372-?	chr6:2151372	0.0			1	NR	7e-06	5.154901959985743	(African American, female)	2.5255146	[1.43-3.62] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LRFN2							chr6:40436322-?	chr6:40436322	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.49119818	[0.29-0.7] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC101928516							chr6:75123102-?	chr6:75123102	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.23713244	[0.14-0.34] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					HTR1B, MEI4							chr6:78202032-?	chr6:78202032	0.0			1	NR	2e-06	5.698970004336019	(African American, female)	0.43643513	[0.26-0.62] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RPS6KA2							chr6:167151365-?	chr6:167151365	0.0			1	NR	9e-06	5.045757490560675	(African American, female)	0.22890568	[0.13-0.33] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MSR1, FGF20							chr8:16075400-?	chr8:16075400	0.0			1	NR	1e-06	6.0	(African American, female)	0.84057987	[0.5-1.18] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PSD3							chr8:18535336-?	chr8:18535336	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.37587717	[0.22-0.54] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SNX31							chr8:101586676-?	chr8:101586676	0.0			1	NR	9e-06	5.045757490560675	(African American, female)	0.3419386	[0.19-0.49] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RXRA							chr9:137305778-?	chr9:137305778	0.0			1	NR	5e-06	5.301029995663981	(African American, female)	0.49382532	[0.28-0.7] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC105376351, PFKP							chr10:2966644-?	chr10:2966644	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.2171892	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					CNTN5							chr11:99950785-?	chr11:99950785	0.0			1	NR	2e-06	5.698970004336019	(African American, female)	0.34013155	[0.2-0.48] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC100507377, ATXN7L3B							chr12:74875129-?	chr12:74875129	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.5055653	[0.29-0.72] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					GLT1D1							chr12:129457162-?	chr12:129457162	0.0			1	NR	1e-05	5.0	(African American, female)	0.50204605	[0.28-0.72] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MTUS2							chr13:29705959-?	chr13:29705959	0.0			1	NR	3e-06	5.522878745280337	(African American, female)	0.2415375	[0.14-0.34] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RBFOX1							chr16:7523475-?	chr16:7523475	0.0			1	NR	8e-07	6.096910013008056	(African American, female)	0.22334339	[0.14-0.31] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC01425, LINC01687							chr21:23293475-?	chr21:23293475	0.0			1	NR	4e-06	5.3979400086720375	(African American, female)	0.49697617	[0.29-0.71] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					APP, CYYR1-AS1							chr21:27699110-?	chr21:27699110	0.0			1	NR	8e-06	5.096910013008056	(African American, female)	0.6045548	[0.34-0.87] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		7q21.11	7	82589141.0	CACNA2D1, PCLO	NA - MTHFD2P5		ENSG00000213530			707.0	rs10486973-?	rs10486973	0.0	10486973	intergenic_variant	1	NR	4e-06	5.3979400086720375	(EA)	0.1312855	[0.076-0.187] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q24.22	8	130638567.0	ASAP1, ADCY8							rs6986527-?	rs6986527	0.0	6986527	intron_variant	1	NR	8e-06	5.096910013008056	(EA)	0.11216259	[0.063-0.161] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		11q24.3	11	129448080.0	BARX2	BARX2			ENSG00000043039			rs10894038-?	rs10894038	0.0	10894038	intron_variant	0	NR	5e-06	5.301029995663981	(EA)	0.13294812	[0.076-0.19] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		12q21.31	12	83113490.0	TMTC2	TMTC2			ENSG00000179104			rs7302697-?	rs7302697	0.0	7302697	intron_variant	0	NR	2e-06	5.698970004336019	(EA)	0.12253226	[0.072-0.173] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		15q21.3	15	58381852.0	AQP9, LIPC	ALDH1A2			ENSG00000128918			rs62001736-?	rs62001736	0.0	62001736	intron_variant	0	NR	6e-06	5.221848749616356	(EA)	0.12384403	[0.07-0.177] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		15q25.1	15	80885396.0	CEMIP	CEMIP			ENSG00000103888			rs4778864-?	rs4778864	0.0	4778864	intron_variant	0	NR	8e-06	5.096910013008056	(EA)	0.15895666	[0.089-0.229] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16q13	16	56953457.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593.0	8466.0	rs56156922-?	rs56156922	0.0	56156922	intergenic_variant	1	NR	3e-19	18.522878745280337	(EA)	0.23222724	[0.18-0.28] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		17q21.32	17	49012936.0	IGF2BP1	IGF2BP1			ENSG00000159217			rs6504592-?	rs6504592	0.0	6504592	splice_region_variant	0	NR	6e-06	5.221848749616356	(EA)	0.24448209	[0.14-0.35] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19q13.2	19	40996617.0	CYP2B6	CYP2B6			ENSG00000197408			rs8101756-?	rs8101756	0.0	8101756	intron_variant	0	NR	3e-06	5.522878745280337	(EA)	0.1292686	[0.075-0.184] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		20q13.11	20	43391040.0	PTPRT, SRSF6	NA - RNU6-743P		ENSG00000201021			14433.0	rs6103272-?	rs6103272	0.0	6103272	intergenic_variant	1	NR	8e-06	5.096910013008056	(EA)	0.11249223	[0.063-0.162] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1q42.11	1	224351238.0	NVL, CNIH4	NVL - CNIH4	ENSG00000143748	ENSG00000143771		21049.0	5620.0	rs11579964-?	rs11579964	0.0	11579964	intergenic_variant	1	NR	8e-06	5.096910013008056	(African American)	0.262103	[0.15-0.38] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		1q44	1	245104608.0	EFCAB2	EFCAB2			ENSG00000203666			rs10927395-?	rs10927395	0.0	10927395	intron_variant	0	NR	5e-06	5.301029995663981	(African American)	0.14135718	[0.081-0.202] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		2p12	2	79262797.0	REG3A, LOC101927987	CTNNA2			ENSG00000066032			rs17705745-?	rs17705745	0.0	17705745	intron_variant	0	NR	5e-06	5.301029995663981	(African American)	0.1226016	[0.07-0.175] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		4q34.3	4	178187327.0	LINC01689, LINC01684	RNU1-45P - NA	ENSG00000253000			70466.0		rs1563700-?	rs1563700	0.0	1563700	intergenic_variant	1	NR	8e-06	5.096910013008056	(African American)	0.1396587	[0.079-0.201] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		5p14.3	5	18421401.0	LINC01689, LINC01684							rs1918340-?	rs1918340	0.0	1918340	intergenic_variant	1	NR	1e-06	6.0	(African American)	0.60006607	[0.36-0.84] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		5p14.2	5	24482366.0	C5orf17, CDH10	Metazoa_SRP - CDH10	ENSG00000276525	ENSG00000040731		32751.0	4734.0	rs1428365-?	rs1428365	0.0	1428365	intergenic_variant	1	NR	4e-06	5.3979400086720375	(African American)	0.16326945	[0.094-0.232] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6p21.1	6	42560164.0	TRERF1, UBR2	NA - UBR2		ENSG00000024048			3865.0	rs9394908-?	rs9394908	0.0	9394908	intergenic_variant	1	NR	9e-07	6.045757490560675	(African American)	0.118978254	[0.072-0.166] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		6p21.1	6	42675358.0	UBR2	UBR2			ENSG00000024048			rs6905989-?	rs6905989	0.0	6905989	intron_variant	0	NR	2e-06	5.698970004336019	(African American)	0.1262191	[0.074-0.179] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		7p13	7	43636921.0	STK17A, COA1	COA1, STK17A			ENSG00000106603, ENSG00000164543			rs17439848-?	rs17439848	0.0	17439848	intron_variant	0	NR	5e-06	5.301029995663981	(African American)	0.28576183	[0.16-0.41] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q13.2	8	68703882.0	C8orf34	C8orf34			ENSG00000165084			rs12543018-?	rs12543018	0.0	12543018	intron_variant	0	NR	7e-06	5.154901959985743	(African American)	0.11472299	[0.065-0.165] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q24.21	8	129686186.0	CCDC26, GSDMC	CCDC26 - MTRF1LP2	ENSG00000229140	ENSG00000224110		2416.0	42558.0	rs11785932-?	rs11785932	0.0	11785932	non_coding_transcript_exon_variant	1	NR	6e-06	5.221848749616356	(African American)	0.1731235	[0.098-0.248] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		8q24.23	8	138669240.0	COL22A1	COL22A1			ENSG00000169436			rs4909828-?	rs4909828	0.0	4909828	intron_variant	0	NR	4e-06	5.3979400086720375	(African American)	0.11563852	[0.067-0.164] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		9p22.2	9	18027288.0	SH3GL2, ADAMTSL1	ADAMTSL1			ENSG00000178031			rs7033195-?	rs7033195	0.0	7033195	intron_variant	0	NR	1e-07	7.0	(African American)	0.13148236	[0.083-0.18] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		10q26.3	10	129758408.0	MGMT	MGMT			ENSG00000170430			rs7075748-?	rs7075748	0.0	7075748	intron_variant	0	NR	4e-06	5.3979400086720375	(African American)	0.12672214	[0.073-0.18] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		12p12.3	12	17199356.0	SKP1P2, LINC02378	RPL7P40 - NA	ENSG00000242991			76896.0		rs9788058-?	rs9788058	0.0	9788058	intergenic_variant	1	NR	8e-06	5.096910013008056	(African American)	0.11375368	[0.064-0.164] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		12q13.12	12	49030833.0	KMT2D	KMT2D			ENSG00000167548			rs11614738-?	rs11614738	0.0	11614738	intron_variant	0	NR	9e-06	5.045757490560675	(African American)	0.2097678	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		12q15	12	68488260.0	LINC02384, RAP1B	LINC02384 - RPSAP12	ENSG00000251301	ENSG00000240087		36597.0	64735.0	rs7311899-?	rs7311899	0.0	7311899	intergenic_variant	1	NR	1e-05	5.0	(African American)	0.10948604	[0.061-0.158] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		14q22.3	14	57182836.0	OTX2-AS1, EXOC5	OTX2-AS1 - EXOC5	ENSG00000248550	ENSG00000070367		30659.0	17671.0	rs11848373-?	rs11848373	0.0	11848373	regulatory_region_variant	1	NR	6e-06	5.221848749616356	(African American)	0.116439104	[0.066-0.167] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16q13	16	56957451.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		12587.0	4472.0	rs183130-?	rs183130	0.0	183130	upstream_gene_variant	1	NR	3e-17	16.522878745280337	(African American)	0.23224984	[0.18-0.29] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		16q21	16	58663987.0	CNOT1, SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		34102.0	1122.0	rs6499965-?	rs6499965	0.0	6499965	intergenic_variant	1	NR	5e-06	5.301029995663981	(African American)	0.14091316	[0.08-0.201] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	3e-06	5.522878745280337	(African American)	0.18373023	[0.11-0.26] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		20q13.2	20	54227811.0	PFDN4, DOK5	PFDN4			ENSG00000101132			rs12625916-?	rs12625916	0.0	12625916	intron_variant	0	NR	7e-06	5.154901959985743	(African American)	0.29461488	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals		21q21.2	21	24409334.0	LINC01689, LINC01684	LINC01684			ENSG00000237484			rs2829047-?	rs2829047	0.0	2829047	intron_variant	0	NR	1e-06	6.0	(African American)	0.118722744	[0.071-0.166] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ACOT7							chr1:6399288-?	chr1:6399288	0.0			1	NR	2e-06	5.698970004336019	(EA, female)	0.541375	[0.32-0.76] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ERRFI1, LINC01714							chr1:8149779-?	chr1:8149779	0.0			1	NR	6e-06	5.221848749616356	(EA, female)	0.83748174	[0.48-1.19] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PRDM2, KAZN							chr1:14193271-?	chr1:14193271	0.0			1	NR	1e-05	5.0	(EA, female)	1.529811	[0.86-2.2] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					STON1-GTF2A1L, FSHR							chr2:49137717-?	chr2:49137717	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.3937552	[0.22-0.56] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					ITPR1							chr3:4659146-?	chr3:4659146	0.0			1	NR	6e-06	5.221848749616356	(EA, female)	0.36077836	[0.21-0.51] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PPARG							chr3:12418612-?	chr3:12418612	0.0			1	NR	1e-05	5.0	(EA, female)	0.35727122	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					MIR1324, FRG2EP							chr3:75682284-?	chr3:75682284	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.334243	[0.19-0.48] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC102546299, LINC01947							chr5:165258171-?	chr5:165258171	0.0			1	NR	3e-06	5.522878745280337	(EA, female)	1.980944	[1.17-2.8] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					INTS4P2, LOC441242							chr7:65130415-?	chr7:65130415	0.0			1	NR	7e-06	5.154901959985743	(EA, female)	1.2170002	[0.69-1.74] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					EN2							chr7:155256864-?	chr7:155256864	0.0			1	NR	5e-06	5.301029995663981	(EA, female)	1.4439292	[0.84-2.05] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LOC101927815, CSMD1							chr8:2734438-?	chr8:2734438	0.0			1	NR	5e-06	5.301029995663981	(EA, female)	0.4497377	[0.26-0.64] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					TMEM261, PTPRD							chr9:8029850-?	chr9:8029850	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.35703498	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					PRKG1							chr10:53418788-?	chr10:53418788	0.0			1	NR	2e-07	6.698970004336019	(EA, female)	1.6922591	[1.06-2.32] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					SSPN, ITPR2							chr12:26470169-?	chr12:26470169	0.0			1	NR	6e-06	5.221848749616356	(EA, female)	0.38279083	[0.22-0.55] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					RBM19, LINC02459							chr12:114544267-?	chr12:114544267	0.0			1	NR	2e-06	5.698970004336019	(EA, female)	0.6775889	[0.41-0.95] unit increase	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02332							chr14:23026298-?	chr14:23026298	0.0			1	NR	8e-06	5.096910013008056	(EA, female)	0.39180258	[0.22-0.56] unit decrease	Illumina [13620258] (imputed)	N
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals					LINC02315							chr14:41589165-?	chr14:41589165	0.0			1	NR	4e-06	5.3979400086720375	(EA, female)	1.0680484	[0.62-1.51] unit increase	Illumina [13620258] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.32	6	32697014.0	HLA-DQB1, HLA-DQA2	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		28631.0	9110.0	rs116303320-?	rs116303320	0.0	116303320	regulatory_region_variant	1	NR	5e-13	12.30102999566398		0.0603	[0.044-0.077] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q16.3	6	100860545.0	ASCC3	ASCC3			ENSG00000112249			rs11963911-?	rs11963911	0.0	11963911	intron_variant	0	NR	3e-08	7.522878745280337		0.0199	[0.013-0.027] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q25.3	6	160576086.0	LPA	LPA			ENSG00000198670			rs74617384-?	rs74617384	0.0	74617384	intron_variant	0	NR	4.0000000000000004e-24	23.39794000867204		0.1337	[0.11-0.16] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.3	7	21566355.0	DNAH11	DNAH11			ENSG00000105877			rs55696093-?	rs55696093	0.0	55696093	intron_variant	0	NR	8e-10	9.096910013008056		0.0232	[0.016-0.031] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.2	7	25957916.0	MIR148A, NFE2L3	MIR148A - NA	ENSG00000199085			7930.0		rs4719841-?	rs4719841	0.0	4719841	intergenic_variant	1	NR	2e-09	8.698970004336019		0.0217	[0.015-0.029] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p13	7	44541277.0	NPC1L1	NPC1L1			ENSG00000015520			rs41279633-?	rs41279633	0.0	41279633	5_prime_UTR_variant	0	NR	5e-12	11.30102999566398		0.0595	[0.043-0.076] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p12.2	7	50270294.0	C7orf72, IKZF1	SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		111038.0	33774.0	rs62447171-?	rs62447171	0.0	62447171	intergenic_variant	1	NR	1e-08	8.0		0.0206	[0.014-0.028] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					MAGI2							chr7:78341454-?	chr7:78341454	0.0			1	NR	2e-09	8.698970004336019		1.5683	[1.06-2.08] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p23.1	8	9326086.0	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38508.0	45004.0	rs4841132-?	rs4841132	0.0	4841132	non_coding_transcript_exon_variant	1	NR	2e-18	17.69897000433602		0.0794	[0.062-0.097] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p22	8	18414928.0	NAT2, PSD3	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13710.0	112375.0	rs4921914-?	rs4921914	0.0	4921914	intergenic_variant	1	NR	7e-12	11.154901959985745		0.0261	[0.019-0.034] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q12.1	8	58480178.0	UBXN2B, CYP7A1	UBXN2B - CYP7A1	ENSG00000215114	ENSG00000167910		28677.0	10000.0	rs10107182-?	rs10107182	0.0	10107182	intergenic_variant	1	NR	2e-18	17.69897000433602		0.0374	[0.029-0.046] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q23.3	8	115646356.0	TRPS1	TRPS1			ENSG00000104447			rs2737245-?	rs2737245	0.0	2737245	intron_variant	0	NR	4e-13	12.397940008672036		0.0281	[0.02-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.13	8	125469835.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-?	rs2954021	0.0	2954021	intron_variant	1	NR	2e-31	30.69897000433602		0.0402	[0.034-0.047] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9q31.1	9	104903458.0	ABCA1	ABCA1			ENSG00000165029			rs2575876-?	rs2575876	0.0	2575876	intron_variant	0	NR	9e-51	50.04575749056068		0.0579	[0.05-0.066] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ABO							chr9:133273983-?	chr9:133273983	0.0			1	NR	6e-46	45.22184874961636		0.056	[0.048-0.064] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q22.1	10	72905766.0	OIT3	OIT3			ENSG00000138315			rs78295286-?	rs78295286	0.0	78295286	intron_variant	0	NR	7e-09	8.154901959985743		0.0465	[0.031-0.062] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q23.33	10	95172943.0	CYP2C8, ACSM6	NA - PAWRP1		ENSG00000225533			10710.0	rs140962577-?	rs140962577	0.0	140962577	intergenic_variant	1	NR	8e-09	8.096910013008056		0.5193	[0.34-0.7] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q25.2	10	112153794.0	GPAM	GPAM			ENSG00000119927			rs1807800-?	rs1807800	0.0	1807800	intron_variant	0	NR	1e-14	14.0		0.031	[0.023-0.039] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11p15.4	11	5226774.0	HBB	HBB			ENSG00000244734			rs11549407-?	rs11549407	0.0	11549407	stop_gained	0	NR	5e-23	22.30102999566398		0.48	[0.39-0.57] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ST5							chr11:8817025-?	chr11:8817025	0.0			1	NR	4e-08	7.397940008672037		1.3691	[0.88-1.86] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11p15.4	11	10296195.0	SBF2, ADM	SBF2 - ADM	ENSG00000133812	ENSG00000148926		1976.0	8878.0	rs114350711-?	rs114350711	0.0	114350711	intergenic_variant	1	NR	4e-08	7.397940008672037		1.2099	[0.78-1.64] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11p15.1	11	18632165.0	SPTY2D1	SPTY2D1			ENSG00000179119			rs11024743-?	rs11024743	0.0	11024743	intron_variant	0	NR	1e-08	8.0		0.0203	[0.013-0.027] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q12.2	11	61829161.0	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs99780-?	rs99780	0.0	99780	intron_variant	0	NR	5e-25	24.30102999566398		0.0365	[0.03-0.043] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q23.3	11	116752498.0	BUD13	BUD13			ENSG00000137656			rs398017699-?	rs398017699	1.0	66505542	intron_variant	0	NR	3e-27	26.522878745280337		0.1043	[0.085-0.123] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q24.2	11	126371958.0	ST3GAL4	ST3GAL4			ENSG00000110080			rs141200184-?	rs141200184	1.0	72085277	intron_variant	0	NR	1e-09	9.0		0.0592	[0.04-0.078] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q21.2	1	150320113.0	MRPS21, PRPF3	MRPS21 - PRPF3	ENSG00000266472	ENSG00000117360		11134.0	1366.0	rs11581793-?	rs11581793	0.0	11581793	regulatory_region_variant	1	NR	2e-08	7.698970004336019		0.1441	[0.094-0.194] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q31.1	2	169013785.0	ABCB11	ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs2241339-?	rs2241339	0.0	2241339	intron_variant	0	NR	9e-31	30.045757490560675		0.0469	[0.039-0.055] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q34	2	210675783.0	CPS1	CPS1			ENSG00000021826			rs1047891-?	rs1047891	0.0	1047891	missense_variant	0	NR	4e-15	14.397940008672036		0.0368	[0.028-0.046] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q37.1	2	232655544.0	EFHD1	EFHD1			ENSG00000115468			rs13395911-?	rs13395911	0.0	13395911	intron_variant	0	NR	2e-20	19.69897000433602		0.0347	[0.027-0.042] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		3q22.3	3	136207780.0	MSL2, PCCB	MSL2 - PCCB	ENSG00000174579	ENSG00000114054		10539.0	42560.0	rs645040-?	rs645040	0.0	645040	upstream_gene_variant	1	NR	2e-10	9.69897000433602		0.0278	[0.019-0.036] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		3q25.1	3	149494481.0	TM4SF4	TM4SF4			ENSG00000169903			rs62269283-?	rs62269283	0.0	62269283	intron_variant	0	NR	3e-15	14.522878745280336		0.0757	[0.057-0.095] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q21.1	4	76495474.0	SHROOM3	SHROOM3			ENSG00000138771			rs12500824-?	rs12500824	0.0	12500824	intron_variant	0	NR	1e-14	14.0		0.0273	[0.02-0.034] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q22.1	4	87255885.0	KLHL8, MIR5705	KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		15571.0	44610.0	rs11935592-?	rs11935592	0.0	11935592	intergenic_variant	1	NR	3e-17	16.522878745280337		0.0313	[0.024-0.039] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q31.21	4	145893489.0	ZNF827	ZNF827			ENSG00000151612			rs7682289-?	rs7682289	0.0	7682289	intron_variant	0	NR	8e-13	12.096910013008056		0.0274	[0.02-0.035] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q11.2	5	56792072.0	C5orf67, MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		185840.0	23477.0	rs144983009-?	rs144983009	0.0	144983009	intergenic_variant	1	NR	1e-10	10.0		0.0348	[0.024-0.045] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.1	7	28143829.0	JAZF1	JAZF1			ENSG00000153814			rs4722763-?	rs4722763	0.0	4722763	intron_variant	0	NR	2e-08	7.698970004336019		0.0215	[0.014-0.029] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p11.2	7	56005148.0	NIPSNAP2, PSPH	NIPSNAP2 - PSPH	ENSG00000146729	ENSG00000146733		4967.0	5903.0	rs4948100-?	rs4948100	0.0	4948100	regulatory_region_variant	1	NR	3e-08	7.522878745280337		0.0218	[0.014-0.029] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q21.12	7	87450286.0	ABCB4	ABCB4			ENSG00000005471			rs4148821-?	rs4148821	0.0	4148821	intron_variant	0	NR	1e-19	19.0		0.0361	[0.028-0.044] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q22.3	8	102650624.0	KLF10	KLF10			ENSG00000155090			rs13275089-?	rs13275089	0.0	13275089	intron_variant	0	NR	3e-08	7.522878745280337		0.0244	[0.016-0.033] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.13	8	125469835.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-?	rs2954021	0.0	2954021	intron_variant	1	NR	2e-19	18.69897000433602		0.0312	[0.024-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.3	8	144506797.0	GPT	GPT			ENSG00000167701			rs147998249-?	rs147998249	0.0	147998249	missense_variant	0	NR	3e-38	37.52287874528034		1.4295	[1.21-1.65] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9p24.1	9	6665010.0	GLDC, KDM4C	RPS3AP54 - RNF2P1	ENSG00000229057	ENSG00000231381		1218.0	3989.0	rs1658972-?	rs1658972	0.0	1658972	intron_variant	1	NR	1e-08	8.0		0.0301	[0.02-0.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9q32	9	114377802.0	AKNA	AKNA			ENSG00000106948			rs4979372-?	rs4979372	0.0	4979372	intron_variant	0	NR	1e-40	40.0		0.0476	[0.041-0.055] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ABO							chr9:133261662-?	chr9:133261662	0.0			1	NR	3e-08	7.522878745280337		0.0194	[0.013-0.026] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q22.3	10	77920756.0	DLG5	DLG5, DLG5			ENSG00000151208, ENSG00000274429			rs754465-?	rs754465	0.0	754465	intron_variant	0	NR	2e-09	8.698970004336019		0.0212	[0.014-0.028] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q24.1	10	96700824.0	PIK3AP1	PIK3AP1			ENSG00000155629			rs45587331-?	rs45587331	0.0	45587331	non_coding_transcript_exon_variant	0	NR	2e-11	10.69897000433602		0.0275	[0.019-0.036] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q24.31	10	100152437.0	ERLIN1	ERLIN1			ENSG00000107566			rs1408579-?	rs1408579	0.0	1408579	intron_variant	0	NR	1e-16	16.0		0.0463	[0.035-0.057] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q25.2	10	112189906.0	GPAM, TECTB	GPAM			ENSG00000119927			rs10787429-?	rs10787429	0.0	10787429	intron_variant	0	NR	2e-12	11.69897000433602		0.0298	[0.021-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q12.2	11	61836038.0	FADS2	FADS2			ENSG00000134824			rs174576-?	rs174576	0.0	174576	intron_variant	0	NR	1e-09	9.0		0.0215	[0.015-0.028] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q21	11	94198621.0	PANX1, IZUMO1R	ARPC3P3 - NA	ENSG00000256745			9624.0		rs1857682-?	rs1857682	0.0	1857682	intron_variant	1	NR	1.0000000000000001e-24	24.0		0.0417	[0.034-0.05] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12p13.33	12	514259.0	B4GALNT3	B4GALNT3			ENSG00000139044			rs60309576-?	rs60309576	0.0	60309576	intron_variant	0	NR	6e-10	9.221848749616356		0.0427	[0.029-0.056] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	109501836.0	UBE3B	UBE3B			ENSG00000151148			rs2241212-?	rs2241212	0.0	2241212	intron_variant	0	NR	2e-11	10.69897000433602		0.0264	[0.019-0.034] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	120968567.0	XLOC_009911, HNF1A-AS1	HNF1A-AS1			ENSG00000241388			rs2243616-?	rs2243616	0.0	2243616	intron_variant	0	NR	2e-16	15.69897000433602		0.0292	[0.022-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	124853983.0	SCARB1	SCARB1			ENSG00000073060			rs10773112-?	rs10773112	0.0	10773112	intron_variant	0	NR	6e-10	9.221848749616356		0.0244	[0.017-0.032] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					MIR5007, PRR20A							chr13:55738505-?	chr13:55738505	0.0			1	NR	8e-09	8.096910013008056		2.1495	[1.42-2.88] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					TXNDC16							chr14:52437710-?	chr14:52437710	0.0			1	NR	3e-09	8.522878745280337		2.9369	[1.96-3.91] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					SOCS4							chr14:55042419-?	chr14:55042419	0.0			1	NR	5e-09	8.301029995663981		2.7875	[1.85-3.72] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-?	rs1800588	0.0	1800588	intron_variant	0	NR	1e-69	69.0		0.0643	[0.057-0.071] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q13	16	56953457.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593.0	8466.0	rs56156922-?	rs56156922	0.0	56156922	intergenic_variant	1	NR	3e-35	34.52287874528034		0.05	[0.042-0.058] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q22.2	16	72045758.0	DHODH, HP	TXNL4B			ENSG00000140830			rs77303550-?	rs77303550	0.0	77303550	intron_variant	0	NR	1e-36	36.0		0.0574	[0.049-0.066] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q24.2	16	88484674.0	ZFPM1	ZFPM1			ENSG00000179588			rs2047596-?	rs2047596	0.0	2047596	intron_variant	0	NR	1e-08	8.0		0.0202	[0.013-0.027] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17p13.1	17	7176937.0	ASGR1	ASGR1			ENSG00000141505			rs754165241-?	rs754165241	0.0	754165241	intron_variant	0	NR	9.999999999999999e-27	26.0		0.5085	[0.42-0.6] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q21.32	17	47659909.0	KPNB1	KPNB1			ENSG00000108424			rs4264433-?	rs4264433	0.0	4264433	intron_variant	0	NR	3e-14	13.522878745280336		0.0278	[0.021-0.035] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q24.2	17	69086821.0	ABCA6	ABCA6			ENSG00000154262			rs740516-?	rs740516	0.0	740516	intron_variant	0	NR	1e-12	12.0		0.0286	[0.021-0.036] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		18q21.1	18	49592553.0	LIPG	LIPG			ENSG00000101670			rs3786247-?	rs3786247	0.0	3786247	3_prime_UTR_variant	0	NR	2.0000000000000002e-29	28.69897000433602		0.0445	[0.037-0.052] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	7868087.0	PRR36	EVI5L - PRR36	ENSG00000142459	ENSG00000183248		3111.0	632.0	rs145043195-?	rs145043195	0.0	145043195	intergenic_variant	1	NR	6e-16	15.221848749616356		5.4257	[4.11-6.74] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	11086210.0	SMARCA4, LDLR	SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		6784.0	3252.0	rs8106503-?	rs8106503	0.0	8106503	upstream_gene_variant	1	NR	2.9999999999999996e-76	75.52287874528034		0.191	[0.17-0.21] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					CLEC17A							chr19:14609794-?	chr19:14609794	0.0			1	NR	3e-14	13.522878745280336		1.1788	[0.88-1.48] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.11	19	19259532.0	HAPLN4	HAPLN4			ENSG00000187664			rs150641967-?	rs150641967	0.0	150641967	intron_variant	0	NR	7e-32	31.154901959985743		0.1329	[0.11-0.16] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	0.0	464.6989700043361		0.3619	[0.35-0.38] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.33	19	49496752.0	RPS11	RPS11			ENSG00000142534			rs2280401-?	rs2280401	0.0	2280401	intron_variant	0	NR	4e-10	9.397940008672036		0.0297	[0.02-0.039] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q12	20	40513876.0	LINC01370, MAFB	LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		502553.0	171972.0	rs2207132-?	rs2207132	0.0	2207132	regulatory_region_variant	1	NR	3e-27	26.522878745280337		0.1677	[0.14-0.2] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q13.12	20	44413724.0	HNF4A	HNF4A			ENSG00000101076			rs1800961-?	rs1800961	0.0	1800961	missense_variant	0	NR	1e-13	13.0		0.0901	[0.066-0.114] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		22q13.31	22	43928850.0	PNPLA3	PNPLA3			ENSG00000100344			rs738408-?	rs738408	0.0	738408	synonymous_variant	0	NR	1e-08	8.0		0.0207	[0.014-0.028] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.13	1	16184399.0	EPHA2, ARHGEF19	EPHA2 - ARHGEF19-AS1	ENSG00000142627	ENSG00000234166		28330.0	13455.0	rs36086195-?	rs36086195	0.0	36086195	regulatory_region_variant	1	NR	5e-09	8.301029995663981		0.0246	[0.016-0.033] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.11	1	26695422.0	ARID1A	ARID1A			ENSG00000117713			rs114165349-?	rs114165349	0.0	114165349	intron_variant	0	NR	2e-08	7.698970004336019		0.0995	[0.065-0.134] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p32.3	1	55039974.0	PCSK9	PCSK9			ENSG00000169174			rs11591147-?	rs11591147	0.0	11591147	missense_variant	0	NR	2e-59	58.69897000433602		0.4533	[0.4-0.51] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p31.3	1	62491359.0	DOCK7	DOCK7			ENSG00000116641			rs10889333-?	rs10889333	0.0	10889333	intron_variant	0	NR	6.0000000000000005e-31	30.22184874961636		0.0522	[0.043-0.061] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p22.1	1	92501859.0	GFI1, EVI5	GFI1 - EVI5	ENSG00000162676	ENSG00000067208		14934.0	6837.0	rs4000736-?	rs4000736	0.0	4000736	intergenic_variant	1	NR	2e-09	8.698970004336019		0.032	[0.022-0.042] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p13.3	1	109274570.0	CELSR2	CELSR2			ENSG00000143126			rs7528419-?	rs7528419	0.0	7528419	3_prime_UTR_variant	0	NR	3e-77	76.52287874528034		0.1017	[0.091-0.112] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q41	1	220796686.0	MARC1	MTARC1			ENSG00000186205			rs2642438-?	rs2642438	0.0	2642438	missense_variant	0	NR	7e-10	9.154901959985745		0.0266	[0.018-0.035] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q42.3	1	234717013.0	LOC101927787, LINC01132	LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		82233.0	7029.0	rs553427-?	rs553427	0.0	553427	intron_variant	1	NR	7.000000000000001e-24	23.154901959985743		0.0377	[0.03-0.045] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					KCNS3, RDH14							chr2:18298301-?	chr2:18298301	0.0			1	NR	3e-12	11.522878745280336		2.7061	[1.95-3.47] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p24.1	2	21041028.0	APOB	APOB			ENSG00000084674			rs1367117-?	rs1367117	0.0	1367117	missense_variant	0	NR	1.0000000000000001e-49	49.0		0.074	[0.064-0.084] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	24346372.0	ITSN2	ITSN2			ENSG00000198399			rs774254956-?	rs774254956	0.0	774254956	intron_variant	0	NR	5e-12	11.30102999566398		2.0168	[1.45-2.59] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-?	rs1260326	0.0	1260326	missense_variant	0	NR	1.9999999999999998e-25	24.69897000433602		0.0366	[0.03-0.043] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ALK, YPEL5							chr2:30145153-?	chr2:30145153	0.0			1	NR	4e-09	8.397940008672037		2.3048	[1.53-3.07] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					LTBP1							chr2:33032836-?	chr2:33032836	0.0			1	NR	3e-08	7.522878745280337		2.1668	[1.4-2.93] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p21	2	43845437.0	ABCG8	ABCG8			ENSG00000143921			rs4299376-?	rs4299376	0.0	4299376	intron_variant	0	NR	3e-41	40.52287874528034		0.0952	[0.081-0.109] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p15	2	62650251.0	TMEM17, EHBP1	RSL24D1P2 - EHBP1	ENSG00000230595	ENSG00000115504		88828.0	23600.0	rs6713090-?	rs6713090	0.0	6713090	intron_variant	1	NR	3e-11	10.522878745280336		0.0284	[0.02-0.037] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q24.1	2	157625480.0	ACVR1C	ACVR1C			ENSG00000123612			rs10164853-?	rs10164853	0.0	10164853	intron_variant	0	NR	5e-09	8.301029995663981		0.0304	[0.02-0.041] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4p16.3	4	3434861.0	RGS12	RGS12			ENSG00000159788			rs13116176-?	rs13116176	0.0	13116176	intron_variant	0	NR	2e-11	10.69897000433602		0.0237	[0.017-0.031] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q13.2	4	68453974.0	TMPRSS11E	TMPRSS11E, TMPRSS11E			ENSG00000274058, ENSG00000087128			rs1919903-?	rs1919903	0.0	1919903	intron_variant	0	NR	6e-09	8.221848749616356		0.0273	[0.018-0.037] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q13.3	5	75360714.0	HMGCR	CERT1, HMGCR			ENSG00000113163, ENSG00000113161			rs12916-?	rs12916	0.0	12916	3_prime_UTR_variant	0	NR	3.9999999999999997e-56	55.39794000867204		0.0545	[0.048-0.061] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Total cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q33.3	5	156964617.0	TIMD4, HAVCR1	TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		1391.0	64796.0	rs6874202-?	rs6874202	0.0	6874202	upstream_gene_variant	1	NR	3e-23	22.522878745280337		0.0437	[0.035-0.052] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q22.3	11	108566127.0	EXPH5	EXPH5			ENSG00000110723			rs2846407-?	rs2846407	0.0	2846407	intron_variant	0	NR	1e-08	8.0		0.0241	[0.016-0.033] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q13.13	12	52901297.0	KRT8	KRT8			ENSG00000170421			rs4531558-?	rs4531558	0.0	4531558	non_coding_transcript_exon_variant	0	NR	5e-08	7.301029995663981		0.0195	[0.012-0.027] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	111280427.0	CUX2	CUX2			ENSG00000111249			rs79105258-?	rs79105258	0.0	79105258	intron_variant	0	NR	2e-27	26.69897000433602		0.0544	[0.045-0.064] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		14q32.13	14	94378610.0	SERPINA1	SERPINA1, SERPINA1			ENSG00000197249, ENSG00000277377			rs28929474-?	rs28929474	0.0	28929474	missense_variant	0	NR	1e-17	17.0		0.2184	[0.17-0.27] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16p13.2	16	8866451.0	CARHSP1	CARHSP1			ENSG00000153048			rs575333217-?	rs575333217	0.0	575333217	intron_variant	0	NR	8e-09	8.096910013008056		0.4102	[0.27-0.55] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q25.3	17	81513660.0	ACTG1	ACTG1			ENSG00000184009			rs11657440-?	rs11657440	0.0	11657440	5_prime_UTR_variant	0	NR	4e-10	9.397940008672036		0.031	[0.021-0.041] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					LINC01892, AKAIN1							chr18:5130163-?	chr18:5130163	0.0			1	NR	3e-08	7.522878745280337		2.989	[1.94-4.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	10236408.0	S1PR2, MRPL4	S1PR2 - MRPL4	ENSG00000267534	ENSG00000105364		5077.0	15493.0	rs8108722-?	rs8108722	0.0	8108722	intergenic_variant	1	NR	2e-10	9.69897000433602		0.0238	[0.017-0.031] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.11	19	19268740.0	TM6SF2	TM6SF2			ENSG00000213996			rs58542926-?	rs58542926	0.0	58542926	missense_variant	0	NR	1e-13	13.0		0.0496	[0.036-0.063] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					LOC105372383, SDHAF1							chr19:35981142-?	chr19:35981142	0.0			1	NR	6e-09	8.221848749616356		0.866	[0.57-1.16] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.2	19	39352092.0	SAMD4B	SAMD4B			ENSG00000179134			rs773561743-?	rs773561743	0.0	773561743	5_prime_UTR_variant	0	NR	2e-12	11.69897000433602		0.8623	[0.62-1.1] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					TRAPPC6A							chr19:45177391-?	chr19:45177391	0.0			1	NR	1.9999999999999998e-42	41.69897000433602		4.4422	[3.8-5.08] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		21q21.3	21	28760989.0	LINC00161, N6AMT1	U6 - NA	ENSG00000266784			17698.0		rs2832059-?	rs2832059	0.0	2832059	intergenic_variant	1	NR	2e-09	8.698970004336019		0.0274	[0.019-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Alanine aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		22q13.31	22	43928847.0	PNPLA3	PNPLA3			ENSG00000100344			rs738409-?	rs738409	0.0	738409	missense_variant	0	NR	2.0000000000000002e-82	81.69897000433602		0.07	[0.063-0.077] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p13.3	1	109928142.0	CSF1	CSF1			ENSG00000184371			rs333947-?	rs333947	0.0	333947	intron_variant	0	NR	3e-26	25.522878745280337		0.0485	[0.039-0.058] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q25.3	1	183833125.0	RGL1	RGL1			ENSG00000143344			rs2491441-?	rs2491441	0.0	2491441	intron_variant	0	NR	7e-11	10.154901959985745		0.0266	[0.019-0.035] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	27558905.0	GCKR, C2orf16	C2orf16			ENSG00000221843			rs182700961-?	rs182700961	0.0	182700961	intron_variant	0	NR	2e-11	10.69897000433602		0.0306	[0.022-0.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q31.1	2	169013785.0	ABCB11	ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs2241339-?	rs2241339	0.0	2241339	intron_variant	0	NR	1e-15	15.0		0.033	[0.025-0.041] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q22.1	4	87255231.0	KLHL8, MIR5705	KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		14917.0	45264.0	rs28664118-?	rs28664118	0.0	28664118	intergenic_variant	1	NR	4e-15	14.397940008672036		0.0305	[0.023-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q31.22	4	145900258.0	ZNF827	ZNF827			ENSG00000151612			rs4835265-?	rs4835265	0.0	4835265	intron_variant	0	NR	2e-11	10.69897000433602		0.0271	[0.019-0.035] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5p13.1	5	39555201.0	LINC02104, LINC00603	CCDC11P1	ENSG00000271334			30475.0		rs2939328-?	rs2939328	0.0	2939328	intergenic_variant	0	NR	3e-09	8.522878745280337		0.0242	[0.016-0.032] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q13.2	5	73110201.0	FCHO2, TMEM171	FCHO2 - TMEM171	ENSG00000157107	ENSG00000157111		19679.0	10368.0	rs554327-?	rs554327	0.0	554327	intergenic_variant	1	NR	3e-11	10.522878745280336		0.025	[0.018-0.032] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.32	6	32606583.0	HLA-DRB1, HLA-DQA1	HLA-DRB1 - HLA-DQA1	ENSG00000196126	ENSG00000196735		16735.0	21596.0	rs2647074-?	rs2647074	0.0	2647074	intron_variant	1	NR	1e-13	13.0		0.0387	[0.029-0.049] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q23.3	6	135097880.0	HBS1L, MYB	HBS1L			ENSG00000112339			rs9399137-?	rs9399137	0.0	9399137	intron_variant	0	NR	1e-09	9.0		0.0237	[0.016-0.031] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q21.11	7	80545045.0	GNAT3, CD36	CD36			ENSG00000135218			rs139761834-?	rs139761834	0.0	139761834	intron_variant	0	NR	1e-12	12.0		0.0796	[0.058-0.102] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9p21.1	9	33117967.0	B4GALT1	B4GALT1			ENSG00000086062			rs7865362-?	rs7865362	0.0	7865362	intron_variant	0	NR	1e-13	13.0		0.0294	[0.022-0.037] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9q32	9	114386047.0	AKNA	AKNA			ENSG00000106948			rs10739409-?	rs10739409	0.0	10739409	intron_variant	0	NR	1e-16	16.0		0.0321	[0.024-0.04] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					FRMD4A							chr10:13693126-?	chr10:13693126	0.0			1	NR	4e-08	7.397940008672037		1.563	[1.01-2.12] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10p12.33	10	17839303.0	MRC1	MRC1			ENSG00000260314			rs377536650-?	rs377536650	1.0	2477656	intron_variant	0	NR	1.9999999999999998e-42	41.69897000433602		0.1619	[0.14-0.19] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					DNAJC1, EBLN1							chr10:22065168-?	chr10:22065168	0.0			1	NR	2e-09	8.698970004336019		0.804	[0.54-1.07] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q24.2	10	99372525.0	CNNM1	CNNM1			ENSG00000119946			rs10509735-?	rs10509735	0.0	10509735	intron_variant	0	NR	5e-24	23.30102999566398		0.0388	[0.031-0.046] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q21	11	94180526.0	PANX1	PANX1			ENSG00000110218			rs12804697-?	rs12804697	0.0	12804697	intron_variant	0	NR	5e-12	11.30102999566398		0.0355	[0.026-0.045] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	111280427.0	CUX2	CUX2			ENSG00000111249			rs79105258-?	rs79105258	0.0	79105258	intron_variant	0	NR	9e-24	23.045757490560675		0.0498	[0.04-0.06] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q21	16	58730951.0	GOT2	GOT2			ENSG00000125166			rs73550818-?	rs73550818	0.0	73550818	intron_variant	0	NR	3e-12	11.522878745280336		0.0295	[0.021-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.2	19	40832467.0	CYP2T1P, CYP2A6	CYP2F2P - CYP2A6	ENSG00000237118	ENSG00000255974		5695.0	11074.0	rs3852868-?	rs3852868	0.0	3852868	intron_variant	1	NR	8e-14	13.096910013008056		0.0315	[0.023-0.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					TRAPPC6A							chr19:45177391-?	chr19:45177391	0.0			1	NR	1e-10	10.0		2.448	[1.7-3.2] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	46932214.0	ARHGAP35	ARHGAP35			ENSG00000160007			rs547445211-?	rs547445211	0.0	547445211	intron_variant	0	NR	2e-08	7.698970004336019		1.9112	[1.25-2.58] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.33	19	49495592.0	RPS11	RPL13A - RPS11	ENSG00000142541	ENSG00000142534		2535.0	773.0	rs34750569-?	rs34750569	0.0	34750569	upstream_gene_variant	1	NR	2e-08	7.698970004336019		0.0283	[0.018-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Aspartate aminotransferase levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		22q13.31	22	43928847.0	PNPLA3	PNPLA3			ENSG00000100344			rs738409-?	rs738409	0.0	738409	missense_variant	0	NR	5e-74	73.30102999566398		0.0692	[0.062-0.077] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.11	1	26958422.0	KDF1	KDF1			ENSG00000175707			rs79598313-?	rs79598313	0.0	79598313	intron_variant	0	NR	2e-10	9.69897000433602		0.119	[0.083-0.155] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p31.3	1	65643762.0	LEPR, PDE4B	LEPR - RN7SL854P	ENSG00000116678	ENSG00000239319		2203.0	117296.0	rs200241668-?	rs200241668	0.0	200241668	downstream_gene_variant	1	NR	4e-44	43.39794000867204		0.0968	[0.083-0.11] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q21.3	1	154445939.0	IL6R	IL6R			ENSG00000160712			rs11265613-?	rs11265613	0.0	11265613	intron_variant	0	NR	8e-38	37.096910013008056		0.0574	[0.049-0.066] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q23.2	1	159712443.0	CRP	CRP			ENSG00000132693			rs1205-?	rs1205	0.0	1205	3_prime_UTR_variant	0	NR	2e-157	156.69897000433602		0.123	[0.11-0.13] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-?	rs1260326	0.0	1260326	missense_variant	0	NR	2e-20	19.69897000433602		0.0413	[0.033-0.05] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q14.1	2	113082998.0	IL1F10, IL1RN	IL1F10 - RNU6-1180P	ENSG00000136697	ENSG00000201805		7155.0	3807.0	rs10176274-?	rs10176274	0.0	10176274	intergenic_variant	1	NR	4e-10	9.397940008672036		0.0378	[0.026-0.05] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q26	6	160634639.0	LPA	LPA			ENSG00000198670			rs7765684-?	rs7765684	0.0	7765684	intron_variant	0	NR	9e-12	11.045757490560677		0.1395	[0.1-0.179] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.3	7	22683285.0	LOC401312, LOC541472	STEAP1B			ENSG00000105889			rs2961309-?	rs2961309	0.0	2961309	intron_variant	0	NR	6e-16	15.221848749616356		0.0443	[0.034-0.055] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p23.1	8	9326721.0	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		39143.0	44369.0	rs4240624-?	rs4240624	0.0	4240624	intron_variant	1	NR	3e-15	14.522878745280336		0.0802	[0.06-0.1] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9p13.2	9	37363641.0	ZCCHC7, GRHPR	ZCCHC7 - LINC01627	ENSG00000147905	ENSG00000224648		5492.0	19537.0	rs779732076-?	rs779732076	0.0	779732076	regulatory_region_variant	1	NR	9e-10	9.045757490560677		1.2473	[0.85-1.65] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	120983004.0	HNF1A	HNF1A			ENSG00000135100			rs1183910-?	rs1183910	0.0	1183910	intron_variant	0	NR	2e-77	76.69897000433602		0.0833	[0.074-0.092] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	125100233.0	AACS	AACS			ENSG00000081760			rs573701243-?	rs573701243	0.0	573701243	intron_variant	0	NR	5e-12	11.30102999566398		0.8426	[0.6-1.08] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		14q24.2	14	72545177.0	RGS6	RGS6			ENSG00000182732			rs2239222-?	rs2239222	0.0	2239222	intron_variant	0	NR	1e-09	9.0		0.0274	[0.019-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q21.3	15	53447229.0	LINC02490, WDR72	LINC02490 - WDR72	ENSG00000259237	ENSG00000166415		316885.0	66512.0	rs79391862-?	rs79391862	0.0	79391862	intron_variant	1	NR	1e-16	16.0		0.1672	[0.13-0.21] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q12.1	16	51402971.0	MIR548AI	UNGP1 - HNRNPA1P48	ENSG00000260818	ENSG00000224578		123859.0	150465.0	rs17616063-?	rs17616063	0.0	17616063	intron_variant	1	NR	6e-16	15.221848749616356		0.1199	[0.091-0.149] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17p13.2	17	6258465.0	WSCD1, AIPL1	RNU6-1264P - BTF3P14	ENSG00000206618	ENSG00000262609		51196.0	63948.0	rs151233628-?	rs151233628	0.0	151233628	regulatory_region_variant	1	NR	3e-08	7.522878745280337		0.0651	[0.042-0.088] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q12	17	37713312.0	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs17138478-?	rs17138478	0.0	17138478	intron_variant	0	NR	1e-08	8.0		0.0337	[0.022-0.045] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	C-reactive protein levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	44908684.0	APOE	APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	2e-140	139.69897000433602		0.1672	[0.15-0.18] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q24	4	102267552.0	SLC39A8	SLC39A8			ENSG00000138821			rs13107325-?	rs13107325	0.0	13107325	missense_variant	0	NR	4e-10	9.397940008672036		0.0865	[0.059-0.114] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q11.2	5	56513300.0	C5orf67	C5orf67			ENSG00000225940			rs157512-?	rs157512	0.0	157512	intron_variant	0	NR	3e-09	8.522878745280337		0.0267	[0.018-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q23.2	5	125012376.0	ZNF608, LOC101927421	LINC02240			ENSG00000260192			rs12516382-?	rs12516382	0.0	12516382	intron_variant	0	NR	5e-09	8.301029995663981		0.0269	[0.018-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.33	6	31364200.0	HLA-B, MICA	HLA-B - DHFRP2	ENSG00000206450	ENSG00000228432		7012.0	2152.0	rs2844583-?	rs2844583	0.0	2844583	intergenic_variant	1	NR	9e-10	9.045757490560677		0.0428	[0.029-0.057] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.32	6	32469837.0	HLA-DRA, HLA-DRB5	HLA-DRB9, HLA-DRB9, HLA-DRB9, HLA-DRB9, HLA-DRB9, HLA-DRB9, HLA-DRB9			ENSG00000234164, ENSG00000232705, ENSG00000228260, ENSG00000227526, ENSG00000196301, ENSG00000237591, ENSG00000226035			rs9405038-?	rs9405038	0.0	9405038	intron_variant	0	NR	1e-13	13.0		0.0366	[0.027-0.046] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.1	6	43790159.0	VEGFA, LINC01512	VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0.0	998584	downstream_gene_variant	1	NR	2e-15	14.69897000433602		0.0346	[0.026-0.043] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q22.1	6	116075818.0	FRK, NT5DC1	FRK - NT5DC1	ENSG00000111816	ENSG00000178425		14927.0	25033.0	rs4946136-?	rs4946136	0.0	4946136	intergenic_variant	1	NR	8e-09	8.096910013008056		0.0255	[0.017-0.034] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q22.33	6	127118902.0	RSPO3	RSPO3			ENSG00000146374			rs577721086-?	rs577721086	0.0	577721086	splice_region_variant	0	NR	3e-08	7.522878745280337		0.0805	[0.052-0.109] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q25.3	6	160587614.0	LPA	LPA			ENSG00000198670			rs41272086-?	rs41272086	0.0	41272086	intron_variant	0	NR	1e-08	8.0		0.0554	[0.036-0.075] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p22.1	7	6421679.0	DAGLB	DAGLB			ENSG00000164535			rs79949326-?	rs79949326	0.0	79949326	intron_variant	0	NR	7e-10	9.154901959985745		0.0316	[0.022-0.042] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p12.2	7	50259481.0	C7orf72, IKZF1	SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		100225.0	44587.0	rs11185602-?	rs11185602	0.0	11185602	intron_variant	1	NR	2e-09	8.698970004336019		0.0266	[0.018-0.035] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q11.23	7	73568544.0	TBL2	TBL2			ENSG00000106638			rs17145738-?	rs17145738	0.0	17145738	3_prime_UTR_variant	0	NR	2e-16	15.69897000433602		0.0547	[0.042-0.068] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q21.11	7	80713459.0	CD36, SEMA3C	CD36 - SEMA3C	ENSG00000135218	ENSG00000075223		34182.0	29079.0	rs189213544-?	rs189213544	0.0	189213544	intergenic_variant	1	NR	1e-18	18.0		0.1447	[0.11-0.18] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q32.2	7	130744427.0	KLF14, MIR29A	KLF14 - H4P1	ENSG00000266265	ENSG00000240680		10220.0	78778.0	rs13234269-?	rs13234269	0.0	13234269	intergenic_variant	1	NR	1e-08	8.0		0.0266	[0.017-0.036] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p23.1	8	9324101.0	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		36523.0	46989.0	rs2126263-?	rs2126263	0.0	2126263	intron_variant	1	NR	7e-20	19.154901959985743		0.0855	[0.067-0.104] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p21.3	8	19962213.0	LPL	LPL			ENSG00000175445			rs328-?	rs328	0.0	328	stop_gained	0	NR	1.9999999999999999e-115	114.69897000433602		0.1511	[0.14-0.16] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q23.3	8	115551652.0	TRPS1	TRPS1			ENSG00000104447			rs1351744-?	rs1351744	0.0	1351744	intron_variant	0	NR	8e-19	18.096910013008056		0.0413	[0.032-0.051] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.12	8	120863941.0	SNTB1, HAS2	SNTB1 - NA	ENSG00000172164			50668.0		rs12547186-?	rs12547186	0.0	12547186	intergenic_variant	1	NR	4e-08	7.397940008672037		0.0247	[0.016-0.034] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.13	8	125487789.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-?	rs28601761	0.0	28601761	intron_variant	1	NR	2e-16	15.69897000433602		0.0417	[0.032-0.052] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9p22.3	9	15295485.0	TTC39B	TTC39B			ENSG00000155158			rs570524-?	rs570524	0.0	570524	intron_variant	0	NR	6e-10	9.221848749616356		0.0501	[0.034-0.066] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		9q31.1	9	104903458.0	ABCA1	ABCA1			ENSG00000165029			rs2575876-?	rs2575876	0.0	2575876	intron_variant	0	NR	1.9999999999999998e-86	85.69897000433602		0.0935	[0.084-0.103] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					EPB41L4B							chr9:109240152-?	chr9:109240152	0.0			1	NR	2e-10	9.69897000433602		0.9773	[0.68-1.28] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q23.33	10	93024020.0	EXOC6	EXOC6			ENSG00000138190			rs7895716-?	rs7895716	0.0	7895716	intron_variant	0	NR	2e-10	9.69897000433602		0.0289	[0.02-0.038] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q25.2	10	112227082.0	GPAM, TECTB	GPAM - TECTB	ENSG00000119927	ENSG00000119913		11705.0	56318.0	rs12413488-?	rs12413488	0.0	12413488	intergenic_variant	1	NR	1e-16	16.0		0.0413	[0.031-0.051] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q26.12	10	121139183.0	WDR11, FGFR2	RPL19P16 - LINC01153	ENSG00000236762	ENSG00000227143		5460.0	39517.0	rs2257129-?	rs2257129	0.0	2257129	regulatory_region_variant	1	NR	2e-11	10.69897000433602		0.0394	[0.028-0.051] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11p11.2	11	47224846.0	DDB2	DDB2			ENSG00000134574			rs7395581-?	rs7395581	0.0	7395581	intron_variant	0	NR	1e-08	8.0		0.0269	[0.017-0.036] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q12.2	11	61818857.0	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs35473591-?	rs35473591	0.0	35473591	intron_variant	0	NR	2e-08	7.698970004336019		0.0376	[0.024-0.051] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q13.1	11	64101635.0	MACROD1	MACROD1, FLRT1			ENSG00000133315, ENSG00000126500			rs2701540-?	rs2701540	0.0	2701540	intron_variant	0	NR	3e-08	7.522878745280337		0.0299	[0.019-0.04] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q13.5	11	75744328.0	MOGAT2, LOC283214	RN7SL786P - DGAT2-DT	ENSG00000263993	ENSG00000247867		1902.0	14127.0	rs600518-?	rs600518	0.0	600518	downstream_gene_variant	1	NR	5e-11	10.30102999566398		0.032	[0.022-0.042] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q23.3	11	116791863.0	APOA5	APOA5			ENSG00000110243			rs651821-?	rs651821	0.0	651821	5_prime_UTR_variant	0	NR	1.0000000000000001e-159	159.0		0.1425	[0.13-0.15] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q24.1	11	122647817.0	MIR100HG, UBASH3B	GLULP3 - UBASH3B	ENSG00000254572	ENSG00000154127		33331.0	7905.0	rs6589939-?	rs6589939	0.0	6589939	regulatory_region_variant	1	NR	7e-09	8.154901959985743		0.0293	[0.019-0.039] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	109551423.0	UBE3B, MMAB	UBE3B - MMAB	ENSG00000151148	ENSG00000139428		14718.0	2292.0	rs12321904-?	rs12321904	0.0	12321904	downstream_gene_variant	1	NR	6e-18	17.221848749616356		0.04	[0.031-0.049] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	111280427.0	CUX2	CUX2			ENSG00000111249			rs79105258-?	rs79105258	0.0	79105258	intron_variant	0	NR	1e-70	70.0		0.1239	[0.11-0.14] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	124869264.0	SCARB1, UBC	SCARB1			ENSG00000073060			rs67053123-?	rs67053123	0.0	67053123	intron_variant	0	NR	4e-40	39.39794000867204		0.0679	[0.058-0.078] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-?	rs1800588	0.0	1800588	intron_variant	0	NR	3e-191	190.52287874528037		0.136	[0.13-0.15] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q21.3	15	58545905.0	LIPC	LIPC			ENSG00000166035			rs749932377-?	rs749932377	0.0	749932377	frameshift_variant	0	NR	1e-09	9.0		0.58	[0.42-0.74] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					LINGO1							chr15:77799744-?	chr15:77799744	0.0			1	NR	7e-09	8.154901959985743		2.3221	[1.54-3.11] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q13	16	56953457.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593.0	8466.0	rs56156922-?	rs56156922	0.0	56156922	intergenic_variant	1	NR	0.0	704.698970004336		0.2751	[0.27-0.28] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					GOT2, APOOP5							chr16:59582373-?	chr16:59582373	0.0			1	NR	3e-17	16.522878745280337		1.9965	[1.53-2.46] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q21	16	60765580.0	LOC729159, MIR4426							rs760008623-?	rs760008623	0.0	760008623	intergenic_variant	1	NR	1e-11	11.0		1.789	[1.27-2.31] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					CDH8, CDH11							chr16:62938187-?	chr16:62938187	0.0			1	NR	6e-16	15.221848749616356		3.3278	[2.52-4.13] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q22.1	16	67275732.0	SLC9A5, PLEKHG4	SLC9A5 - PLEKHG4	ENSG00000135740	ENSG00000196155		3541.0	1778.0	rs187144829-?	rs187144829	0.0	187144829	intergenic_variant	1	NR	5e-40	39.30102999566398		1.5974	[1.36-1.83] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q23.1	16	76424636.0	CNTNAP4	CNTNAP4			ENSG00000152910			rs559636178-?	rs559636178	0.0	559636178	intron_variant	0	NR	2e-10	9.69897000433602		1.3815	[0.96-1.81] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q24.3	2	164645339.0	GRB14, COBLL1	GRB14 - COBLL1	ENSG00000115290	ENSG00000082438		23857.0	8285.0	rs3923113-?	rs3923113	0.0	3923113	intergenic_variant	1	NR	4e-10	9.397940008672036		0.0415	[0.029-0.054] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q35	2	218856230.0	PRKAG3, WNT6	RPL23AP31 - WNT6	ENSG00000232625	ENSG00000115596		14165.0	3575.0	rs200513066-?	rs200513066	0.0	200513066	upstream_gene_variant	1	NR	1e-14	14.0		0.1117	[0.083-0.14] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q36.3	2	226239395.0	LOC646736, MIR5702	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		585377.0	419315.0	rs2972140-?	rs2972140	0.0	2972140	intergenic_variant	1	NR	6e-10	9.221848749616356		0.034	[0.023-0.045] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		3p25.2	3	12332833.0	PPARG	PPARG			ENSG00000132170			rs117350179-?	rs117350179	0.0	117350179	intron_variant	0	NR	2e-09	8.698970004336019		0.0379	[0.026-0.05] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.11	1	25452745.0	TMEM57	MACO1			ENSG00000204178			rs7519530-?	rs7519530	0.0	7519530	intron_variant	0	NR	5e-09	8.301029995663981		0.0278	[0.018-0.037] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.11	1	26958422.0	KDF1	KDF1			ENSG00000175707			rs79598313-?	rs79598313	0.0	79598313	intron_variant	0	NR	5e-11	10.30102999566398		0.113	[0.079-0.147] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p32.3	1	55039974.0	PCSK9	PCSK9			ENSG00000169174			rs11591147-?	rs11591147	0.0	11591147	missense_variant	0	NR	2e-67	66.69897000433602		0.4795	[0.43-0.53] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p31.3	1	62474596.0	DOCK7	DOCK7			ENSG00000116641			rs11442941-?	rs11442941	0.0	11442941	intron_variant	0	NR	2e-11	10.69897000433602		0.0454	[0.032-0.059] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p22.1	1	92597054.0	EVI5	EVI5			ENSG00000067208			rs6603997-?	rs6603997	0.0	6603997	intron_variant	0	NR	2e-08	7.698970004336019		0.0323	[0.021-0.043] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p13.3	1	109274968.0	CELSR2	CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0.0	12740374	3_prime_UTR_variant	0	NR	7e-104	103.15490195998576		0.1324	[0.12-0.14] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q42.13	1	227017202.0	CDC42BPA	CDC42BPA			ENSG00000143776			rs61834007-?	rs61834007	0.0	61834007	intron_variant	0	NR	6e-09	8.221848749616356		1.0905	[0.72-1.46] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q42.3	1	234716457.0	LOC101927787, LINC01132	LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		81677.0	7585.0	rs526936-?	rs526936	0.0	526936	intron_variant	1	NR	1e-21	21.0		0.0424	[0.034-0.051] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					KCNS3, RDH14							chr2:18298301-?	chr2:18298301	0.0			1	NR	1e-16	16.0		3.1527	[2.41-3.9] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p24.1	2	21041028.0	APOB	APOB			ENSG00000084674			rs1367117-?	rs1367117	0.0	1367117	missense_variant	0	NR	2.0000000000000002e-60	59.69897000433602		0.09	[0.079-0.101] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p24.1	2	22355635.0	LINC01822, LINC01884	RNA5SP87 - LINC01830	ENSG00000206882	ENSG00000234207		16632.0	21959.0	rs151337607-?	rs151337607	0.0	151337607	intron_variant	1	NR	4e-17	16.397940008672037		0.14	[0.11-0.17] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	24346372.0	ITSN2	ITSN2			ENSG00000198399			rs774254956-?	rs774254956	0.0	774254956	intron_variant	0	NR	4e-13	12.397940008672036		2.0643	[1.51-2.62] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					BABAM2							chr2:28287669-?	chr2:28287669	0.0			1	NR	5e-14	13.30102999566398		2.4365	[1.8-3.07] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ALK, YPEL5							chr2:30145153-?	chr2:30145153	0.0			1	NR	4e-08	7.397940008672037		2.1086	[1.36-2.86] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p21	2	43845437.0	ABCG8	ABCG8			ENSG00000143921			rs4299376-?	rs4299376	0.0	4299376	intron_variant	0	NR	2.9999999999999997e-44	43.52287874528034		0.0978	[0.084-0.112] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p15	2	62646781.0	TMEM17, EHBP1	RSL24D1P2 - EHBP1	ENSG00000230595	ENSG00000115504		85358.0	27070.0	rs6734002-?	rs6734002	0.0	6734002	intron_variant	1	NR	6e-11	10.221848749616356		0.0323	[0.023-0.042] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q14.1	2	118085225.0	CCDC93, INSIG2	RN7SL111P - INSIG2	ENSG00000243510	ENSG00000125629		68556.0	3227.0	rs55809639-?	rs55809639	0.0	55809639	intergenic_variant	1	NR	1e-09	9.0		0.0699	[0.048-0.092] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q24.1	2	157625480.0	ACVR1C	ACVR1C			ENSG00000123612			rs10164853-?	rs10164853	0.0	10164853	intron_variant	0	NR	4e-09	8.397940008672037		0.0381	[0.025-0.051] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		3p22.3	3	32527140.0	DYNC1LI1	DYNC1LI1			ENSG00000144635			rs62252794-?	rs62252794	0.0	62252794	intron_variant	0	NR	3e-08	7.522878745280337		0.037	[0.024-0.05] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q13.2	4	68453974.0	TMPRSS11E	TMPRSS11E, TMPRSS11E			ENSG00000274058, ENSG00000087128			rs1919903-?	rs1919903	0.0	1919903	intron_variant	0	NR	4e-08	7.397940008672037		0.0301	[0.019-0.041] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q13.3	5	75360714.0	HMGCR	CERT1, HMGCR			ENSG00000113163, ENSG00000113161			rs12916-?	rs12916	0.0	12916	3_prime_UTR_variant	0	NR	7e-58	57.15490195998574		0.0662	[0.058-0.074] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					MAF							chr16:79596851-?	chr16:79596851	0.0			1	NR	3e-08	7.522878745280337		1.5669	[1.01-2.12] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q23.2	16	81501185.0	CMIP	CMIP			ENSG00000153815			rs2925979-?	rs2925979	0.0	2925979	intron_variant	0	NR	2e-18	17.69897000433602		0.0393	[0.03-0.048] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q21.31	17	43763481.0	SOST, DUSP3	SOST - DUSP3	ENSG00000167941	ENSG00000108861		4690.0	2644.0	rs77697917-?	rs77697917	0.0	77697917	upstream_gene_variant	1	NR	2e-41	40.69897000433602		0.2683	[0.23-0.31] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q24.2	17	68781934.0	LINC01482, ABCA8	LINC01482 - ABCA8	ENSG00000267659	ENSG00000141338		18052.0	85355.0	rs34216592-?	rs34216592	0.0	34216592	intergenic_variant	1	NR	8e-09	8.096910013008056		0.0566	[0.037-0.076] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q25.3	17	78391282.0	PGS1	PGS1			ENSG00000087157			rs11657987-?	rs11657987	0.0	11657987	intron_variant	0	NR	5e-09	8.301029995663981		0.0261	[0.017-0.035] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		18q21.1	18	49592553.0	LIPG	LIPG			ENSG00000101670			rs3786247-?	rs3786247	0.0	3786247	3_prime_UTR_variant	0	NR	2.9999999999999997e-47	46.52287874528034		0.076	[0.066-0.086] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	8364439.0	ANGPTL4	ANGPTL4			ENSG00000167772			rs116843064-?	rs116843064	0.0	116843064	missense_variant	0	NR	1.0000000000000001e-28	28.0		0.2189	[0.18-0.26] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	11235874.0	DOCK6	DOCK6			ENSG00000130158			rs3760782-?	rs3760782	0.0	3760782	intron_variant	0	NR	8e-09	8.096910013008056		0.0312	[0.021-0.042] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	44908684.0	APOE	APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	2e-58	57.69897000433602		0.1026	[0.09-0.115] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					MIR4752, LILRA5							chr19:54296373-?	chr19:54296373	0.0			1	NR	7e-18	17.154901959985743		0.0616	[0.048-0.076] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q13.12	20	44413724.0	HNF4A	HNF4A			ENSG00000101076			rs1800961-?	rs1800961	0.0	1800961	missense_variant	0	NR	3e-17	16.522878745280337		0.1125	[0.086-0.139] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q13.12	20	45923216.0	PLTP, PCIF1	PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-?	rs6073958	0.0	6073958	downstream_gene_variant	1	NR	1.9999999999999998e-25	24.69897000433602		0.0626	[0.051-0.074] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		21q22.3	21	44848868.0	PTTG1IP	SUMO3 - PTTG1IP	ENSG00000184900	ENSG00000183255		30089.0	717.0	rs9980195-?	rs9980195	0.0	9980195	intergenic_variant	1	NR	3e-13	12.522878745280336		0.0313	[0.023-0.04] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		22q11.21	22	21610472.0	UBE2L3	UBE2L3			ENSG00000185651			rs4821112-?	rs4821112	0.0	4821112	intron_variant	0	NR	1e-20	20.0		0.0419	[0.033-0.051] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		Xp22.2	X	14875053.0	MOSPD2	MOSPD2			ENSG00000130150			rs139120857-?	rs139120857	0.0	139120857	intron_variant	0	NR	2e-10	9.69897000433602		0.0727	[0.05-0.095] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p36.11	1	26958422.0	KDF1	KDF1			ENSG00000175707			rs79598313-?	rs79598313	0.0	79598313	intron_variant	0	NR	3e-09	8.522878745280337		0.1034	[0.069-0.138] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p34.3	1	39570256.0	LOC101929516	PABPC4-AS1, PABPC4			ENSG00000228060, ENSG00000090621			rs3768321-?	rs3768321	0.0	3768321	intron_variant	0	NR	7e-12	11.154901959985745		0.0388	[0.028-0.05] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p22.1	1	93388629.0	DR1, FNBP1L	Y_RNA - FNBP1L	ENSG00000264495	ENSG00000137942		2812.0	59489.0	rs7417952-?	rs7417952	0.0	7417952	intergenic_variant	1	NR	2e-14	13.69897000433602		0.0341	[0.025-0.043] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p13.3	1	109928142.0	CSF1	CSF1			ENSG00000184371			rs333947-?	rs333947	0.0	333947	intron_variant	0	NR	6e-09	8.221848749616356		0.032	[0.021-0.043] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q25.2	1	178603558.0	C1orf220, MIR4424	RNA5SP69 - MIR4424	ENSG00000201347	ENSG00000266417		42529.0	74191.0	rs2811289-?	rs2811289	0.0	2811289	regulatory_region_variant	1	NR	4e-08	7.397940008672037		0.0232	[0.015-0.031] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q25.3	1	182201657.0	ZNF648, LINC01344	LINC01344			ENSG00000228918			rs1779825-?	rs1779825	0.0	1779825	intron_variant	0	NR	5e-10	9.30102999566398		0.0291	[0.02-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q41	1	220796686.0	MARC1	MTARC1			ENSG00000186205			rs2642438-?	rs2642438	0.0	2642438	missense_variant	0	NR	4e-08	7.397940008672037		0.0282	[0.018-0.038] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q42.13	1	230161390.0	GALNT2	GALNT2			ENSG00000143641			rs2281721-?	rs2281721	0.0	2281721	intron_variant	0	NR	2e-22	21.69897000433602		0.0467	[0.037-0.056] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p24.1	2	20952480.0	LDAH, APOB	LINC02850 - APOB	ENSG00000236436	ENSG00000084674		90819.0	48949.0	rs36143286-?	rs36143286	0.0	36143286	regulatory_region_variant	1	NR	1e-20	20.0		0.0721	[0.057-0.087] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	High density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ALMS1							chr2:73538394-?	chr2:73538394	0.0			1	NR	4e-08	7.397940008672037		2.3703	[1.53-3.21] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q33.3	5	156968992.0	TIMD4, HAVCR1	TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		5766.0	60421.0	rs12657266-?	rs12657266	0.0	12657266	intergenic_variant	1	NR	1e-13	13.0		0.0371	[0.027-0.047] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.32	6	32695482.0	HLA-DQB1, HLA-DQA2	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		27099.0	10642.0	rs112927854-?	rs112927854	0.0	112927854	intergenic_variant	1	NR	4e-09	8.397940008672037		0.0728	[0.049-0.097] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					SLC22A1							rs113569197-?	rs113569197	0.0	35854239		1	NR	3e-09	8.522878745280337		0.05	[0.038-0.062] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6q25.3	6	160589086.0	LPA	LPA			ENSG00000198670			rs10455872-?	rs10455872	0.0	10455872	intron_variant	0	NR	6e-24	23.22184874961636		0.1319	[0.11-0.16] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.3	7	21566355.0	DNAH11	DNAH11			ENSG00000105877			rs55696093-?	rs55696093	0.0	55696093	intron_variant	0	NR	2e-08	7.698970004336019		0.0259	[0.017-0.035] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.2	7	25957916.0	MIR148A, NFE2L3	MIR148A - NA	ENSG00000199085			7930.0		rs4719841-?	rs4719841	0.0	4719841	intergenic_variant	1	NR	3e-15	14.522878745280336		0.0338	[0.025-0.042] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p13	7	44541277.0	NPC1L1	NPC1L1			ENSG00000015520			rs41279633-?	rs41279633	0.0	41279633	5_prime_UTR_variant	0	NR	3e-15	14.522878745280336		0.0674	[0.051-0.084] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q11.23	7	73577262.0	TBL2	TBL2			ENSG00000106638			rs35624969-?	rs35624969	0.0	35624969	intron_variant	0	NR	3e-08	7.522878745280337		0.0511	[0.033-0.069] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					MAGI2							chr7:78341454-?	chr7:78341454	0.0			1	NR	6e-09	8.221848749616356		1.4911	[0.99-1.99] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p23.1	8	9326086.0	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38508.0	45004.0	rs4841132-?	rs4841132	0.0	4841132	non_coding_transcript_exon_variant	1	NR	8e-12	11.096910013008056		0.0639	[0.046-0.082] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q12.1	8	58480178.0	UBXN2B, CYP7A1	UBXN2B - CYP7A1	ENSG00000215114	ENSG00000167910		28677.0	10000.0	rs10107182-?	rs10107182	0.0	10107182	intergenic_variant	1	NR	4e-16	15.397940008672036		0.04	[0.03-0.05] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q23.3	8	115646356.0	TRPS1	TRPS1			ENSG00000104447			rs2737245-?	rs2737245	0.0	2737245	intron_variant	0	NR	2e-11	10.69897000433602		0.0309	[0.022-0.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.13	8	125469835.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-?	rs2954021	0.0	2954021	intron_variant	1	NR	2e-20	19.69897000433602		0.0383	[0.03-0.046] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					ABO							chr9:133273983-?	chr9:133273983	0.0			1	NR	1.9999999999999998e-42	41.69897000433602		0.0649	[0.056-0.074] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q22.1	10	72932888.0	OIT3	OIT3			ENSG00000138315			rs41280378-?	rs41280378	0.0	41280378	3_prime_UTR_variant	0	NR	7e-12	11.154901959985745		0.0409	[0.029-0.053] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q23.33	10	95172943.0	CYP2C8, ACSM6	NA - PAWRP1		ENSG00000225533			10710.0	rs140962577-?	rs140962577	0.0	140962577	intergenic_variant	1	NR	2e-08	7.698970004336019		0.497	[0.32-0.67] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q25.2	10	112171932.0	GPAM	GPAM			ENSG00000119927			rs2792703-?	rs2792703	0.0	2792703	intron_variant	0	NR	2e-11	10.69897000433602		0.032	[0.023-0.041] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11p15.4	11	5226774.0	HBB	HBB			ENSG00000244734			rs11549407-?	rs11549407	0.0	11549407	stop_gained	0	NR	6e-22	21.22184874961636		0.4677	[0.37-0.56] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q12.2	11	61829161.0	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs99780-?	rs99780	0.0	99780	intron_variant	0	NR	1e-17	17.0		0.0362	[0.028-0.044] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q23.3	11	116752498.0	BUD13	BUD13			ENSG00000137656			rs398017699-?	rs398017699	1.0	66505542	intron_variant	0	NR	8e-11	10.096910013008056		0.0626	[0.044-0.081] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q24.2	11	126357828.0	ST3GAL4	ST3GAL4			ENSG00000110080			rs7928577-?	rs7928577	0.0	7928577	intron_variant	0	NR	2e-13	12.69897000433602		0.0455	[0.033-0.058] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12p13.33	12	514259.0	B4GALNT3	B4GALNT3			ENSG00000139044			rs60309576-?	rs60309576	0.0	60309576	intron_variant	0	NR	4e-13	12.397940008672036		0.053	[0.039-0.067] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.11	12	111280427.0	CUX2	CUX2			ENSG00000111249			rs79105258-?	rs79105258	0.0	79105258	intron_variant	0	NR	6e-19	18.22184874961636		0.0598	[0.047-0.073] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		12q24.31	12	120978847.0	HNF1A	HNF1A-AS1, HNF1A			ENSG00000241388, ENSG00000135100			rs1169288-?	rs1169288	0.0	1169288	missense_variant	0	NR	1e-12	12.0		0.0323	[0.023-0.041] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					TXNDC16							chr14:52437710-?	chr14:52437710	0.0			1	NR	3e-09	8.522878745280337		2.8789	[1.93-3.83] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					SOCS4							chr14:55042419-?	chr14:55042419	0.0			1	NR	1e-08	8.0		2.6696	[1.76-3.58] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16p13.13	16	11612244.0	LITAF, SNN	LITAF			ENSG00000189067			rs12445804-?	rs12445804	0.0	12445804	intron_variant	0	NR	1e-08	8.0		0.0291	[0.019-0.039] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q13	16	56953457.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593.0	8466.0	rs56156922-?	rs56156922	0.0	56156922	intergenic_variant	1	NR	6e-14	13.221848749616356		0.0354	[0.026-0.045] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q22.2	16	72063928.0	HPR	HPR, TXNL4B			ENSG00000261701, ENSG00000140830			rs3794695-?	rs3794695	0.0	3794695	intron_variant	0	NR	6e-24	23.22184874961636		0.046	[0.037-0.055] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q24.2	16	88484674.0	ZFPM1	ZFPM1			ENSG00000179588			rs2047596-?	rs2047596	0.0	2047596	intron_variant	0	NR	4e-08	7.397940008672037		0.0234	[0.015-0.032] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17p13.1	17	7176937.0	ASGR1	ASGR1			ENSG00000141505			rs754165241-?	rs754165241	0.0	754165241	intron_variant	0	NR	5e-31	30.30102999566398		0.5426	[0.45-0.63] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q11.2	17	28367840.0	VTN	VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0.0	704	missense_variant	0	NR	1e-10	10.0		0.0289	[0.02-0.038] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q21.32	17	47496995.0	MRPL45P2, NPEPPS	MRPL45P2 - NPEPPS	ENSG00000228782	ENSG00000141279		4503.0	25947.0	rs9897063-?	rs9897063	0.0	9897063	intergenic_variant	1	NR	3e-09	8.522878745280337		0.0374	[0.025-0.05] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q24.2	17	69086821.0	ABCA6	ABCA6			ENSG00000154262			rs740516-?	rs740516	0.0	740516	intron_variant	0	NR	1e-13	13.0		0.0365	[0.027-0.046] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	7868087.0	PRR36	EVI5L - PRR36	ENSG00000142459	ENSG00000183248		3111.0	632.0	rs145043195-?	rs145043195	0.0	145043195	intergenic_variant	1	NR	3e-19	18.522878745280337		5.9617	[4.66-7.26] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	11086585.0	SMARCA4, LDLR	SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		7159.0	2877.0	rs12151108-?	rs12151108	0.0	12151108	upstream_gene_variant	1	NR	1e-100	100.0		0.2177	[0.2-0.24] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					CLEC17A							chr19:14609794-?	chr19:14609794	0.0			1	NR	2e-17	16.69897000433602		1.2914	[0.99-1.59] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.11	19	19259532.0	HAPLN4	HAPLN4			ENSG00000187664			rs150641967-?	rs150641967	0.0	150641967	intron_variant	0	NR	5e-21	20.30102999566398		0.1052	[0.083-0.127] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.12	19	36547291.0	ZNF529	ZNF529			ENSG00000186020			rs1376217616-?	rs1376217616	0.0	1376217616	stop_gained	0	NR	1e-08	8.0		0.6	[0.38-0.82] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	0.0	872.0		0.576	[0.56-0.59] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20p12.1	20	17864040.0	BANF2, SNX5	BANF2 - RNU6-192P	ENSG00000125888	ENSG00000212555		128169.0	39722.0	rs2618566-?	rs2618566	0.0	2618566	regulatory_region_variant	1	NR	9e-11	10.045757490560677		0.0308	[0.022-0.04] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Low density lipoprotein cholesterol levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q12	20	40551182.0	LINC01370, MAFB	LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		539859.0	134666.0	rs1883711-?	rs1883711	0.0	1883711	regulatory_region_variant	1	NR	7.000000000000001e-24	23.154901959985743		0.1602	[0.13-0.19] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p31.3	1	62492087.0	DOCK7	DOCK7			ENSG00000116641			rs10789112-?	rs10789112	0.0	10789112	intron_variant	0	NR	7e-56	55.15490195998574		0.0729	[0.064-0.082] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1p22.1	1	93388960.0	DR1, FNBP1L	Y_RNA - FNBP1L	ENSG00000264495	ENSG00000137942		3143.0	59158.0	rs2114273-?	rs2114273	0.0	2114273	upstream_gene_variant	1	NR	1e-10	10.0		0.0248	[0.017-0.032] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		1q42.13	1	230159169.0	GALNT2	GALNT2			ENSG00000143641			rs2144300-?	rs2144300	0.0	2144300	intron_variant	0	NR	8e-19	18.096910013008056		0.0376	[0.029-0.046] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p24.1	2	20949129.0	LDAH, APOB	LINC02850 - APOB	ENSG00000236436	ENSG00000084674		87468.0	52300.0	rs397870692-?	rs397870692	1.0	5829763	intergenic_variant	1	NR	5e-19	18.30102999566398		0.0662	[0.052-0.081] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-?	rs1260326	0.0	1260326	missense_variant	0	NR	2e-133	132.69897000433602		0.0917	[0.084-0.099] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q24.3	2	164694691.0	COBLL1	COBLL1			ENSG00000082438			rs7607980-?	rs7607980	0.0	7607980	missense_variant	0	NR	2e-10	9.69897000433602		0.0626	[0.043-0.082] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q35	2	218856230.0	PRKAG3, WNT6	RPL23AP31 - WNT6	ENSG00000232625	ENSG00000115596		14165.0	3575.0	rs200513066-?	rs200513066	0.0	200513066	upstream_gene_variant	1	NR	4e-08	7.397940008672037		0.0765	[0.049-0.104] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		2q36.3	2	226257202.0	LOC646736, MIR5702	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		603184.0	401508.0	rs2943656-?	rs2943656	0.0	2943656	regulatory_region_variant	1	NR	3e-13	12.522878745280336		0.0358	[0.026-0.045] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4p16.3	4	3442204.0	HGFAC	HGFAC			ENSG00000109758			rs13108218-?	rs13108218	0.0	13108218	intron_variant	0	NR	3e-18	17.522878745280337		0.0326	[0.025-0.04] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		4q22.1	4	87252540.0	KLHL8, MIR5705	KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		12226.0	47955.0	rs7656630-?	rs7656630	0.0	7656630	intergenic_variant	1	NR	4e-14	13.397940008672036		0.028	[0.021-0.035] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q11.2	5	56565081.0	C5orf67	C5orf67			ENSG00000225940			rs5868014-?	rs5868014	0.0	5868014	intron_variant	0	NR	5e-11	10.30102999566398		0.0572	[0.04-0.074] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		5q33.3	5	156964617.0	TIMD4, HAVCR1	TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		1391.0	64796.0	rs6874202-?	rs6874202	0.0	6874202	upstream_gene_variant	1	NR	6e-14	13.221848749616356		0.0343	[0.025-0.043] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.33	6	31334865.0	HLA-C, HLA-B	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		33223.0	19007.0	rs11968046-?	rs11968046	0.0	11968046	intron_variant	1	NR	2e-11	10.69897000433602		0.0605	[0.043-0.078] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p21.1	6	43789345.0	VEGFA, LINC01512	VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		2858.0	55533.0	rs4711750-?	rs4711750	0.0	4711750	downstream_gene_variant	1	NR	8e-18	17.096910013008056		0.0334	[0.026-0.041] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		6p12.2	6	52767415.0	GSTA2, GSTA1	GSTA12P			ENSG00000217228			rs2608639-?	rs2608639	0.0	2608639	intron_variant	0	NR	1e-09	9.0		0.0289	[0.019-0.038] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7p15.2	7	25955443.0	MIR148A, NFE2L3	MIR148A - NA	ENSG00000199085			5457.0		rs4574742-?	rs4574742	0.0	4574742	intergenic_variant	1	NR	6e-10	9.221848749616356		0.024	[0.016-0.032] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		7q11.23	7	73606007.0	MLXIPL	MLXIPL			ENSG00000009950			rs3812316-?	rs3812316	0.0	3812316	missense_variant	0	NR	9.999999999999999e-85	84.0		0.1139	[0.1-0.13] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p22	8	18415790.0	NAT2, PSD3	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		14572.0	111513.0	rs1495743-?	rs1495743	0.0	1495743	intergenic_variant	1	NR	4e-14	13.397940008672036		0.0309	[0.023-0.039] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8p21.3	8	19962213.0	LPL	LPL			ENSG00000175445			rs328-?	rs328	0.0	328	stop_gained	0	NR	1e-196	196.0		0.1695	[0.16-0.18] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		8q24.13	8	125469835.0	TRIB1, LINC00861	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-?	rs2954021	0.0	2954021	intron_variant	1	NR	1e-70	70.0		0.065	[0.058-0.072] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q21.3	10	63229171.0	JMJD1C	JMJD1C			ENSG00000171988			rs7916868-?	rs7916868	0.0	7916868	intron_variant	0	NR	2e-10	9.69897000433602		0.026	[0.018-0.034] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		10q23.33	10	93071756.0	CYP26C1, CYP26A1	CYP26C1 - CYP26A1	ENSG00000187553	ENSG00000095596		2216.0	1719.0	rs4411227-?	rs4411227	0.0	4411227	intron_variant	1	NR	5e-18	17.30102999566398		0.0344	[0.027-0.042] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q12.2	11	61800281.0	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824			rs174544-?	rs174544	0.0	174544	3_prime_UTR_variant	0	NR	2e-18	17.69897000433602		0.0332	[0.026-0.041] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q13.1	11	64109691.0	FLRT1, MACROD1	FLRT1, MACROD1			ENSG00000126500, ENSG00000133315			rs11231698-?	rs11231698	0.0	11231698	intron_variant	0	NR	1e-08	8.0		0.0259	[0.017-0.035] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		11q23.3	11	116791863.0	APOA5	APOA5			ENSG00000110243			rs651821-?	rs651821	0.0	651821	5_prime_UTR_variant	0	NR	0.0	577.096910013008		0.2269	[0.22-0.24] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals					CBL							chr11:119253525-?	chr11:119253525	0.0			1	NR	2e-09	8.698970004336019		1.7256	[1.16-2.29] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q15.3	15	43735849.0	CATSPER2P1	CATSPER2P1			ENSG00000205771			rs147233090-?	rs147233090	0.0	147233090	intron_variant	0	NR	3e-10	9.522878745280336		0.1209	[0.083-0.159] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q21.3	15	58431476.0	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-?	rs1800588	0.0	1800588	intron_variant	0	NR	8e-55	54.096910013008056		0.061	[0.053-0.069] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		15q23	15	69913634.0	LINC00593, TLE3	DRAIC - NA	ENSG00000245750			70514.0		rs8038587-?	rs8038587	0.0	8038587	regulatory_region_variant	1	NR	4e-08	7.397940008672037		0.0292	[0.019-0.04] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		16q13	16	56953457.0	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593.0	8466.0	rs56156922-?	rs56156922	0.0	56156922	intergenic_variant	1	NR	3e-16	15.522878745280336		0.0346	[0.026-0.043] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q21.31	17	43848758.0	CD300LG	CD300LG			ENSG00000161649			rs72836561-?	rs72836561	0.0	72836561	missense_variant	0	NR	2e-12	11.69897000433602		0.1241	[0.089-0.159] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		17q24.2	17	67961452.0	BPTF	BPTF			ENSG00000171634			rs9899520-?	rs9899520	0.0	9899520	intron_variant	0	NR	1e-08	8.0		0.0267	[0.017-0.036] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	8364439.0	ANGPTL4	ANGPTL4			ENSG00000167772			rs116843064-?	rs116843064	0.0	116843064	missense_variant	0	NR	5e-30	29.30102999566398		0.2155	[0.18-0.25] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.2	19	11239812.0	ANGPTL8	DOCK6, ANGPTL8			ENSG00000130158, ENSG00000130173			rs2278426-?	rs2278426	0.0	2278426	missense_variant	0	NR	3e-15	14.522878745280336		0.0377	[0.028-0.047] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19p13.11	19	19268740.0	TM6SF2	TM6SF2			ENSG00000213996			rs58542926-?	rs58542926	0.0	58542926	missense_variant	0	NR	3e-32	31.522878745280337		0.0823	[0.069-0.096] unit increase	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		19q13.32	19	44912921.0	APOE, APOC1	APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-?	rs483082	0.0	483082	non_coding_transcript_exon_variant	1	NR	1e-85	85.0		0.0948	[0.085-0.104] unit decrease	Illumina [31500000] (imputed)	N
2021-03-22	33339817	Nielsen JB	2020-12-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33339817	Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.	Triglyceride levels	76,081 European ancestry individuals, 127,395 Japanese ancestry individuals		20q13.12	20	45923216.0	PLTP, PCIF1	PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-?	rs6073958	0.0	6073958	downstream_gene_variant	1	NR	3e-24	23.522878745280337		0.0541	[0.044-0.064] unit increase	Illumina [31500000] (imputed)	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19979653.0	PLA2G2A	PLA2G2A			ENSG00000188257			rs11573156-G	rs11573156	0.0	11573156	5_prime_UTR_variant	0	0.23	0.0	471.301029995664		2.31	[2.19-2.43] unit increase	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19978364.0	PLA2G2A	PLA2G2A			ENSG00000188257			rs2307246-T	rs2307246	0.0	2307246	non_coding_transcript_exon_variant	0	0.23	0.0	440.5228787452804		2.27	[2.15-2.39] unit increase	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19965513.0	PLA2G2E, PLA2G2A	PLA2G2E - RN7SL304P	ENSG00000188784	ENSG00000242688		41896.0	5456.0	rs12023742-A	rs12023742	0.0	12023742	intergenic_variant	1	0.38	3.9999999999999997e-138	137.39794000867204		1.15	[1.05-1.25] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19965885.0	PLA2G2E, PLA2G2A	PLA2G2E - RN7SL304P	ENSG00000188784	ENSG00000242688		42268.0	5084.0	rs13375942-C	rs13375942	0.0	13375942	regulatory_region_variant	1	0.26	6e-79	78.22184874961636		0.99	[0.87-1.11] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	20039837.0	PLA2G5	PLA2G5			ENSG00000127472			rs818678-T	rs818678	0.0	818678	intron_variant	0	0.39	9e-41	40.04575749056068		0.65	[0.55-0.75] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19864943.0	PLA2G2E	RNF186 - OTUD3	ENSG00000178828	ENSG00000169914		49660.0	17452.0	rs4654897-C	rs4654897	0.0	4654897	regulatory_region_variant	1	0.26	7e-33	32.15490195998574		0.65	[0.53-0.77] unit increase	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19958994.0	PLA2G2E, PLA2G2A	PLA2G2E - RN7SL304P	ENSG00000188784	ENSG00000242688		35377.0	11975.0	rs12408941-A	rs12408941	0.0	12408941	intergenic_variant	1	0.12	2e-31	30.69897000433602		0.79	[0.63-0.95] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.12	1	20103368.0	PLA2G5, PLA2G2C, PLA2G2D, PLA2G2F	PLA2G5 - PLA2G2D	ENSG00000127472	ENSG00000117215		11457.0	8571.0	rs492738-C	rs492738	0.0	492738	regulatory_region_variant	1	0.38	1.9999999999999998e-26	25.69897000433602		0.47	[0.37-0.57] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	20083047.0	PLA2G5	PLA2G5			ENSG00000127472			rs11573260-T	rs11573260	0.0	11573260	intron_variant	0	0.01	3e-18	17.522878745280337		1.8	[1.37-2.23] unit increase	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19924237.0	PLA2G2E	PLA2G2E - RN7SL304P	ENSG00000188784	ENSG00000242688		620.0	46732.0	rs2233688-C	rs2233688	0.0	2233688	intergenic_variant	1	0.11	9e-17	16.045757490560675		0.63	[0.45-0.81] unit increase	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.12	1	20128727.0	PLA2G5, PLA2G2C, PLA2G2D, PLA2G2F, UBXN10	PLA2G2D - PLA2G2F	ENSG00000117215	ENSG00000158786		9161.0	10596.0	rs12722987-A	rs12722987	0.0	12722987	intergenic_variant	1	0.17	1e-11	11.0		0.38	[0.24-0.52] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19985183.0	PLA2G5, PLA2G2A, PLA2G2E, OTUD3	PLA2G2A - PLA2G5	ENSG00000188257	ENSG00000127472		4767.0	42996.0	rs12568139-G	rs12568139	0.0	12568139	intergenic_variant	1	0.07	2e-11	10.69897000433602		0.72	[0.5-0.94] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		1p36.13	1	19910238.0	OTUD3	OTUD3			ENSG00000169914			rs17401735-G	rs17401735	0.0	17401735	3_prime_UTR_variant	0	0.18	1e-09	9.0		0.37	[0.23-0.51] unit decrease	Illumina [796141]	N
2019-07-29	31070471	Akinkuolie AO	2019-04-11	Arterioscler Thromb Vasc Biol	www.ncbi.nlm.nih.gov/pubmed/31070471	Group IIA Secretory Phospholipase A2 and Incident Cardiovascular Disease.	Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	6,692 European ancestry individuals		17q24.2	17	68883786.0	ABCA8	ABCA8			ENSG00000141338			rs34931250-T	rs34931250	0.0	34931250	splice_region_variant	0	0.05	3e-09	8.522878745280337		0.59	[0.35-0.83] unit increase	Illumina [796141]	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	1p21.1	1	106293321.0	PRMT6							rs1330225-C	rs1330225	0.0	1330225	intergenic_variant	1	0.01	7e-09	8.154901959985743	(MAP, during intervention)	5.16	[3.42-6.90] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	4e-08	7.397940008672037	(DBP, during intervention)	3.2	[2.06-4.34] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	11p11.2	11	44356606.0	ALX4	ALX4 - NA	ENSG00000052850			46467.0		rs11037965-T	rs11037965	0.0	11037965	intergenic_variant	1	0.07	3e-07	6.522878745280337	(MAP, response to intervention)	1.4	[0.87-1.93] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	16q12.1	16	51576036.0	SALL1	HNRNPA1P48			ENSG00000224578			rs2030114-A	rs2030114	0.0	2030114	intron_variant	0	0.01	7e-13	12.154901959985745	(DBP, during intervention)	3.14	[2.28-4.00] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	17q24.2	17	66231245.0	APOH	APOH			ENSG00000091583			rs11867410-C	rs11867410	0.0	11867410	intron_variant	0	0.02	3e-07	6.522878745280337	(DBP, during intervention)	3.96	[2.43-5.49] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	1e-08	8.0	(MAP, during intervention)	3.48	[2.28-4.68] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	6q14.1	6	78846449.0	IRAK1BP1	NA - IRAK1BP1		ENSG00000146243			21102.0	rs16890334-C	rs16890334	0.0	16890334	intergenic_variant	1	0.06	4e-09	8.397940008672037	(SBP, during intervention)	5.43	[3.63-7.23] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	6q14.1	6	78846449.0	IRAK1BP1	NA - IRAK1BP1		ENSG00000146243			21102.0	rs16890334-C	rs16890334	0.0	16890334	intergenic_variant	1	0.06	5e-07	6.301029995663981	(MAP, during intervention)	3.2	[1.95-4.45] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	16q12.1	16	51576036.0	SALL1	HNRNPA1P48			ENSG00000224578			rs2030114-A	rs2030114	0.0	2030114	intron_variant	0	0.01	2e-06	5.698970004336019	(MAP, during intervention)	4.12	[2.43-5.81] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	4q26	4	113940144.0	ARSJ	ARSJ			ENSG00000180801			rs4460079-C	rs4460079	0.0	4460079	intron_variant	0	0.21	3e-06	5.522878745280337	(MAP, during intervention)	1.58	[0.91-2.25] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	17q24.2	17	66231245.0	APOH	APOH			ENSG00000091583			rs11867410-C	rs11867410	0.0	11867410	intron_variant	0	0.02	3e-07	6.522878745280337	(MAP, during intervention)	4.21	[2.58-5.84] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	6e-06	5.221848749616356	(SBP, during intervention)	3.99	[2.27-5.71] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	6q14.1	6	78846449.0	IRAK1BP1	NA - IRAK1BP1		ENSG00000146243			21102.0	rs16890334-C	rs16890334	0.0	16890334	intergenic_variant	1	0.06	1e-10	10.0	(SBP, during intervention)	5.38	[3.73-7.03] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	4q26	4	113940144.0	ARSJ	ARSJ			ENSG00000180801			rs4460079-C	rs4460079	0.0	4460079	intron_variant	0	0.21	2e-07	6.698970004336019	(SBP, during intervention)	2.33	[1.45-3.21] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	4e-08	7.397940008672037	(MAP, during intervention)	3.37	[2.17-4.57] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	6q14.1	6	78846449.0	IRAK1BP1	NA - IRAK1BP1		ENSG00000146243			21102.0	rs16890334-C	rs16890334	0.0	16890334	intergenic_variant	1	0.06	2e-07	6.698970004336019	(SBP, during intervention)	4.32	[2.67-5.97] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	8q12.1	8	57876522.0	FAM110B	LINC01602			ENSG00000205293			rs10504249-G	rs10504249	0.0	10504249	intron_variant	0	0.02	1e-07	7.0	(DBP, response to intervention)	3.22	[2.02-4.42] mmHg increase	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	8q12.1	8	57876522.0	FAM110B	LINC01602			ENSG00000205293			rs10504249-G	rs10504249	0.0	10504249	intron_variant	0	0.02	4e-07	6.3979400086720375	(MAP, response to intervention)	2.95	[1.81-4.09] mmHg increase	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	1p21.1	1	106293321.0	PRMT6							rs1330225-C	rs1330225	0.0	1330225	intergenic_variant	1	0.01	1e-08	8.0	(DBP, during intervention)	5.48	[3.60-7.36] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	5e-07	6.301029995663981	(DBP, during intervention)	3.11	[1.89-4.33] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	2q31.1	2	173462117.0	CDCA7	JPT1P1 - CBY1P1	ENSG00000213148	ENSG00000236832		30305.0	15879.0	rs10930597-T	rs10930597	0.0	10930597	intergenic_variant	1	0.05	7e-06	5.154901959985743	(SBP, during intervention)	3.72	[2.09-5.35] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	5q21.2	5	105011948.0	RAB9BP1	NA - RAB9BP1		ENSG00000232159			87525.0	rs13178964-G	rs13178964	0.0	13178964	intron_variant	1	0.05	5e-07	6.301029995663981	(SBP, during intervention)	3.42	[2.09-4.75] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (low sodium intervention)	1,850 Han Chinese ancestry individuals	660 Han Chinese ancestry individuals	13q22.1	13	72985844.0	PIBF1	PIBF1			ENSG00000083535			rs8002688-T	rs8002688	0.0	8002688	intron_variant	0	0.04	2e-09	8.698970004336019	(SBP, response to intervention)	2.04	[1.37-2.71] mmHg increase	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	8p23.2	8	2923434.0	CSMD1	NA - CSMD1		ENSG00000183117			11919.0	rs2627282-A	rs2627282	0.0	2627282	intergenic_variant	1	0.02	6e-07	6.221848749616356	(DBP, response to intervention)	2.29	[1.39-3.19] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	11p11.2	11	44356606.0	ALX4	ALX4 - NA	ENSG00000052850			46467.0		rs11037965-T	rs11037965	0.0	11037965	intergenic_variant	1	0.07	2e-06	5.698970004336019	(DBP, response to intervention)	1.4	[0.83-1.97] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	8p23.2	8	2923434.0	CSMD1	NA - CSMD1		ENSG00000183117			11919.0	rs2627282-A	rs2627282	0.0	2627282	intergenic_variant	1	0.02	3e-07	6.522878745280337	(MAP, response to intervention)	2.33	[1.45-3.21] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	11p15.5	11	2631427.0	KCNQ1	KCNQ1, KCNQ1, KCNQ1OT1			ENSG00000282076, ENSG00000053918, ENSG00000269821			rs10832417-T	rs10832417	0.0	10832417	non_coding_transcript_exon_variant	0	0.31	4e-07	6.3979400086720375	(MAP, response to intervention)	1.05	[0.64-1.46] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	2q37.1	2	234394166.0	ARL4C	RPS20P12 - LINC01891	ENSG00000237784	ENSG00000231682		64328.0	50424.0	rs11887188-T	rs11887188	0.0	11887188	intergenic_variant	1	0.03	2e-08	7.698970004336019	(DBP, during intervention)	3.28	[2.14-4.42] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	11p15.5	11	2631427.0	KCNQ1	KCNQ1, KCNQ1, KCNQ1OT1			ENSG00000282076, ENSG00000053918, ENSG00000269821			rs10832417-T	rs10832417	0.0	10832417	non_coding_transcript_exon_variant	0	0.31	1e-06	6.0	(SBP, response to intervention)	1.3	[0.77-1.83] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	3q11.2	3	94524869.0	NSUN3	ARMC10P1 - NA	ENSG00000178660			17249.0		rs13067306-A	rs13067306	0.0	13067306	regulatory_region_variant	1	0.01	4e-07	6.3979400086720375	(DBP, during intervention)	4.86	[2.98-6.74] mmHg increase	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	6q14.1	6	78846449.0	IRAK1BP1	NA - IRAK1BP1		ENSG00000146243			21102.0	rs16890334-C	rs16890334	0.0	16890334	intergenic_variant	1	0.06	2e-06	5.698970004336019	(MAP, during intervention)	3.39	[1.98-4.80] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals	3q11.2	3	94524869.0	NSUN3	ARMC10P1 - NA	ENSG00000178660			17249.0		rs13067306-A	rs13067306	0.0	13067306	regulatory_region_variant	1	0.01	5e-06	5.301029995663981	(MAP, during intervention)	4.51	[2.57-6.45] mmHg increase	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium and potassium intervention)	1,836 Han Chinese ancestry individuals	654 Han Chinese ancestry individuals	2q37.1	2	234394166.0	ARL4C	RPS20P12 - LINC01891	ENSG00000237784	ENSG00000231682		64328.0	50424.0	rs11887188-T	rs11887188	0.0	11887188	intergenic_variant	1	0.03	1e-06	6.0	(MAP, during intervention)	2.98	[1.76-4.20] mmHg decrease	Affymetrix [2216774] (imputed)	N
2014-04-26	24165912	He J	2013-10-28	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/24165912	Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese.	Blood pressure measurement (high sodium intervention)	1,840 Han Chinese ancestry individuals	659 Han Chinese ancestry individuals				ARSJ							rs7658266-T	rs7658266b	0.0	7658266b		1	0.21	3e-07	6.522878745280337	(SBP, during intervention)	2.35	[1.45-3.25] mmHg decrease	Affymetrix [2216774] (imputed)	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		1p32.3	1	55039974.0	PCSK9	PCSK9			ENSG00000169174			rs11591147-?	rs11591147	0.0	11591147	missense_variant	0	NR	5e-09	8.301029995663981	(baseline LDL-C)	5.0	[3.43-6.57] mg/dL decrease	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		6q25.3	6	160589086.0	LPA	LPA			ENSG00000198670			rs10455872-?	rs10455872	0.0	10455872	intron_variant	0	NR	5e-15	14.30102999566398	(fractional LDL-C reduction)	6.8	[4.45-9.15] % increase	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		4q22.1	4	88117930.0	ABCG2	ABCG2			ENSG00000118777			rs1481012-?	rs1481012	0.0	1481012	intron_variant	0	NR	2e-15	14.69897000433602	(fractional LDL-C reduction)	5.1	[3.34-6.86] % decrease	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		19q13.32	19	44908822.0	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	2e-47	46.69897000433602	(baseline LDL-C)	6.2	[5.42-6.98] mg/dL decrease	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		6p22.3	6	16161194.0	MYLIP, GMPR, IDOL	MYLIP - MRPL42P2	ENSG00000007944	ENSG00000216364		12946.0	10412.0	rs6924995-?	rs6924995	0.0	6924995	non_coding_transcript_exon_variant	1	NR	5e-07	6.301029995663981	(absolute LDL-C reduction)	4.1	[2.73-5.47] mg/dL increase	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		6q23.2	6	130935224.0	EPB41L2	EPB41L2			ENSG00000079819			rs7769153-?	rs7769153	0.0	7769153	intron_variant	0	NR	2e-07	6.698970004336019	(fractional LDL-C reduction)	10.3	[6.77-13.83] % increase	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		9q22.1	9	88925144.0	S1PR3, SHC3, C9orf47	MIR4289 - PCNPP2	ENSG00000265873	ENSG00000225856		179239.0	45743.0	rs1875620-?	rs1875620	0.0	1875620	regulatory_region_variant	1	NR	7e-07	6.154901959985743	(absolute LDL-C reduction)	2.8	[1.62-3.98] mg/dL increase	Illumina [814418]	N
2012-03-14	22331829	Chasman DI	2012-02-13	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/22331829	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Response to statins (LDL cholesterol change)	6,989 European ancestry individuals		19p12	19	22431320.0	LOC342994, ZNF98	ZNF98			ENSG00000197360			rs931608-?	rs931608	0.0	931608	intron_variant	0	NR	3e-07	6.522878745280337	(absolute LDL-C reduction)	4.2	[2.44-5.96] mg/dL increase	Illumina [814418]	N
2008-06-16	18179892	Wallace C	2008-01-10	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/18179892	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	LDL cholesterol	1,955 European ancestry hypertensive individuals	2,033 European ancestry individuals from 519 families, 1,461 European ancestry twins	1p13.3	1	109279544.0	PSRC1, CELSR2	CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3793.0	12.0	rs599839-G	rs599839	0.0	599839	intergenic_variant	1	0.24	1e-07	7.0		0.95	[0.93-0.97] mMol/l increase	Affymetrix [400496]	N
2008-06-16	18179892	Wallace C	2008-01-10	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/18179892	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	LDL cholesterol	1,955 European ancestry hypertensive individuals	2,033 European ancestry individuals from 519 families, 1,461 European ancestry twins	2p23.3	2	27518370.0	GCKR	GCKR			ENSG00000084734			rs780094-T	rs780094	0.0	780094	intron_variant	0	0.39	5e-07	6.301029995663981				Affymetrix [400496]	N
2008-06-16	18179892	Wallace C	2008-01-10	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/18179892	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	LDL cholesterol	1,955 European ancestry hypertensive individuals	2,033 European ancestry individuals from 519 families, 1,461 European ancestry twins	11q23.3	11	116781707.0	APOA1, APOC3, APOA5	ZPR1			ENSG00000109917			rs6589566-G	rs6589566	0.0	6589566	intron_variant	0	0.06	3e-11	10.522878745280336				Affymetrix [400496]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		15q25.2	15	82683530.0	AP3B2	AP3B2, CPEB1-AS1			ENSG00000103723, ENSG00000259462			rs11638815-C	rs11638815	0.0	11638815	intron_variant	0	0.25	1e-06	6.0	(Change)	4.1	[2.14-6.06] nmol/min/ml increase	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		6q25.3	6	160589086.0	LPA	LPA			ENSG00000198670			rs10455872-G	rs10455872	0.0	10455872	intron_variant	0	0.05	2e-16	15.69897000433602	(percent change)	4.8	[0.82-2.78] percent increase	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		4q22.1	4	88124179.0	ABCG2	ABCG2			ENSG00000118777			rs2199936-A	rs2199936	0.0	2199936	intron_variant	0	0.11	2e-10	9.69897000433602	(percent change)	2.8	[1.82-3.78] percent decrease	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		1p22.3	1	84802560.0	EDG7	NA - LPAR3		ENSG00000171517			9042.0	rs10782529-C	rs10782529	0.0	10782529	intergenic_variant	1	0.36	4e-06	5.3979400086720375	(percent change)	1.7	[1.11-2.29] percent increase	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		14q32.2	14	98033121.0	C14orf177	LINC01550 - NA	ENSG00000246223			54997.0		rs10144042-A	rs10144042	0.0	10144042	intergenic_variant	1	0.24	2e-06	5.698970004336019	(percent change)	1.4	[0.62-2.18] percent decrease	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		15q23	15	69105686.0	NOX5	EWSAT1 - GLCE	ENSG00000212766	ENSG00000138604		9866.0	54898.0	rs1392635-A	rs1392635	0.0	1392635	intergenic_variant	1	0.26	2e-06	5.698970004336019	(percent change)	1.7	[0.92-2.48] percent increase	Illumina [796174]	N
2013-01-31	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2,673 European ancestry cases, 2,656 European ancestry controls		17q25.3	17	80350459.0	RNF213	RNF213			ENSG00000173821			rs12051723-T	rs12051723	0.0	12051723	intron_variant	0	0.14	3e-06	5.522878745280337	(percent change)	2.2	[1.22-3.18] percent increase	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	17q23.1	17	59772890.0	TMEM49	VMP1			ENSG00000062716			rs11650106-C	rs11650106	0.0	11650106	intron_variant	0	0.48	3e-09	8.522878745280337	(activity)	0.0092	[0.0039-0.0145] ng/ml decrease	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	12q24.31	12	124832197.0	SCARB1	SCARB1			ENSG00000073060			rs11057841-T	rs11057841	0.0	11057841	intron_variant	0	0.15	6e-14	13.221848749616356	(activity)	0.0286	[0.019-0.038] ng/ml increase	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	2p23.3	2	27508073.0	GCKR	GCKR			ENSG00000084734			rs1260326-T	rs1260326	0.0	1260326	missense_variant	0	0.44	5e-06	5.301029995663981	(mass)	0.0053	[-0.00215-0.01275] ng/ml decrease	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	16q13	16	56959412.0	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		14548.0	2511.0	rs3764261-T	rs3764261	0.0	3764261	upstream_gene_variant	1	0.34	7e-21	20.154901959985743	(mass)	0.0224	[0.014-0.030] ng/ml increase	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	6p12.3	6	46714342.0	PLA2G7	PLA2G7			ENSG00000146070			rs1362931-A	rs1362931	0.0	1362931	intron_variant	0	0.19	3e-19	18.522878745280337	(activity)	0.0231	[0.016-0.030] ng/ml increase	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	11q12.2	11	60230193.0	MS4A4E	MS4A4E, MS4A4A			ENSG00000214787, ENSG00000110079			rs600550-T	rs600550	0.0	600550	intron_variant	0	0.38	2e-11	10.69897000433602	(activity)	0.0137	[0.0068-0.0206] ng/ml decrease	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	19q13.32	19	44912383.0	APOE, APOC1	APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-T	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	0.11	9.999999999999999e-57	56.0	(activity)	0.071	[0.049-0.093] ng/ml decrease	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	2p24.1	2	21008720.0	APOB	APOB			ENSG00000084674			rs6413458-T	rs6413458	0.0	6413458	synonymous_variant	0	0.02	2e-07	6.698970004336019	(mass)	0.0398	[0.0088-0.0708] ng/ml decrease	Illumina [796174]	N
2013-01-30	23118302	Chu AY	2012-11-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/23118302	Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.	Lipoprotein-associated phospholipase A2 activity and mass	6,851 European ancestry individuals	13,664 European ancestry individuals	1p13.3	1	109274968.0	SORT1	CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	0.22	2e-22	21.69897000433602	(activity)	0.0344	[0.027-0.042] ng/ml decrease	Illumina [796174]	N
2009-12-29	20031604	Cheng YC	2009-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031604	Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.	Matrix metalloproteinase levels	778 Old Order Amish individuals		11q22.2	11	102820751.0	MMP-1	WTAPP1			ENSG00000255282			rs11225434-C	rs11225434	0.0	11225434	intron_variant	0	0.38	9.000000000000001e-29	28.045757490560675		0.39	[NR] unit increase	Affymetrix [338079]	N
2009-12-29	20031604	Cheng YC	2009-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031604	Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.	Matrix metalloproteinase levels	778 Old Order Amish individuals		11q22.3	11	104463511.0	MMP-3, MMP-1	LINC02552			ENSG00000256422			rs11226373-G	rs11226373	0.0	11226373	intron_variant	0	0.15	2e-18	17.69897000433602		0.44	[NR] unit increase	Affymetrix [338079]	N
2009-12-29	20031604	Cheng YC	2009-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031604	Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.	Matrix metalloproteinase levels	778 Old Order Amish individuals		20p11.23	20	19590937.0	SLC24A3	SLC24A3			ENSG00000185052			rs3790268-?	rs3790268	0.0	3790268	intron_variant	0	NR	3e-07	6.522878745280337				Affymetrix [338079]	N
2009-12-29	20031604	Cheng YC	2009-08-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031604	Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.	Matrix metalloproteinase levels	778 Old Order Amish individuals		11q22.2	11	102824377.0	MMP	WTAPP1			ENSG00000255282			rs495366-A	rs495366	0.0	495366	intron_variant	0	0.36	6e-34	33.22184874961636		0.44	[NR] unit decrease	Affymetrix [338079]	N
2011-05-26	21493818	Shaw SY	2011-04-21	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/21493818	Genetic and clinical correlates of early-outgrowth colony-forming units.	Monocyte early outgrowth colony forming units	1,654 European ancestry individuals		6q25.3	6	160368264.0	SLC22A, LPAL2, LPA	SLC22A3			ENSG00000146477			rs402219-G	rs402219	0.0	402219	intron_variant	0	0.3	6e-07	6.221848749616356		0.19	[0.11-0.27] unit increase	Affymetrix [~ 2500000] (imputed)	N
2011-05-26	21493818	Shaw SY	2011-04-21	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/21493818	Genetic and clinical correlates of early-outgrowth colony-forming units.	Monocyte early outgrowth colony forming units	1,654 European ancestry individuals		1q41	1	220803991.0	MOSC1	MTARC1			ENSG00000186205			rs6693017-G	rs6693017	0.0	6693017	intron_variant	0	0.15	3e-07	6.522878745280337		0.24	[0.14-0.34] unit increase	Affymetrix [~ 2500000] (imputed)	N
2011-05-26	21493818	Shaw SY	2011-04-21	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/21493818	Genetic and clinical correlates of early-outgrowth colony-forming units.	Monocyte early outgrowth colony forming units	1,654 European ancestry individuals		2p16.1	2	60054473.0	BCL11A							rs6712720-C	rs6712720	0.0	6712720	intron_variant	1	0.49	4e-06	5.3979400086720375		0.16	[0.08-0.24] unit increase	Affymetrix [~ 2500000] (imputed)	N
2010-01-13	20031538	Heid IM	2008-10-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031538	Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.	HDL cholesterol	Up to 4,274 European ancestry individuals	Up to 15,873 European ancestry individuals	8p21.3	8	19975135.0	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		7876.0	138208.0	rs17482753-T	rs17482753	0.0	17482753	intergenic_variant	1	0.11	3e-11	10.522878745280336		2.02	[NR] mg/dl increase	Affymetrix [up to 2557253] (imputed)	N
2010-01-13	20031538	Heid IM	2008-10-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031538	Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.	HDL cholesterol	Up to 4,274 European ancestry individuals	Up to 15,873 European ancestry individuals	18q21.1	18	49632720.0	LIPG	LIPG - SMUG1P1	ENSG00000101670	ENSG00000267444		33535.0	17630.0	rs7240405-A	rs7240405	0.0	7240405	regulatory_region_variant	1	0.15	5e-10	9.30102999566398		2.27	[NR] mg/dl decrease	Affymetrix [up to 2557253] (imputed)	N
2010-01-13	20031538	Heid IM	2008-10-01	Circ Cardiovasc Genet	www.ncbi.nlm.nih.gov/pubmed/20031538	Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.	HDL cholesterol	Up to 4,274 European ancestry individuals	Up to 15,873 European ancestry individuals	16q13	16	56951227.0	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		6363.0	10696.0	rs9989419-A	rs9989419	0.0	9989419	regulatory_region_variant	1	0.38	9e-27	26.045757490560675		2.66	[NR] mg/dl decrease	Affymetrix [up to 2557253] (imputed)	N
2009-01-14	19074352	Pollin TI	2008-12-17	Science	www.ncbi.nlm.nih.gov/pubmed/19074352	A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.	Triglycerides	809 Old Order Amish individuals	698 Old Order Amish individuals	11q23.3	11	117661016.0	APOA1, APOC3, APOA4, APOA5, DSCAML1	DSCAML1			ENSG00000177103			rs10892151-A	rs10892151	0.0	10892151	intron_variant	0	0.028	3e-29	28.522878745280337				Affymetrix [381934]	N
2021-11-02	34231218	McDonough CW	2021-07-07	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/34231218	Adverse Cardiovascular Outcomes and Antihypertensive treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies (ICAPS).	Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension	10,511 European ancestry individuals		8q21.3	8	90269138.0		LINC00534			ENSG00000253394			rs74551696-A	rs74551696	0.0	74551696	intron_variant	0	0.655	7e-07	6.154901959985743				Affymetrix, Illumina [6400000] (imputed)	N
2021-11-02	34231218	McDonough CW	2021-07-07	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/34231218	Adverse Cardiovascular Outcomes and Antihypertensive treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies (ICAPS).	Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension	10,511 European ancestry individuals		22q13.32	22	48473454.0		ARVCF - TAFA5	ENSG00000099889	ENSG00000219438		28456631.0	16099.0	rs5768651-T	rs5768651	0.0	5768651	intergenic_variant	1	0.272	9e-07	6.045757490560675				Affymetrix, Illumina [6400000] (imputed)	N
2021-11-02	34231218	McDonough CW	2021-07-07	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/34231218	Adverse Cardiovascular Outcomes and Antihypertensive treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies (ICAPS).	Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension	10,511 European ancestry individuals		22q13.32	22	48489977.0		TAFA5			ENSG00000219438			rs6008732-T	rs6008732	0.0	6008732	intron_variant	0	0.215	9e-07	6.045757490560675				Affymetrix, Illumina [6400000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Chitinase-3-like protein 1 levels	21,758 European ancestry individuals	9,173 individuals	1q32.1	1	203194947.0		CHI3L1 - CHIT1	ENSG00000133048	ENSG00000133063		8243.0	17880.0	rs4950931-A	rs4950931	0.0	4950931	intergenic_variant	1	0.79	0.0	1390.301029995664		0.6756	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	2q12.1	2	102354356.0		IL18R1			ENSG00000115604			rs4311080-C	rs4311080	0.0	4311080	intron_variant	0	0.63	2e-196	195.698970004336		0.243	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	2q12.1	2	102599713.0		SLC9A4 - SLC9A2	ENSG00000180251	ENSG00000115616		65741.0	19840.0	rs6725806-T	rs6725806	0.0	6725806	regulatory_region_variant	1	0.25	1.0000000000000001e-60	60.0		0.1507	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	11q24.2	11	126435600.0		KIRREL3, ST3GAL4			ENSG00000149571, ENSG00000110080			rs11603123-A	rs11603123	0.0	11603123	intron_variant	0	0.032	2.9999999999999997e-47	46.52287874528034		0.3712	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	11q24.2	11	126318510.0		DCPS			ENSG00000110063			rs672806-A	rs672806	0.0	672806	intron_variant	0	0.4	1.0000000000000001e-34	34.0		0.0998	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	2q11.2	2	102064141.0		IL1R2 - IL1R1	ENSG00000115590	ENSG00000115594		35597.0	403.0	rs7604529-A	rs7604529	0.0	7604529	regulatory_region_variant	1	0.86	2.0000000000000002e-23	22.69897000433602		0.1119	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	9q34.2	9	133279427.0		ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3403.0	58301.0	rs635634-T	rs635634	0.0	635634	upstream_gene_variant	1	0.2	4e-19	18.39794000867204		0.088	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	17p13.1	17	7166093.0		RPL7AP64 - ASGR1	ENSG00000213876	ENSG00000141505		24501.0	7338.0	rs186021206-A	rs186021206	0.0	186021206	intergenic_variant	1	0.0088	2e-16	15.69897000433602		0.6234	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	2q21.2	2	134256545.0		MGAT5			ENSG00000152127			rs2460382-A	rs2460382	0.0	2460382	intron_variant	0	0.77	1e-14	14.0		0.0714	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	4q24	4	102225733.0		BANK1 - SLC39A8	ENSG00000153064	ENSG00000138821		150921.0	25347.0	rs35518360-A	rs35518360	0.0	35518360	intergenic_variant	1	0.93	4e-10	9.397940008672036		0.1109	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	ST2 protein levels	21,758 European ancestry individuals	9,173 individuals	2q12.1	2	102315366.0		IL1RL1, IL18R1			ENSG00000115602, ENSG00000115604			rs13020553-C	rs13020553	0.0	13020553	intron_variant	0	0.63	0.0	1634.1549019599856		0.6377	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	10p14	10	7730072.0		ITIH2			ENSG00000151655			rs35524242-A	rs35524242	0.0	35524242	missense_variant	0	0.94	1e-239	239.0		0.7799	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	3q21.3	3	126550075.0		C3orf22			ENSG00000180697			rs869463-A	rs869463	0.0	869463	synonymous_variant	0	0.26	4.0000000000000004e-39	38.39794000867204		0.1591	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	10p14	10	7846432.0		TAF3			ENSG00000165632			rs11255401-T	rs11255401	0.0	11255401	intron_variant	0	0.93	3e-17	16.522878745280337		0.1855	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	3q25.32	3	157385890.0		VEPH1			ENSG00000197415			rs60515336-T	rs60515336	0.0	60515336	intron_variant	0	0.044	2e-15	14.69897000433602		0.2149	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	3q25.32	3	157486809.0		VEPH1			ENSG00000197415			rs9859018-A	rs9859018	0.0	9859018	intron_variant	0	0.28	1e-09	9.0		0.0743	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Pentraxin-related protein PTX3 levels	21,758 European ancestry individuals	9,173 individuals	3p21.1	3	52721576.0		NEK4			ENSG00000114904			rs11130319-A	rs11130319	0.0	11130319	intron_variant	0	0.59	7e-09	8.154901959985743		0.0612	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Chitinase-3-like protein 1 levels	21,758 European ancestry individuals	9,173 individuals	8q24.13	8	125487789.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-C	rs28601761	0.0	28601761	intron_variant	1	0.58	3e-43	42.52287874528034		0.109	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Chitinase-3-like protein 1 levels	21,758 European ancestry individuals	9,173 individuals	2p23.3	2	27508073.0		GCKR			ENSG00000084734			rs1260326-T	rs1260326	0.0	1260326	missense_variant	0	0.39	6e-17	16.221848749616356		0.0673	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Chitinase-3-like protein 1 levels	21,758 European ancestry individuals	9,173 individuals	15q22.2	15	60591082.0		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs339969-A	rs339969	0.0	339969	intron_variant	0	0.62	1e-16	16.0		0.0681	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Chitinase-3-like protein 1 levels	21,758 European ancestry individuals	9,173 individuals	2p21	2	41987058.0		C2orf91		ENSG00000162878			60963.0	rs62140201-A	rs62140201	0.0	62140201	intergenic_variant	0	0.029	3e-06	5.522878745280337		0.1457	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102890044.0		BOLA3P1 - RNU7-159P	ENSG00000255469	ENSG00000238562		9198.0	13848.0	rs11225452-A	rs11225452	0.0	11225452	intergenic_variant	1	0.24	1e-11	11.0		0.0648	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	19q13.42	19	54250239.0		LILRB5			ENSG00000105609			rs11668189-A	rs11668189	0.0	11668189	3_prime_UTR_variant	0	0.36	8e-11	10.096910013008056		0.0532	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102844950.0		MMP3 - MMP12	ENSG00000149968	ENSG00000262406		1341.0	17786.0	rs632478-T	rs632478	0.0	632478	intergenic_variant	1	0.49	0.0	821.1549019599858		0.4465	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Heat shock 27 kDa protein levels	21,758 European ancestry individuals	9,173 individuals	6q22.31	6	122472454.0		PKIB			ENSG00000135549			rs10535596-CAT	rs10535596	0.0	10535596	intron_variant	0	0.46	2e-17	16.69897000433602		0.0809	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Heat shock 27 kDa protein levels	21,758 European ancestry individuals	9,173 individuals	7q11.23	7	76301442.0		SRRM3 - HSPB1	ENSG00000177679	ENSG00000106211		14154.0	1231.0	rs2868371-C	rs2868371	0.0	2868371	upstream_gene_variant	1	0.74	0.0	553.0		0.4768	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102771530.0		WTAPP1, MMP10			ENSG00000255282, ENSG00000166670			rs12290253-T	rs12290253	0.0	12290253	intron_variant	0	0.81	1e-48	48.0		0.1925	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102924910.0		RNU7-159P - MMP13	ENSG00000238562	ENSG00000137745		20957.0	18085.0	rs17297226-A	rs17297226	0.0	17297226	intergenic_variant	1	0.75	9e-34	33.045757490560675		0.1396	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	8q23.1	8	105569300.0		ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs6993770-A	rs6993770	0.0	6993770	intron_variant	0	0.73	4.0000000000000004e-24	23.39794000867204		0.1091	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102620518.0		MMP20			ENSG00000137674			rs11383572-G	rs11383572	0.0	11383572	intron_variant	0	0.24	7e-18	17.154901959985743		0.1159	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102320217.0		BIRC3			ENSG00000023445			rs186356272-T	rs186356272	0.0	186356272	intron_variant	0	0.98	2e-15	14.69897000433602		0.4427	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	2q14.1	2	112738876.0		NT5DC4, CKAP2L			ENSG00000144130, ENSG00000169607			rs76036957-A	rs76036957	0.0	76036957	missense_variant	0	0.014	3e-11	10.522878745280336		0.355	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	1q22	1	156449994.0		MIR9-1HG			ENSG00000125462			rs12141791-A	rs12141791	0.0	12141791	intron_variant	0	0.7	8e-11	10.096910013008056		0.0739	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	12q13.3	12	56746722.0		PRIM1			ENSG00000198056			rs2958130-A	rs2958130	0.0	2958130	intron_variant	0	0.65	1e-08	8.0		0.0603	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-1 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102827000.0		WTAPP1			ENSG00000255282			rs471994-A	rs471994	0.0	471994	intron_variant	0	0.37	1e-312	312.0		0.3709	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	2p22.1	2	39839482.0		SLC8A1-AS1			ENSG00000227028			rs13011737-A	rs13011737	0.0	13011737	intron_variant	0	NR	8e-09	8.096910013008056	(Sub-Saharan African)	0.367	[0.24-0.49] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	18q21.2	18	55189482.0		RNA5SP459 - TCF4	ENSG00000252437	ENSG00000196628		42837.0	32703.0	rs8086468-G	rs8086468	0.0	8086468	intergenic_variant	1	NR	9e-09	8.045757490560675	(Sub-Saharan African)	0.623	[0.41-0.83] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	2p16.1	2	56470732.0		CCDC85A - PPIAP63	ENSG00000055813	ENSG00000231570		84560.0	279568.0	rs76616045-A	rs76616045	0.0	76616045	intergenic_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	0.597	[0.39-0.8] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	5q23.1	5	121649636.0		RPL23AP44 - FTMT	ENSG00000244088	ENSG00000181867		73316.0	202246.0	rs111257892-A	rs111257892	0.0	111257892	intergenic_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	0.903	[0.59-1.21] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	2q36.1	2	221342418.0		MIR4268 - EPHA4	ENSG00000266518	ENSG00000116106		1435853.0	75609.0	rs62181095-A	rs62181095	0.0	62181095	intergenic_variant	1	NR	2e-08	7.698970004336019	(Sub-Saharan African)	1.036	[0.67-1.4] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	5q32	5	147773287.0		JAKMIP2			ENSG00000176049			rs115318065-T	rs115318065	0.0	115318065	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.504	[0.33-0.68] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	20q13.13	20	49805992.0		RNU6-919P - SLC9A8	ENSG00000252540	ENSG00000197818		11078.0	6721.0	rs144851001-T	rs144851001	0.0	144851001	intergenic_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.793	[0.51-1.07] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	3q28	3	189258866.0		TPRG1			ENSG00000188001			rs13097624-A	rs13097624	0.0	13097624	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.708	[0.46-0.96] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	1p36.22	1	10682311.0		CASZ1			ENSG00000130940			rs369248421-A	rs369248421	0.0	369248421	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.892	[0.57-1.21] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	7q31.31	7	119185889.0		GTF3AP6 - LINC02476	ENSG00000229982	ENSG00000225546		304601.0	309135.0	rs1986679-G	rs1986679	0.0	1986679	intergenic_variant	1	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.754	[0.49-1.01] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	5q11.2	5	54142685.0		ARL15			ENSG00000185305			rs530241889-CCTAACATGCTCTTATGTTCCAG	rs530241889	0.0	530241889	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.821	[0.53-1.11] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	6p22.3	6	22211445.0		CASC15			ENSG00000272168			rs12523758-T	rs12523758	0.0	12523758	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.363	[0.24-0.49] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	20p11.23	20	19014600.0		SCP2D1-AS1 - SLC24A3	ENSG00000149443	ENSG00000185052		184447.0	198042.0	rs185486220-A	rs185486220	0.0	185486220	intron_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.92	[0.59-1.25] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	16q21	16	58790162.0		GEMIN8P2 - RPL12P36	ENSG00000260451	ENSG00000242423		12599.0	35729.0	rs572463038-T	rs572463038	0.0	572463038	intron_variant	1	NR	5e-08	7.301029995663981	(Sub-Saharan African)	0.761	[0.49-1.03] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	8q21.13	8	80949749.0		ZNF704 - PAG1	ENSG00000164684	ENSG00000076641		74968.0	18061.0	rs115858198-G	rs115858198	0.0	115858198	regulatory_region_variant	1	NR	5e-08	7.301029995663981	(Sub-Saharan African)	0.605	[0.39-0.82] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	4q28.3	4	133014101.0		LINC01256 - PCDH10-DT	ENSG00000251398	ENSG00000250241		335598.0	61210.0	rs112549844-C	rs112549844	0.0	112549844	intergenic_variant	1	NR	3e-12	11.522878745280336	(Sub-Saharan African)	0.983	[0.71-1.26] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	15q26.1	15	92943391.0		CHD2			ENSG00000173575			rs12915024-G	rs12915024	0.0	12915024	non_coding_transcript_exon_variant	0	NR	4e-09	8.397940008672037	(Sub-Saharan African)	0.76	[0.51-1.01] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	16q22.1	16	69790120.0		WWP2			ENSG00000198373			rs146520135-A	rs146520135	0.0	146520135	intron_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	0.924	[0.61-1.24] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry women	3,841 African American women	11q14.3	11	88713194.0		GRM5			ENSG00000168959			rs72962527-C	rs72962527	0.0	72962527	intron_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	0.632	[0.41-0.85] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	3p24.3	3	23698365.0		RNU6-788P - UBE2E1-AS1	ENSG00000212269	ENSG00000223791		56773.0	105659.0	rs6795094-C	rs6795094	0.0	6795094	intergenic_variant	1	NR	9e-09	8.045757490560675	(Sub-Saharan African)	0.624	[0.41-0.84] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	1q44	1	246956365.0		ZNF670-ZNF695, ZNF695			ENSG00000135747, ENSG00000197472			rs370409575-T	rs370409575	0.0	370409575	intron_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	1.154	[0.76-1.55] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	13q32.3	13	100952875.0		NALCN-AS1			ENSG00000233009			rs12428438-G	rs12428438	0.0	12428438	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.654	[0.43-0.88] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	7p15.1	7	28228044.0		JAZF1-AS1			ENSG00000234336			rs537764-A	rs537764	0.0	537764	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.509	[0.33-0.69] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	3p26.3	3	220849.0		CHL1			ENSG00000134121			rs78599746-C	rs78599746	0.0	78599746	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.804	[0.52-1.08] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	2p25.3	2	909755.0		LINC01939 - SNTG2-AS1	ENSG00000228799	ENSG00000235688		4216.0	39502.0	rs372899202-T	rs372899202	0.0	372899202	upstream_gene_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.898	[0.58-1.21] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	11q23.1	11	112654557.0		LINC02763 - NCAM1	ENSG00000254968	ENSG00000149294		29990.0	306690.0	rs140488904-T	rs140488904	0.0	140488904	intron_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	1.005	[0.65-1.36] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	11q14.1	11	83484393.0		DLG2			ENSG00000150672			rs182632926-A	rs182632926	0.0	182632926	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.734	[0.48-0.99] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	2q11.1	2	95544711.0		TRIM64FP - OR7E102P	ENSG00000226185	ENSG00000168992		24604.0	1820.0	rs34119529-A	rs34119529	0.0	34119529	upstream_gene_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.527	[0.34-0.71] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	12q24.31	12	121082118.0		OASL2P - SNORA70	ENSG00000283542	ENSG00000253027		22448.0	24925.0	rs73216105-T	rs73216105	0.0	73216105	downstream_gene_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.727	[0.47-0.98] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	5q32	5	147773287.0		JAKMIP2			ENSG00000176049			rs115318065-T	rs115318065	0.0	115318065	intron_variant	0	NR	4e-09	8.397940008672037	(Sub-Saharan African)	0.778	[0.52-1.03] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	2q14.3	2	128045489.0		SAP130 - Y_RNA	ENSG00000136715	ENSG00000264495		17369.0	22311.0	rs35946814-T	rs35946814	0.0	35946814	intergenic_variant	1	NR	6e-09	8.221848749616356	(Sub-Saharan African)	1.144	[0.76-1.53] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	4q22.3	4	97675699.0		STPG2			ENSG00000163116			rs143881716-A	rs143881716	0.0	143881716	intron_variant	0	NR	7e-09	8.154901959985743	(Sub-Saharan African)	1.079	[0.72-1.44] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals											chr7:94338131-GA	chr7:94338131	0.0			1	NR	8e-09	8.096910013008056	(Sub-Saharan African)	1.198	[0.79-1.6] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	11p15.3	11	12218927.0		MICAL2			ENSG00000133816			rs150558972-G	rs150558972	0.0	150558972	intron_variant	0	NR	9e-09	8.045757490560675	(Sub-Saharan African)	1.314	[0.87-1.76] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals											chr6:130002456-T	chr6:130002456	0.0			1	NR	1e-08	8.0	(Sub-Saharan African)	1.431	[0.94-1.92] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	15q24.2	15	74900663.0		MPI, FAM219B			ENSG00000178802, ENSG00000178761			rs1127796-C	rs1127796	0.0	1127796	3_prime_UTR_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.775	[0.5-1.05] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	12p12.3	12	15311305.0		RERG			ENSG00000134533			rs144056970-T	rs144056970	0.0	144056970	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	1.184	[0.77-1.6] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	9q33.2	9	119960562.0		LINC01613 - MIR147A	ENSG00000261432	ENSG00000207814		22730.0	284417.0	rs6478447-A	rs6478447	0.0	6478447	intergenic_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.676	[0.44-0.91] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	12q23.3	12	107905724.0		ASCL4 - WSCD2	ENSG00000187855	ENSG00000075035		129080.0	223564.0	rs10746102-C	rs10746102	0.0	10746102	upstream_gene_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.453	[0.29-0.61] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in overweight individuals	1,087 Sub-Saharan African ancestry individuals	4,874 African American individuals	22q13.2	22	43450693.0		MPPED1			ENSG00000186732			rs145464088-G	rs145464088	0.0	145464088	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.976	[0.63-1.32] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	11q23.1	11	112654557.0		LINC02763 - NCAM1	ENSG00000254968	ENSG00000149294		29990.0	306690.0	rs140488904-T	rs140488904	0.0	140488904	intron_variant	1	NR	6e-10	9.221848749616356	(Sub-Saharan African)	0.959	[0.66-1.26] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	7p14.1	7	40176241.0		SUGCT			ENSG00000175600			rs201676855-AT	rs201676855	0.0	201676855	intron_variant	0	NR	4e-09	8.397940008672037	(Sub-Saharan African)	0.517	[0.34-0.69] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	5q35.2	5	176803210.0		LINC01574 - UNC5A	ENSG00000248859	ENSG00000113763		59339.0	7309.0	rs867414533-G	rs867414533	0.0	867414533	intergenic_variant	1	NR	4e-09	8.397940008672037	(Sub-Saharan African)	0.925	[0.62-1.23] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry individuals	6,437 African American individuals	7p22.3	7	2237282.0		MRM2			ENSG00000122687			rs62442506-A	rs62442506	0.0	62442506	intron_variant	0	NR	6e-09	8.221848749616356	(Sub-Saharan African)	0.605	[0.4-0.81] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	6p25.3	6	865369.0		EXOC2 - LINC01622	ENSG00000112685	ENSG00000286785		172230.0	92954.0	rs139990703-T	rs139990703	0.0	139990703	intergenic_variant	1	NR	6e-09	8.221848749616356	(Sub-Saharan African)	0.883	[0.59-1.18] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	2p24.3	2	14310216.0		LINC00276			ENSG00000230448			rs115057399-A	rs115057399	0.0	115057399	intron_variant	0	NR	7e-09	8.154901959985743	(Sub-Saharan African)	0.865	[0.57-1.16] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	12q24.31	12	124559245.0		NCOR2			ENSG00000196498			rs11057671-A	rs11057671	0.0	11057671	intron_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	0.586	[0.39-0.79] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	1q32.1	1	200251666.0		CCNQP1 - LINC00862	ENSG00000233827	ENSG00000203721		37344.0	1753.0	rs12045034-C	rs12045034	0.0	12045034	downstream_gene_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	0.806	[0.53-1.08] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	21q21.3	21	29887576.0		GRIK1			ENSG00000171189			rs75187018-A	rs75187018	0.0	75187018	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	1.11	[0.72-1.5] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	18p11.22	18	10439804.0		LINC01254 - APCDD1	ENSG00000260913	ENSG00000154856		25289.0	14831.0	rs59042308-G	rs59042308	0.0	59042308	intergenic_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.877	[0.57-1.18] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	12p12.1	12	21422122.0		SLCO1A2 - PYROXD1	ENSG00000084453	ENSG00000121350		2528.0	15493.0	rs190961853-T	rs190961853	0.0	190961853	upstream_gene_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.792	[0.51-1.07] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	17p13.3	17	245401.0		RPH3AL, RPH3AL, RPH3AL			ENSG00000262334, ENSG00000181031, ENSG00000282013			rs145270784-A	rs145270784	0.0	145270784	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.669	[0.43-0.91] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals											chr2:83064725-G	chr2:83064725	0.0			1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	1.121	[0.72-1.52] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	3q21.2	3	126078683.0		SLC41A3			ENSG00000114544			rs78721717-T	rs78721717	0.0	78721717	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	1.028	[0.66-1.39] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	20q13.12	20	46577550.0		SLC13A3			ENSG00000158296			rs366809-A	rs366809	0.0	366809	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.676	[0.44-0.91] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	17q25.3	17	82845455.0		TBCD			ENSG00000141556			rs139302892-T	rs139302892	0.0	139302892	intron_variant	0	NR	3e-11	10.522878745280336	(Sub-Saharan African)	0.901	[0.64-1.17] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	3p14.3	3	54726888.0		CACNA2D3			ENSG00000157445			rs140581181-A	rs140581181	0.0	140581181	intron_variant	0	NR	9e-09	8.045757490560675	(Sub-Saharan African)	0.873	[0.58-1.17] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	17p13.2	17	5432896.0		C1QBP			ENSG00000108561			rs41307958-AT	rs41307958	0.0	41307958	3_prime_UTR_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.98	[0.64-1.32] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	5q23.1	5	118965421.0		DTWD2			ENSG00000169570			rs185489977-A	rs185489977	0.0	185489977	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.894	[0.58-1.2] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	13q13.3	13	35335031.0		NBEA			ENSG00000172915			rs61949062-G	rs61949062	0.0	61949062	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	1.291	[0.84-1.74] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	1q31.1	1	188962697.0		LINC01035			ENSG00000226486			rs7523148-C	rs7523148	0.0	7523148	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.592	[0.38-0.8] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	1q21.2	1	150514512.0		ECM1 - FALEC	ENSG00000143369	ENSG00000228126		723.0	1245.0	rs72698892-A	rs72698892	0.0	72698892	upstream_gene_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.973	[0.63-1.32] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	7p11.2	7	56759598.0		TRIM60P16 - CICP28	ENSG00000229909	ENSG00000277253		126871.0	45738.0	rs4397350-C	rs4397350	0.0	4397350	intergenic_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.184	[0.12-0.25] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	2,229 Sub-Saharan African ancestry women	1,127 African American women	14q32.12	14	92309623.0		RNU6-366P - SLC24A4	ENSG00000201097	ENSG00000140090		43816.0	12958.0	rs746586-T	rs746586	0.0	746586	intergenic_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.427	[0.27-0.58] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	3,751 Sub-Saharan African ancestry individuals, 1,866 African American individuals		6q14.1	6	80583444.0		RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		113016.0	907995.0	rs2496692-T	rs2496692	0.0	2496692	intergenic_variant	1	NR	6e-09	8.221848749616356		0.21	[0.14-0.28] unit decrease	Affymetrix, Illumina [18199418] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in lean individuals	1,548 Sub-Saharan African ancestry individuals	610 African American individuals	6p22.3	6	24890923.0		RIPOR2			ENSG00000111913			rs9467343-A	rs9467343	0.0	9467343	intron_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	0.719	[0.47-0.97] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in lean individuals	1,548 Sub-Saharan African ancestry individuals	610 African American individuals	3p14.1	3	69318542.0		FRMD4B			ENSG00000114541			rs115983374-G	rs115983374	0.0	115983374	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.784	[0.51-1.06] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	4q28.1	4	123717198.0		LINC01091			ENSG00000249464			rs114711316-G	rs114711316	0.0	114711316	intron_variant	0	NR	4e-10	9.397940008672036	(Sub-Saharan African)	0.905	[0.62-1.19] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	2q31.2	2	178940232.0		CCDC141			ENSG00000163492			rs34491158-T	rs34491158	0.0	34491158	intron_variant	0	NR	3e-09	8.522878745280337	(Sub-Saharan African)	0.909	[0.61-1.21] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	5p13.1	5	40906631.0		CARD6 - C7	ENSG00000132357	ENSG00000112936		46456.0	2866.0	rs146092590-T	rs146092590	0.0	146092590	upstream_gene_variant	1	NR	6e-09	8.221848749616356	(Sub-Saharan African)	0.909	[0.6-1.21] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	9p24.2	9	2736678.0		PUM3			ENSG00000080608			rs142646303-C	rs142646303	0.0	142646303	intron_variant	0	NR	6e-09	8.221848749616356	(Sub-Saharan African)	0.814	[0.54-1.09] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	14q32.12	14	92309623.0		RNU6-366P - SLC24A4	ENSG00000201097	ENSG00000140090		43816.0	12958.0	rs746586-T	rs746586	0.0	746586	intergenic_variant	1	NR	7e-09	8.154901959985743	(Sub-Saharan African)	0.453	[0.3-0.61] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	8p23.1	8	10433706.0		MSRA - LINCR-0001	ENSG00000285250	ENSG00000253641		4815.0	40859.0	rs12550297-A	rs12550297	0.0	12550297	non_coding_transcript_exon_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	0.69	[0.45-0.93] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	11q21	11	94210009.0		ARPC3P3 - IZUMO1R	ENSG00000256745	ENSG00000183560		21012.0	94571.0	rs199783050-G	rs199783050	0.0	199783050	intron_variant	1	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.511	[0.33-0.69] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	12q24.31	12	122899169.0		VPS37B - ABCB9	ENSG00000139722	ENSG00000150967		3042.0	21782.0	rs79454364-C	rs79454364	0.0	79454364	upstream_gene_variant	1	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.885	[0.58-1.19] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	1q21.3	1	150947366.0		SETDB1			ENSG00000143379			rs6694978-T	rs6694978	0.0	6694978	intron_variant	0	NR	3e-08	7.522878745280337	(Sub-Saharan African)	0.937	[0.61-1.27] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	11q14.2	11	88169623.0		RAB38			ENSG00000123892			rs145947865-T	rs145947865	0.0	145947865	intron_variant	0	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.747	[0.48-1.01] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in overweight individuals	2,203 Sub-Saharan African ancestry individuals	1,256 African American individuals	8p11.21	8	40409218.0		SIRLNT - ZMAT4	ENSG00000253802	ENSG00000165061		56085.0	121372.0	rs9886413-A	rs9886413	0.0	9886413	intergenic_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.404	[0.26-0.55] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in type 2 diabetes	1,844 Sub-Saharan African ancestry individuals		13q14.3	13	51334180.0		FAM124A - SERPINE3	ENSG00000150510	ENSG00000253309		49941.0	1593.0	rs9563043-C	rs9563043	0.0	9563043	upstream_gene_variant	1	NR	2e-08	7.698970004336019		0.832	[0.54-1.12] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	14q32.12	14	92309623.0		RNU6-366P - SLC24A4	ENSG00000201097	ENSG00000140090		43816.0	12958.0	rs746586-T	rs746586	0.0	746586	intergenic_variant	1	NR	2e-10	9.69897000433602	(Sub-Saharan African)	0.544	[0.38-0.71] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	13q31.1	13	85396551.0		LINC00351			ENSG00000226317			rs1118414-A	rs1118414	0.0	1118414	intron_variant	0	NR	7e-10	9.154901959985745	(Sub-Saharan African)	1.049	[0.72-1.38] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	8p21.2	8	24234794.0		RNU1-148P - ADAM28	ENSG00000207201	ENSG00000042980		157636.0	59275.0	rs77763171-C	rs77763171	0.0	77763171	intergenic_variant	1	NR	3e-09	8.522878745280337	(Sub-Saharan African)	1.097	[0.74-1.46] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels	1,907 Sub-Saharan African ancestry individuals	1,653 African American individuals	10q24.1	10	96766312.0		RPL13AP5 - MIR607	ENSG00000236552	ENSG00000207976		15413.0	62357.0	rs61856847-C	rs61856847	0.0	61856847	regulatory_region_variant	1	NR	3e-09	8.522878745280337	(Sub-Saharan African)	1.072	[0.72-1.42] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102685590.0		MMP20 - MMP27	ENSG00000137674	ENSG00000137675		60258.0	5897.0	rs1291326-T	rs1291326	0.0	1291326	regulatory_region_variant	1	0.92	2e-38	37.69897000433602		0.1732	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102806398.0		WTAPP1			ENSG00000255282			rs145541733-T	rs145541733	0.0	145541733	intron_variant	0	0.99	3e-17	16.522878745280337		0.3596	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	11q22.3	11	103374204.0		DYNC2H1			ENSG00000187240			rs74973608-A	rs74973608	0.0	74973608	intron_variant	0	0.073	4e-16	15.397940008672036		0.1164	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-3 levels	21,758 European ancestry individuals	9,173 individuals	22q13.1	22	38204535.0		PLA2G6, MAFF			ENSG00000184381, ENSG00000185022			rs2267373-T	rs2267373	0.0	2267373	intron_variant	0	0.58	1e-12	12.0		0.0557	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	1p13.2	1	113021154.0		SLC16A1-AS1, LRIG2-DT, LRIG2-DT			ENSG00000226419, ENSG00000281557, ENSG00000238198			rs201435876-AG	rs201435876	0.0	201435876	intron_variant	0	NR	2e-12	11.69897000433602	(Sub-Saharan African)	1.445	[1.05-1.84] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	11p11.12	11	48986738.0		TRIM53CP			ENSG00000254764			rs866817997-G	rs866817997	0.0	866817997	intron_variant	0	NR	7e-12	11.154901959985745	(Sub-Saharan African)	1.952	[1.4-2.5] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	2q11.1	2	95663508.0		UBTFL3 - GPAT2P1	ENSG00000204699	ENSG00000237510		37272.0	126146.0	rs759790-A	rs759790	0.0	759790	intron_variant	1	NR	8e-11	10.096910013008056	(Sub-Saharan African)	0.851	[0.6-1.1] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	6q22.32	6	126783735.0		RPS4XP9 - RSPO3	ENSG00000217404	ENSG00000146374		99888.0	334936.0	rs562673069-T	rs562673069	0.0	562673069	intron_variant	1	NR	8e-11	10.096910013008056	(Sub-Saharan African)	1.534	[1.08-1.99] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	2p25.3	2	3056120.0		LINC01250			ENSG00000234423			rs77458176-T	rs77458176	0.0	77458176	intron_variant	0	NR	4e-10	9.397940008672036	(Sub-Saharan African)	1.723	[1.19-2.26] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	9p21.2	9	26214480.0		FAM71BP1 - CAAP1	ENSG00000270683	ENSG00000120159		276046.0	626205.0	rs187506962-A	rs187506962	0.0	187506962	regulatory_region_variant	1	NR	4e-10	9.397940008672036	(Sub-Saharan African)	1.393	[0.96-1.83] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	6p25.1	6	5952708.0		RN7SL221P - PKMP5	ENSG00000239472	ENSG00000215057		33864.0	19704.0	rs80081488-A	rs80081488	0.0	80081488	intergenic_variant	1	NR	2e-09	8.698970004336019	(Sub-Saharan African)	0.71	[0.48-0.94] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	13q14.11	13	42067171.0		DGKH			ENSG00000102780			rs4318109-A	rs4318109	0.0	4318109	intron_variant	0	NR	3e-09	8.522878745280337	(Sub-Saharan African)	1.299	[0.88-1.72] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	18q21.2	18	55254431.0		TCF4			ENSG00000196628			rs78245018-C	rs78245018	0.0	78245018	intron_variant	0	NR	7e-09	8.154901959985743	(Sub-Saharan African)	0.837	[0.56-1.12] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	6q25.2	6	153572772.0		RNA5SP225 - MTCO2P31	ENSG00000222806	ENSG00000217160		152200.0	92935.0	rs9371709-C	rs9371709	0.0	9371709	intergenic_variant	1	NR	7e-09	8.154901959985743	(Sub-Saharan African)	0.768	[0.51-1.03] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	14q31.3	14	84989528.0		RNU6-976P - LINC02329	ENSG00000251895	ENSG00000258814		249476.0	396399.0	rs12435146-G	rs12435146	0.0	12435146	intergenic_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	0.843	[0.56-1.13] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	9q31.2	9	107910789.0		RPL36AP6 - RNA5SP293	ENSG00000231293	ENSG00000222459		75960.0	8077.0	rs2210328-G	rs2210328	0.0	2210328	intergenic_variant	1	NR	1e-08	8.0	(Sub-Saharan African)	1.073	[0.71-1.44] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	19p13.3	19	1010756.0		TMEM259			ENSG00000182087			rs10401738-A	rs10401738	0.0	10401738	missense_variant	0	NR	1e-08	8.0	(Sub-Saharan African)	1.194	[0.79-1.6] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	10q21.1	10	52190941.0		PRKG1			ENSG00000185532			rs142108645-T	rs142108645	0.0	142108645	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	0.894	[0.58-1.2] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	2p24.3	2	12346429.0		MIR3681HG			ENSG00000224184			rs181139860-T	rs181139860	0.0	181139860	intron_variant	0	NR	2e-08	7.698970004336019	(Sub-Saharan African)	1.382	[0.9-1.86] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	17q24.3	17	71929357.0		MYL6P5 - ROCR	ENSG00000228118	ENSG00000228639		307921.0	92494.0	rs62064237-T	rs62064237	0.0	62064237	intergenic_variant	1	NR	3e-08	7.522878745280337	(Sub-Saharan African)	1.369	[0.89-1.85] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels in lean individuals	974 Sub-Saharan African ancestry individuals	1,563 African American individuals	13q14.3	13	54539361.0		RPL13AP25 - LINC02335	ENSG00000136149	ENSG00000278630		98046.0	523584.0	rs9536749-G	rs9536749	0.0	9536749	intergenic_variant	1	NR	4e-08	7.397940008672037	(Sub-Saharan African)	0.643	[0.42-0.87] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	2p22.2	2	37920528.0		LINC00211 - RMDN2	ENSG00000237803	ENSG00000115841		44254.0	2659.0	rs75005087-G	rs75005087	0.0	75005087	upstream_gene_variant	1	NR	1e-09	9.0	(Sub-Saharan African)	1.13	[0.77-1.49] unit decrease	Affymetrix, Illumina [NR] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Insulin levels	2,061 Sub-Saharan African ancestry men	2,596 African American men	11p15.1	11	17752170.0		KCNC1			ENSG00000129159			rs56115383-G	rs56115383	0.0	56115383	intron_variant	0	NR	2e-09	8.698970004336019	(Sub-Saharan African)	0.851	[0.57-1.13] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	2q36.1	2	224015781.0		SERPINE2			ENSG00000135919			rs68066031-T	rs68066031	0.0	68066031	intron_variant	0	0.77	2e-87	86.69897000433602		0.229	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	15q26.3	15	101452793.0		PCSK6			ENSG00000140479			rs11639051-A	rs11639051	0.0	11639051	intron_variant	0	0.3	2e-21	20.69897000433602		0.097	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	8q23.1	8	105561297.0		ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs3832566-CA	rs3832566	0.0	3832566	intron_variant	0	0.75	2e-21	20.69897000433602		0.1003	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	10q21.3	10	63306426.0		JMJD1C			ENSG00000171988			rs10761741-T	rs10761741	0.0	10761741	intron_variant	0	0.41	1e-19	19.0		0.0758	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	10q24.32	10	102632823.0		SUFU			ENSG00000107882			rs11594179-T	rs11594179	0.0	11594179	3_prime_UTR_variant	0	0.21	6e-11	10.221848749616356		0.0658	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	7q21.11	7	80629314.0		CD36			ENSG00000135218			rs11770907-A	rs11770907	0.0	11770907	intron_variant	0	0.53	2e-08	7.698970004336019		0.0497	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	12q13.13	12	54318524.0		COPZ1			ENSG00000111481			rs10876550-A	rs10876550	0.0	10876550	intron_variant	0	0.58	7e-07	6.154901959985743		0.0443	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet-derived growth factor subunit B levels	21,758 European ancestry individuals	9,173 individuals	9q22.32	9	96327892.0		SLC35D2			ENSG00000130958			rs149672562-G	rs149672562	0.0	149672562	intron_variant	0	0.76	4e-06	5.3979400086720375		0.0486	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	3p21.31	3	46329312.0		UQCRC2P1 - CCR2	ENSG00000236736	ENSG00000121807		17390.0	24552.0	rs2888526-T	rs2888526	0.0	2888526	intergenic_variant	1	0.094	3e-102	101.52287874528034		0.2727	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	3p22.1	3	42864624.0		CYP8B1, ACKR2, KRBOX1			ENSG00000180432, ENSG00000144648, ENSG00000240747			rs2228467-T	rs2228467	0.0	2228467	missense_variant	0	0.93	6e-37	36.22184874961636		0.1837	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	1q23.2	1	159205564.0		ACKR1, CADM3-AS1			ENSG00000213088, ENSG00000225670			rs12075-A	rs12075	0.0	12075	missense_variant	0	0.56	2e-22	21.69897000433602		0.0779	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	3p21.31	3	46230671.0		CCR3			ENSG00000183625			rs1542756-T	rs1542756	0.0	1542756	intron_variant	0	0.087	5e-20	19.30102999566398		0.1203	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	17q12	17	34206404.0		LINC01989 - CCL2	ENSG00000261156	ENSG00000108691		10467.0	48814.0	rs12601658-A	rs12601658	0.0	12601658	regulatory_region_variant	1	0.23	6e-12	11.221848749616356		0.0644	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	3p22.1	3	42771147.0		CCDC13, LINC02158			ENSG00000244607, ENSG00000225611			rs10865923-C	rs10865923	0.0	10865923	intron_variant	0	0.3	3e-11	10.522878745280336		0.0564	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Monocyte chemoattractant protein-1 levels	21,758 European ancestry individuals	9,173 individuals	3q21.3	3	128602383.0		LINC01565 - RPN1	ENSG00000198685	ENSG00000163902		26297.0	17586.0	rs9811380-A	rs9811380	0.0	9811380	intergenic_variant	1	0.71	1e-08	8.0		0.0521	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Proteinase-activated receptor 1 levels	21,758 European ancestry individuals	9,173 individuals	5q13.3	5	76763476.0		F2R - F2RL1	ENSG00000181104	ENSG00000164251		27706.0	55457.0	rs250727-T	rs250727	0.0	250727	regulatory_region_variant	1	0.55	2.0000000000000002e-39	38.69897000433602		0.1163	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Proteinase-activated receptor 1 levels	21,758 European ancestry individuals	9,173 individuals	5q13.3	5	76657267.0		IQGAP2			ENSG00000145703			rs664494-T	rs664494	0.0	664494	intron_variant	0	0.61	9.999999999999999e-33	32.0		0.1117	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Proteinase-activated receptor 1 levels	21,758 European ancestry individuals	9,173 individuals	10q21.3	10	63306426.0		JMJD1C			ENSG00000171988			rs10761741-T	rs10761741	0.0	10761741	intron_variant	0	0.41	6e-24	23.22184874961636		0.0841	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116714271.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		55976.0	33899.0	rs4938303-C	rs4938303	0.0	4938303	intergenic_variant	1	NR	5e-16	15.30102999566398		0.0814496	[0.062-0.101] unit decrease	Affymetrix [87696910] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Agouti-related protein levels	21,758 European ancestry individuals	9,173 individuals	16q22.1	16	67709521.0		GFOD2			ENSG00000141098			rs74900413-A	rs74900413	0.0	74900413	intron_variant	0	0.018	2e-19	18.69897000433602		0.3202	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Agouti-related protein levels	21,758 European ancestry individuals	9,173 individuals	2q31.1	2	176679823.0		LINC01117			ENSG00000224577			rs4894192-C	rs4894192	0.0	4894192	intron_variant	0	0.67	2e-13	12.69897000433602		0.067	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Agouti-related protein levels	21,758 European ancestry individuals	9,173 individuals	16q22.1	16	68847872.0		TANGO6			ENSG00000103047			rs138539707-T	rs138539707	0.0	138539707	intron_variant	0	0.023	7e-13	12.154901959985745		0.2217	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Agouti-related protein levels	21,758 European ancestry individuals	9,173 individuals	12q24.21	12	115116281.0								rs11451130-A	rs11451130	0.0	11451130	intergenic_variant	1	0.61	9e-11	10.045757490560677		0.058	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102916531.0		RNU7-159P - MMP13	ENSG00000238562	ENSG00000137745		12578.0	26464.0	rs185686655-T	rs185686655	0.0	185686655	intergenic_variant	1	0.12	1.9999999999999999e-63	62.69897000433602		0.2492	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102919134.0		RNU7-159P - MMP13	ENSG00000238562	ENSG00000137745		15181.0	23861.0	rs111850229-T	rs111850229	0.0	111850229	intergenic_variant	1	0.044	9e-30	29.045757490560675		0.2423	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	11q22.3	11	103037030.0		MMP13 - DCUN1D5	ENSG00000137745	ENSG00000137692		81298.0	13656.0	rs72987587-T	rs72987587	0.0	72987587	intergenic_variant	1	0.94	2.0000000000000002e-23	22.69897000433602		0.1792	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	10q21.1	10	52663638.0		LNCAROD			ENSG00000231131			rs7898709-T	rs7898709	0.0	7898709	intron_variant	0	0.89	1e-74	74.0		0.2595	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	10q21.1	10	52652733.0		LNCAROD			ENSG00000231131			rs1159798-A	rs1159798	0.0	1159798	intron_variant	0	0.23	5e-65	64.30102999566398		0.1869	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	8q23.1	8	105578477.0		ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs4541868-A	rs4541868	0.0	4541868	intron_variant	0	0.25	3e-43	42.52287874528034		0.1376	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	10q21.3	10	63344740.0		JMJD1C			ENSG00000171988			rs7896518-A	rs7896518	0.0	7896518	intron_variant	0	0.58	6e-39	38.22184874961636		0.1092	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	10q21.1	10	52369894.0		DKK1 - RPL31P44	ENSG00000107984	ENSG00000213657		51852.0	19218.0	rs7093925-A	rs7093925	0.0	7093925	intergenic_variant	1	0.43	4e-37	36.39794000867204		0.1064	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	16q24.2	16	88509031.0		ZFPM1			ENSG00000179588			rs8045833-A	rs8045833	0.0	8045833	intron_variant	0	0.27	9e-12	11.045757490560677		0.0753	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	10q24.32	10	102632823.0		SUFU			ENSG00000107882			rs11594179-T	rs11594179	0.0	11594179	3_prime_UTR_variant	0	0.21	3e-10	9.522878745280336		0.0633	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	1q23.1	1	156899922.0		PEAR1			ENSG00000187800			rs12041331-A	rs12041331	0.0	12041331	intron_variant	0	0.092	1e-06	6.0		0.0787	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Dickkopf-related protein 1 levels	21,758 European ancestry individuals	9,173 individuals	19q13.42	19	55025227.0		GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6-AS1			ENSG00000275633, ENSG00000278316, ENSG00000275931, ENSG00000277439, ENSG00000278670, ENSG00000274050, ENSG00000276065, ENSG00000276211, ENSG00000274566, ENSG00000088053, ENSG00000267265			rs1613662-A	rs1613662	0.0	1613662	missense_variant	0	0.85	4e-06	5.3979400086720375		0.0535	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	SIR2-like protein 2 levels	21,758 European ancestry individuals	9,173 individuals	19q13.2	19	38889130.0		SIRT2, SIRT2			ENSG00000283100, ENSG00000068903			rs144373891-T	rs144373891	0.0	144373891	missense_variant	0	0.016	7.0000000000000006e-34	33.15490195998574		0.5516	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	SIR2-like protein 2 levels	21,758 European ancestry individuals	9,173 individuals	19q13.42	19	53817685.0		NLRP12			ENSG00000142405			rs62143198-A	rs62143198	0.0	62143198	intron_variant	0	0.21	1e-08	8.0		0.0811	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	SIR2-like protein 2 levels	21,758 European ancestry individuals	9,173 individuals	8p11.22	8	39765027.0		ADAM2			ENSG00000104755			rs71237192-A	rs71237192	1.0	61653294	intron_variant	0	0.65	2e-07	6.698970004336019		0.0673	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Agouti-related protein levels	21,758 European ancestry individuals	9,173 individuals	16q22.1	16	67381180.0		LRRC36			ENSG00000159708			rs142444346-T	rs142444346	0.0	142444346	intron_variant	0	0.0048	5e-62	61.30102999566398		2.5212	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					AC010455.1							chr5:28096209-A	chr5:28096209	0.0			1	NR	3e-08	7.522878745280337		1.11907	[0.73-1.51] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					HS6ST3							chr13:97478887-A	chr13:97478887	0.0			1	NR	2e-08	7.698970004336019		0.611097	[0.4-0.82] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p31.3	1	63079319.0	RP11-5P4.3	LINC01739 - LINC00466	ENSG00000229537	ENSG00000224209		56815.0	79764.0	rs72674216-A	rs72674216	0.0	72674216	intergenic_variant	1	NR	9e-08	7.045757490560675		0.959753	[0.61-1.31] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p31.3	1	67015669.0	SLC35D1	SLC35D1			ENSG00000116704			rs143113754-A	rs143113754	0.0	143113754	intron_variant	0	NR	1e-07	7.0		1.03895	[0.66-1.42] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p31.3	1	67391839.0	IL12RB2	IL12RB2			ENSG00000081985			rs17097330-G	rs17097330	0.0	17097330	intron_variant	0	NR	1e-07	7.0		1.01366	[0.64-1.39] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p31.3	1	67629364.0	RN7SL392P	RNU6-1031P - RN7SL392P	ENSG00000207504	ENSG00000242482		88131.0	27467.0	rs56370400-T	rs56370400	0.0	56370400	intergenic_variant	1	NR	4e-07	6.3979400086720375		1.04809	[0.65-1.45] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p21.3	1	98452845.0	AL160056.1							rs72721860-T	rs72721860	0.0	72721860	regulatory_region_variant	1	NR	3e-07	6.522878745280337		1.0167	[0.63-1.4] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p13.3	1	106787293.0	RP11-110F24.1	NA - MTATP6P14		ENSG00000233449			15462.0	rs115128816-T	rs115128816	0.0	115128816	intergenic_variant	1	NR	4e-07	6.3979400086720375		1.20976	[0.75-1.67] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p13.3	1	107635848.0	VAV3	VAV3			ENSG00000134215			rs114204012-A	rs114204012	0.0	114204012	intron_variant	0	NR	4e-07	6.3979400086720375		1.28919	[0.8-1.78] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p13.2	1	111980076.0	KCND3	KCND3			ENSG00000171385			rs71673444-T	rs71673444	0.0	71673444	intron_variant	0	NR	2e-08	7.698970004336019		1.29895	[0.85-1.75] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1p13.2	1	114362444.0	RP4-591B8.3	MRPL57P1 - TRIM33	ENSG00000273698	ENSG00000197323		83169.0	30346.0	rs11808287-T	rs11808287	0.0	11808287	intergenic_variant	1	NR	3e-07	6.522878745280337		0.503145	[0.31-0.69] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		1q21.3	1	151036732.0	BNIPL	BNIPL			ENSG00000163141			rs41266605-G	rs41266605	0.0	41266605	missense_variant	0	NR	4e-07	6.3979400086720375		1.0687	[0.66-1.48] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					NR							chr1:164471324-G	chr1:164471324	0.0			1	NR	1e-07	7.0		1.46	[1-1.92] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					NR							chr1:173889861-T	chr1:173889861	0.0			1	NR	3e-07	6.522878745280337		1.01135	[0.63-1.4] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					PLEKHA6							chr1:204278060-A	chr1:204278060	0.0			1	NR	3e-07	6.522878745280337		1.01468	[0.63-1.4] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					NR							chr1:209201361-T	chr1:209201361	0.0			1	NR	1e-07	7.0		1.17	[0.7-1.64] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					AC073218.1							chr2:34777314-A	chr2:34777314	0.0			1	NR	8e-08	7.096910013008056		0.830836	[0.53-1.13] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					LINC01122							chr2:58985712-A	chr2:58985712	0.0			1	NR	3e-07	6.522878745280337		1.33771	[0.83-1.85] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr2:184928538-A	chr2:184928538	0.0			1	NR	2e-07	6.698970004336019		1.35648	[0.85-1.87] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					MREG							chr2:216859235-C	chr2:216859235	0.0			1	NR	4e-07	6.3979400086720375		1.29903	[0.8-1.8] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:3663265-T	chr3:3663265	0.0			1	NR	1e-07	7.0		1.17705	[0.74-1.61] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					FYC01							chr3:46100303-T	chr3:46100303	0.0			1	NR	1e-07	7.0		1.00724	[0.64-1.38] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					FYC01							chr3:47010116-A	chr3:47010116	0.0			1	NR	6e-08	7.221848749616356		1.1613	[0.74-1.58] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					FYC01							chr3:47251391-G	chr3:47251391	0.0			1	NR	5e-08	7.301029995663981		1.16451	[0.75-1.58] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					FYC01							chr3:47418822-T	chr3:47418822	0.0			1	NR	1e-07	7.0		1.14109	[0.72-1.56] unit increase	Illumina [NR] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102530902.0		MMP7 - MMP20	ENSG00000137673	ENSG00000137674		152.0	45930.0	rs11568819-A	rs11568819	0.0	11568819	upstream_gene_variant	1	0.062	1.9999999999999998e-222	221.698970004336		0.5757	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102544270.0		MMP7 - MMP20	ENSG00000137673	ENSG00000137674		13520.0	32562.0	rs7946641-A	rs7946641	0.0	7946641	regulatory_region_variant	1	0.43	1e-44	44.0		0.1306	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102527703.0		MMP7			ENSG00000137673			rs17884405-T	rs17884405	0.0	17884405	intron_variant	0	0.22	6e-28	27.22184874961636		0.1398	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	1q32.1	1	202043124.0		ELF3 - Y_RNA	ENSG00000163435	ENSG00000264495		25941.0	27717.0	rs9427716-T	rs9427716	0.0	9427716	regulatory_region_variant	1	0.46	2.0000000000000002e-24	23.69897000433602		0.0952	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102575643.0		MMP7 - MMP20	ENSG00000137673	ENSG00000137674		44893.0	1189.0	rs11607749-T	rs11607749	0.0	11607749	regulatory_region_variant	1	0.29	1e-13	13.0		0.0714	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-7 levels	21,758 European ancestry individuals	9,173 individuals	19q13.42	19	54249344.0		RPS9 - LILRB5	ENSG00000274950	ENSG00000105609		341.0	77.0	rs62133135-T	rs62133135	0.0	62133135	intergenic_variant	1	0.61	1e-10	10.0		0.0575	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	19q13.42	19	54255498.0		LILRB5			ENSG00000105609			rs12975366-T	rs12975366	0.0	12975366	missense_variant	0	0.6	3e-16	15.522878745280336		0.0727	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	13q21.33	13	71876489.0		DACH1 - RPS10P21	ENSG00000276644	ENSG00000232881		9285.0	37215.0	rs117953762-T	rs117953762	0.0	117953762	regulatory_region_variant	1	0.98	2e-06	5.698970004336019		0.1806	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-12 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102850520.0		MMP3 - MMP12	ENSG00000149968	ENSG00000262406		6911.0	12216.0	rs72981675-T	rs72981675	0.0	72981675	regulatory_region_variant	1	0.14	0.0	951.0		0.7478	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Fatty acid-binding protein, adipocyte levels	21,758 European ancestry individuals	9,173 individuals	3p25.2	3	12334457.0		PPARG			ENSG00000132170			rs2012444-T	rs2012444	0.0	2012444	intron_variant	0	0.13	1e-16	16.0		0.0914	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Fatty acid-binding protein, adipocyte levels	21,758 European ancestry individuals	9,173 individuals	8q21.13	8	81483300.0		FABP4 - FTH1P11	ENSG00000170323	ENSG00000237264		64.0	38382.0	rs77878271-A	rs77878271	0.0	77878271	intron_variant	1	0.97	2e-13	12.69897000433602		0.2056	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Fatty acid-binding protein, adipocyte levels	21,758 European ancestry individuals	9,173 individuals	4q31.3	4	154380683.0		DCHS2			ENSG00000197410			rs190775685-A	rs190775685	0.0	190775685	intron_variant	0	0.99	8e-11	10.096910013008056		1.7478	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Fatty acid-binding protein, adipocyte levels	21,758 European ancestry individuals	9,173 individuals	9q33.3	9	123319173.0		STRBP - CRB2	ENSG00000165209	ENSG00000148204		50587.0	36997.0	rs79389622-A	rs79389622	0.0	79389622	regulatory_region_variant	1	0.0088	1e-06	6.0		0.4101	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet endothelial cell adhesion molecule levels	21,758 European ancestry individuals	9,173 individuals	11q24.2	11	126430642.0		KIRREL3, ST3GAL4			ENSG00000149571, ENSG00000110080			rs11600151-T	rs11600151	0.0	11600151	intron_variant	0	0.1	9.999999999999999e-27	26.0		0.1473	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Platelet endothelial cell adhesion molecule levels	21,758 European ancestry individuals	9,173 individuals	9q34.2	9	133273983.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs507666-A	rs507666	0.0	507666	intron_variant	0	0.2	0.0	647.698970004336		0.5304	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Eosinophil cationic protein levels	21,758 European ancestry individuals	9,173 individuals	14q11.2	14	20917832.0		RNASE3 - RNASE2CP	ENSG00000169397	ENSG00000136315		25484.0	1458.0	rs147307766-T	rs147307766	0.0	147307766	intron_variant	1	0.041	6e-80	79.22184874961636		0.5345	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					ABCA3							chr16:2349706-A	chr16:2349706	0.0			1	NR	4e-08	7.397940008672037		1.44005	[0.93-1.95] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr17:29421869-C	chr17:29421869	0.0			1	NR	3e-08	7.522878745280337		1.31621	[0.85-1.78] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		16p13.3	16	6027354.0	RP11-420N3.2:RBFOX1	RBFOX1			ENSG00000078328			rs73522151-C	rs73522151	0.0	73522151	intron_variant	0	NR	3e-07	6.522878745280337		22.1596	[14.03-30.29] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:103798624-C	chr3:103798624	0.0			1	NR	5e-07	6.301029995663981		0.93273	[0.57-1.29] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:107593376-C	chr3:107593376	0.0			1	NR	3e-07	6.522878745280337		1.27038	[0.79-1.75] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:144726355-T	chr3:144726355	0.0			1	NR	1e-07	7.0		1.31262	[0.83-1.8] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:152529052-T	chr3:152529052	0.0			1	NR	1e-07	7.0		1.22374	[0.77-1.67] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:153086913-T	chr3:153086913	0.0			1	NR	1e-07	7.0		1.05184	[0.66-1.44] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					ETV5							chr3:185847872-A	chr3:185847872	0.0			1	NR	2e-07	6.698970004336019		1.22305	[0.77-1.68] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr3:196705485-A	chr3:196705485	0.0			1	NR	4e-07	6.3979400086720375		1.17745	[0.72-1.63] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		5p13.3	5	31204695.0	RP11-152K4.2:CDH6	CDH6			ENSG00000113361			rs72749636-T	rs72749636	0.0	72749636	intron_variant	0	NR	4e-10	9.397940008672036		1.52943	[1.05-2] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		5p13.3	5	31321381.0	CDH6	CDH6			ENSG00000113361			rs184012381-T	rs184012381	0.0	184012381	intron_variant	0	NR	4e-09	8.397940008672037		1.54483	[1.04-2.05] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		5q31.3	5	141919026.0	KIAA0141	PCDH1 - DELE1	ENSG00000156453	ENSG00000081791		39780.0	4829.0	rs6893037-G	rs6893037	0.0	6893037	regulatory_region_variant	1	NR	3e-09	8.522878745280337		1.41713	[0.95-1.88] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					CDKAL1							chr6:21215343-C	chr6:21215343	0.0			1	NR	4e-08	7.397940008672037		1.46107	[0.94-1.98] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		6p21.1	6	44725983.0	SUPT3H	NA - SUPT3H		ENSG00000196284			83334.0	rs35497646-A	rs35497646	0.0	35497646	intergenic_variant	1	NR	4e-09	8.397940008672037		1.21066	[0.81-1.61] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					GRIK2							chr6:102207556-T	chr6:102207556	0.0			1	NR	5e-08	7.301029995663981		1.01604	[0.65-1.38] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					LOC101927668							chr7:20000997-C	chr7:20000997	0.0			1	NR	3e-08	7.522878745280337		1.35924	[0.88-1.84] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					CSMD1							chr8:4432863-A	chr8:4432863	0.0			1	NR	3e-08	7.522878745280337		1.11446	[0.72-1.5] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		8p21.3	8	21341928.0	RP11-24P4.1							rs113613039-A	rs113613039	0.0	113613039	regulatory_region_variant	1	NR	5e-09	8.301029995663981		1.76	[1.3-2.22] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10p13	10	14266189.0	FRMD4A	FRMD4A			ENSG00000151474			rs113220477-G	rs113220477	0.0	113220477	intron_variant	0	NR	1e-07	7.0		1.1197	[0.71-1.53] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10p12.31	10	20883064.0	NEBL	NEBL			ENSG00000078114			rs76296059-C	rs76296059	0.0	76296059	intron_variant	0	NR	5e-09	8.301029995663981		1.457	[0.97-1.94] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10p11.21	10	37398148.0	ANKRD30A	VN1R53P - NA	ENSG00000236313			48576.0		rs112817646-A	rs112817646	0.0	112817646	intergenic_variant	1	NR	1e-08	8.0		1.42197	[0.94-1.9] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr10:37803153-T	chr10:37803153	0.0			1	NR	3e-08	7.522878745280337		1.34186	[0.87-1.81] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr10:65439003-A	chr10:65439003	0.0			1	NR	4e-08	7.397940008672037		1.08009	[0.7-1.46] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10q23.1	10	84588366.0	RPS3AP5	RPS3AP5 - NA	ENSG00000178429			27103.0		rs117302061-G	rs117302061	0.0	117302061	regulatory_region_variant	1	NR	1e-08	8.0		1.15793	[0.77-1.55] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10q24.32	10	102768223.0	WBP1L	WBP1L			ENSG00000166272			rs151137139-G	rs151137139	0.0	151137139	intron_variant	0	NR	2e-07	6.698970004336019		1.55	[1.09-2.01] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		10q26.11	10	118294311.0	FAM204A	CASC2 - FAM204A	ENSG00000177640	ENSG00000165669		84153.0	3614.0	rs151010944-A	rs151010944	0.0	151010944	intergenic_variant	1	NR	1e-09	9.0		1.29293	[0.88-1.71] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		12q12	12	41383444.0	PDZRN4	PDZRN4			ENSG00000165966			rs73126876-C	rs73126876	0.0	73126876	intron_variant	0	NR	4e-09	8.397940008672037		1.16459	[0.78-1.55] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr14:84603367-T	chr14:84603367	0.0			1	NR	2e-08	7.698970004336019		1.06614	[0.7-1.44] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		13q21.31	13	64605454.0	LGMNP1							rs17088924-C	rs17088924	0.0	17088924	regulatory_region_variant	1	NR	3e-09	8.522878745280337		1.14425	[0.77-1.52] unit increase	Illumina [NR] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102778751.0		MMP10, WTAPP1			ENSG00000166670, ENSG00000255282			rs17860955-T	rs17860955	0.0	17860955	splice_acceptor_variant	0	0.98	5e-155	154.30102999566398		1.0464	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102779693.0		WTAPP1, MMP10			ENSG00000255282, ENSG00000166670			rs486055-T	rs486055	0.0	486055	missense_variant	0	0.16	8.999999999999999e-142	141.04575749056067		0.3352	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	19q13.33	19	48703417.0		FUT2			ENSG00000176920			rs601338-A	rs601338	0.0	601338	stop_gained	0	0.45	2.0000000000000003e-34	33.69897000433602		0.1196	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102903080.0		BOLA3P1 - RNU7-159P	ENSG00000255469	ENSG00000238562		22234.0	812.0	rs35054791-T	rs35054791	0.0	35054791	intergenic_variant	1	0.65	3e-22	21.522878745280337		0.1088	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	11q22.2	11	102738268.0		MMP8 - WTAPP1	ENSG00000118113	ENSG00000255282		11218.0	8700.0	rs55930209-A	rs55930209	0.0	55930209	intergenic_variant	1	0.038	4e-18	17.397940008672037		0.2496	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Matrix metalloproteinase-10 levels	21,758 European ancestry individuals	9,173 individuals	6p21.32	6	32442799.0		HLA-DRA, HLA-DRA, HLA-DRA, HLA-DRA, HLA-DRA, HLA-DRA, HLA-DRA, HLA-DRA			ENSG00000228987, ENSG00000206308, ENSG00000230726, ENSG00000277263, ENSG00000204287, ENSG00000226260, ENSG00000227993, ENSG00000234794			rs3129886-T	rs3129886	0.0	3129886	intron_variant	0	0.25	6e-07	6.221848749616356		0.0572	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	9q34.11	9	127906678.0		ST6GALNAC6 - ST6GALNAC4	ENSG00000160408	ENSG00000136840		1270.0	1208.0	rs10819317-A	rs10819317	0.0	10819317	upstream_gene_variant	1	0.82	8e-27	26.096910013008056		0.1402	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	9q21.13	9	76536949.0		GCNT1			ENSG00000187210			rs10781366-A	rs10781366	0.0	10781366	intron_variant	0	0.32	8e-17	16.096910013008056		0.0874	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	1q22	1	155208991.0		THBS3, MTX1			ENSG00000169231, ENSG00000173171			rs760077-A	rs760077	0.0	760077	missense_variant	0	0.39	2e-12	11.69897000433602		0.0684	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	18q21.1	18	47096140.0		KATNAL2			ENSG00000167216			rs143459388-CACT	rs143459388	0.0	143459388	intron_variant	0	0.032	4e-11	10.397940008672036		0.2207	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	14q12	14	32743114.0		AKAP6			ENSG00000151320			rs28815022-T	rs28815022	0.0	28815022	intron_variant	0	0.58	2e-08	7.698970004336019		0.0553	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	12q23.3	12	103765975.0		STAB2			ENSG00000136011			rs138989232-A	rs138989232	0.0	138989232	intron_variant	0	0.0043	7e-08	7.154901959985743		0.5699	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	19q13.43	19	56094474.0		ZNF787			ENSG00000142409			rs57458324-CT	rs57458324	0.0	57458324	intron_variant	0	0.22	1e-05	5.0		0.0762	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	P-selectin glycoprotein ligand 1 levels	21,758 European ancestry individuals	9,173 individuals	12q24.11	12	108611308.0		TMEM119 - SELPLG	ENSG00000183160	ENSG00000110876		12988.0	10587.0	rs11114010-A	rs11114010	0.0	11114010	intergenic_variant	1	0.98	0.0	543.698970004336		1.6516	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals		11q23.2	11	113077853.0	NCAM1	NCAM1			ENSG00000149294			rs141881809-G	rs141881809	0.0	141881809	intron_variant	0	0.02	3e-07	6.522878745280337		19.22	[11.90-26.54] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder	1,180 European ancestry individuals					Intergenic							chr2:150554783-G	chr2:150554783	0.0			1	NR	1e-07	7.0		1.19482	[0.75-1.64] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		15q21.3	15	57907191.0	ALDH1A2	NA - ALDH1A2		ENSG00000128918			46233.0	rs71478642-C	rs71478642	0.0	71478642	intergenic_variant	1	NR	4e-06	5.3979400086720375		17.0997	[10.13-24.07] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		6q13	6	72432701.0	RIMS1	RIMS1 - NA	ENSG00000079841			29558.0		rs75608892-C	rs75608892	0.0	75608892	intergenic_variant	1	NR	8e-06	5.096910013008056		20.9468	[12.07-29.82] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		5q34	5	168725304.0	SLIT3	SLIT3			ENSG00000184347			rs17665285-A	rs17665285	0.0	17665285	intron_variant	0	NR	1e-05	5.0		2.68114	[1.53-3.83] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		2p13.3	2	68758953.0	Intergenic	ARHGAP25			ENSG00000163219			rs72828888-G	rs72828888	0.0	72828888	intron_variant	0	NR	1e-05	5.0		2.97739	[1.7-4.25] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		6q22.31	6	122966272.0	CLVS2	NA - CLVS2		ENSG00000146352			29963.0	rs111851914-A	rs111851914	0.0	111851914	intergenic_variant	1	NR	3e-07	6.522878745280337		12.05	[7.48-16.62] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		20p13	20	2040977.0	RP4-684O24.5	PDYN-AS1 - RPL7P2	ENSG00000233896	ENSG00000227663		10949.0	34578.0	rs1578568-A	rs1578568	0.0	1578568	intergenic_variant	1	NR	1e-06	6.0		11.71	[7.11-16.31] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		12q21.33	12	89872049.0	RP11-654D12.2	NA - BRWD1P2		ENSG00000258290			47388.0	rs12321461-C	rs12321461	0.0	12321461	intron_variant	1	NR	1e-06	6.0		3.26515	[2-4.53] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		2q14.3	2	124607106.0	CNTNAP5	CNTNAP5			ENSG00000155052			rs72841380-A	rs72841380	0.0	72841380	intron_variant	0	NR	1e-06	6.0		11.0145	[6.72-15.3] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		1p36.32	1	5102647.0	RP11-542C10.1	LINC02782 - NA	ENSG00000231510			11748.0		rs4949169-A	rs4949169	0.0	4949169	intergenic_variant	1	NR	2e-06	5.698970004336019		1.94624	[1.18-2.71] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		6q15	6	88091072.0	SPACA1	SPACA1 - CNR1	ENSG00000118434	ENSG00000118432		24234.0	48792.0	rs806447-G	rs806447	0.0	806447	regulatory_region_variant	1	NR	3e-06	5.522878745280337		2.11371	[1.27-2.95] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		6q21	6	105734366.0	RP3-359N14.1							rs75502766-C	rs75502766	0.0	75502766	intron_variant	1	NR	4e-06	5.3979400086720375			[NR]	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		1p12	1	117218457.0	VTCN1	VTCN1 - Metazoa_SRP	ENSG00000134258	ENSG00000276525		7497.0	24755.0	rs150979961-T	rs150979961	0.0	150979961	intergenic_variant	1	NR	4e-06	5.3979400086720375		8.98186	[5.31-12.66] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals					Intergenic							22:28173030-A	22:28173030	0.0			1	NR	4e-06	5.3979400086720375		1.93734	[1.14-2.73] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		5q35.2	5	176824630.0	UNC5A	UNC5A			ENSG00000113763			rs72811286-G	rs72811286	0.0	72811286	intron_variant	0	NR	5e-06	5.301029995663981		12.0554	[7.08-17.04] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		9p22.3	9	16099819.0	CCDC171	CCDC171 - ABCA1	ENSG00000164989	ENSG00000165029		38156.0	88681187.0	rs117746782-C	rs117746782	0.0	117746782	regulatory_region_variant	1	NR	7e-06	5.154901959985743		12.199	[7.08-17.31] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		9p13.3	9	35085149.0	PIGO	FANCG - PIGO	ENSG00000221829	ENSG00000165282		5207.0	3539.0	rs546982-A	rs546982	0.0	546982	regulatory_region_variant	1	NR	8e-06	5.096910013008056		2.08156	[1.2-2.96] unit decrease	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		1p21.1	1	102452798.0	RP11-202K23.1							rs2185431-C	rs2185431	0.0	2185431	intergenic_variant	1	NR	8e-06	5.096910013008056		10.02	[5.6-14.44] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		4q35.1	4	185716742.0	SORBS2	SORBS2			ENSG00000154556			rs12644930-T	rs12644930	0.0	12644930	intron_variant	0	NR	8e-06	5.096910013008056		10.67	[6.73-14.61] unit increase	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		11q13.3	11	69765242.0	AP001888.1	DNAJB6P5 - FGF4	ENSG00000256441	ENSG00000075388		27225.0	5780.0	rs112009437-A	rs112009437	0.0	112009437	intergenic_variant	1	NR	8e-06	5.096910013008056			[NR]	Illumina [NR] (imputed)	N
2021-09-06	33824429	Fjukstad KK	2021-04-06	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/33824429	Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.	Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder	181 European ancestry individuals		5q35.3	5	180502919.0	CNOT6	CNOT6			ENSG00000113300			rs7723088-G	rs7723088	0.0	7723088	intron_variant	0	NR	9e-06	5.045757490560675		5.15361	[2.95-7.35] unit decrease	Illumina [NR] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116733008.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		74713.0	15162.0	rs12272004-A	rs12272004	0.0	12272004	TF_binding_site_variant	1	NR	2e-12	11.69897000433602		0.123196	[0.089-0.158] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116736721.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		78426.0	11449.0	rs1558861-C	rs1558861	0.0	1558861	regulatory_region_variant	1	NR	2e-10	9.69897000433602		0.11155	[0.077-0.146] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116742944.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		84649.0	5226.0	rs12280753-T	rs12280753	0.0	12280753	regulatory_region_variant	1	NR	7e-11	10.154901959985745		0.109742	[0.077-0.143] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116748357.0		BUD13			ENSG00000137656			rs28927680-G	rs28927680	0.0	28927680	3_prime_UTR_variant	0	NR	1e-12	12.0		0.123575	[0.089-0.158] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116755542.0		BUD13			ENSG00000137656			rs11825181-A	rs11825181	0.0	11825181	intron_variant	0	NR	1e-12	12.0		0.124401	[0.09-0.159] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116763146.0		BUD13			ENSG00000137656			rs11820589-A	rs11820589	0.0	11820589	missense_variant	0	NR	1e-12	12.0		0.125458	[0.091-0.16] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116768388.0		BUD13			ENSG00000137656			rs10790162-A	rs10790162	0.0	10790162	intron_variant	0	NR	1e-11	11.0		0.121177	[0.086-0.156] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116778201.0		ZPR1			ENSG00000109917			rs964184-G	rs964184	0.0	964184	3_prime_UTR_variant	0	NR	6e-23	22.22184874961636		0.1287	[0.1-0.15] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116778419.0		ZPR1			ENSG00000109917			rs11823543-A	rs11823543	0.0	11823543	3_prime_UTR_variant	0	NR	1e-10	10.0		0.113384	[0.079-0.148] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116782580.0		ZPR1			ENSG00000109917			rs2075290-C	rs2075290	0.0	2075290	intron_variant	0	NR	1e-12	12.0		0.12476	[0.09-0.159] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116784884.0		ZPR1			ENSG00000109917			rs35120633-A	rs35120633	0.0	35120633	missense_variant	0	NR	3e-11	10.522878745280336		0.119892	[0.085-0.155] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116789970.0		APOA5			ENSG00000110243			rs2266788-G	rs2266788	0.0	2266788	3_prime_UTR_variant	0	NR	4e-12	11.397940008672036		0.122507	[0.088-0.157] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116791691.0		APOA5			ENSG00000110243			rs3135506-C	rs3135506	0.0	3135506	missense_variant	0	NR	5e-11	10.30102999566398		0.118856	[0.083-0.154] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116792991.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-G	rs662799	0.0	662799	upstream_gene_variant	1	NR	1e-11	11.0		0.128819	[0.092-0.166] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	116832924.0		APOC3			ENSG00000110245			rs5128-G	rs5128	0.0	5128	3_prime_UTR_variant	0	NR	2e-14	13.69897000433602		0.11917	[0.089-0.15] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	117037567.0		SIK3			ENSG00000160584			rs7115242-A	rs7115242	0.0	7115242	intron_variant	0	NR	3e-10	9.522878745280336		0.0968812	[0.067-0.127] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	117046528.0		SIK3			ENSG00000160584			rs10750100-T	rs10750100	0.0	10750100	intron_variant	0	NR	3e-10	9.522878745280336		0.0910482	[0.063-0.119] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		11q23.3	11	117166645.0		PAFAH1B2			ENSG00000168092			rs7112513-A	rs7112513	0.0	7112513	intron_variant	0	NR	4e-10	9.397940008672036		0.0909523	[0.062-0.119] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44886339.0		NECTIN2			ENSG00000130202			rs7254892-A	rs7254892	0.0	7254892	intron_variant	0	NR	2e-14	13.69897000433602		0.184831	[0.14-0.23] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44911142.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		1749.0	3105.0	rs72654473-A	rs72654473	0.0	72654473	non_coding_transcript_exon_variant	1	NR	1e-19	19.0		0.12717	[0.1-0.155] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44912383.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-A	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	NR	2e-19	18.69897000433602		0.127332	[0.1-0.155] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44923535.0		APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		4186.0	3264.0	rs141622900-A	rs141622900	0.0	141622900	upstream_gene_variant	1	NR	5e-23	22.30102999566398		0.193384	[0.16-0.23] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals												chr11:116607051-C	chr11:116607051	0.0			1	NR	1e-111	111.0		0.1969	[0.18-0.21] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116786072.0		ZPR1			ENSG00000109917			rs10750096-G	rs10750096	0.0	10750096	intron_variant	0	NR	4e-36	35.39794000867204		0.1464	[0.12-0.17] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116768388.0		BUD13			ENSG00000137656			rs10790162-G	rs10790162	0.0	10790162	intron_variant	0	NR	5e-34	33.30102999566398		0.08	[0.067-0.093] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116733798.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		75503.0	14372.0	rs4938307-C	rs4938307	0.0	4938307	intergenic_variant	1	NR	2e-11	10.69897000433602		0.0381	[0.027-0.049] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116756339.0		BUD13			ENSG00000137656			rs4938309-T	rs4938309	0.0	4938309	intron_variant	0	NR	2e-11	10.69897000433602		0.0477	[0.034-0.062] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116800289.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		7869.0	20411.0	rs4938313-T	rs4938313	0.0	4938313	intergenic_variant	1	NR	2e-11	10.69897000433602		0.0518	[0.037-0.067] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116739578.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		81283.0	8592.0	rs61905084-C	rs61905084	0.0	61905084	regulatory_region_variant	1	NR	8e-11	10.096910013008056		0.0428	[0.03-0.056] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116791863.0		APOA5			ENSG00000110243			rs651821-T	rs651821	0.0	651821	5_prime_UTR_variant	0	NR	1e-10	10.0		0.0563	[0.039-0.073] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116753437.0		BUD13			ENSG00000137656			rs6589564-G	rs6589564	0.0	6589564	intron_variant	0	NR	1e-10	10.0		0.2511	[0.17-0.33] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116769521.0		BUD13			ENSG00000137656			rs6589565-T	rs6589565	0.0	6589565	intron_variant	0	NR	2e-10	9.69897000433602		0.0325	[0.023-0.042] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116799960.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		7540.0	20740.0	rs6589567-T	rs6589567	0.0	6589567	intergenic_variant	1	NR	2e-10	9.69897000433602		0.0277	[0.019-0.036] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116800760.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		8340.0	19940.0	rs6589569-A	rs6589569	0.0	6589569	intergenic_variant	1	NR	2e-10	9.69897000433602		0.0327	[0.023-0.043] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116781775.0		ZPR1			ENSG00000109917			rs7483863-A	rs7483863	0.0	7483863	intron_variant	0	NR	3e-10	9.522878745280336		0.0478	[0.033-0.063] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116754011.0		BUD13			ENSG00000137656			rs7930786-T	rs7930786	0.0	7930786	intron_variant	0	NR	4e-10	9.397940008672036		0.0627	[0.043-0.082] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116741017.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		82722.0	7153.0	rs9326246-T	rs9326246	0.0	9326246	intergenic_variant	1	NR	6e-10	9.221848749616356		0.0706	[0.048-0.093] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116778201.0		ZPR1			ENSG00000109917			rs964184-A	rs964184	0.0	964184	3_prime_UTR_variant	0	NR	7e-10	9.154901959985745		0.0893	[0.061-0.118] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116801108.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		8688.0	19592.0	rs9666150-C	rs9666150	0.0	9666150	intergenic_variant	1	NR	8e-10	9.096910013008056		0.068	[0.046-0.09] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116801107.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		8687.0	19593.0	rs9667814-A	rs9667814	0.0	9667814	intergenic_variant	1	NR	8e-10	9.096910013008056		0.0683	[0.047-0.09] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116741558.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		83263.0	6612.0	rs11216125-G	rs11216125	0.0	11216125	intergenic_variant	1	NR	1.9999999999999998e-30	29.69897000433602		0.0942	[0.078-0.11] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116746524.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		88229.0	1646.0	rs11216126-C	rs11216126	0.0	11216126	intergenic_variant	1	NR	1.9999999999999998e-30	29.69897000433602		0.1061	[0.088-0.124] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116749540.0		BUD13			ENSG00000137656			rs11216129-G	rs11216129	0.0	11216129	intron_variant	0	NR	1.9999999999999998e-30	29.69897000433602		0.1362	[0.11-0.16] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116775346.0		ZPR1			ENSG00000109917			rs11216135-G	rs11216135	0.0	11216135	3_prime_UTR_variant	0	NR	3e-30	29.522878745280337		0.1057	[0.088-0.124] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116801297.0		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		8877.0	19403.0	rs11216140-T	rs11216140	0.0	11216140	intergenic_variant	1	NR	3.9999999999999996e-30	29.39794000867204		0.091	[0.075-0.107] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116776142.0		ZPR1			ENSG00000109917			rs11602073-T	rs11602073	0.0	11602073	3_prime_UTR_variant	0	NR	1.0000000000000001e-29	29.0		0.0741	[0.061-0.087] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116762082.0		BUD13			ENSG00000137656			rs11602240-G	rs11602240	0.0	11602240	intron_variant	0	NR	1.0000000000000001e-29	29.0		0.1243	[0.1-0.15] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116780399.0		ZPR1			ENSG00000109917			rs11604424-T	rs11604424	0.0	11604424	intron_variant	0	NR	1.0000000000000001e-29	29.0		0.0895	[0.074-0.105] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116755159.0		BUD13			ENSG00000137656			rs12421652-C	rs12421652	0.0	12421652	intron_variant	0	NR	5e-27	26.30102999566398		0.1243	[0.1-0.15] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116768976.0		BUD13			ENSG00000137656			rs1268353-T	rs1268353	0.0	1268353	intron_variant	0	NR	3e-26	25.522878745280337		0.0618	[0.05-0.073] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116736652.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		78357.0	11518.0	rs1558860-G	rs1558860	0.0	1558860	regulatory_region_variant	1	NR	3e-23	22.522878745280337		0.0642	[0.051-0.077] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116736721.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		78426.0	11449.0	rs1558861-C	rs1558861	0.0	1558861	regulatory_region_variant	1	NR	6e-23	22.22184874961636		0.1014	[0.081-0.122] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116763841.0		BUD13			ENSG00000137656			rs17119975-A	rs17119975	0.0	17119975	intron_variant	0	NR	4e-22	21.39794000867204		0.0512	[0.041-0.062] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116753987.0		BUD13			ENSG00000137656			rs180326-G	rs180326	0.0	180326	intron_variant	0	NR	6e-14	13.221848749616356		0.0838	[0.062-0.106] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116752943.0		BUD13			ENSG00000137656			rs180327-T	rs180327	0.0	180327	intron_variant	0	NR	7e-14	13.154901959985745		0.068	[0.05-0.086] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116741111.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		82816.0	7059.0	rs180349-G	rs180349	0.0	180349	intergenic_variant	1	NR	9e-14	13.045757490560677		0.0756	[0.056-0.095] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116732961.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		74666.0	15209.0	rs1893460-A	rs1893460	0.0	1893460	TF_binding_site_variant	1	NR	1e-13	13.0		0.1292	[0.095-0.163] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116780747.0		ZPR1			ENSG00000109917			rs1942478-C	rs1942478	0.0	1942478	intron_variant	0	NR	1e-13	13.0		0.093	[0.069-0.117] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116791110.0		APOA5			ENSG00000110243			rs2072560-G	rs2072560	0.0	2072560	missense_variant	0	NR	2e-13	12.69897000433602		0.0735	[0.054-0.093] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116782580.0		ZPR1			ENSG00000109917			rs2075290-C	rs2075290	0.0	2075290	intron_variant	0	NR	2e-13	12.69897000433602		0.0615	[0.045-0.078] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116776891.0		ZPR1			ENSG00000109917			rs2160669-T	rs2160669	0.0	2160669	3_prime_UTR_variant	0	NR	3e-13	12.522878745280336		0.1913	[0.14-0.24] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116789970.0		APOA5			ENSG00000110243			rs2266788-T	rs2266788	0.0	2266788	3_prime_UTR_variant	0	NR	3e-13	12.522878745280336		0.0673	[0.049-0.085] unit increase	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116786845.0		ZPR1			ENSG00000109917			rs3741298-C	rs3741298	0.0	3741298	intron_variant	0	NR	4e-12	11.397940008672036		0.0775	[0.056-0.099] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116760991.0		BUD13			ENSG00000137656			rs3825041-A	rs3825041	0.0	3825041	intron_variant	0	NR	5e-12	11.30102999566398		0.0675	[0.048-0.087] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Cholesterol_[M+H-H2O]1+ levels	5,662 Pakistani ancestry individuals		11q23.3	11	116781585.0		ZPR1			ENSG00000109917			rs4417316-T	rs4417316	0.0	4417316	intron_variant	0	NR	1e-11	11.0		0.0401	[0.029-0.052] unit decrease	Illumina [6720657] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Hydroxycholesterol_[M+H-2H2O]1+ levels	13,814 British ancestry individuals		6p12.3	6	46642168.0		CYP39A1			ENSG00000146233			rs2277119-T	rs2277119	0.0	2277119	missense_variant	0	NR	9e-15	14.045757490560677		0.0896286	[0.067-0.112] unit increase	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Hydroxycholesterol_[M+H-2H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44886339.0		NECTIN2			ENSG00000130202			rs7254892-A	rs7254892	0.0	7254892	intron_variant	0	NR	3e-11	10.522878745280336		0.176693	[0.12-0.23] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Hydroxycholesterol_[M+H-2H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44911142.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		1749.0	3105.0	rs72654473-A	rs72654473	0.0	72654473	non_coding_transcript_exon_variant	1	NR	8e-17	16.096910013008056		0.128443	[0.098-0.159] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Hydroxycholesterol_[M+H-2H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44912383.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-A	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	NR	1e-16	16.0		0.128342	[0.098-0.159] unit decrease	Affymetrix [87696910] (imputed)	N
2022-02-17	34503513	Harshfield EL	2021-09-10	BMC Med	www.ncbi.nlm.nih.gov/pubmed/34503513	Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.	Hydroxycholesterol_[M+H-2H2O]1+ levels	13,814 British ancestry individuals		19q13.32	19	44923535.0		APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		4186.0	3264.0	rs141622900-A	rs141622900	0.0	141622900	upstream_gene_variant	1	NR	4e-20	19.39794000867204		0.198231	[0.16-0.24] unit decrease	Affymetrix [87696910] (imputed)	N
2022-11-17	35995766	Tahir UA	2022-08-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35995766	Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.	Bilirubin levels	2,466 Black/admixed ancestry individuals	up to 1,653 European, Hispanic, Asian or Black individuals	2q37.1	2	233759924.0		UGT1A4, UGT1A7, UGT1A10, UGT1A6, UGT1A3, UGT1A9, UGT1A5, UGT1A8			ENSG00000244474, ENSG00000244122, ENSG00000242515, ENSG00000167165, ENSG00000288702, ENSG00000241119, ENSG00000288705, ENSG00000242366			rs887829-T	rs887829	0.0	887829	intron_variant	0	NR	2.0000000000000002e-82	81.69897000433602		0.563159	[0.51-0.62] unit increase	Illumina [158624]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet glycoprotein VI levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.42	19	55060872.0		RDH13, RDH13, RDH13, RDH13, RDH13, RDH13, RDH13, RDH13, RDH13, RDH13			ENSG00000160439, ENSG00000276826, ENSG00000278284, ENSG00000274418, ENSG00000273944, ENSG00000276341, ENSG00000274504, ENSG00000275474, ENSG00000276684, ENSG00000278149			rs1654451-?	rs1654451	0.0	1654451	intron_variant	0	NR	9e-19	18.045757490560675		0.33	[0.25-0.41] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD109 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	6q13	6	73810154.0		CD109			ENSG00000156535			rs150268193-?	rs150268193	0.0	150268193	missense_variant	0	NR	9.999999999999999e-43	42.0		1.9	[1.63-2.17] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD109 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133256205.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs7853989-?	rs7853989	0.0	7853989	missense_variant	0	NR	2e-17	16.69897000433602		0.32	[0.24-0.4] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD177 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.31	19	43314512.0		CEACAMP4 - CD177	ENSG00000230681	ENSG00000204936		9989.0	39174.0	rs58345181-?	rs58345181	0.0	58345181	intergenic_variant	1	NR	3e-41	40.52287874528034		1.0	[0.86-1.14] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tyrosine-protein phosphatase non-receptor type substrate 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20p13	20	1908219.0		SIRPA			ENSG00000198053			rs59317774-?	rs59317774	0.0	59317774	intron_variant	0	NR	3e-287	286.5228787452804		1.19	[1.13-1.25] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Brevican core protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q23.1	1	156645322.0		BCAN			ENSG00000132692			rs2365715-?	rs2365715	0.0	2365715	intron_variant	0	NR	3e-30	29.522878745280337		0.38	[0.32-0.44] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Lysosomal protective protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12q23.2	12	101821036.0		GNPTAB			ENSG00000111670			rs11111044-?	rs11111044	0.0	11111044	intron_variant	0	NR	3.9999999999999996e-26	25.39794000867204		0.44	[0.36-0.52] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Histidine-rich glycoprotein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q27.3	3	186672838.0		HRG			ENSG00000113905			rs9898-?	rs9898	0.0	9898	missense_variant	0	NR	6.000000000000001e-268	267.2218487496164		0.81	[0.77-0.85] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Transforming growth factor-beta-induced protein ig-h3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5q31.1	5	136057449.0		TGFBI			ENSG00000120708			rs17689879-?	rs17689879	0.0	17689879	intron_variant	0	NR	1.9999999999999999e-56	55.69897000433602		0.44	[0.38-0.5] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Extracellular matrix protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q21.2	1	150448065.0		RPRD2			ENSG00000163125			rs6662108-?	rs6662108	0.0	6662108	intron_variant	0	NR	5e-131	130.30102999566398		0.68	[0.62-0.74] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	A disintegrin and metalloproteinase with thrombospondin motifs 13 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133360409.0		SURF2, SURF2			ENSG00000148291, ENSG00000281024			rs7863933-?	rs7863933	0.0	7863933	missense_variant	0	NR	1e-103	103.0		1.34	[1.22-1.46] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Cytoskeleton-associated protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7q21.3	7	95310807.0		PON1			ENSG00000005421			rs3917532-?	rs3917532	0.0	3917532	intron_variant	0	NR	2e-33	32.69897000433602		0.32	[0.26-0.38] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Cytoskeleton-associated protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	22q12.3	22	36271108.0		APOL1 - MYH9	ENSG00000100342	ENSG00000100345		3578.0	10172.0	rs60295735-?	rs60295735	0.0	60295735	downstream_gene_variant	1	NR	1e-16	16.0		0.34	[0.26-0.42] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Complement factor H-related protein 5 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q31.3	1	197034086.0		CFHR5 - F13B	ENSG00000134389	ENSG00000143278		24408.0	4655.0	rs185102142-?	rs185102142	0.0	185102142	downstream_gene_variant	1	NR	5e-76	75.30102999566398		1.67	[1.49-1.85] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Agouti-related protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	16q22.1	16	67476655.0		ATP6V0D1			ENSG00000159720			rs114322795-?	rs114322795	0.0	114322795	intron_variant	0	NR	2e-40	39.69897000433602		0.46	[0.4-0.52] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Dual specificity mitogen-activated protein kinase kinase 4 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q42.13	1	230158968.0		GALNT2			ENSG00000143641			rs4846913-?	rs4846913	0.0	4846913	intron_variant	0	NR	2e-13	12.69897000433602		0.23	[0.17-0.29] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Dual specificity mitogen-activated protein kinase kinase 4 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q27.3	3	186677324.0		HRG			ENSG00000113905			rs2228243-?	rs2228243	0.0	2228243	missense_variant	0	NR	3e-98	97.52287874528034		0.8	[0.72-0.88] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein FAM3B levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr21-?	chr21	0.0			1	NR	8e-147	146.09691001300806		1.71	[1.57-1.85] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Synaptosomal-associated protein 25 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q11.2	17	28367840.0		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0.0	704	missense_variant	0	NR	3e-23	22.522878745280337		0.26	[0.2-0.32] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Oxidized low-density lipoprotein receptor 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12p13.2	12	10156347.0		CLEC7A - OLR1	ENSG00000172243	ENSG00000173391		26089.0	1954.0	rs34925630-?	rs34925630	0.0	34925630	downstream_gene_variant	1	NR	3e-19	18.522878745280337		0.37	[0.29-0.45] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Transmembrane glycoprotein NMB levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7p15.3	7	23116721.0		KLHL7			ENSG00000122550			rs77982996-?	rs77982996	0.0	77982996	intron_variant	0	NR	1e-15	15.0		2.47	[1.86-3.08] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Carbohydrate sulfotransferase 15 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133273983.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs507666-?	rs507666	0.0	507666	intron_variant	0	NR	3e-17	16.522878745280337		0.3	[0.22-0.38] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	T-lymphocyte surface antigen Ly-9 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q23.3	1	160801407.0		LY9			ENSG00000122224			rs474918-?	rs474918	0.0	474918	intron_variant	0	NR	2e-46	45.69897000433602		0.43	[0.37-0.49] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Low molecular weight phosphotyrosine protein phosphatase levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2p25.3	2	212548.0		FAM110C - SH3YL1	ENSG00000184731	ENSG00000035115		165678.0	5182.0	rs2126129-?	rs2126129	0.0	2126129	downstream_gene_variant	1	NR	3e-287	286.5228787452804		1.15	[1.09-1.21] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Macrophage-capping protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2p11.2	2	85402143.0		CAPG			ENSG00000042493			rs62623452-?	rs62623452	0.0	62623452	start_lost	0	NR	7.999999999999999e-25	24.096910013008056		1.51	[1.22-1.8] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leucine-rich repeat transmembrane protein FLRT2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	14q31.3	14	85343567.0		RNU6-976P - LINC02329	ENSG00000251895	ENSG00000258814		603515.0	42360.0	rs17796783-?	rs17796783	0.0	17796783	intergenic_variant	1	NR	3e-17	16.522878745280337		0.35	[0.27-0.43] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leucine-rich repeat transmembrane protein FLRT3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20p12.1	20	14701217.0		MACROD2			ENSG00000172264			rs1932951-?	rs1932951	0.0	1932951	intron_variant	0	NR	1e-189	189.0		0.72	[0.68-0.76] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.42	19	54278734.0		LILRB2, LILRB2, LILRB2, LILRB2, LILRB2			ENSG00000131042, ENSG00000274513, ENSG00000275463, ENSG00000276146, ENSG00000277751			rs586206-?	rs586206	0.0	586206	intron_variant	0	NR	2e-148	147.69897000433602		0.61	[0.57-0.65] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Limbic system-associated membrane protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q13.31	3	116383969.0		LSAMP			ENSG00000185565			rs1541871-?	rs1541871	0.0	1541871	intron_variant	0	NR	1e-16	16.0		0.34	[0.26-0.42] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Myeloid cell surface antigen CD33 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.41	19	51233128.0		CD33			ENSG00000105383			rs33978622-?	rs33978622	0.0	33978622	intron_variant	0	NR	1e-223	223.0		0.9	[0.84-0.96] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	alpha-2-macroglobulin receptor-associated protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	4p16.3	4	3523929.0		LRPAP1			ENSG00000163956			rs143486729-?	rs143486729	0.0	143486729	intron_variant	0	NR	1e-21	21.0		0.63	[0.49-0.77] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	alpha-2-macroglobulin receptor-associated protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	6p21.33	6	31357496.0		HLA-B - DHFRP2	ENSG00000206450	ENSG00000228432		308.0	8856.0	rs115881826-?	rs115881826	0.0	115881826	non_coding_transcript_exon_variant	1	NR	3e-238	237.52287874528037		1.91	[1.79-2.03] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein D levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5p13.1	5	41256668.0		C6			ENSG00000039537			rs116399172-?	rs116399172	0.0	116399172	intron_variant	0	NR	9.999999999999999e-26	25.0		1.51	[1.24-1.78] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Secreted and transmembrane protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q25.3	17	82334349.0		SECTM1 - TEX19	ENSG00000141574	ENSG00000182459		275.0	24898.0	rs113300592-?	rs113300592	0.0	113300592	upstream_gene_variant	1	NR	2e-12	11.69897000433602		0.43	[0.31-0.55] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Secreted and transmembrane protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.33	19	48704297.0		FUT2			ENSG00000176920			rs571689-?	rs571689	0.0	571689	3_prime_UTR_variant	0	NR	9e-12	11.045757490560677		0.18	[0.12-0.24] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	SPARC-like protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	4q22.1	4	87528662.0		SPARCL1			ENSG00000152583			rs11947225-?	rs11947225	0.0	11947225	intron_variant	0	NR	1e-83	83.0		0.48	[0.44-0.52] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein L1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	16q22.2	16	72054562.0		TXNL4B, HP			ENSG00000140830, ENSG00000257017			rs5471-?	rs5471	0.0	5471	5_prime_UTR_variant	0	NR	1e-58	58.0		0.72	[0.64-0.8] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein L1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	22q12.3	22	36264796.0		APOL1			ENSG00000100342			rs136168-?	rs136168	0.0	136168	intron_variant	0	NR	8.000000000000001e-24	23.096910013008056		0.34	[0.28-0.4] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Neurogenic locus notch homolog protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133256074.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176741-?	rs8176741	0.0	8176741	synonymous_variant	0	NR	1e-38	38.0		0.46	[0.38-0.54] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Scavenger receptor cysteine-rich type 1 protein M130 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11q24.2	11	126369390.0		ST3GAL4			ENSG00000110080			rs7103461-?	rs7103461	0.0	7103461	intron_variant	0	NR	3e-29	28.522878745280337		0.36	[0.3-0.42] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Scavenger receptor cysteine-rich type 1 protein M130 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17p13.1	17	7176937.0		ASGR1			ENSG00000141505			rs758641530-?	rs758641530	1.0	754165241	intron_variant	0	NR	6e-14	13.221848749616356		2.27	[1.68-2.86] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tyrosine-protein kinase transmembrane receptor ROR1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p31.3	1	64142520.0		ROR1, ROR1-AS1			ENSG00000185483, ENSG00000223949			rs34772283-?	rs34772283	0.0	34772283	synonymous_variant	0	NR	7e-32	31.154901959985743		0.57	[0.47-0.67] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Fatty acid-binding protein, liver levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2p11.2	2	88124547.0		FABP1			ENSG00000163586			rs2241883-?	rs2241883	0.0	2241883	missense_variant	0	NR	2e-15	14.69897000433602		0.26	[0.2-0.32] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Secreted frizzled-related protein 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2q32.1	2	182866669.0		FRZB - RNU6-1122P	ENSG00000162998	ENSG00000207178		32.0	7172.0	rs73042128-?	rs73042128	0.0	73042128	upstream_gene_variant	1	NR	7e-44	43.15490195998574		0.46	[0.4-0.52] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein E (isoform E3) levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	1.0000000000000001e-34	34.0		0.42	[0.36-0.48] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein E (isoform E4) levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	8.000000000000001e-29	28.096910013008056		0.38	[0.32-0.44] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	WNT1-inducible-signaling pathway protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q11.2	17	28367840.0		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0.0	704	missense_variant	0	NR	2e-70	69.69897000433602		0.46	[0.4-0.52] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Glucose-6-phosphate isomerase levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12p13.31	12	7405283.0		CD163L1			ENSG00000177675			rs12296814-?	rs12296814	0.0	12296814	intron_variant	0	NR	2e-15	14.69897000433602		0.22	[0.16-0.28] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Serum amyloid A-1 protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11p15.1	11	18269312.0		SAA1			ENSG00000173432			rs1136743-?	rs1136743	0.0	1136743	missense_variant	0	NR	1e-197	197.0		0.8	[0.74-0.86] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Hemoglobin levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	16q22.2	16	71841136.0		ATXN1L			ENSG00000224470			rs4322673-?	rs4322673	0.0	4322673	intron_variant	0	NR	6e-29	28.22184874961636		0.62	[0.5-0.74] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet-derived growth factor receptor alpha levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q31.3	1	196991783.0		CFHR5			ENSG00000134389			rs116469249-?	rs116469249	0.0	116469249	intron_variant	0	NR	9e-28	27.045757490560675		1.44	[1.19-1.69] unit increase	Illumina [NR]	N
2022-11-17	35995766	Tahir UA	2022-08-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35995766	Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.	Uric acid levels	2,466 Black/admixed ancestry individuals	up to 1,653 European, Hispanic, Asian or Black individuals	4p16.1	4	9919559.0		SLC2A9			ENSG00000109667			rs34426626-AC	rs34426626	0.0	34426626	intron_variant	0	NR	6e-16	15.221848749616356		0.237445	[0.18-0.29] unit decrease	Illumina [161234]	N
2022-11-17	35995766	Tahir UA	2022-08-22	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35995766	Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.	Uric acid levels	2,466 Black/admixed ancestry individuals	up to 1,653 European, Hispanic, Asian or Black individuals	11q13.1	11	64600382.0		SLC22A12			ENSG00000197891			rs147647315-A	rs147647315	0.0	147647315	missense_variant	0	NR	2e-12	11.69897000433602		0.87096	[0.63-1.11] unit decrease	Illumina [161234]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Proto-oncogene tyrosine-protein kinase receptor Ret levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	10q11.21	10	43108144.0		RET			ENSG00000165731			rs2742244-?	rs2742244	0.0	2742244	intron_variant	0	NR	7e-16	15.154901959985745		0.29	[0.21-0.37] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q21.33	17	50857161.0		RPL5P33 - TOB1	ENSG00000243521	ENSG00000141232		7891.0	5062.0	rs8066847-?	rs8066847	0.0	8066847	intergenic_variant	1	NR	1.0000000000000001e-29	29.0		0.36	[0.3-0.42] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD48 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q23.3	1	160711985.0		CD48 - SLAMF7	ENSG00000117091	ENSG00000026751		154.0	27072.0	rs352684-?	rs352684	0.0	352684	upstream_gene_variant	1	NR	1e-20	20.0		0.27	[0.21-0.33] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leucine-rich repeats and immunoglobulin-like domains protein 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12q14.1	12	58890047.0		LRIG3			ENSG00000139263			rs144365133-?	rs144365133	0.0	144365133	missense_variant	0	NR	9e-50	49.04575749056068		2.31	[2-2.62] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Calcium/calmodulin-dependent protein kinase type 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q24.2	1	169550311.0		F5			ENSG00000198734			rs1988608-?	rs1988608	0.0	1988608	intron_variant	0	NR	8e-141	140.09691001300806		0.9	[0.82-0.98] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Calcium/calmodulin-dependent protein kinase type 1D levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q11.2	17	28367840.0		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0.0	704	missense_variant	0	NR	5e-79	78.30102999566398		0.49	[0.43-0.55] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Dual specificity mitogen-activated protein kinase kinase 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	13q34	13	113205987.0		PCID2			ENSG00000126226			rs35708060-?	rs35708060	0.0	35708060	intron_variant	0	NR	9e-28	27.045757490560675		0.57	[0.47-0.67] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Mitogen-activated protein kinase 8 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	4q21.3	4	86335376.0		MAPK10			ENSG00000109339			rs6851072-?	rs6851072	0.0	6851072	intron_variant	0	NR	1e-14	14.0		0.21	[0.15-0.27] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Serine/threonine-protein kinase 16 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q11.2	17	28361641.0		TMEM199			ENSG00000244045			rs708100-?	rs708100	0.0	708100	3_prime_UTR_variant	0	NR	3e-11	10.522878745280336		0.18	[0.12-0.24] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tyrosine-protein kinase ZAP-70 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5p13.1	5	41176505.0		C6			ENSG00000039537			rs375762365-?	rs375762365	0.0	375762365	frameshift_variant	0	NR	7e-21	20.154901959985743		1.47	[1.16-1.78] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Proprotein convertase subtilisin/kexin type 7 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11q23.3	11	117174495.0		PAFAH1B2			ENSG00000168092			rs71037472-?	rs71037472	0.0	71037472	intron_variant	0	NR	3e-56	55.52287874528034		0.55	[0.49-0.61] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Fc receptor-like protein 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q23.1	1	157720625.0		FCRL3 - VDAC1P9	ENSG00000160856	ENSG00000232366		19856.0	3555.0	rs6427394-?	rs6427394	0.0	6427394	downstream_gene_variant	1	NR	3e-59	58.52287874528034		0.56	[0.5-0.62] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	OX-2 membrane glycoprotein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr9-?	chr9	0.0			1	NR	2.0000000000000003e-34	33.69897000433602		0.48	[0.4-0.56] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Cell surface glycoprotein CD200 receptor 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q13.2	3	112827064.0		CD200R1L			ENSG00000206531			rs58161637-?	rs58161637	0.0	58161637	frameshift_variant	0	NR	5e-18	17.30102999566398		0.31	[0.23-0.39] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Ubiquitin-like protein ISG15 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p36.33	1	1013490.0		ISG15			ENSG00000187608			rs4615788-?	rs4615788	0.0	4615788	intron_variant	0	NR	1e-85	85.0		0.62	[0.56-0.68] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Thioredoxin domain-containing protein 12 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3p21.31	3	49325085.0		USP4			ENSG00000114316			rs78246922-?	rs78246922	0.0	78246922	intron_variant	0	NR	3e-85	84.52287874528034		1.55	[1.39-1.71] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leucine-rich repeat serine/threonine-protein kinase 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q11.2	17	28367840.0		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0.0	704	missense_variant	0	NR	6e-35	34.22184874961636		0.33	[0.27-0.39] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet receptor Gi24 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	10q22.1	10	71769141.0		VSIR, CDH23			ENSG00000107738, ENSG00000107736			rs10999992-?	rs10999992	0.0	10999992	intron_variant	0	NR	3e-29	28.522878745280337		0.44	[0.36-0.52] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet receptor Gi24 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p34.3	1	38919037.0		RHBDL2			ENSG00000158315			rs72938840-?	rs72938840	0.0	72938840	missense_variant	0	NR	3e-94	93.52287874528034		1.24	[1.12-1.36] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133257367.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176722-?	rs8176722	0.0	8176722	intron_variant	0	NR	3e-80	79.52287874528034		0.7	[0.62-0.78] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	15q24.1	15	74318848.0		CCDC33			ENSG00000140481			rs751527-?	rs751527	0.0	751527	intron_variant	0	NR	8e-15	14.096910013008056		0.22	[0.16-0.28] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Toll-like receptor 4:Lymphocyte antigen 96 complex levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q33.1	9	117713324.0		TLR4			ENSG00000136869			rs4986791-?	rs4986791	0.0	4986791	missense_variant	0	NR	7.0000000000000006e-34	33.15490195998574		1.0	[0.84-1.16] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Toll-like receptor 4:Lymphocyte antigen 96 complex levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133273983.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs507666-?	rs507666	0.0	507666	intron_variant	0	NR	2e-13	12.69897000433602		0.32	[0.24-0.4] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Quinone oxidoreductase-like protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44910319.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		926.0	3928.0	rs75627662-?	rs75627662	0.0	75627662	non_coding_transcript_exon_variant	1	NR	8e-46	45.096910013008056		0.46	[0.4-0.52] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Proprotein convertase subtilisin/kexin type 9 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p32.3	1	55063542.0		PCSK9			ENSG00000169174			rs28362286-?	rs28362286	0.0	28362286	stop_gained	0	NR	4e-38	37.39794000867204		2.13	[1.8-2.46] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Acidic leucine-rich nuclear phosphoprotein 32 family member B levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3p21.1	3	52853656.0		STIMATE-MUSTN1, STIMATE			ENSG00000248592, ENSG00000213533			rs11291203-?	rs11291203	0.0	11291203	intron_variant	0	NR	1e-36	36.0		0.38	[0.32-0.44] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	SPARC-related modular calcium-binding protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	14q24.2	14	69888141.0		SMOC1			ENSG00000198732			rs1958078-?	rs1958078	0.0	1958078	intron_variant	0	NR	1e-18	18.0		0.25	[0.19-0.31] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein FAM3D levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr3-?	chr3	0.0			1	NR	9e-52	51.04575749056068		0.4	[0.34-0.46] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein FAM3D levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133274414.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs532436-?	rs532436	0.0	532436	intron_variant	0	NR	5e-152	151.30102999566398		0.9	[0.84-0.96] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein FAM3D levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.33	19	48707612.0		FUT2 - MAMSTR	ENSG00000176920	ENSG00000176909		1661.0	5113.0	rs2638281-?	rs2638281	0.0	2638281	downstream_gene_variant	1	NR	2.0000000000000002e-29	28.69897000433602		0.27	[0.23-0.31] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Cysteine-rich with EGF-like domain protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3p25.3	3	10014129.0		EMC3 - CIDECP1	ENSG00000125037	ENSG00000186162		2927.0	108.0	rs13075842-?	rs13075842	0.0	13075842	upstream_gene_variant	1	NR	2e-248	247.698970004336		0.84	[0.8-0.88] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Cysteine-rich with EGF-like domain protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3p25.1	3	13438653.0		NUP210 - HDAC11-AS1	ENSG00000132182	ENSG00000244502		18331.0	38329.0	rs58747930-?	rs58747930	0.0	58747930	intergenic_variant	1	NR	5e-12	11.30102999566398		0.19	[0.13-0.25] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Non-histone chromosomal protein HMG-14 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr3-?	chr3	0.0			1	NR	3e-136	135.52287874528034		0.64	[0.58-0.7] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Low-density lipoprotein receptor-related protein 1B levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	9e-50	49.04575749056068		0.66	[0.58-0.74] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein M levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	6p21.33	6	31660336.0		C6orf47-AS1, C6orf47-AS1, C6orf47-AS1, C6orf47-AS1, C6orf47-AS1, C6orf47-AS1, C6orf47, C6orf47, C6orf47, C6orf47, C6orf47, C6orf47			ENSG00000227853, ENSG00000227665, ENSG00000235516, ENSG00000224835, ENSG00000233169, ENSG00000227198, ENSG00000203623, ENSG00000204439, ENSG00000228435, ENSG00000235360, ENSG00000226103, ENSG00000228177			rs805263-?	rs805263	0.0	805263	5_prime_UTR_variant	0	NR	9.999999999999999e-31	30.0		0.53	[0.43-0.63] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	MAP kinase-activated protein kinase 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	13q14.13	13	46055809.0		CPB2, CPB2-AS1			ENSG00000080618, ENSG00000235903			rs1926447-?	rs1926447	0.0	1926447	missense_variant	0	NR	3e-88	87.52287874528034		0.66	[0.6-0.72] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tumor necrosis factor-inducible gene 6 protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2q23.3	2	151290158.0		NMI - TNFAIP6	ENSG00000123609	ENSG00000123610		264.0	67434.0	rs2278089-?	rs2278089	0.0	2278089	upstream_gene_variant	1	NR	7.000000000000001e-31	30.154901959985743		0.34	[0.28-0.4] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Serine/threonine-protein kinase receptor R3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr22-?	chr22	0.0			1	NR	1.9999999999999998e-91	90.69897000433602		0.99	[0.89-1.09] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Interleukin-18 receptor accessory protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2q12.1	2	102445715.0		IL18RAP			ENSG00000115607			rs6748390-?	rs6748390	0.0	6748390	intron_variant	0	NR	1e-40	40.0		0.39	[0.33-0.45] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein Z-dependent protease inhibitor levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	14q32.13	14	94265573.0		PPP4R4			ENSG00000119698			rs1107110-?	rs1107110	0.0	1107110	intron_variant	0	NR	4e-158	157.39794000867204		0.77	[0.71-0.83] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Bactericidal permeability-increasing protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20q11.23	20	38311912.0		BPI			ENSG00000101425			rs5743509-?	rs5743509	0.0	5743509	missense_variant	0	NR	1e-31	31.0		0.8	[0.66-0.94] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin-like growth factor-binding protein 7 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	4q12	4	57074206.0		IGFBP7			ENSG00000163453			rs1714016-?	rs1714016	0.0	1714016	intron_variant	0	NR	2e-27	26.69897000433602		0.3	[0.24-0.36] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Mannose-binding protein C levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	10q21.1	10	52762478.0		LNCAROD - MBL2	ENSG00000231131	ENSG00000165471		6971.0	2902.0	rs533717511-?	rs533717511	1.0	61707081	downstream_gene_variant	1	NR	7e-95	94.15490195998576		0.67	[0.61-0.73] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Interleukin-1 Receptor accessory protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q28	3	190592912.0		IL1RAP			ENSG00000196083			rs6767500-?	rs6767500	0.0	6767500	intron_variant	0	NR	1e-102	102.0		0.79	[0.71-0.87] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Low-density lipoprotein receptor-related protein 8 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p32.3	1	53270464.0		LRP8			ENSG00000157193			rs12028465-?	rs12028465	0.0	12028465	intron_variant	0	NR	1e-12	12.0		0.24	[0.18-0.3] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	A disintegrin and metalloproteinase with thrombospondin motifs 5 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	21q21.3	21	26921481.0		ADAMTS5			ENSG00000154736			rs2830581-?	rs2830581	0.0	2830581	3_prime_UTR_variant	0	NR	8e-137	136.09691001300806		1.12	[1.02-1.22] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin-like growth factor 1 receptor levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133274414.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs532436-?	rs532436	0.0	532436	intron_variant	0	NR	1e-18	18.0		0.32	[0.24-0.4] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Endothelial monocyte-activating polypeptide 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44915533.0		APOC1			ENSG00000130208			rs5117-?	rs5117	0.0	5117	intron_variant	0	NR	5.0000000000000005e-39	38.30102999566398		0.4	[0.34-0.46] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Chitinase-3-like protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q32.1	1	203181771.0		CHI3L1			ENSG00000133048			rs35405821-?	rs35405821	0.0	35405821	non_coding_transcript_exon_variant	0	NR	1.0000000000000001e-187	187.0		0.82	[0.76-0.88] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Bone morphogenetic protein 7 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5q35.3	5	177409531.0		GRK6, F12			ENSG00000198055, ENSG00000131187			rs1801020-?	rs1801020	0.0	1801020	5_prime_UTR_variant	0	NR	1.0000000000000001e-28	28.0		0.29	[0.23-0.35] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin receptor levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133266456.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0.0	2519093	intron_variant	0	NR	3e-73	72.52287874528034		0.72	[0.64-0.8] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD27 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q27.3	3	186677324.0		HRG			ENSG00000113905			rs2228243-?	rs2228243	0.0	2228243	missense_variant	0	NR	8e-83	82.09691001300806		0.72	[0.64-0.8] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet-derived growth factor receptor beta levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5q32	5	150128912.0		PDGFRB			ENSG00000113721			rs3816018-?	rs3816018	0.0	3816018	intron_variant	0	NR	3e-287	286.5228787452804		1.11	[1.07-1.15] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Dickkopf-related protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	10q21.1	10	52669358.0		LNCAROD			ENSG00000231131			rs10762869-?	rs10762869	0.0	10762869	intron_variant	0	NR	7e-19	18.154901959985743		0.24	[0.18-0.3] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein Z-dependent protease inhibitor levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	13q34	13	113156228.0		F10 - PROZ	ENSG00000126218	ENSG00000126231		6699.0	2420.0	rs776904-?	rs776904	0.0	776904	upstream_gene_variant	1	NR	2.0000000000000002e-23	22.69897000433602		0.43	[0.35-0.51] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Peptidoglycan recognition protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	6p21.32	6	32706117.0		HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		37734.0	7.0	rs1794269-?	rs1794269	0.0	1794269	downstream_gene_variant	1	NR	3e-11	10.522878745280336		0.18	[0.12-0.24] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Retinoic acid receptor responder protein 2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7q36.1	7	150338370.0		RARRES2			ENSG00000106538			rs1047586-?	rs1047586	0.0	1047586	missense_variant	0	NR	5e-47	46.30102999566398		0.4	[0.34-0.46] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD209 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133257522.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-?	rs8176719	0.0	8176719	frameshift_variant	0	NR	1.0000000000000001e-237	237.0		0.8	[0.76-0.84] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	CD209 antigen levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19p13.2	19	7744292.0		CD209			ENSG00000090659			rs61058460-?	rs61058460	0.0	61058460	intron_variant	0	NR	2.0000000000000002e-60	59.69897000433602		0.79	[0.69-0.89] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	melanoma-derived growth regulatory protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.2	19	40776370.0		MIA, MIA-RAB4B			ENSG00000261857, ENSG00000268975			rs8107978-?	rs8107978	0.0	8107978	intron_variant	0	NR	1e-150	150.0		0.97	[0.89-1.05] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Receptor tyrosine-protein kinase erbB-3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12q13.2	12	56095610.0		ERBB3			ENSG00000065361			rs75526830-?	rs75526830	0.0	75526830	intron_variant	0	NR	1e-13	13.0		2.31	[1.7-2.92] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Parathyroid hormone-related protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	5q35.3	5	177409531.0		GRK6, F12			ENSG00000198055, ENSG00000131187			rs1801020-?	rs1801020	0.0	1801020	5_prime_UTR_variant	0	NR	4e-22	21.39794000867204		0.25	[0.19-0.31] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tyrosine-protein kinase receptor Tie-1, soluble levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr1-?	chr1	0.0			1	NR	9.000000000000001e-23	22.045757490560675		1.96	[1.57-2.35] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Metalloproteinase inhibitor 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	22q12.3	22	32756387.0		SYN3			ENSG00000185666			rs2413148-?	rs2413148	0.0	2413148	intron_variant	0	NR	3.9999999999999997e-25	24.39794000867204		0.48	[0.38-0.58] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Interleukin-1 receptor antagonist protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2q14.1	2	113083453.0		IL1F10 - RNU6-1180P	ENSG00000136697	ENSG00000201805		7610.0	3352.0	rs6734238-?	rs6734238	0.0	6734238	upstream_gene_variant	1	NR	1.9999999999999998e-30	29.69897000433602		0.31	[0.25-0.37] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Growth-regulated alpha protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	4q13.3	4	73882571.0		CXCL1 - HNRNPA1P55	ENSG00000163739	ENSG00000249920		11263.0	56033.0	rs3097412-?	rs3097412	0.0	3097412	regulatory_region_variant	1	NR	2e-65	64.69897000433602		0.43	[0.37-0.49] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Phospholipase A2, membrane associated levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1p36.13	1	19979653.0		PLA2G2A			ENSG00000188257			rs11573156-?	rs11573156	0.0	11573156	5_prime_UTR_variant	0	NR	1e-64	64.0		0.89	[0.79-0.99] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Parathyroid hormone-related protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr22-?	chr22	0.0			1	NR	7e-22	21.154901959985743		0.25	[0.19-0.31] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Tyrosine-protein kinase receptor Tie-1, soluble levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	9q34.2	9	133262254.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176693-?	rs8176693	0.0	8176693	intron_variant	0	NR	1e-180	180.0		1.13	[1.05-1.21] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Bone morphogenetic protein 10 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2p13.3	2	68845734.0		LINC01888 - BMP10	ENSG00000237576	ENSG00000163217		8008.0	15175.0	rs72830974-?	rs72830974	0.0	72830974	intergenic_variant	1	NR	1e-35	35.0		0.58	[0.48-0.68] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin-like growth factor-binding protein 5 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr2-?	chr2	0.0			1	NR	3e-12	11.522878745280336		0.78	[0.56-1] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Hepatocyte growth factor-like protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3p21.31	3	49639859.0		BSN			ENSG00000164061			rs4855847-?	rs4855847	0.0	4855847	intron_variant	0	NR	8e-216	215.09691001300808		0.75	[0.71-0.79] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	T-lymphocyte activation antigen CD86 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q13.33	3	122110727.0		CD86			ENSG00000114013			rs73858130-?	rs73858130	0.0	73858130	intron_variant	0	NR	1e-64	64.0		0.83	[0.73-0.93] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	T-lymphocyte activation antigen CD86 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11q24.2	11	126371801.0		ST3GAL4			ENSG00000110080			rs10893498-?	rs10893498	0.0	10893498	intron_variant	0	NR	1e-20	20.0		0.3	[0.24-0.36] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Platelet glycoprotein 4 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7q21.11	7	80693122.0		CD36 - SEMA3C	ENSG00000135218	ENSG00000075223		13845.0	49416.0	rs139906208-?	rs139906208	0.0	139906208	intergenic_variant	1	NR	2e-146	145.69897000433602		1.31	[1.21-1.41] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Galectin-3-binding protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	8p22	8	16192147.0		MSR1			ENSG00000038945			rs73665257-?	rs73665257	0.0	73665257	intron_variant	0	NR	2e-20	19.69897000433602		0.37	[0.29-0.45] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Galectin-3-binding protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q25.3	17	78980015.0		LGALS3BP - CANT1	ENSG00000108679	ENSG00000171302		68.0	11701.0	rs111699100-?	rs111699100	0.0	111699100	upstream_gene_variant	1	NR	1.9999999999999998e-30	29.69897000433602		1.48	[1.23-1.73] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	E3 ubiquitin-protein ligase RNF43 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11p15.4	11	6422465.0		APBB1 - HPX	ENSG00000166313	ENSG00000110169		3051.0	8584.0	rs78745000-?	rs78745000	0.0	78745000	upstream_gene_variant	1	NR	3e-25	24.522878745280337		0.67	[0.55-0.79] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Interleukin-18-binding protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	11q13.4	11	71909127.0		OR7E126P - RNF121	ENSG00000254593	ENSG00000137522		5046.0	19891.0	rs147696207-?	rs147696207	0.0	147696207	intron_variant	1	NR	2e-166	165.69897000433602		1.42	[1.32-1.52] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Phosphatidylethanolamine-binding protein 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	12q24.23	12	118159275.0		TAOK3			ENSG00000135090			rs376483165-?	rs376483165	0.0	376483165	intron_variant	0	NR	8.000000000000001e-28	27.096910013008056		1.86	[1.53-2.19] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein A-I levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	16q22.2	16	72213549.0		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		36671.0	22732.0	rs76191194-?	rs76191194	0.0	76191194	regulatory_region_variant	1	NR	8e-36	35.096910013008056		0.51	[0.43-0.59] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein disulfide-isomerase levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	17q25.3	17	82394427.0		OGFOD3			ENSG00000181396			rs62079523-?	rs62079523	0.0	62079523	missense_variant	0	NR	2e-18	17.69897000433602		0.3	[0.24-0.36] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Adhesion G protein-coupled receptor E2 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19p13.12	19	14398152.0		ADGRE5			ENSG00000123146			rs7508244-?	rs7508244	0.0	7508244	non_coding_transcript_exon_variant	0	NR	5e-47	46.30102999566398		0.58	[0.5-0.66] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Neutrophil collagenase levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	5e-35	34.30102999566398		0.45	[0.37-0.53] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Sonic hedgehog protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	1e-16	16.0		0.36	[0.28-0.44] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein S100-A4 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44919330.0		APOC1			ENSG00000130208			rs12721054-?	rs12721054	0.0	12721054	3_prime_UTR_variant	0	NR	7.000000000000001e-24	23.154901959985743		0.49	[0.39-0.59] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.42	19	54632690.0		LILRB1			ENSG00000276452			rs10425827-?	rs10425827	0.0	10425827	synonymous_variant	0	NR	7e-262	261.1549019599857		1.07	[1.01-1.13] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Lipopolysaccharide-binding protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20q11.23	20	38383368.0		LBP - SNHG17	ENSG00000129988	ENSG00000196756		6355.0	36270.0	rs11906988-?	rs11906988	0.0	11906988	downstream_gene_variant	1	NR	2e-31	30.69897000433602		0.34	[0.28-0.4] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	C-reactive protein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	1q23.2	1	159680395.0		OR10J6P - CRPP1	ENSG00000158731	ENSG00000223603		81168.0	24588.0	rs9651048-?	rs9651048	0.0	9651048	intergenic_variant	1	NR	9e-16	15.045757490560677		0.36	[0.26-0.46] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Protein Wnt-7a levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	6q24.3	6	147271241.0		STXBP5			ENSG00000164506			rs75993961-?	rs75993961	0.0	75993961	intron_variant	0	NR	1e-11	11.0		1.15	[0.82-1.48] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	14-3-3 protein beta/alpha levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20q13.12	20	44914941.0		PABPC1L			ENSG00000101104			rs6130713-?	rs6130713	0.0	6130713	intron_variant	0	NR	5e-12	11.30102999566398		0.18	[0.12-0.24] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein B levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-?	rs7412	0.0	7412	missense_variant	0	NR	9.999999999999999e-31	30.0		0.51	[0.43-0.59] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin-like growth factor-binding protein 3 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7p12.3	7	45921046.0		IGFBP3			ENSG00000146674			rs2854746-?	rs2854746	0.0	2854746	missense_variant	0	NR	3e-52	51.52287874528034		0.42	[0.36-0.48] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Insulin-like growth factor I levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7p12.3	7	45921046.0		IGFBP3			ENSG00000146674			rs2854746-?	rs2854746	0.0	2854746	missense_variant	0	NR	1e-17	17.0		0.24	[0.18-0.3] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Vitamin K-dependent protein C levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	20q11.22	20	35196218.0		PROCR			ENSG00000101000			rs11906148-?	rs11906148	0.0	11906148	intron_variant	0	NR	1e-46	46.0		0.89	[0.77-1.01] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Vitamin K-dependent protein C levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	2q14.3	2	127418654.0		PROC			ENSG00000115718			rs41280570-?	rs41280570	0.0	41280570	intron_variant	0	NR	7e-15	14.154901959985745		0.23	[0.17-0.29] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Alpha-2-HS-glycoprotein levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	3q27.3	3	186623604.0		AHSG - Metazoa_SRP	ENSG00000145192	ENSG00000276525		2286.0	6332.0	rs4634107-?	rs4634107	0.0	4634107	intron_variant	1	NR	3e-52	51.52287874528034		0.39	[0.33-0.45] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein E levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	1.0000000000000001e-39	39.0		0.45	[0.39-0.51] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Apolipoprotein E (isoform E2) levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	5e-43	42.30102999566398		0.47	[0.41-0.53] unit increase	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Aspartate aminotransferase, cytoplasmic levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals	7q21.3	7	95305887.0		PON1			ENSG00000005421			rs3917549-?	rs3917549	0.0	3917549	intron_variant	0	NR	1.0000000000000001e-23	23.0		0.27	[0.21-0.33] unit decrease	Illumina [NR]	N
2022-09-27	34814699	Katz DH	2021-11-24	Circulation	www.ncbi.nlm.nih.gov/pubmed/34814699	Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.	Heat shock protein beta-1 levels	1,852 African American or Afro-Caribbean individuals	1,688 African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, European ancestry individuals											chr7-?	chr7	0.0			1	NR	2e-46	45.69897000433602		0.41	[0.35-0.47] unit decrease	Illumina [NR]	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56968820.0		CETP			ENSG00000087237			rs9939224-G	rs9939224	0.0	9939224	intron_variant	0	0.81	1e-47	47.0		0.2	[0.18-0.22] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56972678.0		CETP			ENSG00000087237			rs7499892-T	rs7499892	0.0	7499892	intron_variant	0	0.2	9.999999999999999e-57	56.0		0.22	[0.2-0.24] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56981179.0		CETP			ENSG00000087237			rs5880-C	rs5880	0.0	5880	missense_variant	0	0.06	9e-41	40.04575749056068		0.35	[0.29-0.41] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56982180.0		CETP			ENSG00000087237			rs5882-A	rs5882	0.0	5882	missense_variant	0	0.53	1e-17	17.0		0.09	[0.07-0.11] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		17q21.31	17	43848758.0		CD300LG			ENSG00000161649			rs72836561-T	rs72836561	0.0	72836561	missense_variant	0	0.02	1e-08	8.0		0.21	[0.13-0.29] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		18q21.1	18	49634583.0		LIPG - SMUG1P1	ENSG00000101670	ENSG00000267444		35398.0	15767.0	rs7241918-T	rs7241918	0.0	7241918	intergenic_variant	1	0.88	6e-07	6.221848749616356		0.08	[0.041-0.119] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19p13.2	19	11236817.0		DOCK6			ENSG00000130158			rs737337-C	rs737337	0.0	737337	synonymous_variant	0	0.17	2e-15	14.69897000433602		0.11	[0.09-0.13] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		20q13.12	20	44413724.0		HNF4A			ENSG00000101076			rs1800961-T	rs1800961	0.0	1800961	missense_variant	0	0.02	2e-06	5.698970004336019		0.17	[0.092-0.248] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56960616.0		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-C	rs17231506	0.0	17231506	upstream_gene_variant	1	0.33	2e-104	103.69897000433602		0.25	[0.23-0.27] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		5q13.3	5	75355259.0		HMGCR			ENSG00000113161			rs3846662-G	rs3846662	0.0	3846662	non_coding_transcript_exon_variant	0	0.59	3e-10	9.522878745280336		0.08	[0.06-0.1] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p24.1	2	21011100.0		APOB			ENSG00000084674			rs533617-C	rs533617	0.0	533617	missense_variant	0	0.03	8e-06	5.096910013008056		0.14	[0.081-0.199] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		6q25.3	6	160597142.0		LPA			ENSG00000198670			rs7770628-T	rs7770628	0.0	7770628	intron_variant	0	0.71	3e-06	5.522878745280337		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		9q31.1	9	104902020.0		ABCA1			ENSG00000165029			rs1883025-T	rs1883025	0.0	1883025	intron_variant	0	0.35	2e-06	5.698970004336019		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19959423.0		LPL			ENSG00000175445			rs301-C	rs301	0.0	301	intron_variant	0	0.22	5.9999999999999996e-40	39.22184874961636		0.17	[0.15-0.19] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19961928.0		LPL			ENSG00000175445			rs326-G	rs326	0.0	326	intron_variant	0	0.24	1e-41	41.0		0.17	[0.15-0.19] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19962213.0		LPL			ENSG00000175445			rs328-G	rs328	0.0	328	stop_gained	0	0.1	2.0000000000000002e-29	28.69897000433602		0.21	[0.17-0.25] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19966981.0		LPL			ENSG00000175445			rs13702-C	rs13702	0.0	13702	3_prime_UTR_variant	0	0.24	5e-41	40.30102999566398		0.17	[0.15-0.19] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19973410.0		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		6151.0	139933.0	rs10096633-T	rs10096633	0.0	10096633	intergenic_variant	1	0.1	9e-30	29.045757490560675		0.2	[0.16-0.24] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p23.3	2	27518370.0		GCKR			ENSG00000084734			rs780094-C	rs780094	0.0	780094	intron_variant	0	0.74	4e-06	5.3979400086720375		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116715567.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		57272.0	32603.0	rs7350481-C	rs7350481	0.0	7350481	regulatory_region_variant	1	0.76	8e-14	13.096910013008056		0.1	[0.08-0.12] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		1p31.3	1	62652525.0		DOCK7			ENSG00000116641			rs10889353-C	rs10889353	0.0	10889353	intron_variant	0	0.4	2e-10	9.69897000433602		0.07	[0.05-0.09] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		1p13.3	1	109274968.0		CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	0.26	8.000000000000001e-28	27.096910013008056		0.14	[0.12-0.16] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		1p13.3	1	109275908.0		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0.0	646776	downstream_gene_variant	1	0.74	6e-28	27.22184874961636		0.14	[0.12-0.16] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p24.1	2	21072103.0		APOB - TDRD15	ENSG00000084674	ENSG00000218819		28030.0	51865.0	rs541041-A	rs541041	0.0	541041	intergenic_variant	1	0.88	3e-07	6.522878745280337		0.09	[0.051-0.129] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44906745.0		APOE			ENSG00000130203			rs769449-A	rs769449	0.0	769449	non_coding_transcript_exon_variant	0	0.08	7e-18	17.154901959985743		0.17	[0.13-0.21] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.42	19	54255498.0		LILRB5			ENSG00000105609			rs12975366-C	rs12975366	0.0	12975366	missense_variant	0	0.34	2e-06	5.698970004336019		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		1p13.3	1	109275908.0		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0.0	646776	downstream_gene_variant	1	0.74	1e-37	37.0		0.19	[0.17-0.21] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p24.1	2	21008652.0		APOB			ENSG00000084674			rs676210-A	rs676210	0.0	676210	missense_variant	0	0.54	8e-06	5.096910013008056		0.05	[0.03-0.07] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p24.1	2	21072103.0		APOB - TDRD15	ENSG00000084674	ENSG00000218819		28030.0	51865.0	rs541041-A	rs541041	0.0	541041	intergenic_variant	1	0.87	7e-10	9.154901959985745		0.12	[0.081-0.159] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p23.1	8	9326086.0		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38508.0	45004.0	rs4841132-G	rs4841132	0.0	4841132	non_coding_transcript_exon_variant	1	0.9	4e-12	11.397940008672036		0.12	[0.081-0.159] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8p21.3	8	19948197.0		LPL			ENSG00000175445			rs1801177-A	rs1801177	0.0	1801177	missense_variant	0	0.01	7e-08	7.154901959985743		0.26	[0.16-0.36] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19p13.2	19	11091630.0		LDLR			ENSG00000130164			rs6511720-T	rs6511720	0.0	6511720	intron_variant	0	0.07	3e-12	11.522878745280336		0.17	[0.13-0.21] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44906745.0		APOE			ENSG00000130203			rs769449-A	rs769449	0.0	769449	non_coding_transcript_exon_variant	0	0.08	1e-17	17.0		0.2	[0.16-0.24] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	0.04	5e-62	61.30102999566398		0.55	[0.49-0.61] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	LDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44912383.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-A	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	0.06	6e-27	26.22184874961636		0.28	[0.22-0.34] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		9q31.1	9	104902020.0		ABCA1			ENSG00000165029			rs1883025-T	rs1883025	0.0	1883025	intron_variant	0	0.35	1e-14	14.0		0.09	[0.07-0.11] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116791615.0		APOA5			ENSG00000110243			rs12287066-T	rs12287066	0.0	12287066	synonymous_variant	0	0.02	1e-09	9.0		0.23	[0.15-0.31] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116768388.0		BUD13			ENSG00000137656			rs10790162-G	rs10790162	0.0	10790162	intron_variant	0	0.79	2e-11	10.69897000433602		0.09	[0.07-0.11] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116778201.0		ZPR1			ENSG00000109917			rs964184-C	rs964184	0.0	964184	3_prime_UTR_variant	0	0.76	1e-13	13.0		0.1	[0.08-0.12] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116790676.0		APOA5			ENSG00000110243			rs2075291-A	rs2075291	0.0	2075291	missense_variant	0	0.02	9e-15	14.045757490560677		0.32	[0.24-0.4] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		15q21.3	15	58386313.0		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0.0	10468017	intron_variant	0	0.18	1e-06	6.0		0.07	[0.05-0.09] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		15q21.3	15	58391167.0		ALDH1A2			ENSG00000128918			rs1532085-G	rs1532085	0.0	1532085	intron_variant	0	0.46	6e-11	10.221848749616356		0.07	[0.05-0.09] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		15q21.3	15	58431476.0		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0.0	1800588	intron_variant	0	0.28	4e-15	14.397940008672036		0.1	[0.08-0.12] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	HDL cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56951227.0		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		6363.0	10696.0	rs9989419-G	rs9989419	0.0	9989419	regulatory_region_variant	1	0.63	5e-22	21.30102999566398		0.11	[0.09-0.13] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		2p23.3	2	27508073.0		GCKR			ENSG00000084734			rs1260326-C	rs1260326	0.0	1260326	missense_variant	0	0.74	8e-07	6.096910013008056		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		5q13.3	5	75352778.0		HMGCR			ENSG00000113161			rs12654264-T	rs12654264	0.0	12654264	intron_variant	0	0.58	3e-07	6.522878745280337		0.06	[0.04-0.08] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		5q13.3	5	75355259.0		HMGCR			ENSG00000113161			rs3846662-G	rs3846662	0.0	3846662	non_coding_transcript_exon_variant	0	0.59	2e-07	6.698970004336019		0.06	[0.04-0.08] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		6q25.3	6	160597142.0		LPA			ENSG00000198670			rs7770628-T	rs7770628	0.0	7770628	intron_variant	0	0.71	1e-07	7.0		0.07	[0.05-0.09] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		8q24.13	8	125478730.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		40327.0	380991.0	rs2954029-T	rs2954029	0.0	2954029	intron_variant	1	0.37	1e-07	7.0		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		9q31.1	9	104884939.0		ABCA1			ENSG00000165029			rs4149268-T	rs4149268	0.0	4149268	intron_variant	0	0.52	2e-07	6.698970004336019		0.06	[0.04-0.08] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		9q31.1	9	104902020.0		ABCA1			ENSG00000165029			rs1883025-T	rs1883025	0.0	1883025	intron_variant	0	0.35	4e-13	12.397940008672036		0.09	[0.07-0.11] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116715567.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		57272.0	32603.0	rs7350481-C	rs7350481	0.0	7350481	regulatory_region_variant	1	0.76	1e-10	10.0		0.09	[0.07-0.11] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116768388.0		BUD13			ENSG00000137656			rs10790162-G	rs10790162	0.0	10790162	intron_variant	0	0.79	1e-12	12.0		0.1	[0.08-0.12] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116778201.0		ZPR1			ENSG00000109917			rs964184-C	rs964184	0.0	964184	3_prime_UTR_variant	0	0.76	2e-19	18.69897000433602		0.12	[0.1-0.14] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		11q23.3	11	116791691.0		APOA5			ENSG00000110243			rs3135506-C	rs3135506	0.0	3135506	missense_variant	0	0.02	3e-09	8.522878745280337		0.23	[0.15-0.31] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		14q12	14	24414681.0		NYNRIN			ENSG00000205978			rs8017377-A	rs8017377	0.0	8017377	missense_variant	0	0.32	8e-06	5.096910013008056		0.06	[0.04-0.08] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		16q13	16	56981179.0		CETP			ENSG00000087237			rs5880-C	rs5880	0.0	5880	missense_variant	0	0.06	2e-06	5.698970004336019		0.13	[0.071-0.189] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19p13.2	19	11091630.0		LDLR			ENSG00000130164			rs6511720-T	rs6511720	0.0	6511720	intron_variant	0	0.07	9e-12	11.045757490560677		0.15	[0.11-0.19] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19p13.2	19	11236817.0		DOCK6			ENSG00000130158			rs737337-C	rs737337	0.0	737337	synonymous_variant	0	0.17	1e-06	6.0		0.07	[0.031-0.109] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19p13.11	19	19268740.0		TM6SF2			ENSG00000213996			rs58542926-T	rs58542926	0.0	58542926	missense_variant	0	0.1	4e-10	9.397940008672036		0.12	[0.081-0.159] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44906745.0		APOE			ENSG00000130203			rs769449-A	rs769449	0.0	769449	non_coding_transcript_exon_variant	0	0.08	4e-14	13.397940008672036		0.16	[0.12-0.2] unit increase	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	0.04	3e-49	48.52287874528034		0.44	[0.38-0.5] unit decrease	Illumina [9527863] (imputed)	N
2022-09-29	35945198	Huang QQ	2022-08-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35945198	Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals.	Total cholesterol levels	22,000 Pakistani and Bangladeshi ancestry individuals		19q13.32	19	44912383.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-A	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	0.06	2e-18	17.69897000433602		0.2	[0.16-0.24] unit decrease	Illumina [9527863] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Triglyceride levels	356,574 European ancestry individuals		7q32.2	7	130753772.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		19565.0	69433.0	rs201632637-?	rs201632637	0.0	201632637	intergenic_variant	1	NR	1.9999999999999998e-50	49.69897000433602		0.032	[0.028-0.036] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Triglyceride levels	356,574 European ancestry individuals		20q13.33	20	64080106.0		OPRL1, OPRL1			ENSG00000277044, ENSG00000125510			rs8126001-?	rs8126001	0.0	8126001	5_prime_UTR_variant	0	NR	3e-15	14.522878745280336		0.017	[0.013-0.021] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Triglyceride levels	356,574 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0.0	998584	downstream_gene_variant	1	NR	2.9999999999999996e-76	75.52287874528034		0.04	[0.036-0.044] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Hemoglobin A1c levels	417,018 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-?	rs13389219	0.0	13389219	intron_variant	0	NR	3e-09	8.522878745280337		0.012	[0.0081-0.0159] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Hemoglobin A1c levels	417,018 European ancestry individuals		7q32.2	7	130753772.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		19565.0	69433.0	rs201632637-?	rs201632637	0.0	201632637	intergenic_variant	1	NR	3e-08	7.522878745280337		0.011	[0.0071-0.0149] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Hemoglobin A1c levels	417,018 European ancestry individuals		20q13.33	20	64080106.0		OPRL1, OPRL1			ENSG00000277044, ENSG00000125510			rs8126001-?	rs8126001	0.0	8126001	5_prime_UTR_variant	0	NR	1e-09	9.0		0.012	[0.0081-0.0159] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Hemoglobin A1c levels	417,018 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0.0	998584	downstream_gene_variant	1	NR	3e-26	25.522878745280337		0.02	[0.016-0.024] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-?	rs13389219	0.0	13389219	intron_variant	0	NR	2e-21	20.69897000433602		0.018	[0.014-0.022] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q32.2	7	130753772.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		19565.0	69433.0	rs201632637-?	rs201632637	0.0	201632637	intergenic_variant	1	NR	7e-22	21.154901959985743		0.018	[0.014-0.022] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20q13.33	20	64080106.0		OPRL1, OPRL1			ENSG00000277044, ENSG00000125510			rs8126001-?	rs8126001	0.0	8126001	5_prime_UTR_variant	0	NR	1e-18	18.0		0.017	[0.013-0.021] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0.0	998584	downstream_gene_variant	1	NR	1e-18	18.0		0.017	[0.013-0.021] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	High density lipoprotein cholesterol levels	397,721 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-?	rs13389219	0.0	13389219	intron_variant	0	NR	1.9999999999999998e-50	49.69897000433602		0.028	[0.024-0.032] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	High density lipoprotein cholesterol levels	397,721 European ancestry individuals		7q32.2	7	130753772.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		19565.0	69433.0	rs201632637-?	rs201632637	0.0	201632637	intergenic_variant	1	NR	6e-63	62.22184874961636		0.031	[0.027-0.035] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	High density lipoprotein cholesterol levels	397,721 European ancestry individuals		20q13.33	20	64080106.0		OPRL1, OPRL1			ENSG00000277044, ENSG00000125510			rs8126001-?	rs8126001	0.0	8126001	5_prime_UTR_variant	0	NR	7e-11	10.154901959985745		0.012	[0.0081-0.0159] unit decrease	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	High density lipoprotein cholesterol levels	397,721 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0.0	998584	downstream_gene_variant	1	NR	3e-80	79.52287874528034		0.035	[0.031-0.039] unit increase	Affymetrix [NR] (imputed)	N
2022-04-27	35168826	Wood AC	2022-01-07	Nutr Metab Cardiovasc Dis	www.ncbi.nlm.nih.gov/pubmed/35168826	Identification of genetic loci simultaneously associated with multiple cardiometabolic traits.	Triglyceride levels	356,574 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-?	rs13389219	0.0	13389219	intron_variant	0	NR	7.999999999999999e-63	62.096910013008056		0.037	[0.033-0.041] unit increase	Affymetrix [NR] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	5,694 African ancestry individuals		1p31.1	1	79975074.0		ADH5P2 - HMGB1P18	ENSG00000232676	ENSG00000236407		452871.0	308278.0	rs146502564-?	rs146502564	0.0	146502564	intron_variant	1	NR	1e-10	10.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals												chr7:67346725-?	chr7:67346725	0.0			1	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	6,036 South Asian ancestry individuals												chr9:6347745-?	chr9:6347745	0.0			1	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	6,036 South Asian ancestry individuals		9q21.32	9	82476327.0		MTCO3P40 - RPS6P12	ENSG00000228046	ENSG00000233309		48302.0	267740.0	rs117308488-?	rs117308488	0.0	117308488	intron_variant	1	NR	3e-15	14.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	6,036 South Asian ancestry individuals		22q12.3	22	33782778.0		LARGE1			ENSG00000133424			rs141778563-?	rs141778563	0.0	141778563	intron_variant	0	NR	4e-10	9.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	6,036 South Asian ancestry individuals		3q12.2	3	100711664.0		TFG			ENSG00000114354			rs6777552-?	rs6777552	0.0	6777552	intron_variant	0	NR	3e-10	9.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Creatinine levels	5,694 African ancestry individuals		4p16.2	4	5744227.0		EVC			ENSG00000072840			rs10020512-?	rs10020512	0.0	10020512	intron_variant	0	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Lipoprotein A levels (UKB data field 30790)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	6q26	6	160930900.0		PLG - MAP3K4-AS1	ENSG00000122194	ENSG00000272841		176803.0	59418.0	rs76832359-?	rs76832359	0.0	76832359	intron_variant	1	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Creatinine levels	5,694 African ancestry individuals		10p12.31	10	20250846.0		PLXDC2			ENSG00000120594			rs79443026-?	rs79443026	0.0	79443026	intron_variant	0	NR	6e-13	12.221848749616356				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	233716848.0		UGT1A9, UGT1A7, UGT1A10, UGT1A8, UGT1A5, UGT1A6			ENSG00000241119, ENSG00000244122, ENSG00000242515, ENSG00000242366, ENSG00000288705, ENSG00000167165			rs28898605-?	rs28898605	0.0	28898605	intron_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals		22q13.1	22	39706913.0		CACNA1I - ENTHD1	ENSG00000100346	ENSG00000176177		17178.0	36131.0	rs11704241-?	rs11704241	0.0	11704241	regulatory_region_variant	1	NR	8e-10	9.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	233105179.0		INPP5D, INPP5D			ENSG00000281614, ENSG00000168918			rs9750891-?	rs9750891	0.0	9750891	intron_variant	0	NR	5e-27	26.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals		5q22.1	5	112167145.0		EPB41L4A			ENSG00000129595			rs79850882-?	rs79850882	0.0	79850882	intron_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Triglyceride levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	19q13.32	19	44914382.0		APOC1			ENSG00000130208			rs34954997-?	rs34954997	1.0	11568822	5_prime_UTR_variant	0	NR	9.999999999999999e-27	26.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Urea levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		14q12	14	27607606.0		MIR4307HG - LINC00645	ENSG00000257612	ENSG00000258548		689012.0	4971.0	rs114627470-?	rs114627470	0.0	114627470	intron_variant	1	NR	4e-10	9.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals												chr14:61722955-?	chr14:61722955	0.0			1	NR	8e-10	9.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		8q24.21	8	127820568.0		PVT1			ENSG00000249859			rs10099198-?	rs10099198	0.0	10099198	intron_variant	0	NR	7e-10	9.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		12p13.2	12	11330036.0		PRB4 - PRB1	ENSG00000274839	ENSG00000282673		19600.0	21787.0	rs12829748-?	rs12829748	0.0	12829748	intergenic_variant	1	NR	6e-10	9.221848749616356				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		3q26.2	3	169772149.0		ACTRT3 - MYNN	ENSG00000184378	ENSG00000085274		2588.0	1247.0	rs35100673-?	rs35100673	0.0	35100673	upstream_gene_variant	1	NR	4e-11	10.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	6,036 South Asian ancestry individuals		9q21.32	9	82476327.0		MTCO3P40 - RPS6P12	ENSG00000228046	ENSG00000233309		48302.0	267740.0	rs117308488-?	rs117308488	0.0	117308488	intron_variant	1	NR	1e-13	13.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	6,036 South Asian ancestry individuals		22q12.3	22	33782778.0		LARGE1			ENSG00000133424			rs141778563-?	rs141778563	0.0	141778563	intron_variant	0	NR	7e-10	9.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		4q26	4	116926523.0		RNU6-119P - TRAM1L1	ENSG00000201752	ENSG00000174599		87138.0	157031.0	rs66625858-?	rs66625858	0.0	66625858	intron_variant	1	NR	6e-10	9.221848749616356				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		7p14.1	7	42114246.0		GLI3			ENSG00000106571			rs117934206-?	rs117934206	0.0	117934206	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		7p11.2	7	54745806.0		RPL31P35 - SEC61G	ENSG00000232612	ENSG00000132432		89072.0	6444.0	rs75935752-?	rs75935752	0.0	75935752	intergenic_variant	1	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		1q32.2	1	207444079.0		CD55 - CR2	ENSG00000196352	ENSG00000117322		57275.0	10151.0	rs76922535-?	rs76922535	0.0	76922535	intergenic_variant	1	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	1,988 East Asian ancestry individuals												chr20:14853696-?	chr20:14853696	0.0			1	NR	5e-10	9.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	5,694 African ancestry individuals												chr4:11508981-?	chr4:11508981	0.0			1	NR	2e-12	11.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	5,694 African ancestry individuals												chr7:53750760-?	chr7:53750760	0.0			1	NR	1e-09	9.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	5,694 African ancestry individuals		2q35	2	216689207.0		IGFBP5			ENSG00000115461			rs10932672-?	rs10932672	0.0	10932672	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	5,694 African ancestry individuals		14q11.2	14	20203049.0		OR11G2 - OR11H5P	ENSG00000196832	ENSG00000258625		1974.0	1557.0	rs115410451-?	rs115410451	0.0	115410451	upstream_gene_variant	1	NR	4e-12	11.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	19q13.32	19	44915533.0		APOC1			ENSG00000130208			rs5117-?	rs5117	0.0	5117	intron_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Lipoprotein A levels (UKB data field 30790)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	6q25.3	6	160360018.0		SLC22A3			ENSG00000146477			rs405405-?	rs405405	0.0	405405	intron_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Creatinine levels	5,694 African ancestry individuals		16q21	16	60007262.0		LINC02141			ENSG00000261807			rs245640-?	rs245640	0.0	245640	intron_variant	0	NR	1e-09	9.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals												chr6:93407716-?	chr6:93407716	0.0			1	NR	5e-10	9.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals		7q11.22	7	70623670.0		AUTS2			ENSG00000158321			rs10486866-?	rs10486866	0.0	10486866	intron_variant	0	NR	2e-14	13.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q21.3	10	63530495.0		REEP3			ENSG00000165476			rs764353259-?	rs764353259	0.0	764353259	intron_variant	0	NR	1e-13	13.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals		6q14.2	6	83675570.0		SNAP91			ENSG00000065609			rs62419594-?	rs62419594	0.0	62419594	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		12p12.1	12	21251148.0		SLCO1B1 - SLCO1A2	ENSG00000134538	ENSG00000084453		11352.0	13452.0	rs9804848-?	rs9804848	0.0	9804848	regulatory_region_variant	1	NR	1e-13	13.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	5,694 African ancestry individuals		1p36.32	1	4133350.0		LINC02780 - EEF1DP6	ENSG00000284668	ENSG00000229280		120646.0	42178.0	rs10799206-?	rs10799206	0.0	10799206	regulatory_region_variant	1	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	5,694 African ancestry individuals		10q21.3	10	64266655.0		DBF4P1 - RPL17P35	ENSG00000235489	ENSG00000233900		95805.0	353719.0	rs10995857-?	rs10995857	0.0	10995857	intron_variant	1	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	5,694 African ancestry individuals		16q23.1	16	78902011.0		WWOX			ENSG00000186153			rs2047925-?	rs2047925	0.0	2047925	intron_variant	0	NR	1e-09	9.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	6,036 South Asian ancestry individuals		7q31.32	7	122998966.0		TAS2R16 - SLC13A1	ENSG00000128519	ENSG00000081800		3266.0	114565.0	rs113714930-?	rs113714930	0.0	113714930	upstream_gene_variant	1	NR	2e-11	10.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	6,036 South Asian ancestry individuals		1p32.3	1	53980903.0		HNRNPA3P12 - LDLRAD1	ENSG00000219102	ENSG00000203985		4872.0	26395.0	rs12073859-?	rs12073859	0.0	12073859	upstream_gene_variant	1	NR	1e-09	9.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	6,036 South Asian ancestry individuals		14q32.11	14	89771622.0		CHORDC2P - EFCAB11	ENSG00000259050	ENSG00000140025		33231.0	23047.0	rs77683437-?	rs77683437	0.0	77683437	intron_variant	1	NR	8e-11	10.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	High density lipoprotein cholesterol levels	6,036 South Asian ancestry individuals		5q33.3	5	159772331.0		LINC01847			ENSG00000253311			rs115029012-?	rs115029012	0.0	115029012	intron_variant	0	NR	6e-10	9.221848749616356				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		3q26.31	3	174266048.0		NLGN1			ENSG00000169760			rs60287673-?	rs60287673	0.0	60287673	intron_variant	0	NR	7e-11	10.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Low density lipoprotein cholesterol levels	6,036 South Asian ancestry individuals		3q12.2	3	100711664.0		TFG			ENSG00000114354			rs6777552-?	rs6777552	0.0	6777552	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	6,036 South Asian ancestry individuals		9p24.1	9	5415388.0		PLGRKT			ENSG00000107020			rs75195408-?	rs75195408	0.0	75195408	intron_variant	0	NR	3e-12	11.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		13q14.11	13	41711682.0		VWA8			ENSG00000102763			rs139097437-?	rs139097437	0.0	139097437	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8p12	8	30427575.0		RBPMS			ENSG00000157110			rs2979469-?	rs2979469	0.0	2979469	intron_variant	0	NR	5e-12	11.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		15q22.2	15	60591082.0		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs339969-?	rs339969	0.0	339969	intron_variant	0	NR	4e-14	13.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1p31.1	1	81800220.0		ADGRL2			ENSG00000117114			rs3748770-?	rs3748770	0.0	3748770	intron_variant	0	NR	4.0000000000000004e-24	23.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		14q21.3	14	49973756.0		LINC01588			ENSG00000214900			rs3861491-?	rs3861491	0.0	3861491	intron_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		5q11.2	5	52897294.0		ITGA1			ENSG00000213949			rs4074793-?	rs4074793	0.0	4074793	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		6p24.3	6	7240643.0		RREB1			ENSG00000124782			rs41302867-?	rs41302867	0.0	41302867	intron_variant	0	NR	5e-10	9.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		16q23.2	16	80463704.0		DYNLRB2-AS1			ENSG00000259867			rs4581712-?	rs4581712	0.0	4581712	intron_variant	0	NR	9e-35	34.045757490560675				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		4q31.22	4	145900258.0		ZNF827			ENSG00000151612			rs4835265-?	rs4835265	0.0	4835265	intron_variant	0	NR	1e-106	106.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19q13.33	19	48703160.0		FUT2			ENSG00000176920			rs492602-?	rs492602	0.0	492602	synonymous_variant	0	NR	1e-15	15.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q21.1	10	58542848.0		BICC1			ENSG00000122870			rs542141666-?	rs542141666	1.0	34877289	intron_variant	0	NR	2e-13	12.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		11q14.1	11	78886904.0		TENM4			ENSG00000149256			rs551619-?	rs551619	0.0	551619	intron_variant	0	NR	1e-10	10.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		20p12.1	20	14690567.0		MACROD2			ENSG00000172264			rs6110389-?	rs6110389	0.0	6110389	intron_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		16p13.3	16	372516.0		PGAP6			ENSG00000129925			rs62030794-?	rs62030794	0.0	62030794	3_prime_UTR_variant	0	NR	4e-11	10.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		17q25.3	17	81513977.0		ACTG1			ENSG00000184009			rs62076019-?	rs62076019	0.0	62076019	5_prime_UTR_variant	0	NR	2e-15	14.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2p25.3	2	242793.0		SH3YL1			ENSG00000035115			rs62114506-?	rs62114506	0.0	62114506	splice_region_variant	0	NR	4e-13	12.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		22q13.1	22	38700597.0		JOSD1			ENSG00000100221			rs6519133-?	rs6519133	0.0	6519133	5_prime_UTR_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8p21.3	8	22079930.0		DMTN			ENSG00000158856			rs6557780-?	rs6557780	0.0	6557780	intron_variant	0	NR	1e-13	13.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		5q31.1	5	133053268.0		HSPA4			ENSG00000170606			rs66827546-?	rs66827546	0.0	66827546	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1p36.12	1	23456692.0		ASAP3, ASAP3			ENSG00000088280, ENSG00000282854			rs685059-?	rs685059	0.0	685059	intron_variant	0	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		5q21.3	5	107543091.0		EFNA5			ENSG00000184349			rs6879279-?	rs6879279	0.0	6879279	intron_variant	0	NR	3e-23	22.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1p22.2	1	88691760.0		PKN2			ENSG00000065243			rs71666203-?	rs71666203	0.0	71666203	intron_variant	0	NR	3e-12	11.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19p13.11	19	17734085.0		MAP1S			ENSG00000130479			rs7253117-?	rs7253117	0.0	7253117	intron_variant	0	NR	2e-12	11.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19q13.2	19	41319286.0		CCDC97, TGFB1			ENSG00000142039, ENSG00000105329			rs73045269-?	rs73045269	0.0	73045269	intron_variant	0	NR	8e-18	17.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		13q12.2	13	27869951.0		PLUT			ENSG00000247381			rs1778793-?	rs1778793	0.0	1778793	intron_variant	0	NR	3e-21	20.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		12q24.11	12	111084222.0		CUX2			ENSG00000111249			rs7314285-?	rs7314285	0.0	7314285	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		11q23.3	11	118362919.0		UBE4A			ENSG00000110344			rs74398561-?	rs74398561	0.0	74398561	intron_variant	0	NR	5e-11	10.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q22.3	10	77920676.0		DLG5, DLG5			ENSG00000151208, ENSG00000274429			rs754466-?	rs754466	0.0	754466	intron_variant	0	NR	5.0000000000000004e-82	81.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		3q25.1	3	149489465.0		TM4SF4			ENSG00000169903			rs75559381-?	rs75559381	0.0	75559381	intron_variant	0	NR	9e-12	11.045757490560677				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		7p15.2	7	25982794.0		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		32808.0	169404.0	rs7780562-?	rs7780562	0.0	7780562	intergenic_variant	1	NR	7e-15	14.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		17q24.3	17	72078007.0		LINC02097, SOX9-AS1			ENSG00000226101, ENSG00000234899			rs9913936-?	rs9913936	0.0	9913936	intron_variant	0	NR	8.000000000000001e-29	28.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		18q21.31	18	58419588.0		NEDD4L - MIR122HG	ENSG00000049759	ENSG00000267391		18048.0	26200.0	rs9959832-?	rs9959832	0.0	9959832	downstream_gene_variant	1	NR	2e-85	84.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		6p22.3	6	20687890.0		CDKAL1			ENSG00000145996			rs10440833-?	rs10440833	0.0	10440833	intron_variant	0	NR	9e-10	9.045757490560677				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q23.33	10	92707153.0		HHEX - Y_RNA	ENSG00000152804	ENSG00000264495		11506.0	3346.0	rs11187140-?	rs11187140	0.0	11187140	downstream_gene_variant	1	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		11p15.1	11	17362995.0		NCR3LG1			ENSG00000188211			rs12146652-?	rs12146652	0.0	12146652	intron_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19q13.32	19	45678134.0		GIPR			ENSG00000010310			rs1800437-?	rs1800437	0.0	1800437	missense_variant	0	NR	5e-11	10.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q31.1	2	168912517.0		SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs491443-?	rs491443	0.0	491443	intron_variant	0	NR	3e-20	19.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		9q34.3	9	136340958.0		GPSM1			ENSG00000160360			rs60980157-?	rs60980157	0.0	60980157	stop_gained	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10p13	10	13283784.0		PHYH			ENSG00000107537			rs62619919-?	rs62619919	0.0	62619919	missense_variant	0	NR	2e-12	11.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q25.2	10	112998590.0		TCF7L2			ENSG00000148737			rs7903146-?	rs7903146	0.0	7903146	intron_variant	0	NR	7e-18	17.154901959985743				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		4q22.1	4	87275167.0		KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		34853.0	25328.0	rs28419230-?	rs28419230	0.0	28419230	intergenic_variant	1	NR	4.0000000000000004e-23	22.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q24.31	10	100152307.0		ERLIN1			ENSG00000107566			rs2862954-?	rs2862954	0.0	2862954	missense_variant	0	NR	5e-20	19.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8q24.13	8	125495066.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-?	rs2980888	0.0	2980888	intron_variant	1	NR	5e-10	9.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		22q13.31	22	43928975.0		PNPLA3			ENSG00000100344			rs3747207-?	rs3747207	0.0	3747207	intron_variant	0	NR	9.999999999999999e-92	91.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	High-sensitivity C-reactive protein levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	1p31.3	1	65632970.0		LEPR			ENSG00000116678			rs1938498-?	rs1938498	0.0	1938498	intron_variant	0	NR	6.000000000000001e-107	106.22184874961636				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total cholesterol levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	19q13.32	19	44912383.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-?	rs445925	0.0	445925	non_coding_transcript_exon_variant	1	NR	1e-256	256.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals												chr12:21386505-?	chr12:21386505	0.0			1	NR	4.0000000000000004e-23	22.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	232759547.0		GIGYF2			ENSG00000204120			rs11897789-?	rs11897789	0.0	11897789	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q22.1	10	69333636.0		HK1			ENSG00000156515			rs16926246-?	rs16926246	0.0	16926246	intron_variant	0	NR	6e-10	9.221848749616356				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	233240091.0		ATG16L1, ATG16L1			ENSG00000085978, ENSG00000281089			rs62192926-?	rs62192926	0.0	62192926	intron_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	233779390.0		MROH2A			ENSG00000185038			rs6431631-?	rs6431631	0.0	6431631	missense_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q21.3	10	63530495.0		REEP3			ENSG00000165476			rs764353259-?	rs764353259	0.0	764353259	intron_variant	0	NR	1e-11	11.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals												chr6:53946191-?	chr6:53946191	0.0			1	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		5p13.3	5	31021251.0		HPRT1P2 - RPL19P11	ENSG00000250587	ENSG00000241668		772358.0	32314.0	rs10075805-?	rs10075805	0.0	10075805	regulatory_region_variant	1	NR	1e-69	69.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q11.23	10	50882740.0		A1CF			ENSG00000148584			rs10994838-?	rs10994838	0.0	10994838	intron_variant	0	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		12q24.11	12	108775361.0		Y_RNA - SSH1	ENSG00000264495	ENSG00000084112		36757.0	2830.0	rs11114055-?	rs11114055	0.0	11114055	upstream_gene_variant	1	NR	3e-12	11.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		20p13	20	3200906.0		DDRGK1			ENSG00000198171			rs111769518-?	rs111769518	0.0	111769518	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1q22	1	155135811.0		SLC50A1			ENSG00000169241			rs11264333-?	rs11264333	0.0	11264333	intron_variant	0	NR	6e-51	50.22184874961636				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1q22	1	155752715.0		GON4L			ENSG00000116580			rs12134456-?	rs12134456	0.0	12134456	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		22q11.21	22	17972356.0		MICAL3			ENSG00000243156			rs12157484-?	rs12157484	0.0	12157484	intron_variant	0	NR	7e-32	31.154901959985743				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19p13.3	19	807442.0		PTBP1			ENSG00000011304			rs123698-?	rs123698	0.0	123698	non_coding_transcript_exon_variant	0	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2p14	2	64732197.0		SERTAD2			ENSG00000179833			rs12994639-?	rs12994639	0.0	12994639	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q32.3	2	191245493.0		MYO1B			ENSG00000128641			rs13019004-?	rs13019004	0.0	13019004	5_prime_UTR_variant	0	NR	4e-17	16.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2q37.1	2	232655544.0		EFHD1			ENSG00000115468			rs13395911-?	rs13395911	0.0	13395911	intron_variant	0	NR	5e-16	15.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		14q32.32	14	103105359.0		EXOC3L4			ENSG00000205436			rs139269536-?	rs139269536	1.0	56105443	intron_variant	0	NR	4e-43	42.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2p23.3	2	27522897.0		GCKR			ENSG00000084734			rs141306206-?	rs141306206	0.0	141306206	intron_variant	0	NR	2e-12	11.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19q13.11	19	33377107.0		CEBPG			ENSG00000153879			rs1469084-?	rs1469084	0.0	1469084	intron_variant	0	NR	2e-11	10.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1p36.13	1	16178825.0		EPHA2 - ARHGEF19-AS1	ENSG00000142627	ENSG00000234166		22756.0	19029.0	rs1497406-?	rs1497406	0.0	1497406	intergenic_variant	1	NR	5.000000000000001e-72	71.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		17q12	17	37713312.0		HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs17138478-?	rs17138478	0.0	17138478	intron_variant	0	NR	2e-22	21.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		3q25.33	3	160455812.0		TRIM59			ENSG00000213186			rs17236494-?	rs17236494	0.0	17236494	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		11p13	11	34632224.0		EHF			ENSG00000135373			rs17358295-?	rs17358295	0.0	17358295	intron_variant	0	NR	9e-11	10.045757490560677				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8p22	8	18398199.0		NAT2			ENSG00000156006			rs1961456-?	rs1961456	0.0	1961456	intron_variant	0	NR	7e-13	12.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q24.2	10	99825684.0		ABCC2			ENSG00000023839			rs201579800-?	rs201579800	0.0	201579800	intron_variant	0	NR	1e-10	10.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		22q11.23	22	24602652.0		GGT1			ENSG00000100031			rs2330805-?	rs2330805	0.0	2330805	intron_variant	0	NR	2.0000000000000002e-60	59.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		21q22.3	21	44829837.0		SUMO3 - PTTG1IP	ENSG00000184900	ENSG00000183255		11058.0	19748.0	rs235343-?	rs235343	0.0	235343	intergenic_variant	1	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		1p12	1	119899634.0		ADAM30 - NOTCH2	ENSG00000134249	ENSG00000134250		3119.0	11919.0	rs2487569-?	rs2487569	0.0	2487569	upstream_gene_variant	1	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		6p22.3	6	21926761.0		CASC15			ENSG00000272168			rs28431967-?	rs28431967	0.0	28431967	intron_variant	0	NR	1.0000000000000001e-23	23.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8q24.13	8	125487789.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-?	rs28601761	0.0	28601761	intron_variant	1	NR	8e-11	10.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8q22.1	8	94928370.0		TP53INP1, NDUFAF6			ENSG00000164938, ENSG00000156170			rs2904889-?	rs2904889	0.0	2904889	3_prime_UTR_variant	0	NR	4e-11	10.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		3q24	3	147909823.0		NPM1P28 - LINC02032	ENSG00000240804	ENSG00000241131		317988.0	166609.0	rs143155083-?	rs143155083	0.0	143155083	intergenic_variant	1	NR	4e-12	11.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		21q21.1	21	16942840.0		RNU1-98P - NEK4P1	ENSG00000239023	ENSG00000225735		223683.0	267629.0	rs143228560-?	rs143228560	0.0	143228560	regulatory_region_variant	1	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		3q13.31	3	114579294.0		ZBTB20			ENSG00000181722			rs143505534-?	rs143505534	0.0	143505534	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		10q25.3	10	114345951.0		AFAP1L2			ENSG00000169129			rs146966169-?	rs146966169	0.0	146966169	intron_variant	0	NR	3e-10	9.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		2q31.1	2	174334776.0		LINC01305 - SP9	ENSG00000231453	ENSG00000217236		4133.0	178.0	rs189678020-?	rs189678020	0.0	189678020	non_coding_transcript_exon_variant	1	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		9q34.3	9	135012206.0		FCN1 - OLFM1	ENSG00000085265	ENSG00000130558		94294.0	63216.0	rs7024007-?	rs7024007	0.0	7024007	intergenic_variant	1	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		19q12	19	31472697.0		TSHZ3-AS1 - LINC02841	ENSG00000267662	ENSG00000267407		54903.0	47458.0	rs75655623-?	rs75655623	0.0	75655623	intergenic_variant	1	NR	4e-10	9.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Random glucose levels	6,036 South Asian ancestry individuals		12q24.33	12	128765970.0		TMEM132C - SLC15A4	ENSG00000181234	ENSG00000139370		58059.0	27224.0	rs78405915-?	rs78405915	0.0	78405915	intergenic_variant	1	NR	1e-12	12.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	High density lipoprotein cholesterol levels	5,694 African ancestry individuals		5p13.3	5	29574558.0		LINC02064 - UBL5P1	ENSG00000248391	ENSG00000248418		178463.0	26118.0	rs16899130-?	rs16899130	0.0	16899130	intergenic_variant	1	NR	8e-10	9.096910013008056				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	6,036 South Asian ancestry individuals		4q13.3	4	71055077.0		DCK - SLC4A4	ENSG00000156136	ENSG00000080493		24163.0	7590.0	rs191973452-?	rs191973452	0.0	191973452	intergenic_variant	1	NR	7e-10	9.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	6,036 South Asian ancestry individuals		4q21.21	4	80825314.0		CFAP299			ENSG00000197826			rs6816536-?	rs6816536	0.0	6816536	intron_variant	0	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	High-sensitivity C-reactive protein levels	1,988 East Asian ancestry individuals		8q24.12	8	119351734.0		MIR548AZ - CCN3	ENSG00000276479	ENSG00000136999		26469.0	64712.0	rs2927021-?	rs2927021	0.0	2927021	non_coding_transcript_exon_variant	1	NR	4e-10	9.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Direct bilirubin levels	5,694 African ancestry individuals		9p24.2	9	3747246.0		RFX3-AS1 - GLIS3	ENSG00000232104	ENSG00000107249		55432.0	76881.0	rs4740730-?	rs4740730	0.0	4740730	regulatory_region_variant	1	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	1,988 East Asian ancestry individuals		3p26.1	3	4603729.0		ITPR1			ENSG00000150995			rs55650819-?	rs55650819	0.0	55650819	intron_variant	0	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Albumin levels	6,036 South Asian ancestry individuals		13q13.1	13	32088817.0		FRY			ENSG00000073910			rs73167112-?	rs73167112	0.0	73167112	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Liver enzyme levels (gamma-glutamyl transferase)	5,694 African ancestry individuals		6p12.1	6	53489847.0		NANOGP3 - GCLC	ENSG00000271373	ENSG00000001084		71110.0	7494.0	rs7452766-?	rs7452766	0.0	7452766	intergenic_variant	1	NR	7e-10	9.154901959985745				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	6,036 South Asian ancestry individuals		6q24.1	6	141490967.0		RN7SKP106 - RPS3AP23	ENSG00000222764	ENSG00000218351		4555.0	144683.0	rs75039817-?	rs75039817	0.0	75039817	upstream_gene_variant	1	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Total bilirubin levels	6,036 South Asian ancestry individuals		2q37.1	2	233759599.0		UGT1A4, UGT1A10, UGT1A5, UGT1A8, UGT1A9, UGT1A6, UGT1A7, UGT1A3			ENSG00000244474, ENSG00000242515, ENSG00000288705, ENSG00000242366, ENSG00000241119, ENSG00000167165, ENSG00000244122, ENSG00000288702			rs759174-?	rs759174	0.0	759174	intron_variant	0	NR	3e-39	38.52287874528034				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Glycated hemoglobin levels	1,988 East Asian ancestry individuals		9p24.2	9	4186514.0		GLIS3			ENSG00000107249			rs75382308-?	rs75382308	0.0	75382308	intron_variant	0	NR	9e-10	9.045757490560677				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Urea levels	5,694 African ancestry individuals		7q35	7	147331499.0		CNTNAP2			ENSG00000174469			rs826792-?	rs826792	0.0	826792	intron_variant	0	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals												chr2:27748992-?	chr2:27748992	0.0			1	NR	2e-10	9.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals												chr22:36055987-?	chr22:36055987	0.0			1	NR	4e-09	8.397940008672037				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		9q32	9	114386150.0		AKNA			ENSG00000106948			rs10733608-?	rs10733608	0.0	10733608	intron_variant	0	NR	1e-20	20.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		12q24.31	12	121000508.0		C12orf43, HNF1A			ENSG00000157895, ENSG00000135100			rs1169306-?	rs1169306	0.0	1169306	3_prime_UTR_variant	0	NR	5e-10	9.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		4q23	4	99318162.0		ADH1B			ENSG00000196616			rs1229984-?	rs1229984	0.0	1229984	missense_variant	0	NR	1e-14	14.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		4q22.1	4	87291707.0		KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		51393.0	8788.0	rs13117201-?	rs13117201	0.0	13117201	intergenic_variant	1	NR	4e-46	45.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		3p25.2	3	12348985.0		PPARG			ENSG00000132170			rs17036328-?	rs17036328	0.0	17036328	intron_variant	0	NR	9e-12	11.045757490560677				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19p13.11	19	19283082.0		SUGP1			ENSG00000105705			rs200210321-?	rs200210321	0.0	200210321	intron_variant	0	NR	4.0000000000000006e-45	44.39794000867204				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		8q24.13	8	125487789.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-?	rs28601761	0.0	28601761	intron_variant	1	NR	4e-16	15.397940008672036				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q24.31	10	100152307.0		ERLIN1			ENSG00000107566			rs2862954-?	rs2862954	0.0	2862954	missense_variant	0	NR	2e-35	34.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		7q11.23	7	73577263.0		TBL2			ENSG00000106638			rs35348663-?	rs35348663	0.0	35348663	intron_variant	0	NR	2e-12	11.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-?	rs429358	0.0	429358	missense_variant	0	NR	2.0000000000000002e-24	23.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		16q23.3	16	83946924.0		OSGIN1, MLYCD			ENSG00000140961, ENSG00000103150			rs4782568-?	rs4782568	0.0	4782568	intron_variant	0	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q25.2	10	112187920.0		GPAM			ENSG00000119927			rs4917628-?	rs4917628	0.0	4917628	intron_variant	0	NR	2e-14	13.69897000433602				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		22q13.31	22	43928850.0		PNPLA3			ENSG00000100344			rs738408-?	rs738408	0.0	738408	synonymous_variant	0	NR	9.999999999999999e-192	191.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		10q22.3	10	77920756.0		DLG5, DLG5			ENSG00000151208, ENSG00000274429			rs754465-?	rs754465	0.0	754465	intron_variant	0	NR	3e-09	8.522878745280337				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Alanine aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		6p22.2	6	26098246.0		HFE			ENSG00000010704			rs79220007-?	rs79220007	0.0	79220007	3_prime_UTR_variant	0	NR	3e-14	13.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Apolipoprotein B levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals	23,294 European ancestry women	19q13.32	19	44929021.0		APOC1P1			ENSG00000214855			rs7259350-?	rs7259350	0.0	7259350	intron_variant	0	NR	1e-300	300.0				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		9q32	9	114367312.0		AKNA			ENSG00000106948			rs10119644-?	rs10119644	0.0	10119644	intron_variant	0	NR	2e-09	8.698970004336019				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		2p23.3	2	27508073.0		GCKR			ENSG00000084734			rs1260326-?	rs1260326	0.0	1260326	missense_variant	0	NR	5e-21	20.30102999566398				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		6p22.2	6	26092913.0		HFE			ENSG00000010704			rs1800562-?	rs1800562	0.0	1800562	missense_variant	0	NR	3e-11	10.522878745280336				NR [9487345] (imputed)	N
2022-09-08	35810165	Westerman KE	2022-07-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/35810165	Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers.	Aspartate aminotransferase levels	5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals		19p13.11	19	19283082.0		SUGP1			ENSG00000105705			rs200210321-?	rs200210321	0.0	200210321	intron_variant	0	NR	3e-16	15.522878745280336				NR [9487345] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p34.2	1	42004603.0		HIVEP3			ENSG00000127124			rs238675-G	rs238675	0.0	238675	intron_variant	0	0.26	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.3	6	20488666.0		E2F3			ENSG00000112242			rs1322842-A	rs1322842	0.0	1322842	intron_variant	0	0.39	3e-06	5.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p34.3	1	39206873.0		MACF1			ENSG00000127603			rs17491275-G	rs17491275	0.0	17491275	3_prime_UTR_variant	0	0.16	1e-52	52.0		0.037	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q12.3	18	42334557.0		LINC00907			ENSG00000267586			rs16975918-T	rs16975918	0.0	16975918	intron_variant	0	0.32	3e-07	6.522878745280337		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q22.3	2	147145814.0		LINC01911 - RNU6-692P	ENSG00000231040	ENSG00000207225		267594.0	262528.0	rs429343-A	rs429343	0.0	429343	upstream_gene_variant	1	0.42	6e-08	7.221848749616356		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q31.1	9	100351370.0		TEX10			ENSG00000136891			rs3931548-A	rs3931548	0.0	3931548	intron_variant	0	0.38	2e-06	5.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17p13.2	17	4077854.0		ZZEF1			ENSG00000074755			rs8074454-C	rs8074454	0.0	8074454	intron_variant	0	0.33	4e-08	7.397940008672037		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p13	3	71632336.0		FOXP1 - EIF4E3	ENSG00000114861	ENSG00000163412		48347.0	43078.0	rs7630228-T	rs7630228	0.0	7630228	intron_variant	1	0.56	2e-12	11.69897000433602		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		22q13.32	22	48478600.0		MIR3201 - TAFA5	ENSG00000266508	ENSG00000219438		204185.0	10953.0	rs10854853-T	rs10854853	0.0	10854853	intron_variant	1	0.46	2e-07	6.698970004336019		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q26.31	3	173396515.0		NLGN1			ENSG00000169760			rs529200-G	rs529200	0.0	529200	5_prime_UTR_variant	0	0.53	7e-07	6.154901959985743		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.1	6	29942701.0		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0.0	9260127	non_coding_transcript_exon_variant	0	0.45	4e-13	12.397940008672036		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q23.3	11	119033523.0		SLC37A4 - HYOU1	ENSG00000137700	ENSG00000149428		2617.0	10665.0	rs583893-G	rs583893	0.0	583893	intergenic_variant	1	0.57	3e-12	11.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q21.2	17	42561053.0		HSD17B1 - COASY	ENSG00000108786	ENSG00000068120		5839.0	414.0	rs12945575-T	rs12945575	0.0	12945575	intron_variant	1	0.25	2e-18	17.69897000433602		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q22.2	9	89591874.0		SEMA4D - GADD45G	ENSG00000187764	ENSG00000130222		93744.0	13138.0	rs10681181-TTTG	rs10681181	0.0	10681181	intron_variant	1	0.48	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p11.1	3	88693553.0		NDUFA5P5 - ICE2P2	ENSG00000242365	ENSG00000242705		92151.0	254589.0	rs67518031-G	rs67518031	1.0	34705333	intergenic_variant	1	0.5	6e-06	5.221848749616356		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q21.2	5	104604714.0		LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		198593.0	175574.0	rs254027-A	rs254027	0.0	254027	intron_variant	1	0.44	5e-11	10.30102999566398		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q22.3	16	73061532.0		ZFHX3			ENSG00000140836			rs747489841-AAC	rs747489841	1.0	3081665	non_coding_transcript_exon_variant	0	0.36	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q21.3	2	134840058.0		CCNT2-AS1, ACMSD			ENSG00000224043, ENSG00000153086			rs10496731-T	rs10496731	0.0	10496731	intron_variant	0	0.63	3e-12	11.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q31.1	2	170774748.0		EIF2S2P4 - Y_RNA	ENSG00000128692	ENSG00000264495		21960.0	8419.0	rs4668314-G	rs4668314	0.0	4668314	intron_variant	1	0.39	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q24.3	14	74815413.0		YLPM1			ENSG00000119596			rs12432026-G	rs12432026	0.0	12432026	intron_variant	0	0.54	2e-17	16.69897000433602		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q34.2	9	133273813.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0.0	505922	intron_variant	0	0.32	7e-11	10.154901959985745		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q13.2	12	56100038.0		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0.0	2292238	intron_variant	0	0.59	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q12.3	8	63844100.0		LINC01414			ENSG00000253554			rs4737188-A	rs4737188	0.0	4737188	intron_variant	0	0.53	2e-10	9.69897000433602		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q12.2	16	53768582.0		FTO			ENSG00000140718			rs11642015-T	rs11642015	0.0	11642015	intron_variant	0	0.4	4e-16	15.397940008672036		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q24	4	102267552.0		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0.0	13107325	missense_variant	0	0.07	5e-118	117.30102999566398		0.078	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q21.32	18	60161902.0		RPS3AP49 - RNU4-17P	ENSG00000242060	ENSG00000202468		11537.0	1665.0	rs6567160-C	rs6567160	0.0	6567160	upstream_gene_variant	1	0.23	5e-25	24.30102999566398		0.023	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr6:34650934-C	chr6:34650934	0.0			1	0.14	4.0000000000000003e-28	27.39794000867204		0.027	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16p11.2	16	28814632.0		NPIPB9 - ATXN2L	ENSG00000196993	ENSG00000168488		41825.0	8367.0	rs56186137-G	rs56186137	0.0	56186137	non_coding_transcript_exon_variant	1	0.4	4e-07	6.3979400086720375		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p11.2	11	47508395.0		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0.0	7124681	intron_variant	0	0.41	1.9999999999999998e-97	96.69897000433602		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.2	6	26210918.0		H4C5 - H2BC8	ENSG00000276966	ENSG00000273802		4880.0	4241.0	rs9358912-G	rs9358912	0.0	9358912	intergenic_variant	1	0.73	7e-08	7.154901959985743		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q24.2	17	67858486.0		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0.0	55931203	intron_variant	0	0.19	2e-06	5.698970004336019		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr1:72767554-CA	chr1:72767554	0.0			1	0.79	3e-08	7.522878745280337		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q13.12	12	49869365.0		FAIM2			ENSG00000135472			rs7132908-A	rs7132908	0.0	7132908	3_prime_UTR_variant	0	0.38	9e-08	7.045757490560675		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q13.3	5	75719417.0		POC5 - SLC25A5P9	ENSG00000152359	ENSG00000251078		1969.0	33153.0	rs2112347-T	rs2112347	0.0	2112347	upstream_gene_variant	1	0.64	2e-22	21.69897000433602		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p14.1	11	27688083.0		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0.0	61888762	intron_variant	0	0.32	1e-18	18.0		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q11.2	18	23542244.0		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1.0	36019635	intron_variant	0	0.54	4e-17	16.397940008672037		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p11.2	11	43616425.0		MIR129-2 - HSD17B12	ENSG00000199077	ENSG00000149084		34942.0	64255.0	rs4755725-C	rs4755725	0.0	4755725	intron_variant	1	0.33	7e-07	6.154901959985743		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q22.1	16	69517564.0		CYB5B - NFAT5	ENSG00000103018	ENSG00000102908		51300.0	47530.0	rs8049669-A	rs8049669	0.0	8049669	intergenic_variant	1	0.43	1e-06	6.0		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr15:73322940-A	chr15:73322940	0.0			1	0.59	6e-07	6.221848749616356		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q11.23	7	75420803.0		POM121C			ENSG00000272391			rs236660-C	rs236660	0.0	236660	non_coding_transcript_exon_variant	0	0.57	7e-07	6.154901959985743		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q23.3	5	128021834.0		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0.0	17764730	non_coding_transcript_exon_variant	0	0.75	2e-15	14.69897000433602		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q22.3	3	136609428.0		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0.0	1471740	non_coding_transcript_exon_variant	0	0.74	3e-25	24.522878745280337		0.021	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q42.13	1	230166065.0		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0.0	11122450	intron_variant	0	0.39	5e-212	211.301029995664		0.058	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q24.31	12	122479003.0		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0.0	12369179	intron_variant	0	0.91	3e-34	33.52287874528034		0.038	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p25.2	3	12344838.0		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0.0	4684847	5_prime_UTR_variant	0	0.12	6e-12	11.221848749616356		0.019	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.32	19	45679774.0		GIPR			ENSG00000010310			rs555162510-A	rs555162510	1.0	71338792	intron_variant	0	0.82	2e-06	5.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q25.1	3	150348753.0		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0.0	62271373	regulatory_region_variant	1	0.94	3.9999999999999996e-26	25.39794000867204		0.04	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q22.33	6	127133748.0		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0.0	72959041	intron_variant	0	0.95	9e-33	32.045757490560675		0.05	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q41	1	219457962.0		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0.0	12130231	intron_variant	0	0.41	1e-17	17.0		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q24.31	12	123924955.0		DNAH10, CCDC92			ENSG00000197653, ENSG00000119242			rs7133378-A	rs7133378	0.0	7133378	intron_variant	0	0.32	2e-78	77.69897000433602		0.037	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		22q13.1	22	38203357.0		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0.0	4821764	non_coding_transcript_exon_variant	0	0.42	9.000000000000001e-29	28.045757490560675		0.021	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0.0	13389219	intron_variant	0	0.39	5e-51	50.30102999566398		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q36.3	2	226183055.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0.0	2943653	intron_variant	1	0.33	2e-100	99.69897000433602		0.04	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.11	19	33447894.0		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0.0	7258937	intron_variant	0	0.51	2e-14	13.69897000433602		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q32.2	7	130782095.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0.0	972283	intergenic_variant	1	0.49	2.0000000000000002e-60	59.69897000433602		0.03	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q33.3	5	158503125.0		LINC02227 - EBF1	ENSG00000276778	ENSG00000164330		93352.0	192791.0	rs11135038-G	rs11135038	0.0	11135038	non_coding_transcript_exon_variant	1	0.27	8e-11	10.096910013008056		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q22.1	4	88785492.0		FAM13A			ENSG00000138640			rs987469-C	rs987469	0.0	987469	intron_variant	0	0.54	5.0000000000000004e-29	28.30102999566398		0.02	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q24.13	8	125495066.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0.0	2980888	intron_variant	1	0.7	3e-85	84.52287874528034		0.038	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q11.2	5	56498805.0		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0.0	30351	regulatory_region_variant	1	0.26	2e-38	37.69897000433602		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q36.1	7	150845623.0		AOC1			ENSG00000002726			rs6977416-G	rs6977416	0.0	6977416	intron_variant	0	0.67	7e-17	16.154901959985743		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q13.1	5	68418419.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0.0	4976033	regulatory_region_variant	1	0.6	3e-11	10.522878745280336		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q12.3	11	62612555.0		EML3, ROM1			ENSG00000149499, ENSG00000149489			rs113222038-C	rs113222038	0.0	113222038	5_prime_UTR_variant	0	0.72	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12p12.2	12	20317287.0		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		181124.0	44445.0	rs11045172-C	rs11045172	0.0	11045172	intergenic_variant	1	0.2	7.999999999999999e-32	31.096910013008056		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q23.1	5	119390967.0		TNFAIP8			ENSG00000145779			rs9764678-C	rs9764678	0.0	9764678	intron_variant	0	0.27	2e-14	13.69897000433602		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0.0	998584	downstream_gene_variant	1	0.52	2e-83	82.69897000433602		0.035	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q24.1	6	139516292.0		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0.0	573454216	intron_variant	1	0.6	4.0000000000000004e-23	22.39794000867204		0.019	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4p16.2	4	4988571.0		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0.0	4450871	intergenic_variant	1	0.44	5e-07	6.301029995663981		0.008	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q21.11	8	72523729.0		RNA5SP271 - KCNB2	ENSG00000252509	ENSG00000182674		165914.0	13496.0	rs1808629-G	rs1808629	0.0	1808629	intergenic_variant	1	0.31	7e-09	8.154901959985743		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q16.1	6	97973845.0		MMS22L - MIR2113	ENSG00000146263	ENSG00000238367		690628.0	50686.0	rs6938973-C	rs6938973	0.0	6938973	intron_variant	1	0.6	2e-07	6.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p21.31	3	49883138.0		ACTL11P - MST1R	ENSG00000234667	ENSG00000164078		5833.0	3864.0	rs9843653-C	rs9843653	0.0	9843653	downstream_gene_variant	1	0.51	1e-27	27.0		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9p21.1	9	28414627.0		LINGO2			ENSG00000174482			rs17770336-T	rs17770336	0.0	17770336	intron_variant	0	0.32	8e-09	8.096910013008056		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		19q12	19	29795544.0		C19orf12 - CCNE1	ENSG00000131943	ENSG00000105173		79755.0	16447.0	rs569541320-GA	rs569541320	1.0	145999262	intergenic_variant	1	0.33	8e-09	8.096910013008056		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q32.1	1	201831383.0		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0.0	2678204	intron_variant	0	0.34	1e-06	6.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p22.1	6	28610509.0		ZBED9			ENSG00000232040			rs34388845-G	rs34388845	0.0	34388845	intron_variant	0	0.21	2.0000000000000002e-28	27.69897000433602		0.028	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p22.1	6	29942701.0		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0.0	9260127	non_coding_transcript_exon_variant	0	0.45	4e-17	16.397940008672037		0.016	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		13q31.1	13	80530125.0		RNU6-61P - HNRNPA1P31	ENSG00000202398	ENSG00000227862		160591.0	88973.0	rs68177066-C	rs68177066	0.0	68177066	intergenic_variant	1	0.34	6e-12	11.221848749616356		0.014	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q33.1	2	202105527.0		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0.0	12997625	intron_variant	0	0.53	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		3q26.2	3	171016588.0		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0.0	61791109	intron_variant	0	0.28	3e-08	7.522878745280337		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		8p23.1	8	9615919.0		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0.0	33994795	intron_variant	0	0.36	1e-19	19.0		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		9q21.32	9	83848295.0		KIF27			ENSG00000165115			rs143020014-G	rs143020014	0.0	143020014	intron_variant	0	0.55	5e-09	8.301029995663981		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		9q34.2	9	133273813.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0.0	505922	intron_variant	0	0.32	3e-43	42.52287874528034		0.03	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		15q22.2	15	60616108.0		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs340025-C	rs340025	0.0	340025	intron_variant	0	0.58	1e-07	7.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		12q13.2	12	56100038.0		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0.0	2292238	intron_variant	0	0.59	1e-09	9.0		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		12q13.2	12	56100038.0		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0.0	2292238	intron_variant	0	0.59	2e-08	7.698970004336019		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		16q12.2	16	53768582.0		FTO			ENSG00000140718			rs11642015-T	rs11642015	0.0	11642015	intron_variant	0	0.4	7e-07	6.154901959985743		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		4q24	4	102267552.0		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0.0	13107325	missense_variant	0	0.07	2.9999999999999995e-54	53.52287874528034		0.058	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr6:34650934-C	chr6:34650934	0.0			1	0.14	3e-11	10.522878745280336		0.019	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		11p11.2	11	47508395.0		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0.0	7124681	intron_variant	0	0.41	7e-10	9.154901959985745		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		11p14.1	11	27688083.0		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0.0	61888762	intron_variant	0	0.32	7e-07	6.154901959985743		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		10q23.33	10	94279840.0		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0.0	2274224	missense_variant	0	0.57	1e-09	9.0		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr15:73322940-A	chr15:73322940	0.0			1	0.59	5e-08	7.301029995663981		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr1:113202203-TCTCTC	chr1:113202203	0.0			1	0.8	1e-09	9.0		0.015	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		7q11.23	7	75420803.0		POM121C			ENSG00000272391			rs236660-C	rs236660	0.0	236660	non_coding_transcript_exon_variant	0	0.57	6e-08	7.221848749616356		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		5q23.3	5	128021834.0		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0.0	17764730	non_coding_transcript_exon_variant	0	0.75	3e-06	5.522878745280337		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q42.13	1	230166065.0		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0.0	11122450	intron_variant	0	0.39	3e-09	8.522878745280337		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		3p25.2	3	12344838.0		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0.0	4684847	5_prime_UTR_variant	0	0.12	1e-16	16.0		0.024	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6q22.33	6	127133748.0		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0.0	72959041	intron_variant	0	0.95	4e-09	8.397940008672037		0.029	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q41	1	219457962.0		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0.0	12130231	intron_variant	0	0.41	8e-10	9.096910013008056		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0.0	13389219	intron_variant	0	0.39	1e-07	7.0		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q36.3	2	226183055.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0.0	2943653	intron_variant	1	0.33	4e-17	16.397940008672037		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		19q13.11	19	33447894.0		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0.0	7258937	intron_variant	0	0.51	2e-10	9.69897000433602		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		4q22.1	4	88785492.0		FAM13A			ENSG00000138640			rs987469-C	rs987469	0.0	987469	intron_variant	0	0.54	4e-06	5.3979400086720375		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		8q24.13	8	125495066.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0.0	2980888	intron_variant	1	0.7	2.0000000000000002e-28	27.69897000433602		0.024	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		5q13.1	5	68418419.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0.0	4976033	regulatory_region_variant	1	0.6	4e-08	7.397940008672037		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		17p13.1	17	7550602.0		TNFSF12-TNFSF13, TNFSF12			ENSG00000248871, ENSG00000239697			rs12940684-C	rs12940684	0.0	12940684	intron_variant	0	0.3	4e-10	9.397940008672036		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0.0	998584	downstream_gene_variant	1	0.52	4e-18	17.397940008672037		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p21.33	6	31628105.0		PRRC2A, PRRC2A, PRRC2A, PRRC2A, PRRC2A, PRRC2A			ENSG00000231825, ENSG00000204469, ENSG00000231370, ENSG00000206427, ENSG00000226618, ENSG00000225164			rs1046080-A	rs1046080	0.0	1046080	missense_variant	0	0.72	2e-07	6.698970004336019		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		10p12.31	10	21541175.0		MLLT10			ENSG00000078403			rs11012732-G	rs11012732	0.0	11012732	intron_variant	0	0.33	3e-07	6.522878745280337		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		15q13.3	15	31397340.0		KLF13, KLF13			ENSG00000275746, ENSG00000169926			rs12441543-A	rs12441543	0.0	12441543	intron_variant	0	0.29	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0.0	998584	downstream_gene_variant	1	0.52	3e-18	17.522878745280337		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		20q12	20	40550283.0		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		538960.0	135565.0	rs6029180-G	rs6029180	0.0	6029180	intergenic_variant	1	0.33	6e-10	9.221848749616356		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p14	4	38678394.0		KLF3			ENSG00000109787			rs13132853-A	rs13132853	0.0	13132853	intron_variant	0	0.64	9e-08	7.045757490560675		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6q24.1	6	139516292.0		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0.0	573454216	intron_variant	1	0.6	1e-11	11.0		0.014	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p16.2	4	4988571.0		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0.0	4450871	intergenic_variant	1	0.44	9e-07	6.045757490560675		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2p16.1	2	59067423.0		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0.0	10172678	intron_variant	1	0.4	6e-08	7.221848749616356		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr3:185821409-A	chr3:185821409	0.0			1	0.85	5e-07	6.301029995663981		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q11.2	3	94319241.0		NSUN3 - ARMC10P1	ENSG00000178694	ENSG00000178660		187409.0	187525.0	rs1454687-C	rs1454687	0.0	1454687	intergenic_variant	1	0.48	6e-07	6.221848749616356		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		20p11.21	20	25393146.0		ABHD12 - GINS1	ENSG00000100997	ENSG00000101003		2311.0	14527.0	rs59934506-C	rs59934506	0.0	59934506	intergenic_variant	1	0.44	2e-10	9.69897000433602		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19q13.32	19	47065746.0		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0.0	3810291	3_prime_UTR_variant	0	0.68	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		13q13.1	13	32803692.0		PDS5B - LINC00423	ENSG00000083642	ENSG00000226968		25673.0	73739.0	rs7328213-T	rs7328213	0.0	7328213	intergenic_variant	1	0.55	1e-11	11.0		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q12.3	3	101417558.0		SENP7			ENSG00000138468			rs9859077-G	rs9859077	0.0	9859077	intron_variant	0	0.66	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		1p13.3	1	107074019.0		PRMT6 - NTNG1	ENSG00000198890	ENSG00000162631		6383.0	65988.0	rs9435341-T	rs9435341	0.0	9435341	intergenic_variant	1	0.34	3e-06	5.522878745280337		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11q23.3	11	119033523.0		SLC37A4 - HYOU1	ENSG00000137700	ENSG00000149428		2617.0	10665.0	rs583893-G	rs583893	0.0	583893	intergenic_variant	1	0.57	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p16.3	4	3062277.0		HTT-AS, HTT			ENSG00000251075, ENSG00000197386			rs2798297-A	rs2798297	0.0	2798297	intron_variant	0	0.37	6e-07	6.221848749616356		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		10q21.3	10	68587536.0		TET1			ENSG00000138336			rs112454648-A	rs112454648	0.0	112454648	intron_variant	0	0.44	9e-07	6.045757490560675		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q33.1	2	202105527.0		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0.0	12997625	intron_variant	0	0.53	4e-06	5.3979400086720375		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q26.2	3	171016588.0		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0.0	61791109	intron_variant	0	0.28	2e-08	7.698970004336019		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8q24.3	8	142687834.0		PSCA - LY6K	ENSG00000167653	ENSG00000160886		5109.0	12277.0	rs2717609-A	rs2717609	0.0	2717609	intergenic_variant	1	0.53	5e-07	6.301029995663981		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8p23.1	8	9615919.0		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0.0	33994795	intron_variant	0	0.36	7e-19	18.154901959985743		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		9q34.2	9	133273813.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0.0	505922	intron_variant	0	0.32	2.0000000000000003e-34	33.69897000433602		0.026	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		15q22.2	15	60616108.0		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs340025-C	rs340025	0.0	340025	intron_variant	0	0.58	6e-19	18.22184874961636		0.017	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16q21	16	58081130.0		MMP15 - Y_RNA	ENSG00000102996	ENSG00000264495		34229.0	1938.0	rs7191378-G	rs7191378	0.0	7191378	regulatory_region_variant	1	0.31	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2p16.3	2	48463457.0		PPP1R21			ENSG00000162869			rs4497915-G	rs4497915	0.0	4497915	intron_variant	0	0.54	6e-12	11.221848749616356		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7p14.3	7	32339367.0		PDE1C			ENSG00000154678			rs215669-G	rs215669	0.0	215669	intron_variant	0	0.39	2e-06	5.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p22.3	6	20488666.0		E2F3			ENSG00000112242			rs1322842-A	rs1322842	0.0	1322842	intron_variant	0	0.39	3e-07	6.522878745280337		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q31.1	2	174301908.0		LRRC2P1 - HNRNPA1P39	ENSG00000227180	ENSG00000237804		952.0	8107.0	rs34234296-G	rs34234296	0.0	34234296	upstream_gene_variant	1	0.61	5e-09	8.301029995663981		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p15.3	11	13280328.0		ARNTL			ENSG00000133794			rs72867447-G	rs72867447	0.0	72867447	intron_variant	0	0.57	8e-08	7.096910013008056		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p34.3	1	39206873.0		MACF1			ENSG00000127603			rs17491275-G	rs17491275	0.0	17491275	3_prime_UTR_variant	0	0.16	3e-19	18.522878745280337		0.023	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q22.3	2	147145814.0		LINC01911 - RNU6-692P	ENSG00000231040	ENSG00000207225		267594.0	262528.0	rs429343-A	rs429343	0.0	429343	upstream_gene_variant	1	0.42	2e-06	5.698970004336019		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5p12	5	43204024.0		NIM1K			ENSG00000177453			rs67913249-C	rs67913249	0.0	67913249	intron_variant	0	0.66	6e-06	5.221848749616356		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q26.31	3	173396515.0		NLGN1			ENSG00000169760			rs529200-G	rs529200	0.0	529200	5_prime_UTR_variant	0	0.53	5e-06	5.301029995663981		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p22.1	6	29942701.0		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0.0	9260127	non_coding_transcript_exon_variant	0	0.45	7e-14	13.154901959985745		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q21.2	17	42561053.0		HSD17B1 - COASY	ENSG00000108786	ENSG00000068120		5839.0	414.0	rs12945575-T	rs12945575	0.0	12945575	intron_variant	1	0.25	2e-16	15.69897000433602		0.018	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		9q22.2	9	89591874.0		SEMA4D - GADD45G	ENSG00000187764	ENSG00000130222		93744.0	13138.0	rs10681181-TTTG	rs10681181	0.0	10681181	intron_variant	1	0.48	7e-12	11.154901959985745		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p16.3	4	3062277.0		HTT-AS, HTT			ENSG00000251075, ENSG00000197386			rs2798297-A	rs2798297	0.0	2798297	intron_variant	0	0.37	1e-12	12.0		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q21.2	5	104604714.0		LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		198593.0	175574.0	rs254027-A	rs254027	0.0	254027	intron_variant	1	0.44	2e-08	7.698970004336019		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q33.1	2	202105527.0		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0.0	12997625	intron_variant	0	0.53	2e-07	6.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q26.2	3	171016588.0		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0.0	61791109	intron_variant	0	0.28	3e-07	6.522878745280337		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8p23.1	8	9615919.0		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0.0	33994795	intron_variant	0	0.36	6e-19	18.22184874961636		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16q22.2	16	72217233.0		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		40355.0	19048.0	rs811054-T	rs811054	0.0	811054	intergenic_variant	1	0.54	2e-07	6.698970004336019		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q31.1	2	170774748.0		EIF2S2P4 - Y_RNA	ENSG00000128692	ENSG00000264495		21960.0	8419.0	rs4668314-G	rs4668314	0.0	4668314	intron_variant	1	0.39	2e-11	10.69897000433602		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		9q34.2	9	133273813.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0.0	505922	intron_variant	0	0.32	8e-10	9.096910013008056		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q12.3	8	63844100.0		LINC01414			ENSG00000253554			rs4737188-A	rs4737188	0.0	4737188	intron_variant	0	0.53	2e-07	6.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q24.13	8	125495066.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0.0	2980888	intron_variant	1	0.7	0.0	367.0		0.085	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16q12.2	16	53768582.0		FTO			ENSG00000140718			rs11642015-T	rs11642015	0.0	11642015	intron_variant	0	0.4	8e-20	19.096910013008056		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4q24	4	102267552.0		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0.0	13107325	missense_variant	0	0.07	8e-10	9.096910013008056		0.022	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16p11.2	16	28814632.0		NPIPB9 - ATXN2L	ENSG00000196993	ENSG00000168488		41825.0	8367.0	rs56186137-G	rs56186137	0.0	56186137	non_coding_transcript_exon_variant	1	0.4	2e-07	6.698970004336019		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr14:79940130-T	chr14:79940130	0.0			1	0.2	2e-08	7.698970004336019		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		17q24.2	17	67858486.0		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0.0	55931203	intron_variant	0	0.19	1e-19	19.0		0.023	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p12	4	45180510.0		PRDX4P1 - THAP12P9	ENSG00000248987	ENSG00000248320		235549.0	142743.0	rs10938397-G	rs10938397	0.0	10938397	intergenic_variant	1	0.43	5e-06	5.301029995663981		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11p14.1	11	27688083.0		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0.0	61888762	intron_variant	0	0.32	1e-06	6.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		18q11.2	18	23542244.0		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1.0	36019635	intron_variant	0	0.54	4e-07	6.3979400086720375		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11p11.2	11	43616425.0		MIR129-2 - HSD17B12	ENSG00000199077	ENSG00000149084		34942.0	64255.0	rs4755725-C	rs4755725	0.0	4755725	intron_variant	1	0.33	4e-09	8.397940008672037		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19p13.11	19	18272696.0		IQCN			ENSG00000130518			rs11666808-T	rs11666808	0.0	11666808	intron_variant	0	0.37	2e-09	8.698970004336019		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		10q23.33	10	94279840.0		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0.0	2274224	missense_variant	0	0.57	5e-10	9.30102999566398		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q21.3	5	108142979.0		FBXL17			ENSG00000145743			rs10623997-T	rs10623997	0.0	10623997	intron_variant	0	0.76	2e-07	6.698970004336019		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr1:113202203-TCTCTC	chr1:113202203	0.0			1	0.8	4e-06	5.3979400086720375		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		7q11.23	7	75420803.0		POM121C			ENSG00000272391			rs236660-C	rs236660	0.0	236660	non_coding_transcript_exon_variant	0	0.57	3e-11	10.522878745280336		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q23.3	5	128021834.0		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0.0	17764730	non_coding_transcript_exon_variant	0	0.75	8e-11	10.096910013008056		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q22.3	3	136609428.0		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0.0	1471740	non_coding_transcript_exon_variant	0	0.74	2e-27	26.69897000433602		0.025	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		12q24.31	12	122479003.0		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0.0	12369179	intron_variant	0	0.91	4e-07	6.3979400086720375		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3p25.2	3	12344838.0		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0.0	4684847	5_prime_UTR_variant	0	0.12	3.0000000000000003e-31	30.522878745280337		0.034	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q25.1	3	150348753.0		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0.0	62271373	regulatory_region_variant	1	0.94	9e-07	6.045757490560675		0.022	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6q22.33	6	127133748.0		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0.0	72959041	intron_variant	0	0.95	9e-16	15.045757490560677		0.038	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		1q41	1	219457962.0		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0.0	12130231	intron_variant	0	0.41	4e-14	13.397940008672036		0.015	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		22q13.1	22	38203357.0		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0.0	4821764	non_coding_transcript_exon_variant	0	0.42	7e-17	16.154901959985743		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0.0	13389219	intron_variant	0	0.39	5e-30	29.30102999566398		0.023	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q36.3	2	226183055.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0.0	2943653	intron_variant	1	0.33	4.0000000000000006e-34	33.39794000867204		0.025	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19q13.11	19	33447894.0		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0.0	7258937	intron_variant	0	0.51	8e-06	5.096910013008056		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		7q32.2	7	130782095.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0.0	972283	intergenic_variant	1	0.49	4e-09	8.397940008672037		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8q24.13	8	125495066.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0.0	2980888	intron_variant	1	0.7	4e-70	69.39794000867204		0.038	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q11.2	5	56498805.0		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0.0	30351	regulatory_region_variant	1	0.26	7e-16	15.154901959985745		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q13.1	5	68418419.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0.0	4976033	regulatory_region_variant	1	0.6	3e-11	10.522878745280336		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q23.3	8	115659621.0		TRPS1			ENSG00000104447			rs4876611-G	rs4876611	0.0	4876611	intron_variant	0	0.72	6e-10	9.221848749616356		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p14.1	11	27688083.0		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0.0	61888762	intron_variant	0	0.32	1e-09	9.0		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18q11.2	18	23542244.0		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1.0	36019635	intron_variant	0	0.54	5e-15	14.30102999566398		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19p13.11	19	18272696.0		IQCN			ENSG00000130518			rs11666808-T	rs11666808	0.0	11666808	intron_variant	0	0.37	3e-09	8.522878745280337		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		10q23.33	10	94279840.0		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0.0	2274224	missense_variant	0	0.57	3e-06	5.522878745280337		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16q22.1	16	69517564.0		CYB5B - NFAT5	ENSG00000103018	ENSG00000102908		51300.0	47530.0	rs8049669-A	rs8049669	0.0	8049669	intergenic_variant	1	0.43	4e-16	15.397940008672036		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr15:73322940-A	chr15:73322940	0.0			1	0.59	3e-06	5.522878745280337		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q22.3	3	136609428.0		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0.0	1471740	non_coding_transcript_exon_variant	0	0.74	5e-33	32.30102999566398		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q42.13	1	230166065.0		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0.0	11122450	intron_variant	0	0.39	3.0000000000000005e-131	130.52287874528034		0.048	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q24.31	12	122479003.0		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0.0	12369179	intron_variant	0	0.91	1e-08	8.0		0.02	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3p25.2	3	12344838.0		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0.0	4684847	5_prime_UTR_variant	0	0.12	1e-18	18.0		0.025	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.32	19	45679774.0		GIPR			ENSG00000010310			rs555162510-A	rs555162510	1.0	71338792	intron_variant	0	0.82	2e-06	5.698970004336019		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q25.1	3	150348753.0		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0.0	62271373	regulatory_region_variant	1	0.94	7.999999999999999e-25	24.096910013008056		0.043	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q22.33	6	127133748.0		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0.0	72959041	intron_variant	0	0.95	6e-43	42.22184874961636		0.063	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q41	1	219457962.0		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0.0	12130231	intron_variant	0	0.41	2e-21	20.69897000433602		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q24.31	12	123924955.0		DNAH10, CCDC92			ENSG00000197653, ENSG00000119242			rs7133378-A	rs7133378	0.0	7133378	intron_variant	0	0.32	1.9999999999999998e-42	41.69897000433602		0.029	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		22q13.1	22	38203357.0		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0.0	4821764	non_coding_transcript_exon_variant	0	0.42	2.0000000000000002e-29	28.69897000433602		0.023	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q24.3	2	164672366.0		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0.0	13389219	intron_variant	0	0.39	3.9999999999999997e-84	83.39794000867204		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q36.3	2	226183055.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0.0	2943653	intron_variant	1	0.33	2.9999999999999996e-76	75.52287874528034		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.11	19	33447894.0		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0.0	7258937	intron_variant	0	0.51	3e-06	5.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7q32.2	7	130782095.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0.0	972283	intergenic_variant	1	0.49	2e-62	61.69897000433602		0.033	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q33.3	5	158503125.0		LINC02227 - EBF1	ENSG00000276778	ENSG00000164330		93352.0	192791.0	rs11135038-G	rs11135038	0.0	11135038	non_coding_transcript_exon_variant	1	0.27	3e-10	9.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q25.1	17	75883770.0		TRIM65			ENSG00000141569			rs142186653-C	rs142186653	0.0	142186653	intron_variant	0	0.23	7e-06	5.154901959985743		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4q22.1	4	88785492.0		FAM13A			ENSG00000138640			rs987469-C	rs987469	0.0	987469	intron_variant	0	0.54	1e-14	14.0		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q11.2	5	56498805.0		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0.0	30351	regulatory_region_variant	1	0.26	9e-44	43.04575749056068		0.031	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8p11.23	8	37001668.0		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		65543.0	93482.0	rs12681990-T	rs12681990	0.0	12681990	intergenic_variant	1	0.84	1e-06	6.0		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7q36.1	7	150845623.0		AOC1			ENSG00000002726			rs6977416-G	rs6977416	0.0	6977416	intron_variant	0	0.67	3e-08	7.522878745280337		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q13.1	5	68418419.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0.0	4976033	regulatory_region_variant	1	0.6	2e-21	20.69897000433602		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11q12.3	11	62612555.0		EML3, ROM1			ENSG00000149499, ENSG00000149489			rs113222038-C	rs113222038	0.0	113222038	5_prime_UTR_variant	0	0.72	4e-09	8.397940008672037		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12p12.2	12	20317287.0		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		181124.0	44445.0	rs11045172-C	rs11045172	0.0	11045172	intergenic_variant	1	0.2	8.999999999999998e-25	24.045757490560675		0.025	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q32.1	1	203558684.0		OPTC - ATP2B4	ENSG00000188770	ENSG00000058668		49735.0	68103.0	rs2802774-A	rs2802774	0.0	2802774	intergenic_variant	1	0.55	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q23.1	5	119390967.0		TNFAIP8			ENSG00000145779			rs9764678-C	rs9764678	0.0	9764678	intron_variant	0	0.27	7e-22	21.154901959985743		0.021	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q13.13	12	54028026.0		HOXC6, HOXC4			ENSG00000197757, ENSG00000198353			rs10876529-C	rs10876529	0.0	10876529	intron_variant	0	0.37	5e-09	8.301029995663981		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18p11.32	18	2846814.0		SMCHD1 - EMILIN2	ENSG00000101596	ENSG00000132205		41797.0	192.0	rs11664106-T	rs11664106	0.0	11664106	non_coding_transcript_exon_variant	1	0.37	1e-09	9.0		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p21.1	6	43790159.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0.0	998584	downstream_gene_variant	1	0.52	4e-96	95.39794000867204		0.04	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		20q12	20	40550283.0		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		538960.0	135565.0	rs6029180-G	rs6029180	0.0	6029180	intergenic_variant	1	0.33	2e-14	13.69897000433602		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p14	4	38678394.0		KLF3			ENSG00000109787			rs13132853-A	rs13132853	0.0	13132853	intron_variant	0	0.64	1e-07	7.0		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q24.1	6	139516292.0		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0.0	573454216	intron_variant	1	0.6	2e-44	43.69897000433602		0.028	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p16.2	4	4988571.0		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0.0	4450871	intergenic_variant	1	0.44	1e-12	12.0		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16p11.2	16	31014320.0		STX1B - STX4	ENSG00000099365	ENSG00000103496		3682.0	18569.0	rs34898535-C	rs34898535	0.0	34898535	upstream_gene_variant	1	0.62	3e-15	14.522878745280336		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p31.3	1	62104649.0		PATJ			ENSG00000132849			rs1013293-G	rs1013293	0.0	1013293	intron_variant	0	0.57	1e-06	6.0		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2p16.1	2	59067423.0		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0.0	10172678	intron_variant	1	0.4	3e-11	10.522878745280336		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p21.3	1	97850337.0		DPYD			ENSG00000188641			rs12072739-G	rs12072739	0.0	12072739	intron_variant	0	0.23	2e-13	12.69897000433602		0.017	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q32.1	1	201831383.0		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0.0	2678204	intron_variant	0	0.34	7e-07	6.154901959985743		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q11.2	3	94319241.0		NSUN3 - ARMC10P1	ENSG00000178694	ENSG00000178660		187409.0	187525.0	rs1454687-C	rs1454687	0.0	1454687	intergenic_variant	1	0.48	4e-07	6.3979400086720375		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		10q24.2	10	98013128.0		CRTAC1			ENSG00000095713			rs522110-G	rs522110	0.0	522110	intron_variant	0	0.56	3e-17	16.522878745280337		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr13:99119385-TAA	chr13:99119385	0.0			1	0.71	8e-06	5.096910013008056		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		21q22.3	21	45161883.0		ADARB1			ENSG00000197381			rs394608-C	rs394608	0.0	394608	intron_variant	0	0.54	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q16.3	6	100181202.0		PRDX2P4 - SIM1	ENSG00000213177	ENSG00000112246		44539.0	203807.0	rs57989773-C	rs57989773	0.0	57989773	downstream_gene_variant	1	0.24	4e-08	7.397940008672037		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.32	19	47065746.0		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0.0	3810291	3_prime_UTR_variant	0	0.68	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16p11.2	16	31014320.0		STX1B - STX4	ENSG00000099365	ENSG00000103496		3682.0	18569.0	rs34898535-C	rs34898535	0.0	34898535	upstream_gene_variant	1	0.62	3e-08	7.522878745280337		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p31.3	1	62104649.0		PATJ			ENSG00000132849			rs1013293-G	rs1013293	0.0	1013293	intron_variant	0	0.57	3e-07	6.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		20q13.12	20	47736892.0		SULF2			ENSG00000196562			rs56218501-C	rs56218501	0.0	56218501	missense_variant	0	0.79	7e-17	16.154901959985743		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2p16.1	2	59067423.0		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0.0	10172678	intron_variant	1	0.4	5e-06	5.301029995663981		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q22.1	3	131899697.0		CPNE4			ENSG00000196353			rs9847672-T	rs9847672	0.0	9847672	intron_variant	0	0.28	7e-11	10.154901959985745		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p21.3	1	97850337.0		DPYD			ENSG00000188641			rs12072739-G	rs12072739	0.0	12072739	intron_variant	0	0.23	5e-06	5.301029995663981		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q12.3	18	43188344.0		RIT2 - SYT4	ENSG00000152214	ENSG00000132872		72653.0	79548.0	rs59499656-A	rs59499656	0.0	59499656	intergenic_variant	1	0.66	5e-11	10.30102999566398		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p15.4	11	8669171.0		TRIM66			ENSG00000166436			rs11042030-T	rs11042030	0.0	11042030	intron_variant	0	0.72	8e-06	5.096910013008056		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr3:185821409-A	chr3:185821409	0.0			1	0.85	7.999999999999999e-25	24.096910013008056		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q32.1	1	201831383.0		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0.0	2678204	intron_variant	0	0.34	2e-07	6.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q31.1	4	139942211.0		MAML3			ENSG00000196782			rs57800857-A	rs57800857	0.0	57800857	intron_variant	0	0.63	1e-06	6.0		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q13.2	11	66156746.0		PACS1			ENSG00000175115			rs801738-C	rs801738	0.0	801738	intron_variant	0	0.64	6e-13	12.221848749616356		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q32.12	14	93557626.0		UNC79, UNC79			ENSG00000276416, ENSG00000133958			rs6575340-A	rs6575340	0.0	6575340	intron_variant	0	0.64	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		10q24.2	10	98013128.0		CRTAC1			ENSG00000095713			rs522110-G	rs522110	0.0	522110	intron_variant	0	0.56	3e-14	13.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q21.32	17	49013423.0		IGF2BP1			ENSG00000159217			rs11079849-C	rs11079849	0.0	11079849	intron_variant	0	0.67	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		20q13.33	20	63715839.0		ZGPAT			ENSG00000197114			rs62217799-T	rs62217799	0.0	62217799	intron_variant	0	0.66	2e-10	9.69897000433602		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.1	6	28610509.0		ZBED9			ENSG00000232040			rs34388845-G	rs34388845	0.0	34388845	intron_variant	0	0.21	2e-14	13.69897000433602		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		21q22.3	21	45161883.0		ADARB1			ENSG00000197381			rs394608-C	rs394608	0.0	394608	intron_variant	0	0.54	1e-06	6.0		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q32.32	14	102780133.0		TRAF3			ENSG00000131323			rs3803286-A	rs3803286	0.0	3803286	intron_variant	0	0.33	3e-17	16.522878745280337		0.016	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		13q12.2	13	27438390.0		MTIF3			ENSG00000122033			rs9512696-G	rs9512696	0.0	9512696	intron_variant	0	0.66	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2p22.2	2	36562023.0		FEZ2			ENSG00000171055			rs13410783-G	rs13410783	0.0	13410783	intron_variant	0	0.37	5e-08	7.301029995663981		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q11.2	17	29747545.0		SSH2			ENSG00000141298			rs1038088-G	rs1038088	0.0	1038088	intron_variant	0	0.52	8e-06	5.096910013008056		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.32	19	47065746.0		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0.0	3810291	3_prime_UTR_variant	0	0.68	4e-15	14.397940008672036		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4q24	4	102267552.0		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0.0	13107325	missense_variant	0	0.07	2e-14	13.69897000433602		0.029	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18q21.32	18	60161902.0		RPS3AP49 - RNU4-17P	ENSG00000242060	ENSG00000202468		11537.0	1665.0	rs6567160-C	rs6567160	0.0	6567160	upstream_gene_variant	1	0.23	4e-08	7.397940008672037		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p11.2	11	47508395.0		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0.0	7124681	intron_variant	0	0.41	5e-15	14.30102999566398		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q24.2	17	67858486.0		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0.0	55931203	intron_variant	0	0.19	3e-20	19.522878745280337		0.024	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr1:72767554-CA	chr1:72767554	0.0			1	0.79	3e-06	5.522878745280337		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q23.3	12	108224853.0		WSCD2			ENSG00000075035			rs3764002-C	rs3764002	0.0	3764002	missense_variant	0	0.74	1e-06	6.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Heat shock 27 kDa protein levels	2,858 Greek (founder/geneitc isolate) individuals		11q13.1	11	65169248.0		PDCL2P2 - SPDYC	ENSG00000255058	ENSG00000204710		8866.0	906.0	rs12292693-?	rs12292693	0.0	12292693	upstream_gene_variant	1	NR	4e-11	10.397940008672036		0.2169	[0.15-0.28] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Heat shock 27 kDa protein levels	2,858 Greek (founder/geneitc isolate) individuals		7q11.23	7	76294901.0		SRRM3 - HSPB1	ENSG00000177679	ENSG00000106211		7613.0	7772.0	rs2908203-?	rs2908203	0.0	2908203	TF_binding_site_variant	1	NR	3e-85	84.52287874528034		0.557	[0.5-0.61] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein 7 levels	2,923 Greek (founder/geneitc isolate) individuals												chr4:46732375-?	chr4:46732375	0.0			1	NR	6.999999999999999e-30	29.154901959985743		1.7419	[1.44-2.04] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein 7 levels	2,923 Greek (founder/geneitc isolate) individuals												chr4:56636449-?	chr4:56636449	0.0			1	NR	7e-53	52.15490195998574		2.871	[2.5-3.24] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein 7 levels	2,923 Greek (founder/geneitc isolate) individuals		4q12	4	57085582.0		IGFBP7			ENSG00000163453			rs10570209-?	rs10570209	0.0	10570209	intron_variant	0	NR	2e-16	15.69897000433602		0.3483	[0.27-0.43] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein 7 levels	2,923 Greek (founder/geneitc isolate) individuals		4q13.2	4	67658568.0		UBA6			ENSG00000033178			rs539585543-?	rs539585543	0.0	539585543	intron_variant	0	NR	7.999999999999999e-25	24.096910013008056		2.11	[1.71-2.51] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein 7 levels	2,923 Greek (founder/geneitc isolate) individuals		4q13.3	4	73468743.0		AFP - AFM	ENSG00000081051	ENSG00000079557		12569.0	13002.0	rs1289184022-?	rs1289184022	0.0	1289184022	intergenic_variant	1	NR	1e-15	15.0		1.9427	[1.47-2.42] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein-like 1 levels	2,905 Greek (founder/geneitc isolate) individuals		9p13.1	9	38381311.0		U8 - ALDH1B1	ENSG00000239142	ENSG00000137124		233750.0	11391.0	rs10973772-?	rs10973772	0.0	10973772	downstream_gene_variant	1	NR	6e-33	32.22184874961636		0.3257	[0.27-0.38] unit decrease	Illumina [30565519]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	A disintegrin and metalloproteinase with thrombospondin motifs 13 levels	2,858 Greek (founder/geneitc isolate) individuals		9q34.2	9	133392016.0		STKLD1, STKLD1			ENSG00000198870, ENSG00000281245			rs28502181-?	rs28502181	0.0	28502181	intron_variant	0	NR	7e-22	21.154901959985743		0.5238	[0.42-0.63] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	A disintegrin and metalloproteinase with thrombospondin motifs 13 levels	2,858 Greek (founder/geneitc isolate) individuals		4q35.2	4	186240347.0		KLKB1			ENSG00000164344			rs35984397-?	rs35984397	0.0	35984397	intron_variant	0	NR	5e-16	15.30102999566398		0.2195	[0.17-0.27] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	A disintegrin and metalloproteinase with thrombospondin motifs 13 levels	2,858 Greek (founder/geneitc isolate) individuals		3q27.3	3	186677324.0		HRG			ENSG00000113905			rs2228243-?	rs2228243	0.0	2228243	missense_variant	0	NR	2e-51	50.69897000433602		0.4891	[0.43-0.55] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Adhesion G protein-coupled receptor E2 levels	2,906 Greek (founder/geneitc isolate) individuals		19p13.12	19	14388656.0		ADGRE5			ENSG00000123146			rs8108408-?	rs8108408	0.0	8108408	intron_variant	0	NR	4e-21	20.39794000867204		0.6756	[0.54-0.82] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Agouti-related protein levels	2,857 Greek (founder/geneitc isolate) individuals		16q21	16	66475748.0		BEAN1, BEAN1-AS1			ENSG00000166546, ENSG00000261656			rs58689256-?	rs58689256	0.0	58689256	non_coding_transcript_exon_variant	0	NR	4e-22	21.39794000867204		2.381	[1.9-2.86] unit decrease	Illumina [30481047]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Protein AMBP levels	2,858 Greek (founder/geneitc isolate) individuals		17q11.2	17	28391573.0		SARM1			ENSG00000004139			rs9913833-?	rs9913833	0.0	9913833	intron_variant	0	NR	4e-11	10.397940008672036		0.18	[0.13-0.23] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Angiopoietin-related protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		1q25.2	1	178557948.0		C1orf220 - RNA5SP69	ENSG00000213057	ENSG00000201347		9059.0	2965.0	rs35716224-?	rs35716224	0.0	35716224	upstream_gene_variant	1	NR	4e-13	12.397940008672036		0.1974	[0.14-0.25] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Angiopoietin-related protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		1q25.2	1	178902082.0		RALGPS2			ENSG00000116191			rs2275100-?	rs2275100	0.0	2275100	intron_variant	0	NR	5e-13	12.30102999566398		0.2995	[0.22-0.38] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Scavenger receptor cysteine-rich type 1 protein M130 levels	2,923 Greek (founder/geneitc isolate) individuals		17p13.1	17	7170428.0		RPL7AP64 - ASGR1	ENSG00000213876	ENSG00000141505		28836.0	3003.0	rs72837687-?	rs72837687	0.0	72837687	downstream_gene_variant	1	NR	5e-12	11.30102999566398		0.2744	[0.2-0.35] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Scavenger receptor cysteine-rich type 1 protein M130 levels	2,923 Greek (founder/geneitc isolate) individuals		2q21.2	2	134208991.0		MGAT5			ENSG00000152127			rs62165726-?	rs62165726	0.0	62165726	intron_variant	0	NR	2.0000000000000002e-23	22.69897000433602		0.7155	[0.57-0.86] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Sialomucin core protein 24 levels	2,906 Greek (founder/geneitc isolate) individuals		6q21	6	109423238.0		PPIL6			ENSG00000185250			rs11153180-?	rs11153180	0.0	11153180	intron_variant	0	NR	2.9999999999999995e-54	53.52287874528034		0.4359	[0.38-0.49] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Bone morphogenetic protein 6 levels	2,771 Greek (founder/geneitc isolate) individuals		4q35.2	4	186235351.0		KLKB1			ENSG00000164344			rs57182850-?	rs57182850	0.0	57182850	intron_variant	0	NR	2e-79	78.69897000433602		0.4946	[0.44-0.55] unit increase	Illumina [30279878]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Bone morphogenetic protein 6 levels	2,771 Greek (founder/geneitc isolate) individuals		3q27.3	3	186742138.0		KNG1			ENSG00000113889			rs710446-?	rs710446	0.0	710446	missense_variant	0	NR	5e-16	15.30102999566398		0.2246	[0.17-0.28] unit increase	Illumina [30279878]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Coiled-coil domain-containing protein 80 levels	2,902 Greek (founder/geneitc isolate) individuals		4q35.2	4	186243195.0		KLKB1			ENSG00000164344			rs4253281-?	rs4253281	0.0	4253281	intron_variant	0	NR	6e-25	24.22184874961636		0.2762	[0.22-0.33] unit decrease	Illumina [30554553]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Carcinoembryonic antigenrelated cell adhesion molecule 8 levels	2,858 Greek (founder/geneitc isolate) individuals		1q31.3	1	196733680.0		CFH			ENSG00000000971			rs1329428-?	rs1329428	0.0	1329428	intron_variant	0	NR	3e-14	13.522878745280336		0.2097	[0.16-0.26] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Chitinase-3-like protein 1 levels	2,923 Greek (founder/geneitc isolate) individuals		8q24.13	8	125469835.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-?	rs2954021	0.0	2954021	intron_variant	1	NR	1e-11	11.0		0.1824	[0.13-0.24] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Chitinase-3-like protein 1 levels	2,923 Greek (founder/geneitc isolate) individuals		1q32.1	1	203186575.0		CHI3L1			ENSG00000133048			rs7515776-?	rs7515776	0.0	7515776	intron_variant	0	NR	9.999999999999999e-31	30.0		0.397	[0.33-0.46] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Chitinase-3-like protein 1 levels	2,923 Greek (founder/geneitc isolate) individuals		1q32.1	1	203186754.0		CHI3L1 - CHIT1	ENSG00000133048	ENSG00000133063		50.0	26073.0	rs4950928-?	rs4950928	0.0	4950928	upstream_gene_variant	1	NR	2e-125	124.69897000433602		0.82	[0.75-0.89] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Chordin-like protein 2 levels	2,872 Greek (founder/geneitc isolate) individuals		11q13.4	11	74917698.0		XRRA1			ENSG00000166435			rs117042741-?	rs117042741	0.0	117042741	intron_variant	0	NR	1e-17	17.0		0.6234	[0.48-0.77] unit decrease	Illumina [30483765]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Chordin-like protein 2 levels	2,872 Greek (founder/geneitc isolate) individuals		4q35.2	4	186239096.0		KLKB1			ENSG00000164344			rs12509937-?	rs12509937	0.0	12509937	intron_variant	0	NR	3e-18	17.522878745280337		0.3397	[0.26-0.42] unit decrease	Illumina [30483765]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	CXADR-like membrane protein levels	2,906 Greek (founder/geneitc isolate) individuals		11q24.1	11	123195374.0		CLMP - U8	ENSG00000166250	ENSG00000239142		126.0	106016.0	rs4554898-?	rs4554898	0.0	4554898	intron_variant	1	NR	3e-32	31.522878745280337		0.3103	[0.26-0.36] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	590003.0		RN7SKP146 - CLUL1	ENSG00000222174	ENSG00000079101		3153.0	6985.0	rs515354-?	rs515354	0.0	515354	upstream_gene_variant	1	NR	1.9999999999999998e-50	49.69897000433602		0.631	[0.55-0.71] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	591690.0		RN7SKP146 - CLUL1	ENSG00000222174	ENSG00000079101		4840.0	5298.0	rs12957470-?	rs12957470	0.0	12957470	upstream_gene_variant	1	NR	2e-137	136.69897000433602		0.6366	[0.59-0.69] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	597095.0		CLUL1			ENSG00000079101			rs530344109-?	rs530344109	0.0	530344109	5_prime_UTR_variant	0	NR	4e-14	13.397940008672036		3.3902	[2.51-4.27] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Protein AMBP levels	2,858 Greek (founder/geneitc isolate) individuals		9q32	9	114069709.0		AMBP			ENSG00000106927			rs147941577-?	rs147941577	0.0	147941577	missense_variant	0	NR	3e-24	23.522878745280337		1.2804	[1.03-1.53] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Angiopoietin-related protein 7 levels	2,899 Greek (founder/geneitc isolate) individuals		1p36.22	1	11205728.0		MTOR			ENSG00000198793			rs2253213-?	rs2253213	0.0	2253213	intron_variant	0	NR	6e-17	16.221848749616356		0.2487	[0.19-0.31] unit decrease	Illumina [30561534]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Amyloid-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		19q13.12	19	35871901.0		APLP1			ENSG00000105290			rs767668877-?	rs767668877	0.0	767668877	missense_variant	0	NR	7e-12	11.154901959985745		1.2821	[0.92-1.65] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase receptor UFO levels	2,923 Greek (founder/geneitc isolate) individuals		19q13.2	19	41233275.0		AXL			ENSG00000167601			rs66841352-?	rs66841352	0.0	66841352	intron_variant	0	NR	2e-15	14.69897000433602		0.2215	[0.17-0.28] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Bone morphogenetic protein 6 levels	2,771 Greek (founder/geneitc isolate) individuals		5q35.3	5	177409531.0		GRK6, F12			ENSG00000198055, ENSG00000131187			rs1801020-?	rs1801020	0.0	1801020	5_prime_UTR_variant	0	NR	4.0000000000000004e-39	38.39794000867204		0.423	[0.36-0.49] unit increase	Illumina [30279878]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Sialomucin core protein 24 levels	2,906 Greek (founder/geneitc isolate) individuals		1q32.1	1	202143157.0		ARL8A			ENSG00000143862			rs4363479-?	rs4363479	0.0	4363479	intron_variant	0	NR	8e-13	12.096910013008056		0.3139	[0.23-0.4] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	T-cell surface glycoprotein CD1c levels	2,906 Greek (founder/geneitc isolate) individuals		1q23.1	1	158292108.0		CD1C			ENSG00000158481			rs201448758-?	rs201448758	0.0	201448758	missense_variant	0	NR	9.999999999999999e-31	30.0		1.3798	[1.14-1.61] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	CD2-associated protein levels	2,906 Greek (founder/geneitc isolate) individuals												chr6:47469961-?	chr6:47469961	0.0			1	NR	9.999999999999999e-26	25.0		0.3228	[0.26-0.38] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	T-cell surface glycoprotein CD4 levels	2,858 Greek (founder/geneitc isolate) individuals		12p13.31	12	6787380.0		CD4			ENSG00000010610			rs73053728-?	rs73053728	0.0	73053728	intron_variant	0	NR	1e-38	38.0		0.3505	[0.3-0.4] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	609954.0		CLUL1			ENSG00000079101			rs505171-?	rs505171	0.0	505171	intron_variant	0	NR	1.0000000000000001e-28	28.0		0.3429	[0.28-0.4] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	626518.0		CLUL1			ENSG00000079101			rs509836-?	rs509836	0.0	509836	intron_variant	0	NR	2e-12	11.69897000433602		0.2131	[0.15-0.27] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Clusterin-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		18p11.32	18	627530.0		CLUL1			ENSG00000079101			rs201193638-?	rs201193638	0.0	201193638	splice_donor_variant	0	NR	4e-13	12.397940008672036		1.4262	[1.04-1.81] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Protein delta homolog 1 levels	2,923 Greek (founder/geneitc isolate) individuals		14q32.2	14	100659952.0		LINC00523			ENSG00000196273			rs17576123-?	rs17576123	0.0	17576123	intron_variant	0	NR	7e-20	19.154901959985743		0.3699	[0.29-0.45] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Protein delta homolog 1 levels	2,923 Greek (founder/geneitc isolate) individuals		14q32.2	14	100709875.0		LINC00523 - DLK1	ENSG00000196273	ENSG00000185559		33806.0	15830.0	rs12881545-?	rs12881545	0.0	12881545	TF_binding_site_variant	1	NR	1.0000000000000001e-60	60.0		0.4612	[0.41-0.52] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Fatty acid-binding protein,intestinal levels	2,858 Greek (founder/geneitc isolate) individuals		4q26	4	119349548.0		KLHL2P1			ENSG00000250412			rs6534133-?	rs6534133	0.0	6534133	intron_variant	0	NR	2e-19	18.69897000433602		0.2905	[0.23-0.35] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Fc receptor-like protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		1q23.1	1	157802090.0		FCRL1			ENSG00000163534			rs4971154-?	rs4971154	0.0	4971154	synonymous_variant	0	NR	9e-63	62.04575749056068		0.435	[0.38-0.49] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Low-density lipoprotein receptor levels	2,923 Greek (founder/geneitc isolate) individuals		19q13.32	19	44909976.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		583.0	4271.0	rs1065853-?	rs1065853	0.0	1065853	non_coding_transcript_exon_variant	1	NR	5e-28	27.30102999566398		0.5185	[0.43-0.61] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Leukocyte immunoglobulin-like receptor subfamily A member 5 levels	2,906 Greek (founder/geneitc isolate) individuals		19q13.42	19	54302451.0		MIR4752 - LILRA5	ENSG00000264703	ENSG00000187116		20271.0	4619.0	rs34464703-?	rs34464703	0.0	34464703	intron_variant	1	NR	6e-48	47.22184874961636		0.4652	[0.4-0.53] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Leukocyte immunoglobulin-like receptor subfamily A member 5 levels	2,906 Greek (founder/geneitc isolate) individuals		1q31.3	1	196705584.0		CFH			ENSG00000000971			rs2019727-?	rs2019727	0.0	2019727	intron_variant	0	NR	2e-14	13.69897000433602		0.2436	[0.18-0.31] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Lipoprotein lipase levels	2,858 Greek (founder/geneitc isolate) individuals		8p21.3	8	19909196.0		LPL			ENSG00000175445			rs150799387-?	rs150799387	0.0	150799387	intron_variant	0	NR	3e-63	62.52287874528034		1.2321	[1.09-1.38] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Lipoprotein lipase levels	2,858 Greek (founder/geneitc isolate) individuals		5q35.3	5	177409531.0		GRK6, F12			ENSG00000198055, ENSG00000131187			rs1801020-?	rs1801020	0.0	1801020	5_prime_UTR_variant	0	NR	3e-13	12.522878745280336		0.2413	[0.18-0.31] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Lipoprotein lipase levels	2,858 Greek (founder/geneitc isolate) individuals		4q35.2	4	186235351.0		KLKB1			ENSG00000164344			rs57182850-?	rs57182850	0.0	57182850	intron_variant	0	NR	8e-21	20.096910013008056		0.2546	[0.2-0.31] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Leucine-rich repeats and immunoglobulin-like domains protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		3p14.1	3	65385258.0		MAGI1			ENSG00000151276			rs527819972-?	rs527819972	0.0	527819972	intron_variant	0	NR	5e-15	14.30102999566398		0.905	[0.68-1.13] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Leucine-rich repeats and immunoglobulin-like domains protein 1 levels	2,906 Greek (founder/geneitc isolate) individuals		3p14.1	3	66384219.0		SLC25A26, SLC25A26, LRIG1			ENSG00000282739, ENSG00000144741, ENSG00000144749			rs2306272-?	rs2306272	0.0	2306272	missense_variant	0	NR	2e-183	182.698970004336		0.7538	[0.7-0.8] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein-like 1 levels	2,905 Greek (founder/geneitc isolate) individuals		9p13.1	9	38425041.0		IGFBPL1 - ARMC8P1	ENSG00000137142	ENSG00000225254		587.0	27741.0	rs10973797-?	rs10973797	0.0	10973797	upstream_gene_variant	1	NR	1e-46	46.0		0.3834	[0.33-0.44] unit decrease	Illumina [30565519]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Insulin-like growth factor-binding protein-like 1 levels	2,905 Greek (founder/geneitc isolate) individuals		9p13.1	9	38440326.0		IGFBPL1 - ARMC8P1	ENSG00000137142	ENSG00000225254		15872.0	12456.0	rs11388692-?	rs11388692	0.0	11388692	intron_variant	1	NR	2e-20	19.69897000433602		0.2545	[0.2-0.31] unit decrease	Illumina [30565519]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Interleukin-1 receptor antagonist protein levels	2,858 Greek (founder/geneitc isolate) individuals		2q14.1	2	113078588.0		IL1F10 - RNU6-1180P	ENSG00000136697	ENSG00000201805		2745.0	8217.0	rs11123160-?	rs11123160	0.0	11123160	downstream_gene_variant	1	NR	7e-15	14.154901959985745		0.2416	[0.18-0.3] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Interleukin-1 receptor antagonist protein levels	2,858 Greek (founder/geneitc isolate) individuals		2q14.1	2	113109711.0		IL1RN			ENSG00000136689			rs55709272-?	rs55709272	0.0	55709272	intron_variant	0	NR	3e-17	16.522878745280337		0.2302	[0.18-0.28] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Proteinase-activated receptor 1 levels	2,858 Greek (founder/geneitc isolate) individuals		5q13.3	5	76732299.0		F2R			ENSG00000181104			rs168753-?	rs168753	0.0	168753	intron_variant	0	NR	8e-12	11.096910013008056		0.2576	[0.18-0.33] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Proprotein convertase subtilisin/kexin type 9 levels	2,923 Greek (founder/geneitc isolate) individuals		1p32.3	1	55062245.0		PCSK9			ENSG00000169174			rs643257-?	rs643257	0.0	643257	intron_variant	0	NR	4e-13	12.397940008672036		0.2602	[0.19-0.33] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Platelet-derived growth factor subunit A levels	2,923 Greek (founder/geneitc isolate) individuals		7p22.3	7	623399.0		PRKAR1B			ENSG00000188191			rs149525923-?	rs149525923	0.0	149525923	intron_variant	0	NR	3e-16	15.522878745280336		2.0568	[1.56-2.55] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Platelet endothelial cell adhesion molecule levels	2,923 Greek (founder/geneitc isolate) individuals		9q34.2	9	133254260.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176759-?	rs8176759	0.0	8176759	3_prime_UTR_variant	0	NR	2e-20	19.69897000433602		0.4344	[0.34-0.53] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Low-density lipoprotein receptor-related protein 11 levels	2,906 Greek (founder/geneitc isolate) individuals		6q25.1	6	149227229.0		TAB2			ENSG00000055208			rs190421361-?	rs190421361	0.0	190421361	intron_variant	0	NR	5e-11	10.30102999566398		3.6653	[2.57-4.76] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Low-density lipoprotein receptor-related protein 11 levels	2,906 Greek (founder/geneitc isolate) individuals		6q25.1	6	149594518.0		RPS18P9			ENSG00000220848			rs9765961-?	rs9765961	0.0	9765961	non_coding_transcript_exon_variant	0	NR	6e-51	50.22184874961636		1.2113	[1.05-1.37] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Low-density lipoprotein receptor-related protein 11 levels	2,906 Greek (founder/geneitc isolate) individuals		6q25.1	6	149777466.0		PCMT1			ENSG00000120265			rs3039620-?	rs3039620	0.0	3039620	intron_variant	0	NR	3e-100	99.52287874528034		0.5567	[0.51-0.61] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Multiple coagulation factor deficiency protein 2 levels	2,906 Greek (founder/geneitc isolate) individuals		2p21	2	46914826.0		MCFD2			ENSG00000180398			rs62140549-?	rs62140549	0.0	62140549	intron_variant	0	NR	2e-18	17.69897000433602		0.2899	[0.23-0.35] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Monocyte chemoattractant protein-1 levels	2,923 Greek (founder/geneitc isolate) individuals												chr3:46420583-?	chr3:46420583	0.0			1	NR	1.9999999999999998e-26	25.69897000433602		0.3814	[0.31-0.45] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Monocyte chemoattractant protein-1 levels	2,923 Greek (founder/geneitc isolate) individuals		1q23.2	1	159205564.0		ACKR1, CADM3-AS1			ENSG00000213088, ENSG00000225670			rs12075-?	rs12075	0.0	12075	missense_variant	0	NR	8e-183	182.09691001300808		0.6918	[0.64-0.74] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix extracellular phosphoglycoprotein levels	2,574 Greek (founder/geneitc isolate) individuals		5q35.3	5	177415473.0		GRK6			ENSG00000198055			rs2731672-?	rs2731672	0.0	2731672	intron_variant	0	NR	4e-18	17.397940008672037		0.2915	[0.23-0.36] unit increase	Illumina [29458620]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix extracellular phosphoglycoprotein levels	2,574 Greek (founder/geneitc isolate) individuals		4q35.2	4	186230988.0		KLKB1			ENSG00000164344			rs4241815-?	rs4241815	0.0	4241815	intron_variant	0	NR	1e-19	19.0		0.2625	[0.21-0.32] unit decrease	Illumina [29458620]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase Mer levels	2,858 Greek (founder/geneitc isolate) individuals		2q13	2	111990076.0		MERTK			ENSG00000153208			rs11123073-?	rs11123073	0.0	11123073	intron_variant	0	NR	3e-21	20.522878745280337		0.2554	[0.2-0.31] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Meteorin-like protein levels	2,906 Greek (founder/geneitc isolate) individuals		17q25.3	17	83085299.0		METRNL, METRNL			ENSG00000176845, ENSG00000275031			rs72854240-?	rs72854240	0.0	72854240	missense_variant	0	NR	1.0000000000000001e-24	24.0		0.7389	[0.6-0.88] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-12 levels	2,858 Greek (founder/geneitc isolate) individuals		11q22.2	11	102853480.0		MMP3 - MMP12	ENSG00000149968	ENSG00000262406		9871.0	9256.0	rs72981684-?	rs72981684	0.0	72981684	intergenic_variant	1	NR	8e-87	86.09691001300806		0.8003	[0.72-0.88] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-12 levels	2,858 Greek (founder/geneitc isolate) individuals												chr11:102867320-?	chr11:102867320	0.0			1	NR	1e-14	14.0		1.3768	[1.03-1.73] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-2 levels	2,923 Greek (founder/geneitc isolate) individuals												chr16:55489814-?	chr16:55489814	0.0			1	NR	6e-35	34.22184874961636		2.5901	[2.18-3] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-2 levels	2,923 Greek (founder/geneitc isolate) individuals		16q12.2	16	55496937.0		MMP2			ENSG00000087245			rs144755357-?	rs144755357	0.0	144755357	missense_variant	0	NR	4.0000000000000006e-45	44.39794000867204		2.1812	[1.88-2.48] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-3 levels	2,923 Greek (founder/geneitc isolate) individuals		11q22.2	11	102845217.0		MMP3 - MMP12	ENSG00000149968	ENSG00000262406		1608.0	17519.0	rs35068180-?	rs35068180	0.0	35068180	upstream_gene_variant	1	NR	2e-67	66.69897000433602		0.4513	[0.4-0.5] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-7 levels	2,858 Greek (founder/geneitc isolate) individuals		11q22.2	11	102530902.0		MMP7 - MMP20	ENSG00000137673	ENSG00000137674		152.0	45930.0	rs11568819-?	rs11568819	0.0	11568819	upstream_gene_variant	1	NR	8e-19	18.096910013008056		0.6059	[0.47-0.74] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-7 levels	2,858 Greek (founder/geneitc isolate) individuals		11q22.2	11	102536460.0		MMP7 - MMP20	ENSG00000137673	ENSG00000137674		5710.0	40372.0	rs1943779-?	rs1943779	0.0	1943779	intergenic_variant	1	NR	3.9999999999999997e-25	24.39794000867204		0.2942	[0.24-0.35] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Matrix metalloproteinase-7 levels	2,858 Greek (founder/geneitc isolate) individuals		11q22.2	11	102998578.0		MMP13 - DCUN1D5	ENSG00000137745	ENSG00000137692		42846.0	52108.0	rs1044251682-?	rs1044251682	0.0	1044251682	intergenic_variant	1	NR	6e-24	23.22184874961636		1.3001	[1.05-1.55] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	P-selectin glycoprotein ligand 1 levels	2,858 Greek (founder/geneitc isolate) individuals		12q23.1	12	97893711.0		PAFAH1B2P2 - MIR4495	ENSG00000257501	ENSG00000265861		131852.0	45345.0	rs185338771-?	rs185338771	0.0	185338771	intergenic_variant	1	NR	6e-15	14.221848749616356		2.6259	[1.97-3.29] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	P-selectin glycoprotein ligand 1 levels	2,858 Greek (founder/geneitc isolate) individuals		12q24.11	12	108623488.0		SELPLG			ENSG00000110876			rs7300972-?	rs7300972	0.0	7300972	missense_variant	0	NR	3.9999999999999997e-56	55.39794000867204		1.8123	[1.59-2.04] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	P-selectin glycoprotein ligand 1 levels	2,858 Greek (founder/geneitc isolate) individuals		12q24.11	12	109408221.0		MYO1H			ENSG00000174527			rs919721402-?	rs919721402	0.0	919721402	intron_variant	0	NR	9.999999999999999e-27	26.0		2.646	[2.16-3.13] unit decrease	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Pulmonary surfactant-associated protein D levels	2,914 Greek (founder/geneitc isolate) individuals		6p21.33	6	31365326.0		HLA-B - DHFRP2	ENSG00000206450	ENSG00000228432		8138.0	1026.0	rs140949683-?	rs140949683	0.0	140949683	upstream_gene_variant	1	NR	4e-20	19.39794000867204		1.0272	[0.81-1.25] unit decrease	Illumina [30596778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Pulmonary surfactant-associated protein D levels	2,914 Greek (founder/geneitc isolate) individuals		10q22.3	10	79934597.0		MBL1P - SFTPD	ENSG00000242600	ENSG00000133661		11478.0	2870.0	rs12262739-?	rs12262739	0.0	12262739	intron_variant	1	NR	3e-57	56.52287874528034		0.8325	[0.73-0.93] unit increase	Illumina [30596778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Pulmonary surfactant-associated protein D levels	2,914 Greek (founder/geneitc isolate) individuals		10q22.3	10	79946568.0		SFTPD			ENSG00000133661			rs721917-?	rs721917	0.0	721917	missense_variant	0	NR	1e-196	196.0		0.7207	[0.67-0.77] unit increase	Illumina [30596778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Pulmonary surfactant-associated protein D levels	2,914 Greek (founder/geneitc isolate) individuals		10q22.3	10	80002884.0		DPY19L2P5 - C1DP3	ENSG00000225100	ENSG00000224760		19644.0	21853.0	rs10887331-?	rs10887331	0.0	10887331	intergenic_variant	1	NR	2e-43	42.69897000433602		0.488	[0.42-0.56] unit decrease	Illumina [30596778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Pulmonary surfactant-associated protein D levels	2,914 Greek (founder/geneitc isolate) individuals		16q24.1	16	84369955.0		ATP2C2			ENSG00000064270			rs9927461-?	rs9927461	0.0	9927461	intron_variant	0	NR	5e-11	10.30102999566398		0.2565	[0.18-0.33] unit decrease	Illumina [30596778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Retinoic acid receptor responder protein 2 levels	2,923 Greek (founder/geneitc isolate) individuals		7q36.1	7	150197525.0		ATP6V0E2 - ACTR3C	ENSG00000171130	ENSG00000106526		306321.0	46391.0	rs1249982494-?	rs1249982494	0.0	1249982494	intergenic_variant	1	NR	4e-17	16.397940008672037		2.8153	[2.16-3.47] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Retinoic acid receptor responder protein 2 levels	2,923 Greek (founder/geneitc isolate) individuals		7q36.1	7	150342466.0		RARRES2 - REPIN1-AS1	ENSG00000106538	ENSG00000240449		804.0	21311.0	rs3735167-?	rs3735167	0.0	3735167	non_coding_transcript_exon_variant	1	NR	1e-19	19.0		0.2922	[0.23-0.36] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Eosinophil cationic protein levels	2,901 Greek (founder/geneitc isolate) individuals		14q11.2	14	20887149.0		RNASE1 - RNASE3	ENSG00000129538	ENSG00000169397		84294.0	4236.0	rs145837285-?	rs145837285	0.0	145837285	upstream_gene_variant	1	NR	1e-16	16.0		0.4045	[0.31-0.5] unit increase	Illumina [30562907]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Eosinophil cationic protein levels	2,901 Greek (founder/geneitc isolate) individuals		1q31.3	1	196727803.0		CFH			ENSG00000000971			rs1410996-?	rs1410996	0.0	1410996	intron_variant	0	NR	2e-12	11.69897000433602		0.193	[0.14-0.25] unit decrease	Illumina [30562907]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels	2,906 Greek (founder/geneitc isolate) individuals		1p31.3	1	64147962.0		ROR1-AS1, ROR1			ENSG00000223949, ENSG00000185483			rs6686041-?	rs6686041	0.0	6686041	intron_variant	0	NR	6e-24	23.22184874961636		0.3628	[0.29-0.43] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein phosphatase non-receptor type substrate 1 levels	2,923 Greek (founder/geneitc isolate) individuals		20p13	20	1571784.0		SIRPB1			ENSG00000101307			rs2253427-?	rs2253427	0.0	2253427	missense_variant	0	NR	4.0000000000000006e-45	44.39794000867204		0.477	[0.41-0.54] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein phosphatase non-receptor type substrate 1 levels	2,923 Greek (founder/geneitc isolate) individuals		20p13	20	1903644.0		SIRPA			ENSG00000198053			rs6081096-?	rs6081096	0.0	6081096	intron_variant	0	NR	0.0	383.15490195998575		0.9008	[0.86-0.94] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Metalloproteinase inhibitor 4 levels	2,922 Greek (founder/geneitc isolate) individuals		3p25.2	3	12114388.0		SYN2			ENSG00000157152			rs11707641-?	rs11707641	0.0	11707641	intron_variant	0	NR	4e-16	15.397940008672036		0.3098	[0.24-0.38] unit decrease	Illumina [30603603]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Trem-like transcript 2 protein levels	2,923 Greek (founder/geneitc isolate) individuals		6p21.1	6	41199359.0		TREML2			ENSG00000112195			rs11759347-?	rs11759347	0.0	11759347	intron_variant	0	NR	2e-36	35.69897000433602		0.3756	[0.32-0.43] unit increase	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Transferrin receptor protein 1 levels	2,923 Greek (founder/geneitc isolate) individuals		3q29	3	196073940.0		TFRC			ENSG00000072274			rs3817672-?	rs3817672	0.0	3817672	missense_variant	0	NR	1e-22	22.0		0.2674	[0.21-0.32] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Thioredoxin domain-containing protein 5 levels	2,902 Greek (founder/geneitc isolate) individuals		6p24.3	6	7881920.0		BLOC1S5-TXNDC5, TXNDC5			ENSG00000259040, ENSG00000239264			rs34795283-?	rs34795283	0.0	34795283	3_prime_UTR_variant	0	NR	3e-12	11.522878745280336		0.2666	[0.19-0.34] unit increase	Illumina [30564778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Thioredoxin domain-containing protein 5 levels	2,902 Greek (founder/geneitc isolate) individuals		6p24.3	6	7883235.0		BLOC1S5-TXNDC5, TXNDC5			ENSG00000259040, ENSG00000239264			rs111331197-?	rs111331197	0.0	111331197	missense_variant	0	NR	8e-20	19.096910013008056		1.2124	[0.95-1.47] unit increase	Illumina [30564778]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase receptor TYRO3 levels	2,906 Greek (founder/geneitc isolate) individuals		15q15.1	15	41305239.0		OIP5-AS1			ENSG00000247556			rs1132639-?	rs1132639	0.0	1132639	non_coding_transcript_exon_variant	0	NR	1e-31	31.0		0.3367	[0.28-0.39] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase receptor TYRO3 levels	2,906 Greek (founder/geneitc isolate) individuals		15q15.1	15	41565018.0		TYRO3			ENSG00000092445			rs11639399-?	rs11639399	0.0	11639399	splice_region_variant	0	NR	3e-87	86.52287874528034		0.5686	[0.51-0.62] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Scavenger receptor cysteine-rich domain-containing group B protein levels	2,849 Greek (founder/geneitc isolate) individuals		7q11.23	7	76408266.0		SSC4D, ZP3			ENSG00000146700, ENSG00000188372			rs17149199-?	rs17149199	0.0	17149199	intron_variant	0	NR	2e-73	72.69897000433602		0.8169	[0.73-0.91] unit decrease	Illumina [30421387]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	ST2 protein levels	2,923 Greek (founder/geneitc isolate) individuals		2q12.1	2	102316102.0		IL18R1, IL1RL1			ENSG00000115604, ENSG00000115602			rs950880-?	rs950880	0.0	950880	intron_variant	0	NR	1e-135	135.0		0.6386	[0.59-0.69] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	ST2 protein levels	2,923 Greek (founder/geneitc isolate) individuals		2q12.1	2	102371860.0		IL18R1			ENSG00000115604			rs34318712-?	rs34318712	0.0	34318712	intron_variant	0	NR	3e-33	32.52287874528034		1.0687	[0.89-1.24] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	ST2 protein levels	2,923 Greek (founder/geneitc isolate) individuals		2q12.1	2	102409510.0		IL18R1 - SDR42E1P5	ENSG00000115604	ENSG00000236785		10733.0	1733.0	rs115715837-?	rs115715837	0.0	115715837	upstream_gene_variant	1	NR	6e-21	20.22184874961636		1.1372	[0.9-1.37] unit decrease	Illumina [30603773]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Metalloproteinase inhibitor 4 levels	2,922 Greek (founder/geneitc isolate) individuals		3p25.2	3	12099453.0		SYN2			ENSG00000157152			rs453131-?	rs453131	0.0	453131	intron_variant	0	NR	4.0000000000000004e-24	23.39794000867204		0.4156	[0.34-0.5] unit decrease	Illumina [30603603]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase receptor TYRO3 levels	2,906 Greek (founder/geneitc isolate) individuals		15q15.1	15	41709454.0		MGA			ENSG00000174197			rs181337989-?	rs181337989	0.0	181337989	intron_variant	0	NR	2e-12	11.69897000433602		0.9155	[0.66-1.17] unit increase	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Tyrosine-protein kinase receptor TYRO3 levels	2,906 Greek (founder/geneitc isolate) individuals		9q34.2	9	133266900.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176671-?	rs8176671	0.0	8176671	intron_variant	0	NR	8e-12	11.096910013008056		0.3242	[0.23-0.42] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	Versican core protein levels	2,906 Greek (founder/geneitc isolate) individuals		5q14.3	5	83546398.0		VCAN-AS1, VCAN			ENSG00000249835, ENSG00000038427			rs622134-?	rs622134	0.0	622134	intron_variant	0	NR	4e-20	19.39794000867204		0.2513	[0.2-0.3] unit decrease	Illumina [30566327]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	V-set and immunoglobulin domain-containing protein 2 levels	2,858 Greek (founder/geneitc isolate) individuals		19p13.3	19	5840608.0		FUT6 - FUT3	ENSG00000156413	ENSG00000171124		886.0	2280.0	rs708686-?	rs708686	0.0	708686	upstream_gene_variant	1	NR	8e-13	12.096910013008056		0.2105	[0.15-0.27] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	V-set and immunoglobulin domain-containing protein 2 levels	2,858 Greek (founder/geneitc isolate) individuals		11q24.2	11	124706898.0		SPA17 - NRGN	ENSG00000064199	ENSG00000154146		9380.0	33044.0	rs959226701-?	rs959226701	0.0	959226701	intergenic_variant	1	NR	3e-21	20.522878745280337		2.1704	[1.72-2.62] unit increase	Illumina [30481946]	N
2023-06-19	36349687	Png G	2022-11-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/36349687	Identifying causal serum protein-cardiometabolic trait relationships using whole genome sequencing.	V-set and immunoglobulin domain-containing protein 2 levels	2,858 Greek (founder/geneitc isolate) individuals		11q24.2	11	124749511.0		VSIG2			ENSG00000019102			rs11604175-?	rs11604175	0.0	11604175	intron_variant	0	NR	5e-14	13.30102999566398		0.2399	[0.18-0.3] unit increase	Illumina [30481946]	N
2022-08-03	35470676	Kanbay M	2022-04-26	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/35470676	Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.	Serum uric acid levels	1,573 individuals from up to 1,006 families		4p16.1	4	9924068.0		SLC2A9			ENSG00000109667			rs938554-?	rs938554	0.0	938554	non_coding_transcript_exon_variant	0	NR	4e-16	15.397940008672036		3.808	unit increase	NR [NR]	N
2022-08-03	35470676	Kanbay M	2022-04-26	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/35470676	Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.	Serum uric acid levels	1,573 individuals from up to 1,006 families		4p16.1	4	10043806.0		SLC2A9			ENSG00000109667			rs4637402-?	rs4637402	0.0	4637402	intron_variant	0	NR	4e-13	12.397940008672036		3.46	unit increase	NR [NR]	N
2022-08-03	35470676	Kanbay M	2022-04-26	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/35470676	Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.	Serum uric acid levels	1,573 individuals from up to 1,006 families		4p16.1	4	10054752.0		SLC2A9			ENSG00000109667			rs7671266-?	rs7671266	0.0	7671266	intron_variant	0	NR	6e-13	12.221848749616356		3.442	unit increase	NR [NR]	N
2022-08-03	35470676	Kanbay M	2022-04-26	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/35470676	Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.	Serum uric acid levels	1,573 individuals from up to 1,006 families		10q24.32	10	102162217.0		NOLC1			ENSG00000166197			rs147801768-?	rs147801768	0.0	147801768	missense_variant	0	NR	7e-09	8.154901959985743		33.108	unit decrease	NR [NR]	N
2022-08-03	35470676	Kanbay M	2022-04-26	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/35470676	Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.	Serum uric acid levels	1,573 individuals from up to 1,006 families		11q14.1	11	85757665.0		SYTL2			ENSG00000137501			rs149582759-?	rs149582759	0.0	149582759	missense_variant	0	NR	2e-08	7.698970004336019		27.249	unit decrease	NR [NR]	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62458346.0		RN7SL51P - RN7SL18P	ENSG00000239958	ENSG00000241625		195675.0	32832.0	rs11899341-G	rs11899341	0.0	11899341	intron_variant	1	NR	8e-07	6.096910013008056		1.36	[0.82-1.9] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133168351.0		GBGT1 - OBP2B	ENSG00000148288	ENSG00000280584		4418.0	36926.0	rs13288848-A	rs13288848	0.0	13288848	upstream_gene_variant	1	NR	8e-07	6.096910013008056		1.08	[0.65-1.51] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.3	2	27140196.0		PRR30 - TCF23	ENSG00000186143	ENSG00000163792		786.0	8808.0	rs71401561-C	rs71401561	1.0	59545455	upstream_gene_variant	1	NR	1e-06	6.0		1.02	[0.61-1.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3q22.1	3	132534874.0		DNAJC13			ENSG00000138246			rs9864454-A	rs9864454	0.0	9864454	intron_variant	0	NR	1e-06	6.0		1.23	[0.74-1.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3q25.33	3	160388342.0		IFT80			ENSG00000068885			rs73875259-T	rs73875259	0.0	73875259	intron_variant	0	NR	1e-06	6.0		1.5	[0.9-2.1] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.3	2	27243500.0		CAD			ENSG00000084774			rs2304684-T	rs2304684	0.0	2304684	synonymous_variant	0	NR	1e-06	6.0		1.53	[0.91-2.15] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q23	4	99640927.0		C4orf54			ENSG00000248713			rs1491240-C	rs1491240	0.0	1491240	3_prime_UTR_variant	0	NR	1e-06	6.0		1.18	[0.7-1.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73491970.0		PPP3CB			ENSG00000107758			rs764205681-AAAATAAAT	rs764205681	1.0	141837688	intron_variant	0	NR	1e-06	6.0		1.1	[0.66-1.54] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q13.3	4	73163806.0		ANKRD17			ENSG00000132466			rs76989104-A	rs76989104	0.0	76989104	intron_variant	0	NR	1e-06	6.0		2.25	[1.34-3.16] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3q25.33	3	160539998.0		KPNA4			ENSG00000186432			rs373330528-CT	rs373330528	0.0	373330528	intron_variant	0	NR	1e-06	6.0		1.49	[0.88-2.1] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.2	2	28031902.0		BABAM2			ENSG00000158019			rs4666032-C	rs4666032	0.0	4666032	intron_variant	0	NR	2e-06	5.698970004336019		1.17	[0.69-1.65] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	40546240.0		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		534917.0	139608.0	rs6029174-T	rs6029174	0.0	6029174	intergenic_variant	1	NR	2e-06	5.698970004336019		0.99	[0.59-1.39] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q13.2	4	69048846.0		UGT2B26P - UGT2B7	ENSG00000250919	ENSG00000171234		4268.0	2517.0	rs7442486-T	rs7442486	0.0	7442486	upstream_gene_variant	1	NR	4e-06	5.3979400086720375		0.95	[0.54-1.36] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3p25.2	3	12222622.0		SYN2 - GSTM5P1	ENSG00000157152	ENSG00000236062		30590.0	35179.0	rs188684899-C	rs188684899	0.0	188684899	intron_variant	1	NR	4e-06	5.3979400086720375		0.98	[0.56-1.4] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q16.3	6	100875100.0		ASCC3			ENSG00000112249			rs9498414-T	rs9498414	0.0	9498414	intron_variant	0	NR	4e-06	5.3979400086720375		0.95	[0.55-1.35] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q12.2	11	61827449.0		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs774882452-C	rs774882452	0.0	774882452	intron_variant	0	NR	5e-06	5.301029995663981		1.03	[0.59-1.47] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9p21.3	9	21602753.0		MIR31HG - H3P30	ENSG00000171889	ENSG00000227443		42853.0	35532.0	rs72703483-G	rs72703483	0.0	72703483	intergenic_variant	1	NR	5e-06	5.301029995663981		1.09	[0.63-1.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7p15.3	7	21574588.0		DNAH11			ENSG00000105877			rs145885140-C	rs145885140	0.0	145885140	intron_variant	0	NR	5e-06	5.301029995663981		1.1	[0.63-1.57] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q25.1	17	76044212.0		SRP68			ENSG00000167881			rs2305345-T	rs2305345	0.0	2305345	intron_variant	0	NR	5e-06	5.301029995663981		0.98	[0.56-1.4] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	122925147.0		ABCB9			ENSG00000150967			rs11609798-G	rs11609798	0.0	11609798	intron_variant	0	NR	5e-06	5.301029995663981		0.97	[0.55-1.39] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.23	12	120240578.0		PXN			ENSG00000089159			rs1151824-A	rs1151824	0.0	1151824	intron_variant	0	NR	5e-06	5.301029995663981		0.94	[0.54-1.34] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72653225.0		LINC01572			ENSG00000261008			rs139644991-T	rs139644991	0.0	139644991	intron_variant	0	NR	5e-06	5.301029995663981		2.91	[1.66-4.16] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160426837.0		SLC22A3			ENSG00000146477			rs9355287-C	rs9355287	0.0	9355287	intron_variant	0	NR	5e-06	5.301029995663981		0.95	[0.54-1.36] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21917125.0		LINC01822 - RN7SL117P	ENSG00000229621	ENSG00000264192		206469.0	5868.0	rs147323247-T	rs147323247	0.0	147323247	intron_variant	1	NR	5e-06	5.301029995663981		2.91	[1.66-4.16] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6p21.33	6	31137179.0		PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs9263724-A	rs9263724	0.0	9263724	intron_variant	0	NR	5e-06	5.301029995663981		1.3	[0.74-1.86] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116667859.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		9564.0	80311.0	rs1784127-A	rs1784127	0.0	1784127	intergenic_variant	1	NR	9.999999999999999e-31	30.0		0.9	[0.75-1.05] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80656687.0		CD36			ENSG00000135218			rs75326924-T	rs75326924	0.0	75326924	missense_variant	0	NR	3e-29	28.522878745280337		1.62	[1.34-1.9] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	111280427.0		CUX2			ENSG00000111249			rs79105258-A	rs79105258	0.0	79105258	intron_variant	0	NR	8.000000000000001e-29	28.096910013008056		1.06	[0.87-1.25] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	58284097.0		ALDH1A2			ENSG00000128918			rs6493996-T	rs6493996	0.0	6493996	intron_variant	0	NR	4.0000000000000003e-28	27.39794000867204		0.98	[0.81-1.15] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		20q13.12	20	45928576.0		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		16421.0	6107.0	rs538276778-AAGAG	rs538276778	0.0	538276778	non_coding_transcript_exon_variant	1	NR	1e-27	27.0		1.49	[1.22-1.76] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	111171923.0		CUX2			ENSG00000111249			rs3809297-T	rs3809297	0.0	3809297	intron_variant	0	NR	9.999999999999999e-27	26.0		1.08	[0.88-1.28] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110929440.0		MYL2 - LINC01405	ENSG00000111245	ENSG00000185847		7997.0	5150.0	rs12227162-T	rs12227162	0.0	12227162	intergenic_variant	1	NR	9.999999999999999e-26	25.0		1.12	[0.91-1.33] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80545045.0		CD36			ENSG00000135218			rs139761834-C	rs139761834	0.0	139761834	intron_variant	0	NR	9.000000000000001e-23	22.045757490560675		1.36	[1.09-1.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112971371.0		OAS3			ENSG00000111331			rs2072134-A	rs2072134	0.0	2072134	3_prime_UTR_variant	0	NR	1e-20	20.0		1.08	[0.85-1.31] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p21.3	8	19890937.0		INTS10 - LPL	ENSG00000104613	ENSG00000175445		38854.0	10780.0	rs79396901-C	rs79396901	0.0	79396901	regulatory_region_variant	1	NR	2e-20	19.69897000433602		1.03	[0.81-1.25] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80904640.0		SEMA3C			ENSG00000075223			rs151200960-C	rs151200960	0.0	151200960	intron_variant	0	NR	4e-19	18.39794000867204		1.46	[1.14-1.78] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111504689.0		ATXN2			ENSG00000204842			rs11065933-C	rs11065933	0.0	11065933	intron_variant	0	NR	2e-17	16.69897000433602		0.66	[0.51-0.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80793170.0		SEMA3C			ENSG00000075223			rs145837504-C	rs145837504	0.0	145837504	intron_variant	0	NR	1e-16	16.0		1.3	[0.99-1.61] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		20q13.12	20	46057452.0		SLC12A5			ENSG00000124140			rs116878061-T	rs116878061	0.0	116878061	intron_variant	0	NR	1e-15	15.0		1.36	[1.03-1.69] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	124853983.0		SCARB1			ENSG00000073060			rs10773112-C	rs10773112	0.0	10773112	intron_variant	0	NR	1e-15	15.0		0.59	[0.44-0.74] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104802290.0		ABCA1			ENSG00000165029			rs3831227-CAG	rs3831227	0.0	3831227	intron_variant	0	NR	2e-15	14.69897000433602		0.61	[0.46-0.76] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56749204.0		NUP93			ENSG00000102900			rs75745425-T	rs75745425	0.0	75745425	intron_variant	0	NR	6e-15	14.221848749616356		2.51	[1.88-3.14] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		22q11.21	22	21626349.0		UBE2L3 - YDJC	ENSG00000185651	ENSG00000161179		2315.0	1740.0	rs5754426-C	rs5754426	0.0	5754426	downstream_gene_variant	1	NR	2e-14	13.69897000433602		0.57	[0.42-0.72] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39554832.0		PPIEL			ENSG00000243970			rs1180333-T	rs1180333	0.0	1180333	intron_variant	0	NR	5e-14	13.30102999566398		0.89	[0.66-1.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p21.3	8	19784876.0		CSGALNACT1 - INTS10	ENSG00000147408	ENSG00000104613		26847.0	32515.0	rs79829439-G	rs79829439	0.0	79829439	intergenic_variant	1	NR	1e-13	13.0		1.71	[1.26-2.16] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	68058228.0		DUS2			ENSG00000167264			rs558421282-CT	rs558421282	1.0	112592553	intron_variant	0	NR	2e-13	12.69897000433602		0.75	[0.55-0.95] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115613480.0		TRPS1			ENSG00000104447			rs2737215-C	rs2737215	0.0	2737215	intron_variant	0	NR	2e-13	12.69897000433602		0.66	[0.49-0.83] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	67956073.0		SLC12A4			ENSG00000124067			rs9934405-A	rs9934405	0.0	9934405	intron_variant	0	NR	2e-13	12.69897000433602		0.74	[0.54-0.94] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	113275257.0		TPCN1			ENSG00000186815			rs11066525-C	rs11066525	0.0	11066525	intron_variant	0	NR	3e-13	12.522878745280336		0.98	[0.72-1.24] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q42.13	1	230159169.0		GALNT2			ENSG00000143641			rs2144300-T	rs2144300	0.0	2144300	intron_variant	0	NR	3e-13	12.522878745280336		0.73	[0.54-0.92] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10526761.0		S1PR5 - ATG4D	ENSG00000180739	ENSG00000130734		8830.0	17134.0	rs76127786-A	rs76127786	0.0	76127786	intergenic_variant	1	NR	2e-06	5.698970004336019		0.99	[0.59-1.39] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63083094.0		OTX1 - RPL27P5	ENSG00000115507	ENSG00000232403		25258.0	25024.0	rs12996320-G	rs12996320	0.0	12996320	non_coding_transcript_exon_variant	1	NR	2e-06	5.698970004336019		1.23	[0.73-1.73] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	26468318.0		SNX10 - KIAA0087	ENSG00000086300	ENSG00000122548		93935.0	64803.0	rs6963147-T	rs6963147	0.0	6963147	intron_variant	1	NR	2e-06	5.698970004336019		0.99	[0.59-1.39] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q24.2	6	143056085.0		LINC01277			ENSG00000229017			rs74725456-G	rs74725456	0.0	74725456	intron_variant	0	NR	2e-06	5.698970004336019		1.05	[0.62-1.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20p12.1	20	17614241.0		RRBP1			ENSG00000125844			rs116933131-T	rs116933131	0.0	116933131	intron_variant	0	NR	2e-06	5.698970004336019		2.01	[1.18-2.84] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.1	10	72879221.0		MCU			ENSG00000156026			rs11000435-T	rs11000435	0.0	11000435	intron_variant	0	NR	2e-06	5.698970004336019		1.24	[0.73-1.75] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8p23.1	8	11877660.0		CTSB - OR7E158P	ENSG00000164733	ENSG00000254948		8127.0	42240.0	rs117446686-G	rs117446686	0.0	117446686	regulatory_region_variant	1	NR	2e-06	5.698970004336019		2.49	[1.47-3.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q33.3	5	156758389.0		SGCD			ENSG00000170624			rs1404824155-G	rs1404824155	0.0	1404824155	intron_variant	0	NR	2e-06	5.698970004336019		1.07	[0.63-1.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73598039.0		USP54			ENSG00000166348			rs150991566-T	rs150991566	0.0	150991566	intron_variant	0	NR	2e-06	5.698970004336019		1.12	[0.66-1.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q26	6	160668275.0		LPA - PLG	ENSG00000198670	ENSG00000122194		4000.0	33963.0	rs56393506-T	rs56393506	0.0	56393506	intron_variant	1	NR	2e-06	5.698970004336019		1.53	[0.9-2.16] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17p13.1	17	7160331.0		RPL7AP64 - ASGR1	ENSG00000213876	ENSG00000141505		18739.0	13100.0	rs72837682-C	rs72837682	0.0	72837682	intergenic_variant	1	NR	2e-06	5.698970004336019		0.99	[0.58-1.4] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7q36.3	7	155231111.0		RN7SKP280 - INSIG1-DT	ENSG00000201066	ENSG00000273117		48927.0	64807.0	rs10229853-G	rs10229853	0.0	10229853	regulatory_region_variant	1	NR	3e-06	5.522878745280337		0.97	[0.56-1.38] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	25968613.0		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		18627.0	183585.0	rs2391211-T	rs2391211	0.0	2391211	intergenic_variant	1	NR	3e-06	5.522878745280337		1.01	[0.59-1.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3p21.31	3	47640381.0		SMARCC1			ENSG00000173473			rs78641322-G	rs78641322	0.0	78641322	intron_variant	0	NR	3e-06	5.522878745280337		4.04	[2.34-5.74] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21793955.0		LINC01822 - RN7SL117P	ENSG00000229621	ENSG00000264192		83299.0	129038.0	rs151145935-G	rs151145935	0.0	151145935	intron_variant	1	NR	3e-06	5.522878745280337		3.05	[1.77-4.33] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2q31.1	2	168976242.0		ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs4148785-C	rs4148785	0.0	4148785	intron_variant	0	NR	3e-06	5.522878745280337		1.06	[0.62-1.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8p22	8	18415790.0		NAT2 - PSD3	ENSG00000156006	ENSG00000156011		14572.0	111513.0	rs1495743-C	rs1495743	0.0	1495743	intergenic_variant	1	NR	3e-06	5.522878745280337		1.0	[0.58-1.42] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.3	19	3542985.0		MFSD12, C19orf71			ENSG00000161091, ENSG00000183397			rs12608592-T	rs12608592	0.0	12608592	splice_region_variant	0	NR	3e-06	5.522878745280337		1.04	[0.6-1.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8p23.1	8	11841238.0		FDFT1 - CTSB	ENSG00000284967	ENSG00000164733		1934.0	1286.0	rs1296028-G	rs1296028	0.0	1296028	downstream_gene_variant	1	NR	3e-06	5.522878745280337		1.9	[1.1-2.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p36.11	1	25459488.0		MACO1			ENSG00000204178			rs548179580-A	rs548179580	1.0	67989933	intron_variant	0	NR	3e-06	5.522878745280337		0.99	[0.57-1.41] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49308587.0		DYM			ENSG00000141627			rs139251136-C	rs139251136	0.0	139251136	intron_variant	0	NR	3e-06	5.522878745280337		3.65	[2.12-5.18] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p25.3	2	4258225.0		LINC01304 - NPM1P48	ENSG00000237401	ENSG00000231821		284101.0	255979.0	rs79056462-G	rs79056462	0.0	79056462	intergenic_variant	1	NR	4e-06	5.3979400086720375		1.84	[1.06-2.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q13.2	4	68934160.0		UGT2A3, UGT2A3			ENSG00000135220, ENSG00000278216			rs114809519-A	rs114809519	0.0	114809519	intron_variant	0	NR	4e-06	5.3979400086720375		1.18	[0.68-1.68] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4p16.3	4	3444364.0		HGFAC			ENSG00000109758			rs3748034-T	rs3748034	0.0	3748034	missense_variant	0	NR	4e-06	5.3979400086720375		1.02	[0.59-1.45] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196629197.0		KCNT2 - CFH	ENSG00000162687	ENSG00000000971		19972.0	22846.0	rs47219-T	rs47219	0.0	47219	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.96	[0.55-1.37] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5p13.1	5	39353755.0		C9			ENSG00000113600			rs140926258-A	rs140926258	1.0	3836794	intron_variant	0	NR	4e-06	5.3979400086720375		1.27	[0.73-1.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		22q11.21	22	21575277.0		UBE2L3			ENSG00000185651			rs181361-T	rs181361	0.0	181361	intron_variant	0	NR	4e-06	5.3979400086720375		0.95	[0.54-1.36] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q23.1	12	100400026.0		SLC17A8			ENSG00000179520			rs7959071-G	rs7959071	0.0	7959071	intron_variant	0	NR	4e-06	5.3979400086720375		1.13	[0.65-1.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63536798.0		WDPCP			ENSG00000143951			rs10183368-T	rs10183368	0.0	10183368	intron_variant	0	NR	4e-06	5.3979400086720375		1.06	[0.61-1.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	44908822.0		APOE			ENSG00000130203			rs7412-T	rs7412	0.0	7412	missense_variant	0	NR	1.9999999999999999e-193	192.698970004336		12.34	[11.53-13.15] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p32.3	1	55043912.0		PCSK9			ENSG00000169174			rs151193009-T	rs151193009	0.0	151193009	missense_variant	0	NR	2e-67	66.69897000433602		14.5	[12.86-16.14] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	58431227.0		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs1077835-G	rs1077835	0.0	1077835	intron_variant	0	NR	3e-48	47.52287874528034		3.01	[2.61-3.41] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21019859.0		APOB			ENSG00000084674			rs13306206-A	rs13306206	0.0	13306206	missense_variant	0	NR	2.9999999999999997e-47	46.52287874528034		14.44	[12.48-16.4] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11143211.0		SPC24			ENSG00000161888			rs34774090-CA	rs34774090	0.0	34774090	intron_variant	0	NR	1e-46	46.0		3.23	[2.79-3.67] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21212868.0		TDRD15 - NUTF2P8	ENSG00000218819	ENSG00000270654		68500.0	149424.0	rs536858685-A	rs536858685	0.0	536858685	intergenic_variant	1	NR	1.9999999999999998e-42	41.69897000433602		13.77	[11.79-15.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21207574.0		TDRD15 - NUTF2P8	ENSG00000218819	ENSG00000270654		63206.0	154718.0	rs117186081-A	rs117186081	0.0	117186081	intergenic_variant	1	NR	5e-42	41.30102999566398		13.71	[11.73-15.69] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75370667.0		CERT1			ENSG00000113163			rs7733436-C	rs7733436	0.0	7733436	3_prime_UTR_variant	0	NR	1e-40	40.0		2.72	[2.32-3.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75521119.0		POLK			ENSG00000122008			rs5744552-C	rs5744552	0.0	5744552	intron_variant	0	NR	2.0000000000000002e-39	38.69897000433602		2.68	[2.28-3.08] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56960333.0		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15469.0	1590.0	rs36229491-TA	rs36229491	0.0	36229491	upstream_gene_variant	1	NR	5.0000000000000005e-39	38.30102999566398		3.53	[3-4.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104902020.0		ABCA1			ENSG00000165029			rs1883025-T	rs1883025	0.0	1883025	intron_variant	0	NR	2e-38	37.69897000433602		3.06	[2.6-3.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals												rs8176636-T	rs8176636	0.0	8176636		1	NR	3e-33	32.52287874528034		2.78	[2.33-3.23] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75638184.0		ANKDD1B			ENSG00000189045			rs34341-T	rs34341	0.0	34341	intron_variant	0	NR	6e-33	32.22184874961636		2.45	[2.05-2.85] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75270348.0		ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		33437.0	65981.0	rs369330343-T	rs369330343	0.0	369330343	intergenic_variant	1	NR	1.9999999999999998e-32	31.69897000433602		2.44	[2.04-2.84] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109274968.0		CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	NR	3e-32	31.522878745280337		5.15	[4.3-6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.3	2	27508073.0		GCKR			ENSG00000084734			rs1260326-C	rs1260326	0.0	1260326	missense_variant	0	NR	2.0000000000000002e-28	27.69897000433602		2.29	[1.89-2.69] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11248024.0		DOCK6			ENSG00000130158			rs4804579-C	rs4804579	0.0	4804579	non_coding_transcript_exon_variant	0	NR	7e-27	26.154901959985743		2.46	[2.01-2.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49594230.0		LIPG			ENSG00000101670			rs9953437-A	rs9953437	0.0	9953437	3_prime_UTR_variant	0	NR	9e-26	25.045757490560675		2.15	[1.75-2.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72045758.0		TXNL4B			ENSG00000140830			rs77303550-T	rs77303550	0.0	77303550	intron_variant	0	NR	1e-22	22.0		2.33	[1.87-2.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8q24.13	8	125475993.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		37590.0	383728.0	rs2980868-C	rs2980868	0.0	2980868	intron_variant	1	NR	2e-22	21.69897000433602		2.01	[1.61-2.41] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.3	2	27609188.0		ZNF512			ENSG00000243943			rs2384656-A	rs2384656	0.0	2384656	intron_variant	0	NR	4e-20	19.39794000867204		1.88	[1.48-2.28] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21396237.0		NUTF2P8 - LINC01822	ENSG00000270654	ENSG00000229621		32212.0	291193.0	rs146350463-G	rs146350463	0.0	146350463	intron_variant	1	NR	7e-20	19.154901959985743		7.8	[6.12-9.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112158075.0		GPAM			ENSG00000119927			rs6585139-T	rs6585139	0.0	6585139	intron_variant	0	NR	4e-18	17.397940008672037		1.92	[1.49-2.35] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21595679.0		NUTF2P8 - LINC01822	ENSG00000270654	ENSG00000229621		231654.0	91751.0	rs147821144-G	rs147821144	0.0	147821144	intron_variant	1	NR	6e-17	16.221848749616356		7.16	[5.48-8.84] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9q34.11	9	127998049.0		FAM102A - NAIF1	ENSG00000167106	ENSG00000171169		17060.0	63184.0	rs78940737-GT	rs78940737	0.0	78940737	intergenic_variant	1	NR	7e-17	16.154901959985743		2.18	[1.67-2.69] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q33.3	5	156967430.0		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		4204.0	61983.0	rs9715911-G	rs9715911	0.0	9715911	upstream_gene_variant	1	NR	4e-16	15.397940008672036		1.98	[1.5-2.46] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8q12.1	8	58493931.0		CYP7A1			ENSG00000167910			rs112784971-T	rs112784971	0.0	112784971	intron_variant	0	NR	2e-15	14.69897000433602		1.8	[1.36-2.24] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41134515.0		PLCG1-AS1			ENSG00000226648			rs6129762-G	rs6129762	0.0	6129762	intron_variant	0	NR	3e-15	14.522878745280336		2.01	[1.51-2.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4p16.3	4	3432609.0		RGS12			ENSG00000159788			rs4690096-T	rs4690096	0.0	4690096	intron_variant	0	NR	8e-15	14.096910013008056		1.6	[1.2-2] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41274892.0		ZHX3			ENSG00000174306			rs11478283-TA	rs11478283	0.0	11478283	intron_variant	0	NR	1e-14	14.0		2.01	[1.5-2.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112263726.0		GPAM - TECTB	ENSG00000119927	ENSG00000119913		48349.0	19674.0	rs7895373-T	rs7895373	0.0	7895373	intergenic_variant	1	NR	2e-14	13.69897000433602		1.69	[1.26-2.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41027702.0		RNU2-52P - TOP1	ENSG00000222612	ENSG00000198900		3308.0	1120.0	rs6072249-A	rs6072249	0.0	6072249	upstream_gene_variant	1	NR	8e-14	13.096910013008056		1.96	[1.44-2.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19q13.33	19	49513502.0		FCGRT			ENSG00000104870			rs142385484-T	rs142385484	0.0	142385484	non_coding_transcript_exon_variant	0	NR	3e-13	12.522878745280336		2.1	[1.54-2.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72153963.0		PMFBP1			ENSG00000118557			rs200435297-C	rs200435297	0.0	200435297	intron_variant	0	NR	7e-13	12.154901959985745		2.28	[1.66-2.9] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62600744.0		RSL24D1P2 - EHBP1	ENSG00000230595	ENSG00000115504		39321.0	73107.0	rs11689333-C	rs11689333	0.0	11689333	intron_variant	1	NR	2e-12	11.69897000433602		1.82	[1.32-2.32] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q23.1	12	100501373.0		NR1H4			ENSG00000012504			rs74769460-CT	rs74769460	0.0	74769460	intron_variant	0	NR	3e-12	11.522878745280336		1.56	[1.12-2] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133425034.0		ADAMTS13, ADAMTS13			ENSG00000281244, ENSG00000160323			rs151195287-TACAA	rs151195287	0.0	151195287	intron_variant	0	NR	8e-12	11.096910013008056		2.05	[1.46-2.64] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q23.3	6	135099930.0		HBS1L			ENSG00000112339			rs1179411747-C	rs1179411747	1.0	34208856	intron_variant	0	NR	1e-11	11.0		1.47	[1.05-1.89] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	120978847.0		HNF1A-AS1, HNF1A			ENSG00000241388, ENSG00000135100			rs1169288-C	rs1169288	0.0	1169288	missense_variant	0	NR	3e-11	10.522878745280336		1.37	[0.97-1.77] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72114520.0		PMFBP1			ENSG00000118557			rs12445401-G	rs12445401	0.0	12445401	intron_variant	0	NR	3e-11	10.522878745280336		1.49	[1.05-1.93] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.1	10	72985464.0		PLA2G12B - RPL17P50	ENSG00000138308	ENSG00000213700		30658.0	20369.0	rs10670352-CAA	rs10670352	0.0	10670352	intergenic_variant	1	NR	1e-10	10.0		1.49	[1.04-1.94] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115646356.0		TRPS1			ENSG00000104447			rs2737245-T	rs2737245	0.0	2737245	intron_variant	0	NR	2e-10	9.69897000433602		1.46	[1.01-1.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	124388041.0		NCOR2			ENSG00000196498			rs2660369-C	rs2660369	0.0	2660369	intron_variant	0	NR	3e-10	9.522878745280336		1.38	[0.95-1.81] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47490228.0		MRPL45P2			ENSG00000228782			rs762300732-A	rs762300732	0.0	762300732	non_coding_transcript_exon_variant	0	NR	4e-10	9.397940008672036		1.37	[0.94-1.8] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.2	2	27867953.0		MRPL33, RBKS			ENSG00000243147, ENSG00000171174			rs898034-T	rs898034	0.0	898034	intron_variant	0	NR	1e-09	9.0		1.25	[0.85-1.65] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62943786.0		EHBP1			ENSG00000115504			rs2302567-G	rs2302567	0.0	2302567	intron_variant	0	NR	2e-09	8.698970004336019		1.55	[1.05-2.05] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62774004.0		EHBP1			ENSG00000115504			rs1123508-T	rs1123508	0.0	1123508	intron_variant	0	NR	2e-09	8.698970004336019		1.54	[1.04-2.04] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	22030759.0		RN7SL117P - RNA5SP87	ENSG00000264192	ENSG00000206882		107471.0	308127.0	rs144142940-T	rs144142940	0.0	144142940	intron_variant	1	NR	2e-09	8.698970004336019		5.09	[3.42-6.76] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75099422.0		ANKRD31			ENSG00000145700			rs139927802-C	rs139927802	0.0	139927802	intron_variant	0	NR	2e-09	8.698970004336019		1.4	[0.94-1.86] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q13.5	11	75738599.0		MOGAT2 - RN7SL786P	ENSG00000166391	ENSG00000263993		5641.0	3530.0	rs36016715-C	rs36016715	0.0	36016715	upstream_gene_variant	1	NR	3e-09	8.522878745280337		1.44	[0.97-1.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71512920.0		ZNF19			ENSG00000157429			rs75617080-A	rs75617080	0.0	75617080	intron_variant	0	NR	4e-09	8.397940008672037		2.08	[1.39-2.77] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47659909.0		KPNB1			ENSG00000108424			rs4264433-A	rs4264433	0.0	4264433	intron_variant	0	NR	4e-09	8.397940008672037		1.29	[0.86-1.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11007140.0		SMARCA4			ENSG00000127616			rs117302066-T	rs117302066	0.0	117302066	intron_variant	0	NR	5e-09	8.301029995663981		3.59	[2.38-4.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47377204.0		EFCAB13			ENSG00000178852			rs12453233-T	rs12453233	0.0	12453233	intron_variant	0	NR	1e-08	8.0		1.36	[0.9-1.82] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116752943.0		BUD13			ENSG00000137656			rs180327-C	rs180327	0.0	180327	intron_variant	0	NR	1e-08	8.0		1.17	[0.77-1.57] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q42.2	1	234528619.0		LINC01354			ENSG00000231768			rs12070208-C	rs12070208	0.0	12070208	non_coding_transcript_exon_variant	0	NR	2e-08	7.698970004336019		1.33	[0.87-1.79] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10751825.0		DNM2			ENSG00000079805			rs77997860-G	rs77997860	0.0	77997860	intron_variant	0	NR	2e-08	7.698970004336019		1.95	[1.27-2.63] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3p21.1	3	52566689.0		PBRM1, SMIM4			ENSG00000163939, ENSG00000168273			rs75404951-G	rs75404951	0.0	75404951	intron_variant	0	NR	2e-08	7.698970004336019		2.15	[1.4-2.9] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20648432.0		HS1BP3			ENSG00000118960			rs75352129-T	rs75352129	0.0	75352129	intron_variant	0	NR	3e-08	7.522878745280337		3.66	[2.37-4.95] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3p21.1	3	52695944.0		GLT8D1			ENSG00000016864			rs2276812-T	rs2276812	0.0	2276812	missense_variant	0	NR	3e-08	7.522878745280337		2.12	[1.37-2.87] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		22q13.31	22	45226470.0		KIAA0930			ENSG00000100364			rs5766564-A	rs5766564	0.0	5766564	intron_variant	0	NR	3e-08	7.522878745280337		1.21	[0.78-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92671033.0		EVI5			ENSG00000067208			rs1176740948-TA	rs1176740948	1.0	57856629	intron_variant	0	NR	4e-08	7.397940008672037		2.33	[1.5-3.16] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116956336.0		SIK3			ENSG00000160584			rs1359468163-C	rs1359468163	1.0	67306337	intron_variant	0	NR	4e-08	7.397940008672037		1.46	[0.94-1.98] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73102036.0		P4HA1 - NUDT13	ENSG00000122884	ENSG00000166321		5062.0	8339.0	rs79087956-CAA	rs79087956	0.0	79087956	upstream_gene_variant	1	NR	4e-08	7.397940008672037		1.24	[0.8-1.68] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196851978.0		CFHR1 - CFHR4	ENSG00000244414	ENSG00000134365		19789.0	36036.0	rs10922142-A	rs10922142	0.0	10922142	intron_variant	1	NR	4e-08	7.397940008672037		1.13	[0.72-1.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	124831101.0		SCARB1			ENSG00000073060			rs7485656-A	rs7485656	0.0	7485656	intron_variant	0	NR	5e-08	7.301029995663981		1.21	[0.78-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92518498.0		EVI5			ENSG00000067208			rs3903212-A	rs3903212	0.0	3903212	intron_variant	0	NR	5e-08	7.301029995663981		2.24	[1.44-3.04] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	45698914.0		QPCTL			ENSG00000011478			rs2287019-T	rs2287019	0.0	2287019	intron_variant	0	NR	5e-08	7.301029995663981		1.44	[0.92-1.96] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47260069.0		ITGB3			ENSG00000259207			rs4629025-T	rs4629025	0.0	4629025	intron_variant	0	NR	5e-08	7.301029995663981		1.13	[0.72-1.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10860596.0		C19orf38			ENSG00000214212			rs537916240-G	rs537916240	0.0	537916240	intron_variant	0	NR	6e-08	7.221848749616356		3.37	[2.15-4.59] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	117071783.0		SIK3			ENSG00000160584			rs761166016-A	rs761166016	1.0	57735255	intron_variant	0	NR	6e-08	7.221848749616356		1.64	[1.05-2.23] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	45870383.0		FOXA3			ENSG00000170608			rs60694100-T	rs60694100	0.0	60694100	intron_variant	0	NR	8e-08	7.096910013008056		2.12	[1.35-2.89] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92783482.0		EVI5			ENSG00000067208			rs11164811-T	rs11164811	0.0	11164811	intron_variant	0	NR	8e-08	7.096910013008056		2.19	[1.39-2.99] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92557898.0		EVI5			ENSG00000067208			rs111289258-G	rs111289258	0.0	111289258	intron_variant	0	NR	1e-07	7.0		2.1	[1.32-2.88] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q42.3	1	234717312.0		LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		82532.0	6730.0	rs556107-C	rs556107	0.0	556107	intron_variant	1	NR	1e-07	7.0		1.28	[0.81-1.75] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	58284964.0		ALDH1A2			ENSG00000128918			rs10162642-A	rs10162642	0.0	10162642	intron_variant	0	NR	2e-07	6.698970004336019		1.64	[1.03-2.25] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196733680.0		CFH			ENSG00000000971			rs1329428-T	rs1329428	0.0	1329428	intron_variant	0	NR	2e-07	6.698970004336019		1.07	[0.67-1.47] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12p13.31	12	8946400.0		M6PR			ENSG00000003056			rs149871778-GAAC	rs149871778	1.0	3217106	splice_acceptor_variant	0	NR	2e-07	6.698970004336019		1.16	[0.72-1.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q21.21	4	78698045.0		LINC01094 - BMP2K-DT	ENSG00000251442	ENSG00000260278		14860.0	75609.0	rs75759936-A	rs75759936	0.0	75759936	intergenic_variant	1	NR	2e-07	6.698970004336019		1.54	[0.96-2.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160568256.0		LPA			ENSG00000198670			rs9355291-T	rs9355291	0.0	9355291	intron_variant	0	NR	3e-07	6.522878745280337		1.04	[0.64-1.44] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		22q13.31	22	45336447.0		FAM118A			ENSG00000100376			rs11704481-A	rs11704481	0.0	11704481	intron_variant	0	NR	3e-07	6.522878745280337		1.07	[0.66-1.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73343965.0		CFAP70			ENSG00000156042			rs547729852-AT	rs547729852	1.0	200528605	intron_variant	0	NR	4e-07	6.3979400086720375		1.13	[0.69-1.57] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160030640.0		IGF2R			ENSG00000197081			rs3839348-CAGGCGGT	rs3839348	0.0	3839348	intron_variant	0	NR	5e-07	6.301029995663981		1.03	[0.63-1.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3q25.33	3	160289746.0		IFT80			ENSG00000068885			rs11709336-C	rs11709336	0.0	11709336	intron_variant	0	NR	5e-07	6.301029995663981		1.55	[0.95-2.15] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q41	1	220796686.0		MTARC1			ENSG00000186205			rs2642438-A	rs2642438	0.0	2642438	missense_variant	0	NR	5e-07	6.301029995663981		1.41	[0.86-1.96] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11255308.0		DOCK6			ENSG00000130158			rs1188476045-CT	rs1188476045	0.0	1188476045	intron_variant	0	NR	5e-07	6.301029995663981		1.02	[0.62-1.42] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10645756.0		SLC44A2 - ILF3-DT	ENSG00000129353	ENSG00000267100		1199.0	6106.0	rs10405536-G	rs10405536	0.0	10405536	downstream_gene_variant	1	NR	5e-07	6.301029995663981		1.07	[0.65-1.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q24.2	11	126363774.0		ST3GAL4			ENSG00000110080			rs7952602-C	rs7952602	0.0	7952602	intron_variant	0	NR	6e-07	6.221848749616356		1.15	[0.7-1.6] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75741555.0		POC5 - SLC25A5P9	ENSG00000152359	ENSG00000251078		24107.0	11015.0	rs113117080-C	rs113117080	0.0	113117080	intergenic_variant	1	NR	7e-07	6.154901959985743		1.59	[0.96-2.22] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92914774.0		DIPK1A			ENSG00000154511			rs78071833-GA	rs78071833	0.0	78071833	intron_variant	0	NR	7e-07	6.154901959985743		2.27	[1.37-3.17] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92655550.0		EVI5			ENSG00000067208			rs10735781-G	rs10735781	0.0	10735781	intron_variant	0	NR	1e-07	7.0		2.2	[1.39-3.01] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71633448.0		MARVELD3			ENSG00000140832			rs148809817-T	rs148809817	0.0	148809817	intron_variant	0	NR	2e-07	6.698970004336019		2.39	[1.49-3.29] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		11q13.5	11	75839472.0		UVRAG			ENSG00000198382			rs34249186-ATG	rs34249186	0.0	34249186	intron_variant	0	NR	2e-07	6.698970004336019		1.28	[0.8-1.76] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	120967323.0		HNF1A-AS1			ENSG00000241388			rs2251468-A	rs2251468	0.0	2251468	intron_variant	0	NR	2e-07	6.698970004336019		1.07	[0.67-1.47] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104784949.0		ABCA1			ENSG00000165029			rs11789818-T	rs11789818	0.0	11789818	intron_variant	0	NR	3e-07	6.522878745280337		1.09	[0.67-1.51] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p23.2	2	27727970.0		LINC01460 - MRPL33	ENSG00000205334	ENSG00000243147		11232.0	43747.0	rs10432705-A	rs10432705	0.0	10432705	regulatory_region_variant	1	NR	3e-07	6.522878745280337		1.13	[0.69-1.57] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20172648.0		RPS16P2 - RN7SL140P	ENSG00000213729	ENSG00000266059		16591.0	2698.0	rs2090034-A	rs2090034	0.0	2090034	upstream_gene_variant	1	NR	5e-06	5.301029995663981		0.98	[0.56-1.4] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p36.11	1	25311722.0		RHD, RSRP1			ENSG00000187010, ENSG00000117616			rs3094243-A	rs3094243	0.0	3094243	intron_variant	0	NR	6e-06	5.221848749616356		1.02	[0.58-1.46] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2q31.1	2	173356129.0		CDCA7			ENSG00000144354			rs147884651-G	rs147884651	0.0	147884651	intron_variant	0	NR	6e-06	5.221848749616356		1.22	[0.69-1.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		6p21.32	6	32664821.0		HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1			ENSG00000233209, ENSG00000179344, ENSG00000225824, ENSG00000231939, ENSG00000231286			rs17412833-T	rs17412833	0.0	17412833	missense_variant	0	NR	6e-06	5.221848749616356		1.23	[0.7-1.76] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	40561719.0		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		550396.0	124129.0	rs6129631-C	rs6129631	0.0	6129631	regulatory_region_variant	1	NR	6e-06	5.221848749616356		0.94	[0.53-1.35] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41407325.0		CHD6			ENSG00000124177			rs6029662-G	rs6029662	0.0	6029662	intron_variant	0	NR	6e-06	5.221848749616356		0.93	[0.53-1.33] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q12.2	16	55832466.0		CES1, CES1			ENSG00000198848, ENSG00000262243			rs9921399-T	rs9921399	0.0	9921399	intron_variant	0	NR	6e-06	5.221848749616356		0.93	[0.52-1.34] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92292450.0		GLMN			ENSG00000174842			rs150150088-A	rs150150088	0.0	150150088	intron_variant	0	NR	6e-06	5.221848749616356		2.96	[1.67-4.25] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7q33	7	135539190.0		CNOT4 - NUP205	ENSG00000080802	ENSG00000155561		29063.0	18727.0	rs17404165-C	rs17404165	0.0	17404165	intergenic_variant	1	NR	7e-06	5.154901959985743		1.14	[0.64-1.64] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		22q12.2	22	30207585.0		HORMAD2 - LIF-AS1	ENSG00000176635	ENSG00000232530		30510.0	31609.0	rs7288576-T	rs7288576	0.0	7288576	upstream_gene_variant	1	NR	7e-06	5.154901959985743		1.63	[0.92-2.34] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12p13.33	12	3046817.0		TEAD4 - TSPAN9	ENSG00000197905	ENSG00000011105		6141.0	30538.0	rs2159412-C	rs2159412	0.0	2159412	downstream_gene_variant	1	NR	7e-06	5.154901959985743		1.46	[0.82-2.1] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q21.1	12	71859732.0		TBC1D15			ENSG00000121749			rs144169978-T	rs144169978	0.0	144169978	intron_variant	0	NR	7e-06	5.154901959985743		3.57	[2.01-5.13] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17p13.1	17	7266684.0		Y_RNA - SLC2A4	ENSG00000264495	ENSG00000181856		518.0	15034.0	rs1475373485-CAA	rs1475373485	0.0	1475373485	upstream_gene_variant	1	NR	7e-06	5.154901959985743		0.96	[0.54-1.38] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		10q26.13	10	121552023.0		FGFR2			ENSG00000066468			rs41302327-CAA	rs41302327	0.0	41302327	non_coding_transcript_exon_variant	0	NR	7e-06	5.154901959985743		1.63	[0.92-2.34] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2p14	2	64152538.0		PELI1 - LINC00309	ENSG00000197329	ENSG00000230923		8118.0	32540.0	rs10170666-A	rs10170666	0.0	10170666	intron_variant	1	NR	7e-06	5.154901959985743		1.13	[0.64-1.62] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109393147.0		SORT1			ENSG00000134243			rs555998901-C	rs555998901	0.0	555998901	5_prime_UTR_variant	0	NR	7e-06	5.154901959985743		4.29	[2.41-6.17] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4p16.1	4	8832142.0		GPR78 - HMX1	ENSG00000155269	ENSG00000215612		212381.0	13934.0	rs147075068-T	rs147075068	0.0	147075068	intergenic_variant	1	NR	8e-06	5.096910013008056		2.4	[1.35-3.45] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17p13.1	17	7265674.0		CLDN7 - Y_RNA	ENSG00000181885	ENSG00000264495		1691.0	381.0	rs409942-T	rs409942	0.0	409942	upstream_gene_variant	1	NR	8e-06	5.096910013008056		0.96	[0.54-1.38] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		17q11.2	17	28318007.0		KRT18P55 - TMEM97	ENSG00000265480	ENSG00000109084		224.0	1193.0	rs75697736-A	rs75697736	0.0	75697736	upstream_gene_variant	1	NR	8e-06	5.096910013008056		1.17	[0.66-1.68] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	44795801.0		CBLC			ENSG00000142273			rs141177830-T	rs141177830	0.0	141177830	intron_variant	0	NR	8e-06	5.096910013008056		3.43	[1.93-4.93] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		8q23.1	8	106046433.0		ZFPM2-AS1			ENSG00000251003			rs79012045-C	rs79012045	0.0	79012045	intron_variant	0	NR	8e-06	5.096910013008056		2.21	[1.24-3.18] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		3p21.31	3	47987214.0		MAP4			ENSG00000047849			rs80310766-C	rs80310766	0.0	80310766	intron_variant	0	NR	8e-06	5.096910013008056		3.86	[2.16-5.56] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72288150.0		LINC01572			ENSG00000261008			rs75241913-C	rs75241913	0.0	75241913	intron_variant	0	NR	8e-06	5.096910013008056		0.99	[0.55-1.43] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		15q25.1	15	79031219.0		RASGRF1			ENSG00000058335			rs75616922-C	rs75616922	0.0	75616922	intron_variant	0	NR	8e-06	5.096910013008056		2.66	[1.49-3.83] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1q21.3	1	151270272.0		PSMD4 - ZNF687-AS1	ENSG00000159352	ENSG00000232671		2793.0	9406.0	rs72708494-G	rs72708494	0.0	72708494	downstream_gene_variant	1	NR	9e-06	5.045757490560675		1.49	[0.83-2.15] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		7p12.2	7	50276437.0		SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		117181.0	27631.0	rs1203524616-T	rs1203524616	1.0	79211009	upstream_gene_variant	1	NR	9e-06	5.045757490560675		0.94	[0.53-1.35] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		16q24.1	16	85939386.0		LINC02132 - LINC01082	ENSG00000268804	ENSG00000269186		3163.0	256568.0	rs8062669-T	rs8062669	0.0	8062669	intron_variant	1	NR	9e-06	5.045757490560675		1.11	[0.62-1.6] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		1p31.1	1	80197647.0		ADH5P2 - HMGB1P18	ENSG00000232676	ENSG00000236407		675444.0	85705.0	rs1222983994-CA	rs1222983994	0.0	1222983994	intergenic_variant	1	NR	9e-06	5.045757490560675		0.91	[0.51-1.31] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		4q34.3	4	179979276.0		RNA5SP173 - NDUFB5P1	ENSG00000201727	ENSG00000251025		1572446.0	594188.0	rs5864625-C	rs5864625	0.0	5864625	intron_variant	1	NR	9e-06	5.045757490560675		1.01	[0.57-1.45] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	50060071.0		MYO5B			ENSG00000167306			rs181486925-A	rs181486925	0.0	181486925	intron_variant	0	NR	9e-06	5.045757490560675		3.78	[2.11-5.45] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	125067543.0		AACS			ENSG00000081760			rs1425808295-AT	rs1425808295	1.0	35230801	intron_variant	0	NR	9e-06	5.045757490560675		0.92	[0.51-1.33] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		2q24.1	2	157566554.0		ACVR1C			ENSG00000123612			rs4389284-G	rs4389284	0.0	4389284	intron_variant	0	NR	1e-05	5.0		1.01	[0.56-1.46] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Total cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	58541794.0		LIPC			ENSG00000166035			rs6078-A	rs6078	0.0	6078	missense_variant	0	NR	1e-05	5.0		1.0	[0.56-1.44] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56957451.0		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		12587.0	4472.0	rs183130-T	rs183130	0.0	183130	upstream_gene_variant	1	NR	1e-300	300.0		3.88	[3.69-4.07] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116791863.0		APOA5			ENSG00000110243			rs651821-C	rs651821	0.0	651821	5_prime_UTR_variant	0	NR	3.0000000000000004e-247	246.52287874528037		2.66	[2.51-2.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	58431227.0		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs1077835-G	rs1077835	0.0	1077835	intron_variant	0	NR	4e-158	157.39794000867204		1.97	[1.83-2.11] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p21.3	8	19992481.0		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		25222.0	120862.0	rs73600084-C	rs73600084	0.0	73600084	intergenic_variant	1	NR	2e-96	95.69897000433602		2.3	[2.08-2.52] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104903458.0		ABCA1			ENSG00000165029			rs2575876-A	rs2575876	0.0	2575876	intron_variant	0	NR	4.9999999999999997e-64	63.30102999566398		1.42	[1.26-1.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49594230.0		LIPG			ENSG00000101670			rs9953437-A	rs9953437	0.0	9953437	3_prime_UTR_variant	0	NR	2e-59	58.69897000433602		1.19	[1.05-1.33] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	44908684.0		APOE			ENSG00000130203			rs429358-C	rs429358	0.0	429358	missense_variant	0	NR	1e-46	46.0		1.78	[1.54-2.02] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111681367.0		BRAP			ENSG00000089234			rs11066001-C	rs11066001	0.0	11066001	intron_variant	0	NR	4e-46	45.39794000867204		1.44	[1.24-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111803962.0		ALDH2			ENSG00000111275			rs671-A	rs671	0.0	671	missense_variant	0	NR	4e-46	45.39794000867204		1.44	[1.24-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112030402.0		NAA25			ENSG00000111300			rs11066132-T	rs11066132	0.0	11066132	intron_variant	0	NR	5.999999999999999e-44	43.22184874961636		1.4	[1.2-1.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112298314.0		HECTD4			ENSG00000173064			rs77768175-G	rs77768175	0.0	77768175	intron_variant	0	NR	5.999999999999999e-44	43.22184874961636		1.4	[1.2-1.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	117180532.0		SIDT2			ENSG00000149577			rs1375471766-C	rs1375471766	1.0	35242634	intron_variant	0	NR	7e-44	43.15490195998574		1.03	[0.88-1.18] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112492671.0		PTPN11			ENSG00000179295			rs11066325-C	rs11066325	0.0	11066325	intron_variant	0	NR	3e-43	42.52287874528034		1.37	[1.18-1.56] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112136812.0		TRAFD1			ENSG00000135148			rs12231737-T	rs12231737	0.0	12231737	intron_variant	0	NR	7e-43	42.15490195998574		1.35	[1.16-1.54] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111398968.0		LINC02356			ENSG00000257595			rs149212747-AC	rs149212747	0.0	149212747	intron_variant	0	NR	1.9999999999999998e-42	41.69897000433602		1.32	[1.13-1.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112680092.0		RPH3A			ENSG00000089169			rs77753011-T	rs77753011	0.0	77753011	intron_variant	0	NR	7.0000000000000006e-34	33.15490195998574		1.23	[1.03-1.43] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116979045.0		SIK3			ENSG00000160584			rs74942197-G	rs74942197	0.0	74942197	intron_variant	0	NR	7.000000000000001e-31	30.154901959985743		3.65	[3.03-4.27] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q26.12	10	121177844.0		RPL19P16 - LINC01153	ENSG00000236762	ENSG00000227143		44121.0	856.0	rs3962120-A	rs3962120	0.0	3962120	upstream_gene_variant	1	NR	5e-10	9.30102999566398		0.5	[0.34-0.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56549936.0		BBS2			ENSG00000125124			rs117332104-C	rs117332104	0.0	117332104	intron_variant	0	NR	6e-10	9.221848749616356		1.99	[1.36-2.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	109575834.0		MVK			ENSG00000110921			rs6606734-G	rs6606734	0.0	6606734	intron_variant	0	NR	6e-10	9.221848749616356		0.5	[0.34-0.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160568256.0		LPA			ENSG00000198670			rs9355291-T	rs9355291	0.0	9355291	intron_variant	0	NR	7e-10	9.154901959985745		0.45	[0.31-0.59] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109928142.0		CSF1			ENSG00000184371			rs333947-A	rs333947	0.0	333947	intron_variant	0	NR	1e-09	9.0		0.47	[0.32-0.62] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39146885.0		MACF1			ENSG00000127603			rs66848709-C	rs66848709	0.0	66848709	intron_variant	0	NR	1e-09	9.0		0.61	[0.41-0.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q27	6	167945942.0		AFDN			ENSG00000130396			rs77984694-A	rs77984694	0.0	77984694	intron_variant	0	NR	1e-09	9.0		0.56	[0.38-0.74] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		4q23	4	99524081.0		C4orf17			ENSG00000138813			rs10012712-A	rs10012712	0.0	10012712	intron_variant	0	NR	2e-09	8.698970004336019		0.52	[0.35-0.69] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	67511626.0		ATP6V0D1-DT - RIPOR1	ENSG00000270049	ENSG00000039523		5649.0	6792.0	rs117353960-A	rs117353960	0.0	117353960	intergenic_variant	1	NR	2e-09	8.698970004336019		0.74	[0.5-0.98] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110021680.0		ANKRD13A			ENSG00000076513			rs75584653-T	rs75584653	0.0	75584653	non_coding_transcript_exon_variant	0	NR	2e-09	8.698970004336019		0.76	[0.51-1.01] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39277153.0		MACF1			ENSG00000127603			rs1235613599-GAA	rs1235613599	0.0	1235613599	intron_variant	0	NR	3e-09	8.522878745280337		0.54	[0.36-0.72] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20956506.0		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		94845.0	44923.0	rs36145916-T	rs36145916	0.0	36145916	intergenic_variant	1	NR	3e-09	8.522878745280337		0.6	[0.4-0.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	109904793.0		TCHP			ENSG00000139437			rs74416240-A	rs74416240	0.0	74416240	splice_region_variant	0	NR	3e-09	8.522878745280337		0.75	[0.5-1] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12p12.2	12	20308670.0		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		172507.0	53062.0	rs1373570-T	rs1373570	0.0	1373570	intergenic_variant	1	NR	3e-09	8.522878745280337		0.57	[0.38-0.76] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	93086630.0		MTF2			ENSG00000143033			rs11164870-C	rs11164870	0.0	11164870	intron_variant	0	NR	4e-09	8.397940008672037		0.45	[0.3-0.6] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q13.2	5	73618438.0		UTP15 - ARHGEF28	ENSG00000164338	ENSG00000214944		35058.0	7720.0	rs35211645-G	rs35211645	0.0	35211645	intergenic_variant	1	NR	5e-09	8.301029995663981		0.45	[0.3-0.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		22q11.21	22	21454896.0		Metazoa_SRP - Metazoa_SRP	ENSG00000276525	ENSG00000276525		58306.0	9067.0	rs463426-T	rs463426	0.0	463426	downstream_gene_variant	1	NR	5e-09	8.301029995663981		0.43	[0.28-0.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	111914942.0		MAPKAPK5 - ADAM1B	ENSG00000089022	ENSG00000226469		12720.0	12076.0	rs1225535157-TA	rs1225535157	0.0	1225535157	intergenic_variant	1	NR	9e-09	8.045757490560675		0.42	[0.28-0.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11p15.5	11	270333.0		PSMD13 - NLRP6	ENSG00000185627	ENSG00000174885		17349.0	8074.0	rs56319941-A	rs56319941	0.0	56319941	upstream_gene_variant	1	NR	1e-08	8.0		0.52	[0.34-0.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		4q23	4	99626023.0		MTTP - C4orf54	ENSG00000138823	ENSG00000248713		2026.0	10506.0	rs1979659-A	rs1979659	0.0	1979659	upstream_gene_variant	1	NR	1e-08	8.0		0.49	[0.32-0.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	116097142.0		LINC00536			ENSG00000249917			rs77474870-T	rs77474870	0.0	77474870	intron_variant	0	NR	1e-08	8.0		0.71	[0.46-0.96] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56851415.0		NUP93 - MIR138-2	ENSG00000102900	ENSG00000207649		1129.0	7103.0	rs185110451-T	rs185110451	0.0	185110451	downstream_gene_variant	1	NR	1e-08	8.0		1.39	[0.91-1.87] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80394649.0		CD36			ENSG00000135218			rs10267010-C	rs10267010	0.0	10267010	intron_variant	0	NR	2e-08	7.698970004336019		0.91	[0.59-1.23] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q11.23	7	73589985.0		TBL2 - MLXIPL	ENSG00000106638	ENSG00000009950		11194.0	3209.0	rs145099458-T	rs145099458	0.0	145099458	downstream_gene_variant	1	NR	2e-08	7.698970004336019		0.71	[0.46-0.96] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104684081.0		OR13C1P - OR13D1	ENSG00000235248	ENSG00000179055		25026.0	10437.0	rs10820706-T	rs10820706	0.0	10820706	intergenic_variant	1	NR	2e-08	7.698970004336019		0.45	[0.3-0.6] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115452760.0		TRPS1			ENSG00000104447			rs800888-C	rs800888	0.0	800888	intron_variant	0	NR	4e-13	12.397940008672036		0.66	[0.48-0.84] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q23.2	16	81501185.0		CMIP			ENSG00000153815			rs2925979-T	rs2925979	0.0	2925979	intron_variant	0	NR	4e-13	12.397940008672036		0.55	[0.4-0.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	113127578.0		RASAL1			ENSG00000111344			rs12229054-A	rs12229054	0.0	12229054	intron_variant	0	NR	5e-13	12.30102999566398		0.81	[0.59-1.03] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112157077.0		GPAM			ENSG00000119927			rs2254532-A	rs2254532	0.0	2254532	3_prime_UTR_variant	0	NR	5e-13	12.30102999566398		0.57	[0.42-0.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	68259417.0		PLA2G15			ENSG00000103066			rs3743739-C	rs3743739	0.0	3743739	synonymous_variant	0	NR	6e-13	12.221848749616356		0.73	[0.53-0.93] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	68241613.0		ESRP2 - PLA2G15	ENSG00000103067	ENSG00000103066		3511.0	3691.0	rs7197756-C	rs7197756	0.0	7197756	upstream_gene_variant	1	NR	1e-12	12.0		0.72	[0.52-0.92] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	68116624.0		NFATC3			ENSG00000072736			rs12447640-G	rs12447640	0.0	12447640	intron_variant	0	NR	1e-12	12.0		0.72	[0.52-0.92] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q24.13	8	125487789.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-G	rs28601761	0.0	28601761	intron_variant	1	NR	5e-12	11.30102999566398		0.62	[0.44-0.8] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	117421613.0		CEP164 - DSCAML1	ENSG00000110274	ENSG00000177103		8347.0	6159.0	rs77182024-A	rs77182024	0.0	77182024	intergenic_variant	1	NR	6e-12	11.221848749616356		1.97	[1.41-2.53] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		14q32.33	14	104801891.0		ZBTB42			ENSG00000179627			rs4983387-A	rs4983387	0.0	4983387	missense_variant	0	NR	7e-12	11.154901959985745		0.52	[0.37-0.67] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	117319043.0		CEP164			ENSG00000110274			rs74351220-G	rs74351220	0.0	74351220	intron_variant	0	NR	7e-12	11.154901959985745		1.93	[1.38-2.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112265120.0		GPAM - TECTB	ENSG00000119927	ENSG00000119913		49743.0	18280.0	rs578186224-CA	rs578186224	1.0	11384201	intergenic_variant	1	NR	7e-12	11.154901959985745		0.53	[0.38-0.68] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q25.3	1	182150381.0		LINC01344			ENSG00000228918			rs6694132-T	rs6694132	0.0	6694132	non_coding_transcript_exon_variant	0	NR	1e-11	11.0		0.54	[0.38-0.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	113483541.0		LHX5-AS1 - LINC01234	ENSG00000257935	ENSG00000249550		2905.0	100345.0	rs79317416-A	rs79317416	0.0	79317416	downstream_gene_variant	1	NR	3e-11	10.522878745280336		0.92	[0.65-1.19] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	122716898.0		HCAR3 - HCAR1	ENSG00000255398	ENSG00000196917		87.0	9178.0	rs1265397838-TAA	rs1265397838	0.0	1265397838	upstream_gene_variant	1	NR	4e-11	10.397940008672036		0.49	[0.34-0.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	93360081.0		DR1			ENSG00000117505			rs1559828-T	rs1559828	0.0	1559828	intron_variant	0	NR	6e-11	10.221848749616356		0.49	[0.34-0.64] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110237558.0		IFT81 - ATP2A2	ENSG00000122970	ENSG00000174437		18765.0	43198.0	rs144825998-T	rs144825998	0.0	144825998	intergenic_variant	1	NR	1e-10	10.0		0.86	[0.6-1.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112826950.0		RPH3A			ENSG00000089169			rs4767014-C	rs4767014	0.0	4767014	intron_variant	0	NR	1e-10	10.0		0.54	[0.38-0.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	93199594.0		CCDC18			ENSG00000122483			rs1537758-A	rs1537758	0.0	1537758	intron_variant	0	NR	1e-10	10.0		0.49	[0.34-0.64] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110121764.0		C12orf76 - IFT81	ENSG00000174456	ENSG00000122970		48128.0	2571.0	rs181629169-C	rs181629169	0.0	181629169	upstream_gene_variant	1	NR	2e-10	9.69897000433602		0.78	[0.54-1.02] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39113314.0		MACF1			ENSG00000127603			rs4660416-G	rs4660416	0.0	4660416	intron_variant	0	NR	4e-10	9.397940008672036		0.64	[0.44-0.84] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p12.2	7	50284680.0		SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		125424.0	19388.0	rs4917130-G	rs4917130	0.0	4917130	intergenic_variant	1	NR	4e-10	9.397940008672036		0.46	[0.31-0.61] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39394270.0		MACF1			ENSG00000127603			rs200922247-T	rs200922247	0.0	200922247	intron_variant	0	NR	5e-10	9.30102999566398		0.74	[0.51-0.97] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q27	6	167842561.0		AFDN			ENSG00000130396			rs62427660-A	rs62427660	0.0	62427660	intron_variant	0	NR	5e-10	9.30102999566398		0.59	[0.4-0.78] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	81121206.0		SEMA3C - EIF4EP4	ENSG00000075223	ENSG00000232968		198847.0	341830.0	rs150501400-G	rs150501400	0.0	150501400	regulatory_region_variant	1	NR	5e-10	9.30102999566398		0.9	[0.62-1.18] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110826619.0		PPP1CC - RPL29P25	ENSG00000186298	ENSG00000241286		83680.0	14919.0	rs1385188511-A	rs1385188511	0.0	1385188511	regulatory_region_variant	1	NR	2e-08	7.698970004336019		0.66	[0.43-0.89] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56270974.0		GNAO1			ENSG00000087258			rs117076764-T	rs117076764	0.0	117076764	non_coding_transcript_exon_variant	0	NR	3e-08	7.522878745280337		1.36	[0.88-1.84] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.33	6	31363723.0		HLA-B - DHFRP2	ENSG00000206450	ENSG00000228432		6535.0	2629.0	rs4959062-C	rs4959062	0.0	4959062	upstream_gene_variant	1	NR	3e-08	7.522878745280337		0.57	[0.37-0.77] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q23.33	10	93079885.0		CYP26A1 - NIP7P1	ENSG00000095596	ENSG00000232805		2000.0	26987.0	rs2068888-G	rs2068888	0.0	2068888	downstream_gene_variant	1	NR	3e-08	7.522878745280337		0.45	[0.29-0.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q13.2	11	66538257.0		ZDHHC24			ENSG00000174165			rs11227522-C	rs11227522	0.0	11227522	3_prime_UTR_variant	0	NR	3e-08	7.522878745280337		0.46	[0.3-0.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q13.1	11	65638922.0		SIPA1			ENSG00000213445			rs2509948-T	rs2509948	0.0	2509948	intron_variant	0	NR	4e-08	7.397940008672037		0.49	[0.32-0.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2q36.3	2	226303242.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		649224.0	355468.0	rs7585533-A	rs7585533	0.0	7585533	regulatory_region_variant	1	NR	5e-08	7.301029995663981		0.78	[0.5-1.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160447295.0		SLC22A3			ENSG00000146477			rs2457575-G	rs2457575	0.0	2457575	intron_variant	0	NR	6e-08	7.221848749616356		0.4	[0.26-0.54] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	109467563.0		KCTD10			ENSG00000110906			rs6606725-A	rs6606725	0.0	6606725	intron_variant	0	NR	6e-08	7.221848749616356		0.43	[0.28-0.58] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	122701007.0		KNTC1 - HCAR2	ENSG00000184445	ENSG00000182782		74611.0	286.0	rs597343-T	rs597343	0.0	597343	intron_variant	1	NR	6e-08	7.221848749616356		0.4	[0.26-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.2	1	39667434.0		NT5C1A			ENSG00000116981			rs58397081-T	rs58397081	0.0	58397081	intron_variant	0	NR	7e-08	7.154901959985743		0.64	[0.41-0.87] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q13.2	11	66426130.0		NPAS4			ENSG00000174576			rs1311394076-T	rs1311394076	1.0	3215144	3_prime_UTR_variant	0	NR	8e-08	7.096910013008056		0.43	[0.27-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115948504.0		TRPS1 - LINC00536	ENSG00000104447	ENSG00000249917		138831.0	2007.0	rs7828742-A	rs7828742	0.0	7828742	downstream_gene_variant	1	NR	9e-08	7.045757490560675		0.4	[0.25-0.55] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p22.1	6	28382936.0		ZSCAN12			ENSG00000158691			rs376874208-G	rs376874208	0.0	376874208	intron_variant	0	NR	9e-08	7.045757490560675		0.68	[0.43-0.93] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q32.2	7	130751700.0		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		17493.0	71505.0	rs11979110-T	rs11979110	0.0	11979110	intergenic_variant	1	NR	9e-08	7.045757490560675		0.43	[0.27-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.1	6	43791136.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		4649.0	53742.0	rs6905288-G	rs6905288	0.0	6905288	downstream_gene_variant	1	NR	1e-07	7.0		0.46	[0.29-0.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	45009889.0		RELB			ENSG00000104856			rs765662577-G	rs765662577	0.0	765662577	intron_variant	0	NR	1e-07	7.0		0.42	[0.27-0.57] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	57816569.0		POLR2M - ALDH1A2	ENSG00000255529	ENSG00000128918		33807.0	136855.0	rs573784-C	rs573784	0.0	573784	intergenic_variant	1	NR	2e-07	6.698970004336019		0.39	[0.24-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2q36.3	2	226171838.0		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		517820.0	486872.0	rs36083960-CA, rs36083960-CA	rs36083960, rs36083960	1.0		intergenic_variant	1	NR	2e-07	6.698970004336019		0.67	[0.42-0.92] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49745172.0		SMUG1P1 - ACAA2	ENSG00000267444	ENSG00000167315		94012.0	36992.0	rs77965826-T	rs77965826	0.0	77965826	upstream_gene_variant	1	NR	2e-07	6.698970004336019		0.95	[0.6-1.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.32	6	32363689.0		TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1, TSBP1, TSBP1, TSBP1, TSBP1, TSBP1, TSBP1, TSBP1			ENSG00000230602, ENSG00000228738, ENSG00000229903, ENSG00000225834, ENSG00000226228, ENSG00000224507, ENSG00000225914, ENSG00000234280, ENSG00000232106, ENSG00000206245, ENSG00000204296, ENSG00000206310, ENSG00000226892, ENSG00000237881, ENSG00000236672			rs9279601-TA	rs9279601	0.0	9279601	intron_variant	0	NR	2e-07	6.698970004336019		0.43	[0.27-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q11.23	7	73441939.0		BAZ1B			ENSG00000009954			rs2240466-A	rs2240466	0.0	2240466	3_prime_UTR_variant	0	NR	2e-07	6.698970004336019		0.62	[0.39-0.85] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q12.2	16	55890229.0		CES5A			ENSG00000159398			rs1288244004-G	rs1288244004	1.0	11388912	intron_variant	0	NR	2e-07	6.698970004336019		0.61	[0.38-0.84] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		19q13.11	19	33408159.0		PEPD			ENSG00000124299			rs731839-A	rs731839	0.0	731839	intron_variant	0	NR	3e-07	6.522878745280337		0.38	[0.24-0.52] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		4q22.1	4	88813436.0		FAM13A			ENSG00000138640			rs1350506-T	rs1350506	0.0	1350506	intron_variant	0	NR	3e-07	6.522878745280337		0.42	[0.26-0.58] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	122893022.0		VPS37B			ENSG00000139722			rs4759387-C	rs4759387	0.0	4759387	intron_variant	0	NR	3e-07	6.522878745280337		0.46	[0.28-0.64] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112385286.0		ACSL5			ENSG00000197142			rs58854276-G	rs58854276	0.0	58854276	intron_variant	0	NR	4e-07	6.3979400086720375		0.37	[0.23-0.51] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q13.1	11	65508194.0		MALAT1 - SNRPGP19	ENSG00000251562	ENSG00000270526		1678.0	6209.0	rs75889480-C	rs75889480	0.0	75889480	downstream_gene_variant	1	NR	4e-07	6.3979400086720375		0.47	[0.29-0.65] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.32	6	32544756.0		HLA-DRB5 - RNU1-61P	ENSG00000198502	ENSG00000251916		14469.0	5184.0	rs202207567-T	rs202207567	0.0	202207567	downstream_gene_variant	1	NR	5e-07	6.301029995663981		0.4	[0.25-0.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	123400366.0		KMT5A			ENSG00000183955			rs35326700-A	rs35326700	0.0	35326700	intron_variant	0	NR	5e-07	6.301029995663981		0.39	[0.24-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		18q11.2	18	23352787.0		TMEM241			ENSG00000134490			rs1501410-T	rs1501410	0.0	1501410	intron_variant	0	NR	5e-07	6.301029995663981		0.45	[0.27-0.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q41	1	220796686.0		MTARC1			ENSG00000186205			rs2642438-A	rs2642438	0.0	2642438	missense_variant	0	NR	6e-07	6.221848749616356		0.5	[0.3-0.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	67641507.0		CTCF - CARMIL2	ENSG00000102974	ENSG00000159753		2330.0	3481.0	rs140623181-T	rs140623181	0.0	140623181	upstream_gene_variant	1	NR	6e-07	6.221848749616356		0.6	[0.36-0.84] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.33	6	31567605.0		NFKBIL1 - LTA	ENSG00000206440	ENSG00000173503		8776.0	4449.0	rs9281525-T	rs9281525	0.0	9281525	intron_variant	1	NR	7e-07	6.154901959985743		0.38	[0.23-0.53] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q25.3	1	182250560.0		LINC01344			ENSG00000228918			rs2254793-T	rs2254793	0.0	2254793	intron_variant	0	NR	8e-07	6.096910013008056		0.36	[0.22-0.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	38988113.0		EIF1P2 - AKIRIN1	ENSG00000235549	ENSG00000174574		29188.0	3163.0	rs34848020-G	rs34848020	0.0	34848020	upstream_gene_variant	1	NR	8e-07	6.096910013008056		0.44	[0.27-0.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p35.3	1	28271776.0		SESN2, SESN2			ENSG00000285069, ENSG00000130766			rs74896528-T	rs74896528	0.0	74896528	missense_variant	0	NR	9e-07	6.045757490560675		1.16	[0.7-1.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	57084503.0		NLRC5 - CPNE2-DT	ENSG00000140853	ENSG00000260148		972.0	6710.0	rs8049437-A	rs8049437	0.0	8049437	downstream_gene_variant	1	NR	9e-07	6.045757490560675		0.7	[0.42-0.98] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		17q24.2	17	68903569.0		ABCA8			ENSG00000141338			rs3744494-C	rs3744494	0.0	3744494	intron_variant	0	NR	9e-07	6.045757490560675		0.36	[0.22-0.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		3p25.2	3	12179924.0		SYN2			ENSG00000157152			rs6805092-T	rs6805092	0.0	6805092	intron_variant	0	NR	1e-06	6.0		0.83	[0.5-1.16] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q24.13	8	125637814.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		199411.0	221907.0	rs28469864-G	rs28469864	0.0	28469864	TF_binding_site_variant	1	NR	1e-06	6.0		0.39	[0.23-0.55] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		21q22.3	21	44875071.0		PTTG1IP - ITGB2	ENSG00000183255	ENSG00000160255		1168.0	10882.0	rs235374-C	rs235374	0.0	235374	non_coding_transcript_exon_variant	1	NR	1e-06	6.0		0.38	[0.23-0.53] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49619796.0		LIPG - SMUG1P1	ENSG00000101670	ENSG00000267444		20611.0	30554.0	rs11661190-T	rs11661190	0.0	11661190	regulatory_region_variant	1	NR	1e-06	6.0		0.41	[0.24-0.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		18q11.2	18	23484311.0		RIOK3			ENSG00000101782			rs17187092-A	rs17187092	0.0	17187092	intron_variant	0	NR	1e-06	6.0		0.44	[0.26-0.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	56119578.0		GNAO1-DT			ENSG00000246379			rs79545763-C	rs79545763	0.0	79545763	intron_variant	0	NR	1e-06	6.0		1.36	[0.81-1.91] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		3p21.31	3	47538668.0		ELP6 - RN7SL870P	ENSG00000163832	ENSG00000244732		24956.0	21561.0	rs56185965-A	rs56185965	0.0	56185965	intergenic_variant	1	NR	1e-06	6.0		0.45	[0.27-0.63] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p21.1	7	17874977.0		SNX13			ENSG00000071189			rs6461354-C	rs6461354	0.0	6461354	intron_variant	0	NR	2e-06	5.698970004336019		0.35	[0.21-0.49] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q13.3	12	56966190.0		RDH16 - GPR182	ENSG00000139547	ENSG00000166856		6816.0	28302.0	rs11172076-T	rs11172076	0.0	11172076	intergenic_variant	1	NR	2e-06	5.698970004336019		0.42	[0.25-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p21.3	8	19834515.0		INTS10			ENSG00000104613			rs2934-C	rs2934	0.0	2934	intron_variant	0	NR	2e-06	5.698970004336019		0.36	[0.21-0.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115845649.0		TRPS1 - LINC00536	ENSG00000104447	ENSG00000249917		35976.0	104862.0	rs79303479-G	rs79303479	0.0	79303479	regulatory_region_variant	1	NR	2e-06	5.698970004336019		0.47	[0.28-0.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11p11.2	11	47315832.0		MADD			ENSG00000110514			rs1275799798-CTTT	rs1275799798	0.0	1275799798	intron_variant	0	NR	2e-06	5.698970004336019		0.36	[0.21-0.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		17q25.3	17	78398368.0		PGS1			ENSG00000087157			rs2292644-T	rs2292644	0.0	2292644	intron_variant	0	NR	2e-06	5.698970004336019		0.35	[0.2-0.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q25.3	1	182204576.0		LINC01344			ENSG00000228918			rs10911031-A	rs10911031	0.0	10911031	intron_variant	0	NR	2e-06	5.698970004336019		0.38	[0.22-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q42.2	1	234527887.0		LINC01354			ENSG00000231768			rs7545686-C	rs7545686	0.0	7545686	non_coding_transcript_exon_variant	0	NR	2e-06	5.698970004336019		1.1	[0.65-1.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q24.1	11	122657315.0		UBASH3B			ENSG00000154127			rs11601869-A	rs11601869	0.0	11601869	intron_variant	0	NR	2e-06	5.698970004336019		0.48	[0.28-0.68] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		4q23	4	99742665.0		C4orf54 - DAPP1	ENSG00000248713	ENSG00000070190		84837.0	74162.0	rs11729858-A	rs11729858	0.0	11729858	intergenic_variant	1	NR	2e-06	5.698970004336019		0.44	[0.26-0.62] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12p13.31	12	7373269.0		CD163L1			ENSG00000177675			rs11053518-G	rs11053518	0.0	11053518	intron_variant	0	NR	2e-06	5.698970004336019		0.35	[0.2-0.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2p16.2	2	54004909.0		ACYP2			ENSG00000170634			rs111264695-A	rs111264695	0.0	111264695	intron_variant	0	NR	2e-06	5.698970004336019		0.35	[0.21-0.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q14.1	11	77501155.0		PAK1 - CLNS1A	ENSG00000149269	ENSG00000074201		26520.0	13781.0	rs112693639-A	rs112693639	0.0	112693639	regulatory_region_variant	1	NR	3e-06	5.522878745280337		0.36	[0.21-0.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p12.3	6	50910118.0		RPS17P5 - FTH1P5	ENSG00000060303	ENSG00000230204		52456.0	2594.0	rs12174274-G	rs12174274	0.0	12174274	downstream_gene_variant	1	NR	3e-06	5.522878745280337		0.42	[0.24-0.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p21.3	8	20114857.0		RPL30P9 - SLC18A1	ENSG00000242709	ENSG00000036565		1185.0	29998.0	rs1039122-T	rs1039122	0.0	1039122	intron_variant	1	NR	3e-06	5.522878745280337		1.1	[0.64-1.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.32	6	32649851.0		HLA-DQA1 - HLA-DQB1	ENSG00000196735	ENSG00000231286		2789.0	9616.0	rs28826696-T	rs28826696	0.0	28826696	downstream_gene_variant	1	NR	3e-06	5.522878745280337		0.43	[0.25-0.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8p23.1	8	9320758.0		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		33180.0	50332.0	rs6984305-A	rs6984305	0.0	6984305	intron_variant	1	NR	3e-06	5.522878745280337		1.67	[0.97-2.37] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q13.1	5	68412402.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		110581.0	442508.0	rs10072935-A	rs10072935	0.0	10072935	intergenic_variant	1	NR	3e-06	5.522878745280337		0.36	[0.21-0.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q33.3	5	158764760.0		EBF1			ENSG00000164330			rs11740542-G	rs11740542	0.0	11740542	intron_variant	0	NR	3e-06	5.522878745280337		0.69	[0.4-0.98] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q23.1	5	119543023.0		HSD17B4			ENSG00000133835			rs35401573-T	rs35401573	0.0	35401573	non_coding_transcript_exon_variant	0	NR	3e-06	5.522878745280337		1.09	[0.63-1.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q21.3	10	63537960.0		REEP3			ENSG00000165476			rs12770839-A	rs12770839	0.0	12770839	intron_variant	0	NR	3e-06	5.522878745280337		0.36	[0.21-0.51] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		9q32	9	112196038.0		SUSD1 - PTBP3	ENSG00000106868	ENSG00000119314		20741.0	21678.0	rs34892025-A	rs34892025	0.0	34892025	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.38	[0.22-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q22.3	8	100727910.0		PABPC1 - RNU6ATAC41P	ENSG00000070756	ENSG00000221527		5101.0	11892.0	rs74686575-T	rs74686575	0.0	74686575	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.56	[0.32-0.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1q25.2	1	178603843.0		RNA5SP69 - MIR4424	ENSG00000201347	ENSG00000266417		42814.0	73906.0	rs2811290-T	rs2811290	0.0	2811290	regulatory_region_variant	1	NR	4e-06	5.3979400086720375		0.34	[0.2-0.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q22.1	7	100011271.0		AZGP1P1 - ZKSCAN1	ENSG00000214313	ENSG00000106261		23433.0	4301.0	rs375218610-TCTTCCTTC	rs375218610	0.0	375218610	intron_variant	1	NR	4e-06	5.3979400086720375		0.6	[0.35-0.85] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q13.3	8	70204688.0		NCOA2			ENSG00000140396			rs4236982-G	rs4236982	0.0	4236982	intron_variant	0	NR	4e-06	5.3979400086720375		0.34	[0.19-0.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q23.3	11	116416620.0		LINC02703 - LINC02151	ENSG00000257067	ENSG00000236437		473439.0	80279.0	rs534082-T	rs534082	0.0	534082	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.59	[0.34-0.84] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	109046321.0		USP30			ENSG00000135093			rs10850337-G	rs10850337	0.0	10850337	intron_variant	0	NR	4e-06	5.3979400086720375		0.35	[0.2-0.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q12.2	16	53306168.0		CHD9			ENSG00000177200			rs3760010-A	rs3760010	0.0	3760010	intron_variant	0	NR	4e-06	5.3979400086720375		0.34	[0.2-0.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112323514.0		GUCY2GP			ENSG00000243316			rs724548-C	rs724548	0.0	724548	intron_variant	0	NR	7e-06	5.154901959985743		0.33	[0.19-0.47] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		15q23	15	69881625.0		DRAIC - TLE3	ENSG00000245750	ENSG00000140332		38505.0	166165.0	rs7166273-C	rs7166273	0.0	7166273	regulatory_region_variant	1	NR	7e-06	5.154901959985743		0.37	[0.21-0.53] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.33	6	31425214.0		MICA - LINC01149	ENSG00000235233	ENSG00000230174		9899.0	16453.0	rs72848707-T	rs72848707	0.0	72848707	intron_variant	1	NR	7e-06	5.154901959985743		0.38	[0.21-0.55] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q22.31	6	118403228.0		SLC35F1 - CEP85L	ENSG00000196376	ENSG00000111860		85552.0	57544.0	rs141982607-G	rs141982607	0.0	141982607	intergenic_variant	1	NR	7e-06	5.154901959985743		1.48	[0.84-2.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p22.3	7	998875.0		C7orf50			ENSG00000146540			rs58309652-A	rs58309652	0.0	58309652	intron_variant	0	NR	7e-06	5.154901959985743		0.92	[0.52-1.32] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5p14.1	5	26405321.0		RNU4-43P - CCNB3P1	ENSG00000222560	ENSG00000249616		392296.0	334432.0	rs75168324-C	rs75168324	0.0	75168324	intergenic_variant	1	NR	7e-06	5.154901959985743		1.52	[0.86-2.18] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q31.32	7	123468012.0		IQUB			ENSG00000164675			rs117825187-C	rs117825187	0.0	117825187	intron_variant	0	NR	7e-06	5.154901959985743		1.34	[0.76-1.92] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		13q14.3	13	50556231.0		DLEU7, DLEU1			ENSG00000186047, ENSG00000176124			rs7999759-T	rs7999759	0.0	7999759	intron_variant	0	NR	7e-06	5.154901959985743		0.52	[0.29-0.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7q21.11	7	80626053.0		CD36			ENSG00000135218			rs10265780-G	rs10265780	0.0	10265780	intron_variant	0	NR	7e-06	5.154901959985743		0.34	[0.19-0.49] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q21.3	10	63414939.0		JMJD1C			ENSG00000171988			rs11438680-GA	rs11438680	0.0	11438680	intron_variant	0	NR	8e-06	5.096910013008056		0.33	[0.18-0.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92578717.0		EVI5			ENSG00000067208			rs1390016785-T	rs1390016785	1.0	71586756	intron_variant	0	NR	8e-06	5.096910013008056		0.78	[0.44-1.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q26	6	163415404.0		QKI			ENSG00000112531			rs370301190-T	rs370301190	0.0	370301190	intron_variant	0	NR	8e-06	5.096910013008056		0.63	[0.35-0.91] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2q31.1	2	171598423.0		RPL21P38 - DYNC1I2	ENSG00000233934	ENSG00000077380		11164.0	88986.0	rs6745725-C	rs6745725	0.0	6745725	regulatory_region_variant	1	NR	8e-06	5.096910013008056		0.34	[0.19-0.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47314284.0		EFCAB13-DT			ENSG00000263293			rs7209109-G	rs7209109	0.0	7209109	intron_variant	0	NR	8e-06	5.096910013008056		0.39	[0.22-0.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q13.3	12	57454856.0		INHBE			ENSG00000139269			rs3809114-A	rs3809114	0.0	3809114	5_prime_UTR_variant	0	NR	8e-06	5.096910013008056		0.33	[0.18-0.48] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q13.3	12	57081818.0		NEMP1			ENSG00000166881			rs141773786-G	rs141773786	0.0	141773786	intron_variant	0	NR	8e-06	5.096910013008056		0.46	[0.26-0.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q13.3	12	56963538.0		RDH16 - GPR182	ENSG00000139547	ENSG00000166856		4164.0	30954.0	rs201201155-G	rs201201155	0.0	201201155	upstream_gene_variant	1	NR	8e-06	5.096910013008056		0.47	[0.26-0.68] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		15q25.2	15	82779738.0		FSD2			ENSG00000186628			rs12913102-T	rs12913102	0.0	12913102	intron_variant	0	NR	8e-06	5.096910013008056		0.33	[0.19-0.47] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		21q21.1	21	17040295.0		RNU1-98P - NEK4P1	ENSG00000239023	ENSG00000225735		321138.0	170174.0	rs1491358771-CTT	rs1491358771	1.0	71187584	intergenic_variant	1	NR	8e-06	5.096910013008056		0.39	[0.22-0.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		3q26.31	3	175018627.0		NAALADL2			ENSG00000177694			rs13070767-G	rs13070767	0.0	13070767	intron_variant	0	NR	8e-06	5.096910013008056		0.63	[0.35-0.91] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q23.1	5	119342495.0		TNFAIP8			ENSG00000145779			rs193008699-A	rs193008699	0.0	193008699	intron_variant	0	NR	9e-06	5.045757490560675		1.15	[0.64-1.66] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		19q13.42	19	54415222.0		TTYH1, TTYH1			ENSG00000276887, ENSG00000276537			rs138197681-T	rs138197681	0.0	138197681	5_prime_UTR_variant	0	NR	9e-06	5.045757490560675		1.26	[0.71-1.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		4p13	4	41372138.0		LIMCH1			ENSG00000064042			rs74782545-G	rs74782545	0.0	74782545	intron_variant	0	NR	9e-06	5.045757490560675		0.49	[0.27-0.71] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6p21.32	6	32223882.0		NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4			ENSG00000235396, ENSG00000223355, ENSG00000204301, ENSG00000232339, ENSG00000234876, ENSG00000206312, ENSG00000238196			rs752055480-T	rs752055480	0.0	752055480	inframe_insertion	0	NR	9e-06	5.045757490560675		0.33	[0.18-0.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		5q21.1	5	100175919.0		RNU6-1119P - FAM174A-DT	ENSG00000207077	ENSG00000247877		22140.0	252205.0	rs12653469-A	rs12653469	0.0	12653469	intergenic_variant	1	NR	1e-05	5.0		0.39	[0.22-0.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	123154214.0		MPHOSPH9			ENSG00000051825			rs1339541275-G	rs1339541275	0.0	1339541275	intron_variant	0	NR	4e-06	5.3979400086720375		0.36	[0.21-0.51] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p34.3	1	39012505.0		AKIRIN1 - NDUFS5	ENSG00000174574	ENSG00000168653		6446.0	13813.0	rs7548674-A	rs7548674	0.0	7548674	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.55	[0.31-0.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92810843.0		EVI5 - RPL5	ENSG00000067208	ENSG00000122406		18439.0	21170.0	rs7540710-G	rs7540710	0.0	7540710	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.76	[0.44-1.08] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		17q21.31	17	43829711.0		MPP3			ENSG00000161647			rs2240008-T	rs2240008	0.0	2240008	synonymous_variant	0	NR	5e-06	5.301029995663981		0.53	[0.3-0.76] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		2p12	2	77417122.0		LRRTM4			ENSG00000176204			rs290012-C	rs290012	0.0	290012	intron_variant	0	NR	5e-06	5.301029995663981		0.46	[0.26-0.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	26353463.0		SNX10			ENSG00000086300			rs12113583-T	rs12113583	0.0	12113583	intron_variant	0	NR	5e-06	5.301029995663981		0.35	[0.2-0.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q22.1	16	67357078.0		LRRC36			ENSG00000159708			rs17768997-C	rs17768997	0.0	17768997	intron_variant	0	NR	5e-06	5.301029995663981		0.42	[0.24-0.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q12.2	16	53120449.0		CHD9			ENSG00000177200			rs11075750-G	rs11075750	0.0	11075750	intron_variant	0	NR	5e-06	5.301029995663981		0.41	[0.23-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		20p12.1	20	17615510.0		RRBP1			ENSG00000125844			rs1132274-C	rs1132274	0.0	1132274	missense_variant	0	NR	5e-06	5.301029995663981		0.33	[0.19-0.47] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	25951791.0		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		1805.0	200407.0	rs56762262-T	rs56762262	0.0	56762262	non_coding_transcript_exon_variant	1	NR	5e-06	5.301029995663981		0.57	[0.32-0.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	111233272.0		CUX2			ENSG00000111249			rs11065836-A	rs11065836	0.0	11065836	intron_variant	0	NR	5e-06	5.301029995663981		0.34	[0.19-0.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		16q13	16	57186480.0		RSPRY1			ENSG00000159579			rs368188405-T	rs368188405	0.0	368188405	5_prime_UTR_variant	0	NR	6e-06	5.221848749616356		1.36	[0.77-1.95] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		1p35.2	1	30918163.0		SDC3 - RN7SL371P	ENSG00000162512	ENSG00000266210		9405.0	306.0	rs4949326-G	rs4949326	0.0	4949326	downstream_gene_variant	1	NR	6e-06	5.221848749616356		0.36	[0.21-0.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q26	6	160697115.0		LPA - PLG	ENSG00000198670	ENSG00000122194		32840.0	5123.0	rs140799884-C	rs140799884	1.0	71033587	upstream_gene_variant	1	NR	6e-06	5.221848749616356		0.36	[0.2-0.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q14.1	12	61271998.0		Y_RNA - DUX4L52	ENSG00000264495	ENSG00000258336		930057.0	328069.0	rs138095542-G	rs138095542	0.0	138095542	intergenic_variant	1	NR	6e-06	5.221848749616356		1.2	[0.68-1.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	7149936.0		INSR			ENSG00000171105			rs200764220-G	rs200764220	0.0	200764220	intron_variant	0	NR	6e-06	5.221848749616356		0.33	[0.19-0.47] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		8q24.12	8	121277830.0		SNTB1 - RPL35AP19	ENSG00000172164	ENSG00000239872		464557.0	102307.0	rs62528344-A	rs62528344	0.0	62528344	intergenic_variant	1	NR	6e-06	5.221848749616356		0.34	[0.19-0.49] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		17q22	17	58766603.0		PPM1E			ENSG00000175175			rs1398591585-G	rs1398591585	0.0	1398591585	intron_variant	0	NR	6e-06	5.221848749616356		0.35	[0.2-0.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		6q21	6	105610663.0		PREP - LINC02836	ENSG00000085377	ENSG00000237567		156601.0	2004.0	rs6568382-C	rs6568382	0.0	6568382	downstream_gene_variant	1	NR	6e-06	5.221848749616356		0.33	[0.19-0.47] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12p12.2	12	20281493.0		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		145330.0	80239.0	rs192448-A	rs192448	0.0	192448	intergenic_variant	1	NR	6e-06	5.221848749616356		0.51	[0.29-0.73] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		11q13.2	11	66700998.0		SPTBN2			ENSG00000173898			rs506028-G	rs506028	0.0	506028	missense_variant	0	NR	6e-06	5.221848749616356		0.38	[0.22-0.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q23.33	10	92837771.0		EXOC6			ENSG00000138190			rs4933240-C	rs4933240	0.0	4933240	intron_variant	0	NR	7e-06	5.154901959985743		0.34	[0.19-0.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q26.12	10	121152041.0		RPL19P16 - LINC01153	ENSG00000236762	ENSG00000227143		18318.0	26659.0	rs11199799-G	rs11199799	0.0	11199799	intergenic_variant	1	NR	7e-06	5.154901959985743		0.41	[0.23-0.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	109350227.0		MYO1H			ENSG00000174527			rs11066360-G	rs11066360	0.0	11066360	intron_variant	0	NR	7e-06	5.154901959985743		0.5	[0.28-0.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		10q11.22	10	45523383.0		MARCHF8, MARCHF8			ENSG00000165406, ENSG00000278545			rs11239549-G	rs11239549	0.0	11239549	intron_variant	0	NR	7e-06	5.154901959985743		0.58	[0.33-0.83] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	HDL cholesterol levels	58,701 Korean ancestry individuals		7p22.3	7	1117718.0		C7orf50			ENSG00000146540			rs56356304-G	rs56356304	0.0	56356304	intron_variant	0	NR	1e-05	5.0		0.79	[0.44-1.14] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	44886339.0		NECTIN2			ENSG00000130202			rs7254892-A	rs7254892	0.0	7254892	intron_variant	0	NR	1e-306	306.0		14.86	[14.09-15.63] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p32.3	1	55043912.0		PCSK9			ENSG00000169174			rs151193009-T	rs151193009	0.0	151193009	missense_variant	0	NR	2.0000000000000002e-81	80.69897000433602		14.49	[13.01-15.97] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11131631.0		SPC24, LDLR			ENSG00000161888, ENSG00000130164			rs2738464-G	rs2738464	0.0	2738464	3_prime_UTR_variant	0	NR	2.0000000000000002e-60	59.69897000433602		3.36	[2.96-3.76] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21019859.0		APOB			ENSG00000084674			rs13306206-A	rs13306206	0.0	13306206	missense_variant	0	NR	2e-59	58.69897000433602		14.75	[12.97-16.53] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21212868.0		TDRD15 - NUTF2P8	ENSG00000218819	ENSG00000270654		68500.0	149424.0	rs536858685-A	rs536858685	0.0	536858685	intergenic_variant	1	NR	5e-52	51.30102999566398		13.9	[12.11-15.69] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109274968.0		CELSR2			ENSG00000143126			rs12740374-T	rs12740374	0.0	12740374	3_prime_UTR_variant	0	NR	2e-48	47.69897000433602		5.77	[5-6.54] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75370667.0		CERT1			ENSG00000113163			rs7733436-C	rs7733436	0.0	7733436	3_prime_UTR_variant	0	NR	9.000000000000001e-45	44.04575749056068		2.6	[2.24-2.96] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75521119.0		POLK			ENSG00000122008			rs5744552-C	rs5744552	0.0	5744552	intron_variant	0	NR	5e-43	42.30102999566398		2.55	[2.19-2.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133271182.0		ABO, ABO			ENSG00000175164, ENSG00000281879			rs550057-T	rs550057	0.0	550057	intron_variant	0	NR	2e-41	40.69897000433602		2.83	[2.42-3.24] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75270348.0		ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		33437.0	65981.0	rs369330343-T	rs369330343	0.0	369330343	intergenic_variant	1	NR	5e-36	35.30102999566398		2.34	[1.97-2.71] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75638184.0		ANKDD1B			ENSG00000189045			rs34341-T	rs34341	0.0	34341	intron_variant	0	NR	2e-35	34.69897000433602		2.31	[1.95-2.67] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21396237.0		NUTF2P8 - LINC01822	ENSG00000270654	ENSG00000229621		32212.0	291193.0	rs146350463-G	rs146350463	0.0	146350463	intron_variant	1	NR	2.0000000000000002e-24	23.69897000433602		7.91	[6.39-9.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72045758.0		TXNL4B			ENSG00000140830			rs77303550-T	rs77303550	0.0	77303550	intron_variant	0	NR	6e-24	23.22184874961636		2.17	[1.75-2.59] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11233119.0		DOCK6			ENSG00000130158			rs17699089-G	rs17699089	0.0	17699089	intron_variant	0	NR	2e-21	20.69897000433602		1.96	[1.55-2.37] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21595679.0		NUTF2P8 - LINC01822	ENSG00000270654	ENSG00000229621		231654.0	91751.0	rs147821144-G	rs147821144	0.0	147821144	intron_variant	1	NR	9e-21	20.045757490560675		7.26	[5.74-8.78] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20941728.0		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		80067.0	59701.0	rs4356624-A	rs4356624	0.0	4356624	intergenic_variant	1	NR	7e-19	18.154901959985743		2.03	[1.58-2.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133425034.0		ADAMTS13, ADAMTS13			ENSG00000281244, ENSG00000160323			rs151195287-TACAA	rs151195287	0.0	151195287	intron_variant	0	NR	2e-16	15.69897000433602		2.24	[1.71-2.77] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112158075.0		GPAM			ENSG00000119927			rs6585139-T	rs6585139	0.0	6585139	intron_variant	0	NR	3e-16	15.522878745280336		1.64	[1.25-2.03] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41127415.0		PLCG1-AS1			ENSG00000226648			rs74357907-T	rs74357907	0.0	74357907	intron_variant	0	NR	4e-15	14.397940008672036		1.7	[1.28-2.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62589016.0		RSL24D1P2 - EHBP1	ENSG00000230595	ENSG00000115504		27593.0	84835.0	rs11679950-G	rs11679950	0.0	11679950	intron_variant	1	NR	4e-15	14.397940008672036		1.84	[1.38-2.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72183119.0		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		6241.0	53162.0	rs61483465-C	rs61483465	0.0	61483465	regulatory_region_variant	1	NR	2e-14	13.69897000433602		1.58	[1.18-1.98] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41331702.0		ADI1P1 - LPIN3	ENSG00000235102	ENSG00000132793		42.0	9119.0	rs6029632-G	rs6029632	0.0	6029632	downstream_gene_variant	1	NR	2e-14	13.69897000433602		1.68	[1.25-2.11] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11q12.2	11	61827449.0		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs774882452-C	rs774882452	0.0	774882452	intron_variant	0	NR	3e-14	13.522878745280336		1.55	[1.15-1.95] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75140286.0		ANKRD31			ENSG00000145700			rs866492486-A	rs866492486	0.0	866492486	intron_variant	0	NR	7e-14	13.154901959985745		1.41	[1.04-1.78] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p34.1	1	45322907.0		ZSWIM5 - HPDL	ENSG00000162415	ENSG00000186603		16698.0	3988.0	rs1171043882-T	rs1171043882	0.0	1171043882.0	upstream_gene_variant	1	NR	7e-06	5.154901959985743		0.84	[0.48-1.2] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17p13.1	17	7100096.0		CLEC10A - ASGR2	ENSG00000132514	ENSG00000161944		19789.0	1226.0	rs7212330-G	rs7212330	0.0	7212330.0	downstream_gene_variant	1	NR	7e-06	5.154901959985743		1.59	[0.9-2.28] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2q34	2	208539843.0		PTH2R			ENSG00000144407			rs1188978596-GT	rs1188978596	1.0	35935458.0	intron_variant	0	NR	7e-06	5.154901959985743		2.08	[1.17-2.99] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		7q34	7	142699743.0		TRBV26 - TRBVB	ENSG00000249912	ENSG00000282047		3560.0	11641.0	rs4725594-T	rs4725594	0.0	4725594.0	downstream_gene_variant	1	NR	8e-06	5.096910013008056		0.87	[0.49-1.25] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q11.2	17	28219456.0		NLK - PYY2	ENSG00000087095	ENSG00000237575		23075.0	7107.0	rs57544712-T	rs57544712	0.0	57544712.0	non_coding_transcript_exon_variant	1	NR	8e-06	5.096910013008056		0.95	[0.54-1.36] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q41	1	220796686.0		MTARC1			ENSG00000186205			rs2642438-A	rs2642438	0.0	2642438.0	missense_variant	0	NR	8e-06	5.096910013008056		1.14	[0.64-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	53454733.0		LINC02490 - WDR72	ENSG00000259237	ENSG00000166415		324389.0	59008.0	rs12439545-A	rs12439545	0.0	12439545.0	downstream_gene_variant	1	NR	8e-06	5.096910013008056		1.07	[0.6-1.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9p13.3	9	34063164.0		RN7SKP114 - DCAF12	ENSG00000222259	ENSG00000198876		12920.0	23223.0	rs10758238-T	rs10758238	0.0	10758238.0	intergenic_variant	1	NR	8e-06	5.096910013008056		0.92	[0.51-1.33] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3q25.33	3	160329825.0		IFT80			ENSG00000068885			rs1340168841-C	rs1340168841	1.0	144967861.0	intron_variant	0	NR	8e-06	5.096910013008056		1.24	[0.69-1.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3p21.31	3	47987214.0		MAP4			ENSG00000047849			rs80310766-C	rs80310766	0.0	80310766.0	intron_variant	0	NR	9e-06	5.045757490560675		3.49	[1.95-5.03] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p22.1	1	92802397.0		EVI5 - RPL5	ENSG00000067208	ENSG00000122406		9993.0	29616.0	rs3042571-A	rs3042571	0.0	3042571.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.75	[0.98-2.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q42.3	1	234721929.0		LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		87149.0	2113.0	rs484084-T	rs484084	0.0	484084.0	upstream_gene_variant	1	NR	9e-06	5.045757490560675		0.9	[0.5-1.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	116791863.0		APOA5			ENSG00000110243			rs651821-C	rs651821	0.0	651821.0	5_prime_UTR_variant	0	NR	1e-300	300.0		19.23	[18.4-20.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	27508073.0		GCKR			ENSG00000084734			rs1260326-C	rs1260326	0.0	1260326.0	missense_variant	0	NR	1e-118	118.0		9.23	[8.45-10.01] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	27375230.0		SNX17			ENSG00000115234			rs4665972-C	rs4665972	0.0	4665972.0	intron_variant	0	NR	5.999999999999999e-97	96.22184874961636		8.38	[7.6-9.16] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8p21.3	8	19966163.0		LPL			ENSG00000175445			rs1803924-T	rs1803924	0.0	1803924.0	3_prime_UTR_variant	0	NR	8.000000000000001e-81	80.09691001300806		11.33	[10.17-12.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	27609188.0		ZNF512			ENSG00000243943			rs2384656-A	rs2384656	0.0	2384656.0	intron_variant	0	NR	1e-74	74.0		7.22	[6.45-7.99] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	116661831.0		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		3536.0	86339.0	rs118175510-C	rs118175510	0.0	118175510.0	downstream_gene_variant	1	NR	4e-74	73.39794000867204		11.31	[10.09-12.53] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	117120135.0		SIK3 - PAFAH1B2	ENSG00000160584	ENSG00000168092		21698.0	24149.0	rs12366015-G	rs12366015	0.0	12366015.0	upstream_gene_variant	1	NR	2e-64	63.69897000433602		6.72	[5.94-7.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	116967001.0		SIK3			ENSG00000160584			rs148406912-C	rs148406912	0.0	148406912.0	intron_variant	0	NR	1e-61	61.0		8.64	[7.62-9.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19q13.32	19	44913484.0		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0.0	438811.0	non_coding_transcript_exon_variant	1	NR	4e-59	58.39794000867204		8.64	[7.6-9.68] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	117221335.0		PCSK7			ENSG00000160613			rs78628783-T	rs78628783	0.0	78628783.0	non_coding_transcript_exon_variant	0	NR	6e-46	45.22184874961636		8.45	[7.29-9.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		7q11.23	7	73604194.0		MLXIPL			ENSG00000009950			rs34166762-C	rs34166762	0.0	34166762.0	intron_variant	0	NR	1e-35	35.0		8.13	[6.85-9.41] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8q24.13	8	125469835.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		31432.0	389886.0	rs2954021-A	rs2954021	0.0	2954021.0	intron_variant	1	NR	5e-35	34.30102999566398		4.93	[4.15-5.71] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		7q11.23	7	73502358.0		BAZ1B			ENSG00000009954			rs146842229-C	rs146842229	0.0	146842229.0	intron_variant	0	NR	8e-33	32.096910013008056		7.73	[6.46-9] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160030640.0		IGF2R			ENSG00000197081			rs3839348-CAGGCGGT	rs3839348	0.0	3839348.0	intron_variant	0	NR	7e-07	6.154901959985743		0.92	[0.56-1.28] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47659909.0		KPNB1			ENSG00000108424			rs4264433-A	rs4264433	0.0	4264433.0	intron_variant	0	NR	7e-07	6.154901959985743		0.98	[0.59-1.37] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19q13.33	19	49495592.0		RPL13A - RPS11	ENSG00000142541	ENSG00000142534		2535.0	773.0	rs34750569-C	rs34750569	0.0	34750569.0	upstream_gene_variant	1	NR	8e-07	6.096910013008056		1.23	[0.74-1.72] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73349061.0		CFAP70			ENSG00000156042			rs374390627-CAAAA	rs374390627	0.0	374390627.0	intron_variant	0	NR	9e-07	6.045757490560675		0.99	[0.59-1.39] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		7p15.3	7	21574588.0		DNAH11			ENSG00000105877			rs145885140-C	rs145885140	0.0	145885140.0	intron_variant	0	NR	1e-06	6.0		1.06	[0.63-1.49] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p34.1	1	45975806.0		MAST2			ENSG00000086015			rs79749798-T	rs79749798	0.0	79749798.0	intron_variant	0	NR	1e-06	6.0		2.0	[1.19-2.81] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196665337.0		CFH			ENSG00000000971			rs28688002-A	rs28688002	0.0	28688002.0	intron_variant	0	NR	1e-06	6.0		0.92	[0.55-1.29] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10642292.0		SLC44A2			ENSG00000129353			rs10405617-A	rs10405617	0.0	10405617.0	intron_variant	0	NR	1e-06	6.0		0.95	[0.57-1.33] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q21.2	17	42147152.0		RAB5C			ENSG00000108774			rs71377264-A	rs71377264	0.0	71377264.0	intron_variant	0	NR	1e-06	6.0		1.54	[0.91-2.17] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		15q21.3	15	52796800.0		ONECUT1 - RPSAP55	ENSG00000169856	ENSG00000214896		5722.0	88795.0	rs77695287-C	rs77695287	0.0	77695287.0	downstream_gene_variant	1	NR	1e-06	6.0		1.24	[0.74-1.74] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47644429.0		KPNB1-DT			ENSG00000263766			rs11650372-A	rs11650372	0.0	11650372.0	intron_variant	0	NR	1e-06	6.0		0.96	[0.57-1.35] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17p13.1	17	7281162.0		Y_RNA - SLC2A4	ENSG00000264495	ENSG00000181856		14996.0	556.0	rs5415-T	rs5415	0.0	5415.0	upstream_gene_variant	1	NR	1e-06	6.0		0.97	[0.58-1.36] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q16.3	6	101020715.0		GRIK2			ENSG00000164418			rs1321204-G	rs1321204	0.0	1321204.0	intron_variant	0	NR	1e-06	6.0		0.9	[0.54-1.26] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63536798.0		WDPCP			ENSG00000143951			rs10183368-T	rs10183368	0.0	10183368.0	intron_variant	0	NR	2e-06	5.698970004336019		1.0	[0.59-1.41] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47361521.0		EFCAB13			ENSG00000178852			rs769594276-C	rs769594276	1.0	10538163.0	splice_region_variant	0	NR	2e-06	5.698970004336019		1.03	[0.61-1.45] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.3	16	73523747.0		ZFHX3			ENSG00000140836			rs918725-T	rs918725	0.0	918725.0	intron_variant	0	NR	2e-06	5.698970004336019		0.9	[0.53-1.27] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11q24.2	11	126367386.0		ST3GAL4			ENSG00000110080			rs60648773-A	rs60648773	0.0	60648773.0	intron_variant	0	NR	2e-06	5.698970004336019		0.95	[0.56-1.34] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11q12.2	11	61721496.0		DAGLA			ENSG00000134780			rs2903825-T	rs2903825	0.0	2903825.0	intron_variant	0	NR	2e-06	5.698970004336019		0.9	[0.53-1.27] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73491970.0		PPP3CB			ENSG00000107758			rs764205681-AAAATAAAT	rs764205681	1.0	141837688.0	intron_variant	0	NR	2e-06	5.698970004336019		0.98	[0.58-1.38] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p32.3	1	55044227.0		PCSK9			ENSG00000169174			rs2479411-T	rs2479411	0.0	2479411.0	intron_variant	0	NR	3e-06	5.522878745280337		1.82	[1.06-2.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3p21.1	3	52695944.0		GLT8D1			ENSG00000016864			rs2276812-T	rs2276812	0.0	2276812.0	missense_variant	0	NR	3e-06	5.522878745280337		1.63	[0.95-2.31] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q24.2	6	143056085.0		LINC01277			ENSG00000229017			rs74725456-G	rs74725456	0.0	74725456.0	intron_variant	0	NR	3e-06	5.522878745280337		0.93	[0.54-1.32] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q42.2	1	234528619.0		LINC01354			ENSG00000231768			rs12070208-C	rs12070208	0.0	12070208.0	non_coding_transcript_exon_variant	0	NR	3e-06	5.522878745280337		1.0	[0.58-1.42] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12p13.32	12	4390244.0		FGF23 - FGF6	ENSG00000118972	ENSG00000111241		10532.0	37911.0	rs74585266-T	rs74585266	0.0	74585266.0	intron_variant	1	NR	3e-06	5.522878745280337		1.68	[0.98-2.38] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133527785.0		MYMK			ENSG00000187616			rs79300738-G	rs79300738	0.0	79300738.0	intron_variant	0	NR	3e-06	5.522878745280337		0.93	[0.54-1.32] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	44996130.0		CLPTM1 - RELB	ENSG00000104853	ENSG00000104856		2789.0	5319.0	rs56784978-C	rs56784978	0.0	56784978.0	downstream_gene_variant	1	NR	4e-10	9.397940008672036		1.16	[0.8-1.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		8q12.1	8	58493931.0		CYP7A1			ENSG00000167910			rs112784971-T	rs112784971	0.0	112784971.0	intron_variant	0	NR	4e-10	9.397940008672036		1.28	[0.88-1.68] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62929697.0		EHBP1			ENSG00000115504			rs4671454-G	rs4671454	0.0	4671454.0	intron_variant	0	NR	5e-10	9.30102999566398		1.43	[0.98-1.88] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10860596.0		C19orf38			ENSG00000214212			rs537916240-G	rs537916240	0.0	537916240.0	intron_variant	0	NR	8e-10	9.096910013008056		3.47	[2.36-4.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q31.1	9	104899461.0		ABCA1			ENSG00000165029			rs2740488-C	rs2740488	0.0	2740488.0	intron_variant	0	NR	9e-10	9.045757490560677		1.31	[0.89-1.73] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.2	10	73231642.0		DNAJC9, FAM149B1			ENSG00000213551, ENSG00000138286			rs529339225-T	rs529339225	0.0	529339225.0	intron_variant	0	NR	2e-09	8.698970004336019		1.29	[0.87-1.71] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q34.2	9	133168351.0		GBGT1 - OBP2B	ENSG00000148288	ENSG00000280584		4418.0	36926.0	rs13288848-A	rs13288848	0.0	13288848.0	upstream_gene_variant	1	NR	3e-09	8.522878745280337		1.18	[0.79-1.57] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20p12.1	20	17615942.0		RRBP1			ENSG00000125844			rs2229893-A	rs2229893	0.0	2229893.0	missense_variant	0	NR	3e-09	8.522878745280337		2.1	[1.41-2.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10751825.0		DNM2			ENSG00000079805			rs77997860-G	rs77997860	0.0	77997860.0	intron_variant	0	NR	3e-09	8.522878745280337		1.86	[1.24-2.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q11.2	17	28326181.0		TMEM97			ENSG00000109084			rs7226182-C	rs7226182	0.0	7226182.0	intron_variant	0	NR	5e-09	8.301029995663981		1.41	[0.94-1.88] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.1	10	73045874.0		P4HA1			ENSG00000122884			rs537895197-CAAA	rs537895197	0.0	537895197.0	intron_variant	0	NR	5e-09	8.301029995663981		1.22	[0.81-1.63] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21793955.0		LINC01822 - RN7SL117P	ENSG00000229621	ENSG00000264192		83299.0	129038.0	rs151145935-G	rs151145935	0.0	151145935.0	intron_variant	1	NR	6e-09	8.221848749616356		3.46	[2.29-4.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.1	10	72775230.0		MCU			ENSG00000156026			rs77625657-G	rs77625657	0.0	77625657.0	intron_variant	0	NR	8e-09	8.096910013008056		1.36	[0.9-1.82] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111398968.0		LINC02356			ENSG00000257595			rs149212747-AC	rs149212747	0.0	149212747.0	intron_variant	0	NR	1e-08	8.0		1.41	[0.93-1.89] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	21917125.0		LINC01822 - RN7SL117P	ENSG00000229621	ENSG00000264192		206469.0	5868.0	rs147323247-T	rs147323247	0.0	147323247.0	intron_variant	1	NR	1e-08	8.0		3.32	[2.18-4.46] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	110976657.0		LINC01405 - CUX2	ENSG00000185847	ENSG00000111249		17564.0	57508.0	rs12229654-G	rs12229654	0.0	12229654.0	intergenic_variant	1	NR	1e-08	8.0		1.53	[1-2.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71512920.0		ZNF19			ENSG00000157429			rs75617080-A	rs75617080	0.0	75617080.0	intron_variant	0	NR	1e-08	8.0		1.81	[1.18-2.44] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75741555.0		POC5 - SLC25A5P9	ENSG00000152359	ENSG00000251078		24107.0	11015.0	rs113117080-C	rs113117080	0.0	113117080.0	intergenic_variant	1	NR	2e-08	7.698970004336019		1.64	[1.07-2.21] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p32.3	1	55164478.0		USP24			ENSG00000162402			rs6663252-C	rs6663252	0.0	6663252.0	intron_variant	0	NR	2e-08	7.698970004336019		1.53	[1-2.06] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q23.3	6	135081201.0		HBS1L			ENSG00000112339			rs9399136-C	rs9399136	0.0	9399136.0	intron_variant	0	NR	2e-08	7.698970004336019		1.11	[0.72-1.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	10641828.0		SLC44A2			ENSG00000129353			rs12461470-C	rs12461470	0.0	12461470.0	intron_variant	0	NR	2e-08	7.698970004336019		1.11	[0.72-1.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		4p16.3	4	3440284.0		RGS12 - HGFAC	ENSG00000159788	ENSG00000109758		371.0	1684.0	rs762861-C	rs762861	0.0	762861.0	upstream_gene_variant	1	NR	2e-08	7.698970004336019		1.04	[0.67-1.41] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	111191585.0		CUX2			ENSG00000111249			rs11065828-A	rs11065828	0.0	11065828.0	intron_variant	0	NR	3e-08	7.522878745280337		1.33	[0.86-1.8] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	45698914.0		QPCTL			ENSG00000011478			rs2287019-T	rs2287019	0.0	2287019.0	intron_variant	0	NR	4e-08	7.397940008672037		1.32	[0.85-1.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q21.32	17	47471135.0		MRPL45P2			ENSG00000228782			rs57380730-CTTTATTTATTTA	rs57380730	0.0	57380730.0	intron_variant	0	NR	5e-08	7.301029995663981		1.17	[0.75-1.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q24.3	17	69497553.0		MAP2K6			ENSG00000108984			rs2715819-C	rs2715819	0.0	2715819.0	intron_variant	0	NR	3e-06	5.522878745280337		0.87	[0.51-1.23] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5p13.1	5	39353755.0		C9			ENSG00000113600			rs140926258-A	rs140926258	1.0	3836794.0	intron_variant	0	NR	3e-06	5.522878745280337		1.17	[0.68-1.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109622444.0		AMPD2			ENSG00000116337			rs145601158-A	rs145601158	0.0	145601158.0	intron_variant	0	NR	3e-06	5.522878745280337		4.01	[2.32-5.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q21.13	9	76180075.0		PCSK5			ENSG00000099139			rs73458380-G	rs73458380	0.0	73458380.0	intron_variant	0	NR	3e-06	5.522878745280337		1.29	[0.75-1.83] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3p21.1	3	52566689.0		PBRM1, SMIM4			ENSG00000163939, ENSG00000168273			rs75404951-G	rs75404951	0.0	75404951.0	intron_variant	0	NR	4e-06	5.3979400086720375		1.61	[0.93-2.29] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q23.3	16	83941726.0		MLYCD, OSGIN1			ENSG00000103150, ENSG00000140961			rs8048734-T	rs8048734	0.0	8048734.0	intron_variant	0	NR	4e-06	5.3979400086720375		1.21	[0.7-1.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p14	2	63976868.0		VPS54			ENSG00000143952			rs13014029-G	rs13014029	0.0	13014029.0	intron_variant	0	NR	4e-06	5.3979400086720375		1.06	[0.61-1.51] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		8p23.1	8	9320015.0		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		32437.0	51075.0	rs983311-C	rs983311	0.0	983311.0	non_coding_transcript_exon_variant	1	NR	4e-06	5.3979400086720375		3.97	[2.28-5.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		13q12.2	13	27903493.0		PLUT			ENSG00000247381			rs138977414-G	rs138977414	0.0	138977414.0	intron_variant	0	NR	4e-06	5.3979400086720375		3.53	[2.03-5.03] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63218314.0		WDPCP			ENSG00000143951			rs74262063-C	rs74262063	0.0	74262063.0	intron_variant	0	NR	4e-06	5.3979400086720375		0.89	[0.51-1.27] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	22552116.0		LINC01884 - RN7SKP27	ENSG00000233587	ENSG00000222616		3316.0	309436.0	rs143786000-T	rs143786000	0.0	143786000.0	downstream_gene_variant	1	NR	4e-06	5.3979400086720375		3.58	[2.06-5.1] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9p21.3	9	21653649.0		H3P30 - KHSRPP1	ENSG00000227443	ENSG00000229835		14973.0	41527.0	rs4978127-G	rs4978127	0.0	4978127.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		1.0	[0.57-1.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		4q13.2	4	68934160.0		UGT2A3, UGT2A3			ENSG00000135220, ENSG00000278216			rs114809519-A	rs114809519	0.0	114809519.0	intron_variant	0	NR	4e-06	5.3979400086720375		1.07	[0.62-1.52] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		4p16.3	4	3415757.0		RGS12			ENSG00000159788			rs3213506-A	rs3213506	0.0	3213506.0	intron_variant	0	NR	5e-06	5.301029995663981		0.85	[0.49-1.21] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		4q24	4	104162201.0		LINC02503 - CXXC4	ENSG00000249614	ENSG00000168772		124658.0	306107.0	rs542128145-C	rs542128145	0.0	542128145.0	intergenic_variant	1	NR	5e-06	5.301029995663981		1.05	[0.6-1.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		22q12.2	22	30210938.0		HORMAD2 - LIF-AS1	ENSG00000176635	ENSG00000232530		33863.0	28256.0	rs12484740-G	rs12484740	0.0	12484740.0	upstream_gene_variant	1	NR	5e-06	5.301029995663981		1.52	[0.87-2.17] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3p21.31	3	47640381.0		SMARCC1			ENSG00000173473			rs78641322-G	rs78641322	0.0	78641322.0	intron_variant	0	NR	5e-06	5.301029995663981		3.58	[2.04-5.12] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11p11.2	11	43519798.0		TTC17 - CTBP2P6	ENSG00000052841	ENSG00000213697		24865.0	2238.0	rs140716095-T	rs140716095	0.0	140716095.0	upstream_gene_variant	1	NR	5e-06	5.301029995663981		1.87	[1.07-2.67] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		3q22.1	3	132534874.0		DNAJC13			ENSG00000138246			rs9864454-A	rs9864454	0.0	9864454.0	intron_variant	0	NR	6e-06	5.221848749616356		1.04	[0.59-1.49] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		22q12.2	22	30908868.0		OSBP2 - MORC2-AS1	ENSG00000184792	ENSG00000235989		1044.0	13440.0	rs1170378770-TA	rs1170378770	0.0	1170378770.0	downstream_gene_variant	1	NR	6e-06	5.221848749616356		0.88	[0.5-1.26] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q16.3	6	100634864.0		ASCC3			ENSG00000112249			rs796228183-C	rs796228183	0.0	796228183.0	intron_variant	0	NR	6e-06	5.221848749616356		0.84	[0.47-1.21] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p36.11	1	25311722.0		RHD, RSRP1			ENSG00000187010, ENSG00000117616			rs3094243-A	rs3094243	0.0	3094243.0	intron_variant	0	NR	6e-06	5.221848749616356		0.92	[0.52-1.32] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20428846.0		RNA5SP86 - RHOB	ENSG00000212171	ENSG00000143878		27122.0	18228.0	rs190481017-T	rs190481017	0.0	190481017.0	intergenic_variant	1	NR	7e-06	5.154901959985743		3.91	[2.21-5.61] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63716123.0		WDPCP			ENSG00000143951			rs17619717-A	rs17619717	0.0	17619717.0	intron_variant	0	NR	7e-06	5.154901959985743		1.04	[0.59-1.49] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		8q22.1	8	94840560.0		INTS8			ENSG00000164941			rs11395069-G	rs11395069	0.0	11395069.0	intron_variant	0	NR	7e-06	5.154901959985743		0.85	[0.48-1.22] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196629197.0		KCNT2 - CFH	ENSG00000162687	ENSG00000000971		19972.0	22846.0	rs47219-T	rs47219	0.0	47219.0	intergenic_variant	1	NR	7e-08	7.154901959985743		1.02	[0.65-1.39] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	124388041.0		NCOR2			ENSG00000196498			rs2660369-C	rs2660369	0.0	2660369.0	intron_variant	0	NR	7e-08	7.154901959985743		1.07	[0.68-1.46] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11q24.2	11	126363774.0		ST3GAL4			ENSG00000110080			rs7952602-C	rs7952602	0.0	7952602.0	intron_variant	0	NR	8e-08	7.096910013008056		1.13	[0.72-1.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		22q13.31	22	45226470.0		KIAA0930			ENSG00000100364			rs5766564-A	rs5766564	0.0	5766564.0	intron_variant	0	NR	8e-08	7.096910013008056		1.07	[0.68-1.46] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		11p15.4	11	5664389.0		TRIM5			ENSG00000132256			rs55723753-A	rs55723753	0.0	55723753.0	3_prime_UTR_variant	0	NR	8e-08	7.096910013008056		1.1	[0.7-1.5] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.11	12	111080689.0		CUX2			ENSG00000111249			rs78572043-G	rs78572043	0.0	78572043.0	intron_variant	0	NR	9e-08	7.045757490560675		1.43	[0.9-1.96] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	25968613.0		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		18627.0	183585.0	rs2391211-T	rs2391211	0.0	2391211.0	intergenic_variant	1	NR	1e-07	7.0		1.04	[0.66-1.42] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71633448.0		MARVELD3			ENSG00000140832			rs148809817-T	rs148809817	0.0	148809817.0	intron_variant	0	NR	1e-07	7.0		2.19	[1.38-3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		7p15.2	7	26465239.0		SNX10 - KIAA0087	ENSG00000086300	ENSG00000122548		90856.0	67882.0	rs73685215-T	rs73685215	0.0	73685215.0	intron_variant	1	NR	1e-07	7.0		1.02	[0.64-1.4] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q25.3	6	160574924.0		LPA			ENSG00000198670			rs7454595-C	rs7454595	0.0	7454595.0	intron_variant	0	NR	1e-07	7.0		1.53	[0.96-2.1] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p14	2	64152538.0		PELI1 - LINC00309	ENSG00000197329	ENSG00000230923		8118.0	32540.0	rs10170666-A	rs10170666	0.0	10170666.0	intron_variant	1	NR	2e-07	6.698970004336019		1.19	[0.74-1.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20q12	20	40565587.0		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		554264.0	120261.0	rs6129632-T	rs6129632	0.0	6129632.0	regulatory_region_variant	1	NR	2e-07	6.698970004336019		0.98	[0.61-1.35] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q12.2	16	55832466.0		CES1, CES1			ENSG00000198848, ENSG00000262243			rs9921399-T	rs9921399	0.0	9921399.0	intron_variant	0	NR	2e-07	6.698970004336019		0.98	[0.61-1.35] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q13.3	5	75027336.0		GCNT4			ENSG00000176928			rs186589980-T	rs186589980	0.0	186589980.0	3_prime_UTR_variant	0	NR	2e-07	6.698970004336019		1.43	[0.89-1.97] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q11.2	17	28015880.0		LINC01992 - SNORA70	ENSG00000260019	ENSG00000253027		24093.0	6450.0	rs60968542-C	rs60968542	0.0	60968542.0	upstream_gene_variant	1	NR	2e-07	6.698970004336019		1.29	[0.8-1.78] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62458346.0		RN7SL51P - RN7SL18P	ENSG00000239958	ENSG00000241625		195675.0	32832.0	rs11899341-G	rs11899341	0.0	11899341.0	intron_variant	1	NR	2e-07	6.698970004336019		1.3	[0.81-1.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		6q16.3	6	100875100.0		ASCC3			ENSG00000112249			rs9498414-T	rs9498414	0.0	9498414.0	intron_variant	0	NR	2e-07	6.698970004336019		0.97	[0.6-1.34] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	72288150.0		LINC01572			ENSG00000261008			rs75241913-C	rs75241913	0.0	75241913.0	intron_variant	0	NR	2e-07	6.698970004336019		1.04	[0.65-1.43] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		17q25.1	17	76047789.0		SRP68			ENSG00000167881			rs529100948-C	rs529100948	1.0	5822115.0	intron_variant	0	NR	3e-07	6.522878745280337		0.96	[0.59-1.33] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1p13.3	1	109393147.0		SORT1			ENSG00000134243			rs555998901-C	rs555998901	0.0	555998901.0	5_prime_UTR_variant	0	NR	4e-07	6.3979400086720375		4.44	[2.73-6.15] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	63042469.0		EHBP1			ENSG00000115504			rs6739804-T	rs6739804	0.0	6739804.0	intron_variant	0	NR	4e-07	6.3979400086720375		1.05	[0.64-1.46] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	22361426.0		RNA5SP87 - LINC01830	ENSG00000206882	ENSG00000234207		22423.0	16168.0	rs138797374-A	rs138797374	0.0	138797374.0	intron_variant	1	NR	4e-07	6.3979400086720375		4.14	[2.54-5.74] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		18q21.1	18	49594230.0		LIPG			ENSG00000101670			rs9953437-A	rs9953437	0.0	9953437.0	3_prime_UTR_variant	0	NR	5e-07	6.301029995663981		0.94	[0.58-1.3] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19q13.32	19	45870383.0		FOXA3			ENSG00000170608			rs60694100-T	rs60694100	0.0	60694100.0	intron_variant	0	NR	6e-07	6.221848749616356		1.78	[1.08-2.48] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	120785815.0		SPPL3			ENSG00000157837			rs1221386678-TA	rs1221386678	0.0	1221386678.0	intron_variant	0	NR	7e-07	6.154901959985743		0.96	[0.58-1.34] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q22.1	10	72932888.0		OIT3			ENSG00000138315			rs41280378-G	rs41280378	0.0	41280378.0	3_prime_UTR_variant	0	NR	9e-14	13.045757490560677		1.61	[1.19-2.03] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41229905.0		ZHX3			ENSG00000174306			rs2092203-C	rs2092203	0.0	2092203.0	intron_variant	0	NR	1e-13	13.0		1.75	[1.29-2.21] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		9q34.11	9	127998049.0		FAM102A - NAIF1	ENSG00000167106	ENSG00000171169		17060.0	63184.0	rs78940737-GT	rs78940737	0.0	78940737.0	intergenic_variant	1	NR	2e-13	12.69897000433602		1.75	[1.29-2.21] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		8q24.13	8	125478730.0		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		40327.0	380991.0	rs2954029-A	rs2954029	0.0	2954029.0	intron_variant	1	NR	2e-13	12.69897000433602		1.38	[1.01-1.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	22030759.0		RN7SL117P - RNA5SP87	ENSG00000264192	ENSG00000206882		107471.0	308127.0	rs144142940-T	rs144142940	0.0	144142940.0	intron_variant	1	NR	2e-13	12.69897000433602		5.67	[4.15-7.19] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		20q12	20	41025905.0		RNU2-52P - TOP1	ENSG00000222612	ENSG00000198900		1511.0	2917.0	rs6129730-A	rs6129730	0.0	6129730.0	upstream_gene_variant	1	NR	2e-12	11.69897000433602		1.46	[1.05-1.87] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		8q23.3	8	115646356.0		TRPS1			ENSG00000104447			rs2737245-T	rs2737245	0.0	2737245.0	intron_variant	0	NR	2e-12	11.69897000433602		1.46	[1.05-1.87] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		10q25.2	10	112259786.0		GPAM - TECTB	ENSG00000119927	ENSG00000119913		44409.0	23614.0	rs4918732-A	rs4918732	0.0	4918732.0	intergenic_variant	1	NR	6e-12	11.221848749616356		1.33	[0.95-1.71] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.31	12	120978847.0		HNF1A-AS1, HNF1A			ENSG00000241388, ENSG00000135100			rs1169288-C	rs1169288	0.0	1169288.0	missense_variant	0	NR	1e-11	11.0		1.27	[0.91-1.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111681367.0		BRAP			ENSG00000089234			rs11066001-C	rs11066001	0.0	11066001.0	intron_variant	0	NR	2e-11	10.69897000433602		1.73	[1.23-2.23] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		5q33.3	5	156967430.0		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		4204.0	61983.0	rs9715911-G	rs9715911	0.0	9715911.0	upstream_gene_variant	1	NR	2e-11	10.69897000433602		1.47	[1.04-1.9] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71769926.0		AP1G1			ENSG00000166747			rs2270828-T	rs2270828	0.0	2270828.0	intron_variant	0	NR	3e-11	10.522878745280336		2.12	[1.49-2.75] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.12	12	111803962.0		ALDH2			ENSG00000111275			rs671-A	rs671	0.0	671.0	missense_variant	0	NR	4e-11	10.397940008672036		1.7	[1.2-2.2] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112298314.0		HECTD4			ENSG00000173064			rs77768175-G	rs77768175	0.0	77768175.0	intron_variant	0	NR	4e-11	10.397940008672036		1.69	[1.19-2.19] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196733680.0		CFH			ENSG00000000971			rs1329428-T	rs1329428	0.0	1329428.0	intron_variant	0	NR	5e-11	10.30102999566398		1.23	[0.87-1.59] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q23.1	12	100501373.0		NR1H4			ENSG00000012504			rs74769460-CT	rs74769460	0.0	74769460.0	intron_variant	0	NR	7e-11	10.154901959985745		1.32	[0.92-1.72] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112492671.0		PTPN11			ENSG00000179295			rs11066325-C	rs11066325	0.0	11066325.0	intron_variant	0	NR	8e-11	10.096910013008056		1.64	[1.15-2.13] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		1q31.3	1	196853723.0		CFHR1 - CFHR4	ENSG00000244414	ENSG00000134365		21534.0	34291.0	rs1963606-T	rs1963606	0.0	1963606.0	intron_variant	1	NR	9e-11	10.045757490560677		1.22	[0.85-1.59] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		19p13.2	19	11007140.0		SMARCA4			ENSG00000127616			rs117302066-T	rs117302066	0.0	117302066.0	intron_variant	0	NR	1e-10	10.0		3.62	[2.52-4.72] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	111996040.0		TMEM116			ENSG00000198270			rs780019520-C	rs780019520	1.0	60431093.0	intron_variant	0	NR	1e-10	10.0		1.21	[0.84-1.58] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112680092.0		RPH3A			ENSG00000089169			rs77753011-T	rs77753011	0.0	77753011.0	intron_variant	0	NR	1e-10	10.0		1.66	[1.15-2.17] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		12q24.13	12	112189546.0		HECTD4			ENSG00000173064			rs144504271-A	rs144504271	0.0	144504271.0	intron_variant	0	NR	2e-10	9.69897000433602		1.61	[1.12-2.1] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p24.1	2	20648432.0		HS1BP3			ENSG00000118960			rs75352129-T	rs75352129	0.0	75352129.0	intron_variant	0	NR	2e-10	9.69897000433602		3.8	[2.63-4.97] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		16q22.2	16	71895328.0		IST1, ZNF821			ENSG00000182149, ENSG00000102984			rs3812989-T	rs3812989	0.0	3812989.0	non_coding_transcript_exon_variant	0	NR	2e-10	9.69897000433602		2.29	[1.59-2.99] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	LDL cholesterol levels	58,701 Korean ancestry individuals		2p15	2	62730771.0		EHBP1			ENSG00000115504			rs111765463-CAGAT	rs111765463	0.0	111765463.0	intron_variant	0	NR	2e-10	9.69897000433602		1.34	[0.93-1.75] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q21.3	10	63432671.0		JMJD1C			ENSG00000171988			rs10761767-T	rs10761767	0.0	10761767.0	intron_variant	0	NR	1e-09	9.0		2.51	[1.7-3.32] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32555302.0		HLA-DRB6			ENSG00000229391			rs116783436-T	rs116783436	0.0	116783436.0	intron_variant	0	NR	1e-09	9.0		5.93	[4.02-7.84] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q21.3	10	63200957.0		JMJD1C			ENSG00000171988			rs7099425-C	rs7099425	0.0	7099425.0	intron_variant	0	NR	1e-09	9.0		2.48	[1.68-3.28] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8q12.1	8	58468205.0		UBXN2B - CYP7A1	ENSG00000215114	ENSG00000167910		16704.0	21973.0	rs975395769-A	rs975395769	0.0	975395769.0	intergenic_variant	1	NR	2e-09	8.698970004336019		2.66	[1.79-3.53] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q21.3	10	63306059.0		JMJD1C			ENSG00000171988			rs7897326-T	rs7897326	0.0	7897326.0	intron_variant	0	NR	3e-09	8.522878745280337		2.41	[1.62-3.2] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19392764.0		GATAD2A			ENSG00000167491			rs10408875-C	rs10408875	0.0	10408875.0	intron_variant	0	NR	8e-09	8.096910013008056		3.57	[2.36-4.78] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		20q13.12	20	46057452.0		SLC12A5			ENSG00000124140			rs116878061-T	rs116878061	0.0	116878061.0	intron_variant	0	NR	9e-09	8.045757490560675		5.27	[3.47-7.07] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q23.33	10	93079885.0		CYP26A1 - NIP7P1	ENSG00000095596	ENSG00000232805		2000.0	26987.0	rs2068888-G	rs2068888	0.0	2068888.0	downstream_gene_variant	1	NR	9e-09	8.045757490560675		2.55	[1.68-3.42] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1p31.3	1	62852751.0		ATG4C			ENSG00000125703			rs1308613826-AT	rs1308613826	1.0	11330137.0	intron_variant	0	NR	1e-08	8.0		2.32	[1.53-3.11] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p24.1	2	21147375.0		TDRD15 - NUTF2P8	ENSG00000218819	ENSG00000270654		3007.0	214917.0	rs79783818-A	rs79783818	0.0	79783818.0	downstream_gene_variant	1	NR	1e-08	8.0		3.17	[2.08-4.26] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		4q22.1	4	87252540.0		KLHL8 - MIR5705	ENSG00000145332	ENSG00000263981		12226.0	47955.0	rs7656630-C	rs7656630	0.0	7656630.0	intergenic_variant	1	NR	2e-08	7.698970004336019		2.24	[1.45-3.03] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		22q13.31	22	46219983.0		PPARA			ENSG00000186951			rs1800234-C	rs1800234	0.0	1800234.0	missense_variant	0	NR	2e-08	7.698970004336019		5.09	[3.3-6.88] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.2	19	11236817.0		DOCK6			ENSG00000130158			rs737337-C	rs737337	0.0	737337.0	synonymous_variant	0	NR	3e-08	7.522878745280337		2.44	[1.58-3.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32657665.0		HLA-DQA1 - HLA-DQB1	ENSG00000196735	ENSG00000231286		10603.0	1802.0	rs34046799-A	rs34046799	0.0	34046799.0	upstream_gene_variant	1	NR	3e-08	7.522878745280337		5.01	[3.23-6.79] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31640165.0		BAG6, BAG6, BAG6, BAG6, BAG6, BAG6			ENSG00000229524, ENSG00000233348, ENSG00000204463, ENSG00000227761, ENSG00000096155, ENSG00000228760			rs9267525-C	rs9267525	0.0	9267525.0	non_coding_transcript_exon_variant	0	NR	2e-07	6.698970004336019		6.083	[3.78-8.39] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p24.1	2	20937176.0		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		75515.0	64253.0	rs76203970-A	rs76203970	0.0	76203970.0	intergenic_variant	1	NR	7e-08	7.154901959985743		3.213	[2.05-4.38] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31349656.0		LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		48014.0	4216.0	rs2523621-T	rs2523621	0.0	2523621.0	intron_variant	1	NR	8e-08	7.096910013008056		2.173	[1.38-2.97] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q21.3	10	63640471.0		MRPL35P2 - RPL7AP50	ENSG00000232075	ENSG00000213609		5644.0	261980.0	rs1255491-C	rs1255491	0.0	1255491.0	intron_variant	1	NR	1e-07	7.0		2.515	[1.59-3.44] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q26.12	10	121150416.0		RPL19P16 - LINC01153	ENSG00000236762	ENSG00000227143		16693.0	28284.0	rs1907256-A	rs1907256	0.0	1907256.0	intergenic_variant	1	NR	1e-07	7.0		2.167	[1.37-2.97] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1p31.3	1	62401183.0		KANK4 - USP1	ENSG00000132854	ENSG00000162607		81749.0	35114.0	rs4439380-A	rs4439380	0.0	4439380.0	regulatory_region_variant	1	NR	1e-07	7.0		2.118	[1.33-2.91] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8p21.3	8	19719785.0		CSGALNACT1			ENSG00000147408			rs534122841-T	rs534122841	0.0	534122841.0	intron_variant	0	NR	1e-07	7.0		7.284	[4.57-10] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8p22	8	18419130.0		NAT2 - PSD3	ENSG00000156006	ENSG00000156011		17912.0	108173.0	rs13255048-G	rs13255048	0.0	13255048.0	intergenic_variant	1	NR	2e-07	6.698970004336019		2.079	[1.3-2.86] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19q13.33	19	49513502.0		FCGRT			ENSG00000104870			rs142385484-T	rs142385484	0.0	142385484.0	non_coding_transcript_exon_variant	0	NR	2e-07	6.698970004336019		2.913	[1.82-4.01] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32432929.0		TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25166.0	6949.0	rs11759143-G	rs11759143	0.0	11759143.0	intergenic_variant	1	NR	2e-07	6.698970004336019		6.531	[4.08-8.98] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q25.2	15	82763676.0		FSD2			ENSG00000186628			rs10669061-CTT	rs10669061	0.0	10669061.0	intron_variant	0	NR	2e-07	6.698970004336019		2.054	[1.28-2.83] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.2	2	27783817.0		MRPL33, RBKS			ENSG00000243147, ENSG00000171174			rs75634311-C	rs75634311	0.0	75634311.0	intron_variant	0	NR	4.0000000000000003e-28	27.39794000867204		5.13	[4.22-6.04] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1p31.3	1	62687529.0		DOCK7			ENSG00000116641			rs771992392-T	rs771992392	1.0	56280080.0	intron_variant	0	NR	6e-24	23.22184874961636		5.25	[4.23-6.27] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1p31.3	1	62502763.0		DOCK7			ENSG00000116641			rs5774606-ATTTTTTT	rs5774606	0.0	5774606.0	intron_variant	0	NR	1.0000000000000001e-23	23.0		5.27	[4.24-6.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	27163931.0		TCF23 - SLC5A6	ENSG00000163792	ENSG00000138074		6957.0	35656.0	rs1275539-T	rs1275539	0.0	1275539.0	upstream_gene_variant	1	NR	7.000000000000001e-23	22.154901959985743		4.48	[3.59-5.37] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.2	2	28031902.0		BABAM2			ENSG00000158019			rs4666032-C	rs4666032	0.0	4666032.0	intron_variant	0	NR	6e-22	21.22184874961636		4.53	[3.61-5.45] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		7q11.23	7	73397257.0		FKBP6 - Y_RNA	ENSG00000077800	ENSG00000264495		38620.0	6531.0	rs42131-T	rs42131	0.0	42131.0	intergenic_variant	1	NR	2e-18	17.69897000433602		5.36	[4.16-6.56] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19268740.0		TM6SF2			ENSG00000213996			rs58542926-T	rs58542926	0.0	58542926.0	missense_variant	0	NR	4e-18	17.397940008672037		6.56	[5.08-8.04] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	117421613.0		CEP164 - DSCAML1	ENSG00000110274	ENSG00000177103		8347.0	6159.0	rs77182024-A	rs77182024	0.0	77182024.0	intergenic_variant	1	NR	7e-17	16.154901959985743		13.0	[9.95-16.05] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q21.3	15	58431476.0		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0.0	1800588.0	intron_variant	0	NR	3e-16	15.522878745280336		3.27	[2.48-4.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	26996115.0		MAPRE3, MAPRE3-AS1			ENSG00000084764, ENSG00000205500			rs140381363-A	rs140381363	0.0	140381363.0	intron_variant	0	NR	6e-16	15.221848749616356		3.92	[2.97-4.87] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	27265564.0		SLC30A3			ENSG00000115194			rs6547521-C	rs6547521	0.0	6547521.0	intron_variant	0	NR	4e-15	14.397940008672036		4.64	[3.48-5.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		4p16.3	4	3445429.0		HGFAC			ENSG00000109758			rs4690098-T	rs4690098	0.0	4690098.0	non_coding_transcript_exon_variant	0	NR	4e-14	13.397940008672036		3.01	[2.23-3.79] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.2	2	27896053.0		MRPL33, BABAM2			ENSG00000243147, ENSG00000158019			rs141361525-G	rs141361525	0.0	141361525.0	intron_variant	0	NR	4e-14	13.397940008672036		6.33	[4.69-7.97] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q12.2	11	61856709.0		FADS2			ENSG00000134824			rs97384-T	rs97384	0.0	97384.0	non_coding_transcript_exon_variant	0	NR	5e-14	13.30102999566398		3.14	[2.32-3.96] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p24.1	2	21029662.0		APOB			ENSG00000084674			rs13306194-A	rs13306194	0.0	13306194.0	missense_variant	0	NR	1e-13	13.0		4.52	[3.33-5.71] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		20q13.12	20	45928576.0		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		16421.0	6107.0	rs538276778-AAGAG	rs538276778	0.0	538276778.0	non_coding_transcript_exon_variant	1	NR	3e-13	12.522878745280336		5.42	[3.97-6.87] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8p21.3	8	19857453.0		INTS10 - LPL	ENSG00000104613	ENSG00000175445		5370.0	44264.0	rs79035076-A	rs79035076	0.0	79035076.0	intergenic_variant	1	NR	4e-13	12.397940008672036		9.93	[7.25-12.61] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19611167.0		PBX4			ENSG00000105717			rs12610191-T	rs12610191	0.0	12610191.0	intron_variant	0	NR	3e-12	11.522878745280336		4.68	[3.36-6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31778771.0		VARS1, VARS1, VARS1, VARS1, VARS1, VARS1, VARS1			ENSG00000226589, ENSG00000227686, ENSG00000231945, ENSG00000231116, ENSG00000096171, ENSG00000204394, ENSG00000224264			rs909267-C	rs909267	0.0	909267.0	intron_variant	0	NR	2e-11	10.69897000433602		6.5	[4.6-8.4] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19502813.0		GATAD2A			ENSG00000167491			rs57009615-G	rs57009615	0.0	57009615.0	intron_variant	0	NR	4e-11	10.397940008672036		3.81	[2.68-4.94] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	116561349.0		LINC02151 - LINC02702	ENSG00000236437	ENSG00000237937		60719.0	78073.0	rs11216006-T	rs11216006	0.0	11216006.0	intergenic_variant	1	NR	1e-10	10.0		2.77	[1.93-3.61] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		4q21.3	4	87067356.0		AFF1			ENSG00000172493			rs236681-G	rs236681	0.0	236681.0	intron_variant	0	NR	2e-10	9.69897000433602		2.62	[1.81-3.43] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	26895811.0		DPYSL5			ENSG00000157851			rs12617848-T	rs12617848	0.0	12617848.0	intron_variant	0	NR	4e-10	9.397940008672036		3.09	[2.12-4.06] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.2	2	28206261.0		BABAM2			ENSG00000158019			rs34922334-A	rs34922334	0.0	34922334.0	intron_variant	0	NR	7e-10	9.154901959985745		2.69	[1.84-3.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		5q33.3	5	156977360.0		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		14134.0	52053.0	rs10055656-C	rs10055656	0.0	10055656.0	intergenic_variant	1	NR	1e-09	9.0		2.96	[2.01-3.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		22q11.23	22	23757077.0		VPREB3 - C22orf15	ENSG00000128218	ENSG00000273579		2652.0	5913.0	rs56152551-T	rs56152551	0.0	56152551.0	upstream_gene_variant	1	NR	7e-06	5.154901959985743		1.843	[1.04-2.65] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3q29	3	194514975.0		LINC00884			ENSG00000233058			rs28660329-G	rs28660329	0.0	28660329.0	intron_variant	0	NR	7e-06	5.154901959985743		1.892	[1.07-2.72] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1p35.3	1	29446014.0		LINC01756 - LINC01648	ENSG00000230523	ENSG00000233399		95900.0	567938.0	rs114116510-A	rs114116510	0.0	114116510.0	intergenic_variant	1	NR	7e-06	5.154901959985743		5.315	[3-7.63] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2q22.3	2	147055633.0		LINC01911 - RNU6-692P	ENSG00000231040	ENSG00000207225		177413.0	352709.0	rs1221254524-G	rs1221254524	1.0	66842815.0	intergenic_variant	1	NR	7e-06	5.154901959985743		1.771	[1-2.54] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		18p11.31	18	5967910.0		L3MBTL4			ENSG00000154655			rs1539806-C	rs1539806	0.0	1539806.0	intron_variant	0	NR	7e-06	5.154901959985743		2.482	[1.4-3.57] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q26.1	15	89480327.0		RHCG			ENSG00000140519			rs17807723-A	rs17807723	0.0	17807723.0	missense_variant	0	NR	7e-06	5.154901959985743		4.713	[2.66-6.77] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1q32.2	1	209675087.0		HSD11B1-AS1			ENSG00000227591			rs932374-G	rs932374	0.0	932374.0	intron_variant	0	NR	7e-06	5.154901959985743		1.788	[1.01-2.57] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6q21	6	108862359.0		ARMC2			ENSG00000118690			rs2806361-C	rs2806361	0.0	2806361.0	intron_variant	0	NR	8e-06	5.096910013008056		2.023	[1.14-2.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p22.1	6	29285152.0		OR2U2P - OR14J1	ENSG00000249415	ENSG00000234100		15731.0	16549.0	rs72844806-T	rs72844806	0.0	72844806.0	intron_variant	1	NR	8e-06	5.096910013008056		6.443	[3.62-9.27] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		14q23.3	14	65211957.0		LINC02324			ENSG00000255002			rs1258809909-C	rs1258809909	1.0	11294879.0	intron_variant	0	NR	8e-06	5.096910013008056		2.1	[1.18-3.02] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		13q13.3	13	37380328.0		RPS12P24 - LINC01048	ENSG00000230283	ENSG00000230390		159082.0	101139.0	rs78623643-G	rs78623643	0.0	78623643.0	intergenic_variant	1	NR	8e-06	5.096910013008056		7.705	[4.32-11.09] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		7q22.1	7	99742636.0		CYP3A7 - CYP3A4	ENSG00000160870	ENSG00000160868		7440.0	14324.0	rs939955-G	rs939955	0.0	939955.0	intergenic_variant	1	NR	8e-06	5.096910013008056		2.145	[1.2-3.09] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		4p16.3	4	3286022.0		MSANTD1 - RGS12	ENSG00000188981	ENSG00000159788		14284.0	6999.0	rs4690084-T	rs4690084	0.0	4690084.0	intergenic_variant	1	NR	9e-06	5.045757490560675		2.765	[1.55-3.98] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3q29	3	192753747.0		FGF12			ENSG00000114279			rs1553561-T	rs1553561	0.0	1553561.0	intron_variant	0	NR	9e-06	5.045757490560675		1.959	[1.1-2.82] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19484205.0		GATAD2A			ENSG00000167491			rs10404728-T	rs10404728	0.0	10404728.0	intron_variant	0	NR	9e-06	5.045757490560675		2.058	[1.15-2.97] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p12	19	20264300.0		BNIP3P17 - BNIP3P18	ENSG00000271524	ENSG00000269055		41837.0	3517.0	rs142072955-G	rs142072955	0.0	142072955.0	intron_variant	1	NR	9e-06	5.045757490560675		6.5	[3.63-9.37] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		4q22.1	4	87352895.0		HSD17B11			ENSG00000198189			rs113239639-T	rs113239639	0.0	113239639.0	intron_variant	0	NR	1e-05	5.0		1.978	[1.1-2.85] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31112655.0		C6orf15 - PSORS1C1	ENSG00000229432	ENSG00000235487		80.0	2095.0	rs2233969-G	rs2233969	0.0	2233969.0	upstream_gene_variant	1	NR	2e-07	6.698970004336019		2.438	[1.52-3.36] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		16q23.2	16	81501185.0		CMIP			ENSG00000153815			rs2925979-T	rs2925979	0.0	2925979.0	intron_variant	0	NR	3e-07	6.522878745280337		2.106	[1.3-2.91] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		12q24.33	12	132730359.0		ANKLE2			ENSG00000176915			rs546416652-CCCCAGCAACAGCAA	rs546416652	0.0	546416652.0	5_prime_UTR_variant	0	NR	3e-07	6.522878745280337		2.072	[1.28-2.86] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31924864.0		C2, C2, C2, C2, C2, C2			ENSG00000166278, ENSG00000235696, ENSG00000231543, ENSG00000235017, ENSG00000226560, ENSG00000206372			rs9267677-C	rs9267677	0.0	9267677.0	intron_variant	0	NR	3e-07	6.522878745280337		5.958	[3.67-8.24] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32140585.0		FKBPL - PRRT1	ENSG00000230907	ENSG00000227122		10297.0	7774.0	rs421602-G	rs421602	0.0	421602.0	intergenic_variant	1	NR	3e-07	6.522878745280337		5.732	[3.53-7.93] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q13.1	11	65508761.0		MALAT1 - SNRPGP19	ENSG00000251562	ENSG00000270526		2245.0	5642.0	rs1491190920-C	rs1491190920	1.0	529361751.0	downstream_gene_variant	1	NR	4e-07	6.3979400086720375		2.344	[1.44-3.25] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.1	6	43791136.0		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		4649.0	53742.0	rs6905288-G	rs6905288	0.0	6905288.0	downstream_gene_variant	1	NR	4e-07	6.3979400086720375		2.375	[1.45-3.3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q21.3	15	58537016.0		LIPC			ENSG00000166035			rs8035006-T	rs8035006	0.0	8035006.0	intron_variant	0	NR	6e-07	6.221848749616356		2.083	[1.26-2.9] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	30998024.0		MUC21 - MUC22	ENSG00000223590	ENSG00000261272		8121.0	12450.0	rs551634406-AAAAAAAAAAAAAAATAT	rs551634406	0.0	551634406.0	intergenic_variant	1	NR	6e-07	6.221848749616356		2.006	[1.22-2.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		18q22.3	18	72496803.0		LINC01899 - CBLN2	ENSG00000265352	ENSG00000141668		708675.0	39877.0	rs74551020-C	rs74551020	0.0	74551020.0	intergenic_variant	1	NR	7e-07	6.154901959985743		2.947	[1.78-4.11] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		21q21.1	21	20503588.0		RPS3AP1 - LINC00320	ENSG00000233206	ENSG00000224924		72826.0	147862.0	rs28818801-A	rs28818801	0.0	28818801.0	intergenic_variant	1	NR	8e-07	6.096910013008056		2.203	[1.33-3.08] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.33	6	31084417.0		RNU6-1133P - C6orf15	ENSG00000222895	ENSG00000229432		1308.0	26806.0	rs369432848-GTTGTT	rs369432848	0.0	369432848.0	downstream_gene_variant	1	NR	8e-07	6.096910013008056		2.956	[1.78-4.13] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q25.1	10	105873378.0		LINC02627 - LINC02624	ENSG00000229466	ENSG00000229775		53029.0	266765.0	rs2644508-T	rs2644508	0.0	2644508.0	intron_variant	1	NR	9e-07	6.045757490560675		2.037	[1.23-2.85] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19q13.11	19	33389443.0		PEPD			ENSG00000124299			rs12610925-G	rs12610925	0.0	12610925.0	intron_variant	0	NR	1e-06	6.0		2.314	[1.38-3.24] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2q14.1	2	113240268.0		PAX8, PAX8-AS1			ENSG00000125618, ENSG00000189223			rs3738911-A	rs3738911	0.0	3738911.0	non_coding_transcript_exon_variant	0	NR	1e-06	6.0		3.417	[2.03-4.8] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q21.3	10	66308543.0		CTNNA3			ENSG00000183230			rs200281690-A	rs200281690	0.0	200281690.0	intron_variant	0	NR	1e-06	6.0		7.245	[4.3-10.19] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q21.3	15	56470708.0		MNS1 - ZNF280D	ENSG00000138587	ENSG00000137871		5571.0	159468.0	rs1711483-G	rs1711483	0.0	1711483.0	intergenic_variant	1	NR	2e-06	5.698970004336019		3.473	[2.05-4.9] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p22.2	6	25734242.0		H2AC2P - SLC17A4	ENSG00000216436	ENSG00000146039		1415.0	20457.0	rs4236039-C	rs4236039	0.0	4236039.0	upstream_gene_variant	1	NR	2e-06	5.698970004336019		3.263	[1.92-4.6] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		8q12.1	8	58569240.0		SDCBP			ENSG00000137575			rs141697009-TTGCCATGTTGGCCATGACAAACATGACAACA	rs141697009	1.0	60423272.0	intron_variant	0	NR	2e-06	5.698970004336019		2.061	[1.21-2.91] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q12.2	11	61753974.0		MYRF-AS1, MYRF			ENSG00000124915, ENSG00000124920			rs520987-C	rs520987	0.0	520987.0	intron_variant	0	NR	2e-06	5.698970004336019		2.034	[1.2-2.87] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		16q13	16	56971567.0		CETP			ENSG00000087237			rs1532624-A	rs1532624	0.0	1532624.0	intron_variant	0	NR	2e-06	5.698970004336019		2.126	[1.25-3] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		22q13.31	22	43928847.0		PNPLA3			ENSG00000100344			rs738409-G	rs738409	0.0	738409.0	missense_variant	0	NR	2e-06	5.698970004336019		1.912	[1.13-2.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		5q13.1	5	68400517.0		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		98696.0	454393.0	rs10038774-C	rs10038774	0.0	10038774.0	intergenic_variant	1	NR	2e-06	5.698970004336019		1.938	[1.14-2.74] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		9q34.11	9	128002338.0		FAM102A - NAIF1	ENSG00000167106	ENSG00000171169		21349.0	58895.0	rs71495666-C	rs71495666	1.0	11323171.0	intergenic_variant	1	NR	2e-06	5.698970004336019		1.88	[1.1-2.66] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		20p12.1	20	17872606.0		BANF2 - RNU6-192P	ENSG00000125888	ENSG00000212555		136735.0	31156.0	rs2745796-T	rs2745796	0.0	2745796.0	upstream_gene_variant	1	NR	2e-06	5.698970004336019		2.949	[1.73-4.17] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		16q24.1	16	85269101.0		GSE1			ENSG00000131149			rs8058443-C	rs8058443	0.0	8058443.0	intron_variant	0	NR	3e-06	5.522878745280337		1.948	[1.13-2.76] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3p24.2	3	24357798.0		THRB			ENSG00000151090			rs138201810-A	rs138201810	0.0	138201810.0	intron_variant	0	NR	3e-06	5.522878745280337		5.395	[3.12-7.67] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32278100.0		TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1, TSBP1-AS1			ENSG00000230602, ENSG00000228738, ENSG00000229903, ENSG00000225834, ENSG00000226228, ENSG00000224507, ENSG00000225914			rs201859396-T	rs201859396	0.0	201859396.0	intron_variant	0	NR	3e-06	5.522878745280337		5.958	[3.45-8.47] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q26.3	15	101524805.0		PCSK6			ENSG00000140479			rs2084152-T	rs2084152	0.0	2084152.0	intron_variant	0	NR	4e-06	5.3979400086720375		1.839	[1.06-2.62] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6p21.32	6	32772190.0		HLA-DQB2 - HLA-DOB	ENSG00000226165	ENSG00000243496		8658.0	40573.0	rs1383264-A	rs1383264	0.0	1383264.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		2.274	[1.3-3.25] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		6q14.1	6	77113990.0		LINC02540 - HTR1B	ENSG00000236635	ENSG00000135312		520169.0	346934.0	rs56841019-T	rs56841019	0.0	56841019.0	intergenic_variant	1	NR	5e-06	5.301029995663981		2.303	[1.32-3.29] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10q25.2	10	112180571.0		GPAM			ENSG00000119927			rs2792751-T	rs2792751	0.0	2792751.0	missense_variant	0	NR	5e-06	5.301029995663981		1.959	[1.12-2.8] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		17p13.3	17	556826.0		VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs60712804-A	rs60712804	0.0	60712804.0	intron_variant	0	NR	5e-06	5.301029995663981		1.894	[1.08-2.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		16q22.1	16	69746476.0		NOB1			ENSG00000141101			rs118002214-C	rs118002214	0.0	118002214.0	intron_variant	0	NR	5e-06	5.301029995663981		3.533	[2.02-5.05] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		9q31.1	9	104902020.0		ABCA1			ENSG00000165029			rs1883025-T	rs1883025	0.0	1883025.0	intron_variant	0	NR	5e-06	5.301029995663981		2.082	[1.19-2.98] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		1q23.1	1	157424203.0		LINC02772 - FCRL5	ENSG00000271736	ENSG00000143297		140235.0	89174.0	rs4971152-A	rs4971152	0.0	4971152.0	intergenic_variant	1	NR	5e-06	5.301029995663981		1.922	[1.1-2.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		19p13.11	19	19814339.0		ZNF56P, ZNF506			ENSG00000267419, ENSG00000081665			rs2335363-T	rs2335363	0.0	2335363.0	intron_variant	0	NR	5e-06	5.301029995663981		1.843	[1.05-2.64] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11p15.5	11	2796706.0		KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs234882-G	rs234882	0.0	234882.0	intron_variant	0	NR	6e-06	5.221848749616356		1.817	[1.03-2.6] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3p24.2	3	24037103.0		NR1D2 - LINC00691	ENSG00000174738	ENSG00000224074		56486.0	59166.0	rs6550838-C	rs6550838	0.0	6550838.0	intergenic_variant	1	NR	6e-06	5.221848749616356		1.791	[1.02-2.57] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2q37.3	2	240230647.0		OTOS - U3	ENSG00000178602	ENSG00000222666		86085.0	58569.0	rs113913124-T	rs113913124	0.0	113913124.0	intron_variant	1	NR	6e-06	5.221848749616356		5.937	[3.37-8.5] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		15q12	15	25889048.0		ATP10A-DT - LINC02346	ENSG00000259011	ENSG00000206187		11837.0	13071.0	rs73358320-C	rs73358320	0.0	73358320.0	intergenic_variant	1	NR	6e-06	5.221848749616356		4.576	[2.59-6.56] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		2p23.3	2	24713548.0		NCOA1			ENSG00000084676			rs56293917-G	rs56293917	0.0	56293917.0	intron_variant	0	NR	6e-06	5.221848749616356		1.942	[1.1-2.78] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		22q12.3	22	35102885.0		ISX - LINC01399	ENSG00000175329	ENSG00000233080		15498.0	16939.0	rs9622141-G	rs9622141	0.0	9622141.0	TF_binding_site_variant	1	NR	6e-06	5.221848749616356		3.65	[2.07-5.23] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		10p13	10	15598766.0		ITGA8			ENSG00000077943			rs143296562-G	rs143296562	0.0	143296562.0	intron_variant	0	NR	7e-06	5.154901959985743		6.294	[3.56-9.03] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		17p13.2	17	4031318.0		ZZEF1			ENSG00000074755			rs372245182-AAAATAAATAAATAAATAAATAAAT	rs372245182	0.0	372245182.0	intron_variant	0	NR	7e-06	5.154901959985743		2.913	[1.65-4.18] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3q26.2	3	169919207.0		SAMD7			ENSG00000187033			rs16854614-G	rs16854614	0.0	16854614.0	intron_variant	0	NR	7e-06	5.154901959985743		4.7	[2.65-6.75] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		3q26.31	3	172458830.0		GHSR - TNFSF10	ENSG00000121853	ENSG00000121858		10374.0	46678.0	rs55742802-G	rs55742802	0.0	55742802.0	intergenic_variant	1	NR	7e-06	5.154901959985743		6.745	[3.81-9.68] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		17q25.1	17	74919322.0		USH1G			ENSG00000182040			rs77815441-A	rs77815441	0.0	77815441.0	intron_variant	0	NR	7e-06	5.154901959985743		5.359	[3.02-7.7] unit decrease	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		7q21.3	7	94567995.0		SGCE			ENSG00000127990			rs72615134-G	rs72615134	0.0	72615134.0	intron_variant	0	NR	7e-06	5.154901959985743		3.301	[1.86-4.74] unit increase	Affymetrix [7975321] (imputed)	N
2023-01-09	35884923	Lee SB	2022-07-06	Biomedicines	www.ncbi.nlm.nih.gov/pubmed/35884923	Dyslipidaemia-Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease.	Triglyceride levels	58,701 Korean ancestry individuals		11q23.3	11	116450493.0		LINC02703 - LINC02151	ENSG00000257067	ENSG00000236437		507312.0	46406.0	rs2851406-T	rs2851406	0.0	2851406.0	intergenic_variant	1	NR	7e-06	5.154901959985743		4.884	[2.76-7.01] unit increase	Affymetrix [7975321] (imputed)	N
2023-05-04	35097025	de Haan A	2022-01-14	Front Cardiovasc Med	www.ncbi.nlm.nih.gov/pubmed/35097025	Genetic Determinants of Serum Calcification Propensity and Cardiovascular Outcomes in the General Population.	Serum calciprotein particle maturation time (T50)	2,739 European ancestry individuals		3q27.3	3	186619924.0		AHSG			ENSG00000145192			rs4917-T	rs4917	0.0	4917.0	missense_variant	0	0.381	2e-101	100.69897000433602		32.85	unit decrease	Illumina [NR] (imputed)	N
2023-05-04	35097025	de Haan A	2022-01-14	Front Cardiovasc Med	www.ncbi.nlm.nih.gov/pubmed/35097025	Genetic Determinants of Serum Calcification Propensity and Cardiovascular Outcomes in the General Population.	Serum calciprotein particle maturation time (T50)	2,739 European ancestry individuals		3q27.3	3	186612673.0		DNAJB11 - AHSG	ENSG00000090520	ENSG00000145192		26873.0	387.0	rs2077119-G	rs2077119	0.0	2077119.0	intron_variant	1	0.424	7.999999999999999e-91	90.09691001300806		31.3117	unit increase	Illumina [NR] (imputed)	N
2023-05-04	35097025	de Haan A	2022-01-14	Front Cardiovasc Med	www.ncbi.nlm.nih.gov/pubmed/35097025	Genetic Determinants of Serum Calcification Propensity and Cardiovascular Outcomes in the General Population.	Serum calciprotein particle maturation time (T50)	2,739 European ancestry individuals		3q27.3	3	186626825.0		AHSG - Metazoa_SRP	ENSG00000145192	ENSG00000276525		5507.0	3111.0	rs9870756-T	rs9870756	0.0	9870756.0	intron_variant	1	0.15	3e-08	7.522878745280337		34.7919	unit decrease	Illumina [NR] (imputed)	N
